0001493152-23-007486.txt : 20230314 0001493152-23-007486.hdr.sgml : 20230314 20230313194308 ACCESSION NUMBER: 0001493152-23-007486 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 95 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGRIFORCE GROWING SYSTEMS LTD. CENTRAL INDEX KEY: 0001826397 STANDARD INDUSTRIAL CLASSIFICATION: PREFABRICATED METAL BUILDINGS & COMPONENTS [3448] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40578 FILM NUMBER: 23728803 BUSINESS ADDRESS: STREET 1: 300 - 2233 COLUMBIA STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0M6 BUSINESS PHONE: 1-866-226-3514 MAIL ADDRESS: STREET 1: 300 - 2233 COLUMBIA STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0M6 10-K 1 form10-k.htm
0001826397 false FY A1 Unlimited Unlimited 0001826397 2022-01-01 2022-12-31 0001826397 AGRI:CommonSharesMember 2022-01-01 2022-12-31 0001826397 AGRI:SeriesWarrantsMember 2022-01-01 2022-12-31 0001826397 2022-06-30 0001826397 2023-03-13 0001826397 2022-12-31 0001826397 2021-12-31 0001826397 2021-01-01 2021-12-31 0001826397 us-gaap:CommonStockMember 2020-12-31 0001826397 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2020-12-31 0001826397 us-gaap:RetainedEarningsMember 2020-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001826397 2020-12-31 0001826397 us-gaap:CommonStockMember 2021-12-31 0001826397 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2021-12-31 0001826397 us-gaap:RetainedEarningsMember 2021-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001826397 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001826397 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2021-01-01 2021-12-31 0001826397 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001826397 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001826397 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2022-01-01 2022-12-31 0001826397 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001826397 us-gaap:CommonStockMember 2022-12-31 0001826397 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2022-12-31 0001826397 us-gaap:RetainedEarningsMember 2022-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001826397 AGRI:AgriFORCEGrowingSystemsLtdMember 2022-01-01 2022-12-31 0001826397 AGRI:UnFoodCompanyCanadaLtdMember 2022-01-01 2022-12-31 0001826397 AGRI:WestPenderHoldingsIncMember 2022-01-01 2022-12-31 0001826397 AGRI:AgriFORCEInvestmentsIncMember 2022-01-01 2022-12-31 0001826397 AGRI:WestPenderManagementCoMember 2022-01-01 2022-12-31 0001826397 AGRI:AGIIPCoMember 2022-01-01 2022-12-31 0001826397 AGRI:UnFoodCompanyCanadaMember 2022-01-01 2022-12-31 0001826397 srt:MinimumMember 2022-12-31 0001826397 AGRI:IPOWarrantMember 2022-12-31 0001826397 AGRI:IPOWarrantMember 2021-12-31 0001826397 2022-01-02 0001826397 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001826397 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001826397 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001826397 AGRI:LandPurchaseAndSaleAgreementMember AGRI:StrongholdPowerSystemMember srt:ScenarioForecastMember 2023-03-31 0001826397 AGRI:LandPurchaseAndSaleAgreementMember AGRI:StrongholdPowerSystemMember AGRI:FirstStockDepositsMember 2022-09-09 0001826397 AGRI:LandPurchaseAndSaleAgreementMember AGRI:StrongholdPowerSystemMember AGRI:SecondStockDepositsMember 2022-09-09 0001826397 AGRI:LandPurchaseAgreementMember AGRI:StrongholdPowerSystemMember AGRI:SecondStockDepositsMember 2022-09-09 0001826397 AGRI:LandPurchaseAndSaleAgreementMember AGRI:StrongholdPowerSystemMember 2022-08-31 2022-08-31 0001826397 AGRI:LandPurchaseAndSaleAgreementMember AGRI:StrongholdPowerSystemMember 2022-12-31 0001826397 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001826397 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001826397 us-gaap:ComputerEquipmentMember 2022-12-31 0001826397 us-gaap:ComputerEquipmentMember 2021-12-31 0001826397 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001826397 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001826397 AGRI:AssetPurchaseAgreementMember AGRI:MannaNutritionalGroupLLCMember 2022-12-31 0001826397 AGRI:AssetPurchaseAgreementMember AGRI:MannaNutritionalGroupLLCMember 2021-12-31 0001826397 AGRI:PrefundedWarrantsMember 2022-12-31 0001826397 AGRI:PrefundedWarrantsMember 2022-01-01 2022-12-31 0001826397 us-gaap:SubsequentEventMember 2023-01-02 2023-01-03 0001826397 AGRI:AccreditedInvestorsMember AGRI:SecuritiesPurchaseAgreementMember 2021-03-24 0001826397 AGRI:AccreditedInvestorsMember AGRI:SecuritiesPurchaseAgreementMember 2021-03-23 2021-03-24 0001826397 AGRI:AccreditedInvestorsMember 2021-06-23 2021-06-24 0001826397 AGRI:BridgeWarrantMember 2021-06-24 0001826397 AGRI:DefinitiveAgreementMember AGRI:InvestorsMember 2022-06-30 0001826397 AGRI:DefinitiveAgreementMember AGRI:InvestorsMember 2022-06-29 2022-06-30 0001826397 AGRI:DefinitiveAgreementMember AGRI:InvestorsMember AGRI:FirstTwelveMonthsMember 2022-06-30 0001826397 AGRI:DefinitiveAgreementMember AGRI:InvestorsMember AGRI:SubsequentTwelveMonthsMember 2022-06-30 0001826397 AGRI:DefinitiveAgreementMember AGRI:InvestorsMember AGRI:ThereafterMember 2022-06-30 0001826397 AGRI:DefinitiveAgreementMember AGRI:InvestorsMember AGRI:AdditionalTranchesMember 2022-06-30 0001826397 AGRI:InvestorsMember 2022-01-01 2022-12-31 0001826397 us-gaap:SubsequentEventMember AGRI:TrancheMember 2023-03-10 0001826397 us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2023-03-10 0001826397 srt:MinimumMember 2022-01-01 2022-12-31 0001826397 srt:MaximumMember 2022-01-01 2022-12-31 0001826397 AGRI:AlternaBankMember AGRI:LoanAgreementMember 2020-12-31 0001826397 AGRI:AlternaBankMember AGRI:LoanAgreementMember 2021-12-31 0001826397 AGRI:AlternaBankMember AGRI:LoanAgreementMember 2021-04-01 2021-04-30 0001826397 AGRI:AlternaBankMember AGRI:LoanAgreementMember 2021-01-01 2021-12-31 0001826397 AGRI:AlternaBankMember AGRI:LoanAgreementMember 2022-01-01 2022-12-31 0001826397 AGRI:AlternaBankMember AGRI:LoanAgreementMember 2022-12-31 0001826397 AGRI:SeriesAWarrantsMember 2022-12-31 0001826397 us-gaap:WarrantMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-12-31 0001826397 us-gaap:IPOMember us-gaap:FairValueInputsLevel1Member 2022-01-01 2022-12-31 0001826397 us-gaap:IPOMember 2021-01-01 2021-12-31 0001826397 AGRI:DebentureWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-01-01 2022-06-30 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-06-30 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-06-30 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-06-30 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-06-30 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-06-30 0001826397 AGRI:BridgeWarrantMember 2021-10-26 2021-10-27 0001826397 AGRI:BridgeWarrantMember us-gaap:MeasurementInputSharePriceMember 2021-10-27 0001826397 AGRI:BridgeWarrantMember us-gaap:MeasurementInputExpectedTermMember 2021-10-27 0001826397 AGRI:BridgeWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-10-27 0001826397 AGRI:DebentureConvertibleMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001826397 AGRI:DebentureConvertibleMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputPriceVolatilityMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedTermMember 2022-06-30 0001826397 AGRI:IPOAndRepresentativeWarrantsMember 2021-12-31 0001826397 AGRI:DebentureWarrantsMember 2021-12-31 0001826397 AGRI:DebentureConvertibleFeatureMember 2021-12-31 0001826397 AGRI:IPOAndRepresentativeWarrantsMember 2022-01-01 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-01-01 2022-12-31 0001826397 AGRI:DebentureConvertibleFeatureMember 2022-01-01 2022-12-31 0001826397 AGRI:IPOAndRepresentativeWarrantsMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-12-31 0001826397 AGRI:DebentureConvertibleFeatureMember 2022-12-31 0001826397 AGRI:OptionPlanMember 2019-05-27 2019-05-28 0001826397 AGRI:ReverseSplitMember 2021-12-31 0001826397 2020-01-01 2020-12-31 0001826397 AGRI:StockOptionOneMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionOneMember 2022-12-31 0001826397 AGRI:StockOptionTwoMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionTwoMember 2022-12-31 0001826397 AGRI:StockOptionThreeMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionThreeMember 2022-12-31 0001826397 AGRI:StockOptionFourMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionFourMember 2022-12-31 0001826397 AGRI:StockOptionFiveMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionFiveMember 2022-12-31 0001826397 AGRI:WarrantsGrantedOneMember 2021-01-01 2021-12-31 0001826397 AGRI:WarrantsGrantedTwoMember 2021-01-01 2021-12-31 0001826397 AGRI:WarrantsExercisedOneMember 2021-01-01 2021-12-31 0001826397 AGRI:WarrantsGrantedOneMember 2022-01-01 2022-12-31 0001826397 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001826397 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001826397 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001826397 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001826397 AGRI:PrefundedWarrantsMember 2022-01-01 2022-12-31 0001826397 AGRI:PrefundedWarrantsMember 2021-01-01 2021-12-31 0001826397 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001826397 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-12-31 0001826397 AGRI:NonCapitalLossesCarryforwardMember country:CA 2022-12-31 0001826397 AGRI:NonCapitalLossesCarryforwardMember country:CA 2021-12-31 0001826397 AGRI:NonCapitalLossesCarryforwardMember country:CA 2022-01-01 2022-12-31 0001826397 us-gaap:CapitalLossCarryforwardMember country:US 2022-12-31 0001826397 us-gaap:CapitalLossCarryforwardMember country:US 2021-12-31 0001826397 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2022-12-31 0001826397 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2021-12-31 0001826397 AGRI:DavidWelchMember 2022-01-01 2022-12-31 0001826397 AGRI:DavidWelchMember 2021-01-01 2021-12-31 0001826397 AGRI:InvestorsMember us-gaap:SubsequentEventMember 2023-01-17 0001826397 AGRI:InvestorsMember us-gaap:SubsequentEventMember 2023-01-18 0001826397 AGRI:InvestorsMember us-gaap:SubsequentEventMember 2023-01-17 2023-01-18 0001826397 AGRI:PrefundedWarrantsMember AGRI:MannaNutritionalGroupLLCMember us-gaap:SubsequentEventMember 2023-01-01 2023-03-13 0001826397 AGRI:ConsultantMember us-gaap:SubsequentEventMember 2023-01-01 2023-03-13 0001826397 AGRI:BerryPeopleLLCMember us-gaap:SubsequentEventMember 2023-01-23 2023-01-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:CAD xbrli:pure iso4217:CAD xbrli:shares AGRI:CADP

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

  (Mark One)    
  ☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022.

  

 

or

 

  ☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from [—Date—] to [—Date—]

  

 

Commission File Number: 001-40578

 

AGRIFORCE GROWING SYSTEMS LTD.

(Exact name of registrant as specified in its charter)

 

British Columbia   Not Applicable

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

   

 

300 – 2233 Columbia Street

Vancouver, BC, Canada

   V5Y 0M6
(Address of principal executive offices)   (Zip Code)

 

(604) 757-0952

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares   AGRI   NASDAQ Capital Market
Series A Warrants   AGRIW   NASDAQ Capital Market

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such fi les). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐   Accelerated filer ☐
  Non-accelerated filer ☒   Smaller reporting company ☒
  Emerging growth company ☒    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of June 30, 2022 was approximately $28,755,938. Shares of the registrant’s common stock held by each officer and director and each person known to the registrant to own 10% or more of the outstanding voting power of the registrant have been excluded in that such persons may be deemed affiliates. This determination of affiliate status is not a determination for other purposes.

 

APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY

 

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☐ No ☐

 

(APPLICABLE ONLY TO CORPORATE REGISTRANTS)

 

As of March 13, 2023, the registrant has 18,156,154 shares of common stock, no par value per share, outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424(b) or (c) under the Securities Act of 1933. The listed documents should be clearly described for identification purposes (e.g., annual report to security holders for fiscal year ended December 24, 1980).

 

 

 

 
 

 

Table of Contents

 

  PART I  
Item 1. Business 4
Item 1A. Risk Factors 15
Item 1B. Unresolved Staff Comments 28
Item 2. Properties 28
Item 3. Legal Proceedings 28
Item 4. Mine Safety Disclosures 28
  PART II  
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29
Item 6. Selected Financial Data 30
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 30
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 34
Item 8. Financial Statements and Supplementary Data F-1
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 35
Item 9A. Controls and Procedures 35
Item 9B. Other Information 35
  PART III  
Item 10. Directors, Executive Officers and Corporate Governance 36
Item 11. Executive Compensation 40
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 41
Item 13. Certain Relationships and Related Transactions, and Director Independence 41
Item 14. Principal Accounting Fees and Services 42
  PART IV  
Item 15. Exhibits, Financial Statement Schedules 43

 

2

 

 

Cautionary Note Regarding Forward-Looking Information

 

This report on Form 10-K contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding our assumptions about financial performance; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations; and the economy in general or the future of the defense industry, all of which were subject to various risks and uncertainties.

 

When used in this Report on Form 10- K and other reports, statements, and information we have filed with the Securities and Exchange Commission (“Commission” or “SEC”), in our press releases, presentations to securities analysts or investors, in oral statements made by or with the approval of an executive officer, the words or phrases “believes,” “may,” “will,” “expects,” “should,” “continue,” “anticipates,” “intends,” “will likely result,” “estimates,” “projects” or similar expressions and variations thereof are intended to identify such forward-looking statements. However, any statements contained in this Report on Form 10-K that are not statements of historical fact may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors.

 

We do not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in this annual report. In this Form 10-K, AgriFORCE Growing Systems Ltd. (“AgriFORCE™” or the “Company”) has identified important factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.

 

3

 

 

PART I

 

Item 1. Business

 

Overview

 

AgriFORCE™ was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the Business Corporations Act (British Columbia) on December 22, 2017. The Company’s registered and records office address is at 300 – 2233 Columbia Street, Vancouver, BC, Canada, V5Y 0M6.

 

Our Business

 

AgriFORCE™ is dedicated to positively transforming farm, food, and family every day, everywhere. We aim to achieve this goal by providing novel agriculturally focused consulting, facility solutions, and products & services through our Solutions division, and by leveraging innovative technologies and processes to deliver healthier more nutritious food to consumers through our Brands division.

 

The AgriFORCE™ Solutions division is dedicated to transforming modern agricultural development “Building from the Seed to Deliver sustainable, Efficient, and Healthier crops” through our integrated Agtech platform 2.0 combining knowledge and IP with CEA equipment solutions, including our FORCEGH+™” solution, implementing solutions that are best suited to the crops and environment chosen.

 

Our AgriFORCE™ Brands division is focused on the development and commercialization of plant-based ingredients and products that deliver more nutritious “Food to Table”. We will market and commercialize both branded consumer product offerings and ingredient supplies.

 

AgriFORCE™ Solutions

 

Understanding Our Approach – The AgriFORCE™ Precision Growth Method

 

Traditional farming includes three fundamental approaches: outdoor, greenhouse and indoor. AgriFORCE™ introduces a unique fourth method, the AgriFORCE™ precision growth method, which is informed by cutting-edge science and leveraging the latest advances in artificial intelligence (AI) and Internet of Things (IoT).

 

4

 

 

With a carefully optimized approach to facility design, IoT, AI utilization, nutrient delivery, and micro-propagation, we have devised an intricate, scientific and high success-oriented approach designed to produce much greater efficacy yields using fewer resources. This method is intended to outperform traditional growing methods using a specific combination of new and traditional techniques required to attain this efficiency. We call it precision growth. The AgriFORCE™ precision growth method focuses on addressing some of the most important legacy challenges in agriculture: environmental impact, operational efficiency and yield volumes.

 

The AgriFORCE™ precision growth method presents a tremendous opportunity to positively disrupt all corners of the industry. The market size of just the nutraceutical and plant-based pharmaceutical and vaccine/therapeutics market is over $500 billion. Including the traditional hydroponics high value crops and controlled-environment food markets, the addressable market approaches nearly $1 trillion. (1)(2)(3).

 

The AgriFORCE™ Model – Managing the Difficulties of Agricultural Verticals with Modern Technology and Innovation

 

Our intellectual property combines a uniquely engineered facility design and automated growing system to provide a clear solution to the biggest problems plaguing most high value crop agricultural verticals. It delivers a clean, self-contained environment that maximizes natural sunlight and offers near ideal supplemental lighting. It also limits human intervention and – crucially – it was designed to provide superior quality control. It was also created to drastically reduce environmental impact, substantially decrease utility demands, as well as lower production costs, while delivering customers daily harvests and higher crop yields.

 

Plants grow most robustly and flavorfully in full natural sunlight. While it may seem counterintuitive to some, even the clearest of glass greenhouses inhibit the full light spectrum of the sun. However, new translucent and transparent membrane materials have emerged recently that enable the near-full-transmission of the sun’s light spectrum.

 

(1) https://home.kpmg/pl/en/home/insights/2015/04/nutraceuticals-the-future-of-intelligent-food.html

(2) https://link.springer.com/article/10.1057/jcb.2010.37

(3) https://medium.com/artemis/lets-talk-about-market-size-316842f1ab27

 

5

 

 

Our Position in the Ag-Tech Sector

 

The Ag-Tech sector is severely underserved by the capital markets, and we see an opportunity to acquire global companies who have provided solutions to the industry and are leading innovation moving forward. We are creating a separate corporate office to aggressively pursue such acquisitions. The robustness of our engagement with potential targets has confirmed our belief and desire to be part of a larger integrated Ag-Tech solutions provider, where each separate element of the business has its existing legacy business and can leverage across areas of expertise to expand their business footprint. We believe that there is currently no one that we are aware of who is pursuing this model in the US capital markets environment at this time.

 

The AgriFORCE™ Grow House

 

The Company is an agriculture-focused technology company that delivers innovative and reliable, financially robust solutions for high value crops through our proprietary facility design and automation IP to businesses and enterprises globally. The Company intends to operate in the plant based pharmaceutical, nutraceutical, and high value crop markets using its unique patented facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops in a controlled environment (“FORCEGH+™”). The Company has designed FORCEGH+™ facilities to produce in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible while substantially eliminating the need for the use of pesticides, fungicides and/or irradiation.

 

The Company continues to develop its solution for fruits and vegetables focusing on the integration of its current structure with a new form of vertical grow technology.

 

BUSINESS PLAN

 

PHASE 1 (COMPLETED):

 

  ●

Conceptualization, engineering, and design of facility and systems. (complete)

  ● Completed selection process of key environmental systems with preferred vendors. (complete)
  ● Selection and Land Purchase agreement in Coachella, CA subject to financing. (complete)
  ●

ForceFilm material ordered. (complete)

 

PHASE 2:

 

  ● Complete the timing of financing for, and purchase of, the selected parcel in Coachella, CA, subject to market conditions,
  ● Complete feasibility study for new contracts’ structures for facilities with new independent operators.
  ● Identify procurement of AgriFORCE™ IP specific automated grow system, supplemental grow lighting and controls systems, and manufacture of the building envelope materials.
  ● Conceptualization and design of vertical grow solutions.
  ● Initiate the design of an R&D facility for food solutions and plant-based pharma.

 

6

 

 

PHASE 3:

 

  ● Complete the delivery and installation of facilities. Proof of quantitative and qualitative benefits will drive both sales pipeline acceleration for subsequent years.
  ● Complete the design of an R&D facility for food solutions and plant-based pharma. Commence engagement with universities and pharmaceutical companies.
  ● Review potential licensing opportunities for the Solutions patent portfolio.

 

PHASE 4:

 

  ● Focus on delivery and installation of additional facilities.
  ● Expand geographic presence into other geographies by introducing the FORCEGH+™ to other international markets with a view to securing additional locations and markets.

 

AgriFORCE™ Brands

 

The Company purchased Intellectual Property (“IP”) from Manna Nutritional Group, LLC (“Manna”), a privately held firm based in Boise, Idaho on September 10, 2021. The IP encompasses a granted patent to naturally process and convert grain, pulses and root vegetables, resulting in low-starch, low-sugar, high-protein, fiber-rich baking flour as well as produces a natural sweetener juice. The core process is covered under the Patent Nr. 11,540,538 in the U.S. and key international markets. The all-natural process is designed to unlock nutritional properties, flavors and other qualities in a range of modern, ancient and heritage grains, pulses and root vegetables to create specialized all-natural baking and all-purpose flours, sweeteners, juices, naturally sweet cereals and other valuation products, providing numerous opportunities for dietary nutritional, performance and culinary applications.

 

Wheat and Flour Market

 

Modern diet is believed to be a contributor to health risks such as heart disease, cancer, diabetes and obesity, due in part to the consumption of highly processed foods that are low in natural fiber, protein and nutrition; and extremely high in simple starch, sugar and calories. These “empty carbs” produce glycemic swings that may cause overeating by triggering cravings for food high in sugar, salt and starch. As an example, conventional baking flour is low in natural fiber (~ 2-3%), low-to-average in protein (~ 9%), and very high in starch (~ 75%)(4). Whole wheat flour is only marginally better.

 

(4) Based on protein, fiber, and starch content figures from a nationally certified independent laboratory, as compared to standard all-purpose flour.

 

7

 

 

In contrast, foods high in fiber help to satiate hunger, suppress cravings and raise metabolism(5). They also assist in weight loss, lower cholesterol, and may reduce the risk of cancer, heart disease and diabetes.

 

Advantages of the UN(THINK)™ Foods IP

 

The Controlled Enzymatic Reaction & Endothermic Saccharification with Managed Natural Germination (“CERES-MNG”) patented process allows for the development and manufacturing of all-natural flours that are significantly higher in fibers, nutrients and proteins and significantly lower in carbohydrates and calories than standard baking flour.

 

CERES-MNG baking flour produced from soft white wheat has 40 times more fiber, three (3) times more protein and 75% less net carbohydrates than regular all- purpose flour8 (6).

 

 

Source: Independent analysis by Eurofins Food Chemistry Testing Madison, Inc, February 2022

 

The CERES-MNG patent will help develop new flours and products from modern, ancient and heritage grains, seeds, legumes and tubers/root vegetables.

 

(5) https://my.clevelandclinic.org/health/articles/14400-improving-your-health-with-fiber

(6) Based on protein, fiber, and starch content figures from a nationally certified independent laboratory, as compared to standard all-purpose flour.

 

8

 

 

Products that AgriFORCE™ intends to develop for commercialization from the CERES-MNG patented process under the UN(THINK)™ foods brand:

 

  - High protein, high fiber, low carb modern, heritage and ancient grain flours (for use in breads, baked goods, doughs, pastry, snacks, and pasta)
  - Protein flours and protein additives
  - High protein, high fiber, low carb cereals and snacks
  - High protein, high fiber, low carb oat based dairy alternatives
  - Better tasting, cleaner label high protein, high fiber, low carb nutrition bars
  - High protein, high fiber low carb nutrition juices
  - Sweeteners – liquid, granulated
  - High protein, high fiber, low carb pet foods and snacks

 

We intend to commercialize these products behind three (3) main sales channels:

 

  - Ingredients
  - Branded ingredients
  - Consumer brand

 

The business opportunity for AgriFORCE™ to successfully commercialize premium specialized products from the UN(THINK)™ foods IP – by capturing a conservatively very small percentage share of the category it is targeting to enter in the premium segments. We estimate these revenues to be between $500 million and $1 billion by 2030 (excluding any potential revenues from the Maltose-Power Juice applications).

 

    Breads &Bakery     Functional Flours     Pulse Flours     Dairy Alternatives     Nutrition Bars     Total  
Global market size of target categories   $ 222B     $ 48B     $ 17B     $ 6B     $ 45B          
Potential market share     0.1 %     1 %     1 %     1 %     0.1 %        
AgriFORCE™ potential net revenues   $ 100-200M     $ 200-480M     $ 100- 170M     $ 30-60M     $ 20-40M     $ 450-950M  

 

Sources: Grand View Research Reports, San Francisco CA, 2018 Estimates.

 

9

 

 

While we are working on setting up a pilot plant in Canada to produce the UN(THINK)™ power wheat flour for the end of 2023, our patented process allows us to develop a gold-standard sprouted wheat flour, which we have qualified and have made available for sale through brokers as of January 2023 in Canada and the USA, under the UN(THINK)™ Awakened Grains™ brand. This new Awakened Grains™ flour will provide enhanced nutrition with over five times more fiber, up to two times more protein and 77% of net carbs versus conventional all purpose flour (source: Eurofins Food Chemistry Madison, Inc, December 2022).

 

BUSINESS PLAN

 

AgriFORCE™’s organic growth plan is to actively establish and deploy the commercialization of products, following the acquisition of the Manna IP, is focused on four distinct phases:

 

PHASE 1 (COMPLETED):

 

  ● Product and process testing and validation. (completed)
  ● Filing of US and international patent. (completed)
  ● Conceptual engineering and preliminary budgeting on commercial pilot plant. (completed)
  ● Creation of the UN(THINK)™ foods brand. (completed)
  ● Qualification and operational and commercial set up of the Awakened Grains™ line of products (completed)

 

PHASE 2:

 

  ● Launch of the UN(THINK)™ Awakened Grains™ sprouted flour range of products in business to business (“B2B”) and direct to consumers (“D2C”) channels.
  ● Design, build, start-up, and operation of the pilot plant for the fully processed and patented flours
  ● Develop range of finished products behind the wheat grain flours, qualify patented process for pulse/legume, and rice based protein flours.
  ● Collaborate with Nutritional Flour Medical Research Institute (an IRS section 501(c)(3) Medical Research Organization) funded by private & public research grants.

 

PHASE 3:

 

  ● Launch first range of fully patent processed products in US/Canada (UN(THINK)™ power wheat flour.
  ● Drive business with finished products in D2C, retail, food service.
  ● Drive business as ingredients for bakery, snack and plant based protein products manufacturers.
  ● Develop manufacturing base through partnerships and licensing.
  ● Conceptual engineering and preliminary budgeting on large-scale processing plant.

 

PHASE 4:

 

  ● Expand product range in US/Canada.
  ● Expand business to other geographies internationally.
  ● Design, build, start-up, and operation of large-scale processing plan.

 

Merger and Acquisition (“M&A”)

 

With respect to M&A growth, the Company is aggressively pursuing acquisitions in the agriculture technology space. The Company believes that a buy and build strategy will provide unique opportunities for innovation across each segment of the Ag-Tech market we serve. Our unique IP combined with the know-how and IP of acquired companies will create additional value if the way we grow or produce crops. The Company believes there is currently no other public traded publicly in the United States pursing this model.

 

10

 

 

Manna Nutritional Group Asset Acquisition

 

On September 10, 2021, the Company signed a definitive asset purchase agreement to acquire food production and processing IP from Manna.

 

On May 10, 2022, the Company completed an amendment to its asset purchase agreement with Manna Nutritional Group LLC, dated September 10, 2021. The amendment required the issuance of prefunded warrants instead of shares over several tranches and contained covenants to obtain shareholder approval of the acquisition transactions before the prefunded warrants can be exercised into Company common shares.

 

The transaction was fully approved by the shareholders on December 15, 2022. The Company paid consideration of $1,475,000 in cash and issued 7,379,969 prefunded warrants valued at $12,106,677 adjusted for foreign exchange differences of $492,300. Subject to a 9.99% stopped and SEC Rule 144 restrictions, the prefunded warrants will vest in tranches up until March 10, 2024. When vested the tranches of prefunded warrants will be converted into an equal number of common shares.

 

Delphy Groep BV Acquisition

 

On February 10, 2022, the Company signed a definitive share purchase agreement (the “Delphy Agreement”) to acquire Delphy, a Netherlands-based AgTech consultancy firm, for €23.5 million through a combination of cash and stock. The definitive agreement follows the binding letter of intent as previously announced in the Company’s press release in October 2021. Delphy, which optimizes production of plant-based foods and flowers, has multinational operations in Europe, Asia, and Africa, with approximately 200 employees and consultants. Delphy’s client list includes agriculture companies, governments, universities, and leading AgTech suppliers, who turn to the company to drive agricultural innovation, solutions, and operational expertise. The Delphy Agreement was negotiated at arm’s length and is not a related party transaction.

 

On September 22, 2022, the Company entered an amendment to the Delphy Agreement, pursuant to which the parties agreed to reduce the total purchase from €$23.5 million to €17.7 million, plus a potential earnout of up to €6.0 million over two (2) years, based on achieving future performance milestones. The Company also agreed to pay interest in the amount of €0.2 million on the purchase price and additional interest from November 15, 2022 up to January 15, 2023 (the “Long Stop Date”).

 

Management is currently in negotiating an amendment which will extend the Long Stop Date past January 15, 2023. Neither party has provided notice to terminate the agreement.

 

Deroose Plants NV Binding Letter of Intent

 

On February 23, 2022, the Company signed a binding letter of intent (the “Deroose LOI”) with Deroose Plants NV (“Deroose”), one of the largest tissue culture propagation companies in the world with a leadership position in horticulture, plantation crops, and fruit and vegetables. Founded in 1980, Deroose has multi-national operations in Europe, North America, and Asia, and over 800 employees.

 

The Deroose LOI is subject to completion of standard due diligence and entry into a definitive purchase agreement, which shall include commercially standard terms and conditions, including, but not limited to, representations and warranties, covenants, events of default and conditions to closing.

 

The net purchase price by the Company is expected to be approximately €61 million. The purchase price represents approximately €41 million for the Deroose business on a cash and debt free basis and €20 million for the genetic IP portfolio.

 

The parties are working through the Letter of Intent. Neither party has provided notice to terminate the agreement.

 

Stronghold Land Acquisition

 

On August 30, 2022, the Company entered into a Purchase and Sale Agreement (“PSA”) with Stronghold Power Systems, Inc. (“Stronghold”) to purchase approximately 34 acres of land in Coachella California. The purchase price is $4,300,000, payable as follows: (i) $1,500,000 in cash and (ii) $2,800,000 in restricted shares of common stock of the Company. The stock is being issued in the form of prefunded warrants in two tranches: (i) $1,700,000 (695,866 prefunded warrants) issued within five days of entry into the PSA, and (ii) $1,100,000 (450,266 prefunded warrants) at closing of the transaction. The first tranche shall be void if closing of the transaction does not occur by March 31, 2023. The prefunded warrants per share exercise price is $2.443 which is subject to certain adjustments. Issuance of all securities in this transaction are exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. Under the terms of the agreement, Stronghold must complete certain permitting, zoning, and infrastructure work by March 31, 2023, to close the transaction.

 

Corporate Structure

 

The Company currently has the following wholly-owned subsidiaries, which perform the following functions – AgriFORCE Investments holds the Company’s U.S. investments, West Pender Holdings retains real estate assets, West Pender Management is a management company, AGI IP holds the Company’s intellectual property in the U.S., un(Think) Food Company will manufacture food products in the U.S. and un(Think) Food Company Canada Ltd. manufactures food products in Canada:

 

Name of Subsidiary   Jurisdiction of Incorporation   Date of Incorporation
AgriFORCE Investments Inc. (US)   Delaware   April 9, 2019
West Pender Holdings, Inc.   Delaware   September 1, 2018
AGI IP Co.   Nevada   March 5, 2020
West Pender Management Co.   Nevada   July 9, 2019
un(Think) Food Company   Nevada   June 20, 2022
un(Think) Food Company Canada Ltd.*   British Columbia   December 4, 2019

 

* un(Think) Food Company Canada Ltd. changed its name from Daybreak AG Systems Ltd. during the year ended December 31, 2022.

 

Summary Three Year History

 

From the date of Incorporation (December 22, 2017) to the date of this filing, the Company has largely been engaged in completion of its initial corporate organization, assembling its management team, completing the design and engineering of its IP and filing the appropriate intellectual property protection and taking the initial steps to implement its business plan through the commencement of initial operations. Significant milestones during this period are as follows:

 

  ● The Company has substantially finalized the final design and engineering drawings for the FORCEGH+™.
     
  ● On November 30, 2021, the Company signed an offtake agreement with Humboldt Bliss, Ltd., a Barbadian limited company (“Humboldt”). Under the terms of the contract, AgriFORCE™ is responsible for constructing its proprietary facility and providing the full Standard Operating Procedures (“SOP”s) of the FORCEGH+™ and Humboldt is responsible for securing the project’s land as well as operating the facility. David Welch, a director of the Company, owns a controlling interest in Humboldt and is a related party. Mr. Welch recused himself from the final deliberation and approval of the agreement by the board.
     
  ● On February 18, 2022, the Company signed a license agreement with Radical Clean Solutions Ltd (“Radical”), a New York corporation that has developed a patent pending product line consisting of smart hydroxyl generation systems to eliminate 99.99+% of all pathogens, virus, mold, volatile organic compounds and allergy triggers, to commercialize the proprietary hydroxyl generating devices within the controlled environment agriculture (“CEA”) and food manufacturing industries. The license grants the rights to AgriFORCE™ in perpetuity as well as joint patent ownership rights for application in CEA. The Company has been working on commercializing these devices for food manufacturing plants, greenhouses, vertical growing facilities, as well as food, storage, and produce transportation. This is with a goal to drive food security, improve product freshness, and lengthen shelf-life.
     
  ● On May 18, 2022, the Company completed the acquisition of the food processing intellectual property of Manna Nutritional Group (Manna).

 

11

 

 

Financing

 

On March 24, 2021, the Company entered into a securities purchase agreement with certain accredited investors for the purchase of $750,000 in principal amount ($600,000 subscription amount) of senior secured debentures originally due June 24, 2021 (the “Bridge Loan”). On June 24, 2021, the due date was extended to July 12, 2021. The imputed interest rate is encompassed within the original issue discount of the debentures and no additional cash interest was due. The debentures were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, to certain purchasers who are accredited investors within the meaning of Rule 501 under the Securities Act of 1933, as amended. Each debenture holder will receive a warrant to purchase shares of common stock in an amount equal to 50% of the principal amount divided by 80% of the initial public offering price of the Company’s common stock. The warrants are exercisable at 80% of the initial public offering price. Transaction costs of $69,000 have been recorded in connection with the Bridge Loan. The Bridge Loan was fully repaid on July 13, 2021.

 

On June 30, 2022, the Company entered into security purchase agreements with certain accredited investors (the “Convertible Debt Investors”) for the purchase of $14,025,000 in convertible debentures (the “Debentures”) due December 31, 2024. The interest rates on the Debentures are 5% for the first 12 months, 6% for the subsequent 12 months, and 8% per annum thereafter. Principal repayments will be made in 25 equal monthly installments and began on September 1, 2022. The Debenture may be extended by six months at the election of the Company by paying a sum equal to six months interest on the principal amount outstanding at the end of the 18th month, at the rate of 8% per annum. The Debentures are convertible into common shares at $2.22 per share. The Convertible Debt Investors have the right to purchase additional tranches of $5,000,000 each, up to a total additional principal amount of $33,000,000. In addition, the Convertible Debt Investors received 4,106,418 warrants at a strike price of $2.442, which expire on December 31, 2025 (the “Debenture Warrants”). The Debenture Warrants and Debentures each have down round provisions whereby the conversion and strike prices will be adjusted downward if the Company issues equity instruments at lower prices. On January 17, 2023, the Convertible Debt Investors purchased an additional tranche of $5,076,923. The convertible debt and warrants were issued with an exercise price of $1.24. The issuance of the additional tranche triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $1.24.

 

Intellectual Property

 

In accordance with industry practice, the Company protects its proprietary products, technology and its competitive advantage through a combination of contractual provisions and trade secret, copyright and trademark laws in Canada, the United States and in other jurisdictions in which it conducts its business. The Company also has confidentiality agreements, assignment agreements and license agreements with employees and third parties, which limit access to and use of its intellectual property.

 

Patents

 

We hold seven (7) patents in the United States and 15 international patents. We also have 18 pending patent applications. These patents and patents applications are directed to, among other things, technologies planned to be utilized in FORCEGH+™ and UN(THINK)™ foods.

 

Competitor Comparison and Differentiation

 

Solutions

 

The Company believes that it has no direct competitors who provide a proprietary facility design and automated grow system as well as a system of operational processes designed to optimize the performance of the Company’s grow houses. On a broader basis, the competitive landscape includes greenhouse vendors, agriculture systems providers, automated grow system vendors, and system/solutions consultants.

 

12

 

 

The Company believes it has developed one of the world’s most technologically advanced indoor agriculture systems by focusing on competitive differentiators to deliver vastly improved results beyond conventional indoor approaches. By conceiving new IP, as well as utilizing tried trued tested existing Ag-Tech and Bio-Tech solutions, the Company delivers integrated unique architectural design, intelligent automation and advanced growing processes to create precisely controlled growing environments optimized for each nominated crop variety. These precision ecosystems should enable the Company to cost-effectively produce the cleanest, greenest and most flavorful produce, as well as consistent medical-grade plant-based nutraceuticals and pharmaceuticals, available.

 

Brands

 

Our patented technology naturally processes and converts grains, pulses, and root vegetables into low-starch, low-sugar, high-protein fiber-rich baking flour products. The Company is developing a range of consumer products to transform the consumers’ diet in multiple verticals.

 

The Company’s UN(THINK)™ power flour has 40 times more fiber, 3 times more protein, and 75% less net carbs than regular all-purpose flour8.

 

(8) Based on protein, fiber, and starch content figures from a nationally certified independent laboratory, as compared to standard all purpose flour.

 

Recent Developments

 

Convertible Debt Financing

 

On January 17, 2023, the Convertible Debt Investors purchased an additional tranche of $5,076,923 in convertible debentures and received 2,661,289 warrants. The convertible debt and warrants were issued with an exercise price of $1.24. The issuance of the additional tranche triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $1.24.

 

Berry People LLC Binding Letter of Intent

 

On January 24, the Company announced it has entered into a binding letter of intent (“BP LOI”) to acquire Berry People LLC, (“Berry People”), a berry business with an increasingly international footprint and a scalable business model. The acquisition bolsters the AgriFORCE™ Brands division and allows the Company to realize commercial synergies with UN(THINK)™.

 

Berry People was founded in 2017 by berry industry veterans to create a new platform to meet market demand for a branded, year-round supply of organic and conventional berries. Berry People quickly established a recognized global trade brand and scalable operations, comprised of over 200 retail and foodservice clients and over 100 grower and exporter clients across the US, Canada, Mexico, and Peru. Berry People had net revenues of USD $37 (unaudited) million for the year ended December 31, 2022.

 

The LOI states, among other things that:

 

●the transaction will be subject to completion of due diligence to the Company’s satisfaction and, after satisfactory due diligence, the reaching of agreement on the terms of the purchase pursuant to a definitive purchase agreement, including conditions precedent for closing of the transaction;
●the parties will sign the definitive purchase agreement no later than April 30, 2023, unless agreed to by both parties; and
●Berry People will not enter into any negotiations with other parties for a period of three months following the execution of the BP LOI.

 

13

 

 

The BP LOI sets forth a purchase price of $28.0 million, consisting of $18.2 million in cash and $9.8 million in AgriFORCE™ restricted shares, will be paid at closing to acquire 70% of Berry People’s equity interests. Berry People will have the opportunity for future earnouts during the five years after closing based on future revenue and EBITDA targets associated with agreed upon growth targets.

 

In collaboration with AgriFORCE™, Berry People aims to further develop backward integration into agricultural production via farming joint ventures and deploy licensed and developed IP as part of a scalable franchising model. The berries market was $9.65 billion in 2021 in the U.S. alone7, with growth rates of around 10% or more each year since 2019— a trend that is expected to continue.

 

(7) As per IRI Integrated Fresh, Latest 52 WE 3/20/2022

 

Manna Patent Issuance

 

On January 3, 2023, Manna satisfied all its contractual obligations when the patent was approved by the US Patents Office and title was transferred to the Company. The Company issued 1,637,049 shares upon exercise of vested tranches of Manna’s prefunded warrants in relation to this transaction on January 3, 2023.

 

Employees

 

As of March 13, 2023, the Company has 15 employees and three consultants. The Company also relies on consultants and contractors to conduct its operations. The Company anticipates that it will be hiring additional employees to support its planned activities.

 

Operations

 

The Company primary operating activities are in California, USA and Saskatoon, Canada. The Company’s head office is located in Vancouver, Canada.

 

Status as an Emerging Growth Company

 

On April 5, 2012, the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected to avail ourselves of this extended transition period and, as a result, we will adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for private companies.

 

We are in the process of evaluating the benefits of relying on other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, as an “emerging growth company,” we intend to rely on certain of these exemptions from, without limitation, (i) providing an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act and (ii) complying with any requirement that may be adopted by the Public Company Accounting Oversight Board (PCAOB) regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis. We will remain an “emerging growth company” until the earliest of (a) the last day of our fiscal year following the fifth anniversary of the closing of this offering, (b) the last day of the first fiscal year in which our annual gross revenues exceed $1.07 billion, (c) the last day of our fiscal year in which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, or Exchange Act (which would occur if the market value of our equity securities that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter), or (d) the date on which we have issued more than $1 billion in nonconvertible debt during the preceding three-year period.

 

14

 

 

Item 1A. Risk Factors

 

Risks Relating to the Company’s Business

 

The Company is an early stage company with little operating history, a history of losses and the Company cannot assure profitability.

 

The Company currently has no revenues and does not have any history of revenue generating operations. The Company has been involved in the design and development of its CEA FORCEGH+™ facility which incorporates the Company’s AgriFORCE™ micropropagation laboratories, acquisition and advancement of the UN(THINK)™ foods IP, product base, development of its pilot plant, and transacting with potential revenue generating acquirees. While the Company has invested considerably in these business plans, no FORCEGH+™ facility has been constructed to date, the Company has not generated revenue from UN(THINK)™, nor has the Company completed any acquisition of revenue generating companies. The commercial or operating viability of the Company’s business plans have not been proven. There is no assurance that the revenue generated from its operations, and if those revenues, when and if generated, will be sufficient to sustain operations, nonetheless achieve profitability.

 

There is no assurance that the Company’s FORCEGH+™ facilities or micropropagation laboratories will operate as intended.

 

The Company’s initial state of its business operations will be to construct and deploy its initial FORCEGH+™ facility and micropropagation laboratories. However, the Company has yet to complete construction of any laboratories. Accordingly, this component of the Company’s business plan is subject to considerable risks, including:

 

  ● there is no assurance that the laboratories will achieve the intended plantlet production rates;
  ● the costs of constructing and operating the laboratories may be greater than anticipated;
  ● the potential offtake partners who have indicated a willingness to deploy the laboratories at their existing cultivation operations may withdraw and determine not to deploy the laboratories;
  ● there is no assurance that the facilities will deliver the intended benefits of high production yields, lower crop losses and reduced operation costs;
  ● if the company is not able to fully develop the grow house or it does not operate as intended, it could prevent the company from realizing any of its business goals or achieving profitability;
  ● the costs of constructing the grow houses may be greater than anticipated and the Company may not be able to recover these greater costs through increases in the lease rates, license fees and services fees that it charges to its customers; and
  ● the costs of operating the grow house may be greater than anticipated.

 

There is no assurance that UN(THINK)™ will operate as intended.

 

The Company’s plans for developing and advancing the UN(THINK)™ are in its preliminary stages. The Company has yet to fully launch their range of products in either the B2B or D2C channels. Accordingly, this component of the Company’s business plan is subject to considerable risks, including:

 

  ● the costs of constructing and operating the pilot plant may be greater than anticipated;
  ● the potential B2B and D2C sales may not achieved the planned levels of sales;
  ● there is no assurance that the pilot plant will deliver the planned production levels or scale;
  ● if the company is not able to fully develop the pilot plan, it could prevent the company from realizing any of its business goals or achieving profitability;
  ● the costs of operating the AgriFORCE™ pilot plant may be greater than anticipated.
  ● the quality of product from the co-manufacturing may not be sufficient.
  ● the cost from co-manufacturing may be greater than anticipated.
  ● the demand for the products may not be as high as predicted.
  ● the pricing of the products may deter potential buyers and may not cover the cost of production.
  ● the brand may not attract sufficient volume.

 

We may not realize the anticipated benefits of, and synergies from, acquisitions and may become responsible for certain liabilities and integration costs as a result.

 

The businesses we have proposed to acquire have previously operated independently from us. The proposed integrations of our operations with the proposed businesses acquisitions are intended to result in financial and operational benefits, and business synergies. There can be no assurance, however, regarding when or the extent to which we will be able to realize these and other benefits. Integration may also be difficult, unpredictable, and subject to delay because of possible company culture conflicts, system integrations, regulatory compliance, and other factors. Difficulties associated with the integration of the proposed business acquisitions could have a material adverse effect on our business.

 

Fluctuations in the exchange rate of foreign currencies could result in losses.

 

We incur a portion of our operating expenses in Canadian dollars, and in the future, as we expand into other foreign countries, we expect to incur operating expenses in other foreign currencies. We are exposed to foreign exchange rate fluctuations as the financial results of our international operations are translated from the local functional currency into U.S. dollars upon consolidation. A decline in the U.S. dollar relative to foreign functional currencies would increase our non-U.S. revenue and improve our operating results. Conversely, if the U.S. dollar strengthens relative to foreign functional currencies, our revenue and operating results would be adversely affected. We have not previously engaged in foreign currency hedging. If we decide to hedge our foreign currency exchange rate exposure, we may not be able to hedge effectively due to lack of experience, unreasonable costs or illiquid markets.

 

15

 

 

The Company will require additional financing and there is no assurance that additional financing will be available when required.

 

The Company will require substantial additional capital in order to execute its business plan. Existing funds will not be sufficient and additional financing will be needed for this purpose and for other purposes. The Company plans to achieve this additional financing through equity and/or debt financing which will likely be dilutive to the position of then current shareholders. However, there is no assurance that this financing will be available at favorable terms, if at all, when required, given the Company’s small asset base and current lack of revenue.

 

The Company had negative cash flow for the year ended December 31, 2022.

 

The Company had negative cash flows from operating activities for year ended December 31, 2022. To the extent that the Company has negative cash flows from operating activities in future periods, it may need to allocate a portion of its cash reserves to fund such negative cash flow. The Company may also be required to raise additional funds through the issuance of equity or debt securities. There can be no assurance that the Company will be able to generate a positive cash flow from operating activities, that additional capital or other types of financing will be available when needed or that these financings will be on terms favorable to the Company. The Company’s actual financial position and results of operations may differ materially from the expectations of the Company’s management.

 

The Company’s actual financial position and results of operations may differ materially from the expectations of the Company’s management.

 

The Company’s actual financial position and results of operations may differ materially from management’s expectations. The process for estimating the Company’s revenue, net income and cash flow requires the use of judgment in determining the appropriate assumptions and estimates. These estimates and assumptions may be revised as additional information becomes available and as additional analyses are performed. In addition, the assumptions used in planning may not prove to be accurate, and other factors may affect the Company’s financial condition or results of operations. As a result, the Company’s revenue, net income and cash flow may differ materially from the Company’s projected revenue, net income and cash flow.

 

The Company expects to incur significant ongoing costs and obligations related to its investment in infrastructure, growth, regulatory compliance and operations.

 

The Company expects to incur significant ongoing costs and obligations related to its planned investments. To the extent that these costs may be greater than anticipated or the Company may not be able to generate revenues or raise additional financing to cover these costs, these operating expenses could have a material adverse impact on the Company’s results of operations, financial condition and cash flows. In addition, future changes in regulations, more vigorous enforcement thereof or other unanticipated events could increase costs and have a material adverse effect on the business, results of operations and financial condition of the Company. The Company may not be able to recover sufficient revenues to offset its higher operating expenses or to recoup its initial capital investment. The Company may incur significant losses in the future for a number of reasons, including, unforeseen expenses, difficulties, complications and delays, and other unknown events. If the Company is unable to achieve and sustain profitability, the market price of our securities may significantly decrease.

 

16

 

 

There is no assurance the Company will be able to repatriate or distribute funds for investment from the United States to Canada or elsewhere.

 

In the event that any of the Company’s investments, or any proceeds thereof, any dividends or distributions there from, or any profits or revenues accruing from such investments in the United States were found to be in violation of money laundering legislation or otherwise, such transactions may be viewed as proceeds of crime under applicable federal laws, rules and regulations or any other applicable legislation. This could restrict or otherwise jeopardize the ability of the Company to declare or pay dividends, effect other distributions or subsequently repatriate such funds back to Canada or elsewhere.

 

The Company may not be able to effectively manage its growth and operations, which could materially and adversely affect its business.

 

If the Company implements it business plan as intended, it may in the future experience rapid growth and development in a relatively short period of time. The management of this growth will require, among other things, continued development of the Company’s financial and management controls and management information systems, stringent control of costs, the ability to attract and retain qualified management personnel and the training of new personnel. The Company intends to utilize outsourced resources, and hire additional personnel, to manage its expected growth and expansion. Failure to successfully manage its possible growth and development could have a material adverse effect on the Company’s business and the value of the shares.

 

The Company may face significant competition from other facilities.

 

Many other businesses in California engage in similar activities to the Company, leasing commercial space to agricultural producers generally, and providing additional products and services to similar customers. The Company cannot assure you that it will be able to compete successfully against current and future competitors. Competitive pressures faced by the Company could have a material adverse effect on its business, operating results and financial condition.

 

The Company may face significant competition from other facilities.

 

Many other businesses in California engage in similar activities to the Company, leasing commercial space to agricultural producers generally, and providing additional products and services to similar customers. The Company cannot assure you that it will be able to compete successfully against current and future competitors. Competitive pressures faced by the Company could have a material adverse effect on its business, operating results and financial condition.

 

The Company may face significant competition from other nutritious food companies.

 

We face significant competition from other nutritious food companies. Many of our competitions may have established brands, more experience and competency in the industry, larger fulfillment infrastructure, significantly more marketing and other financial resources, and larger customers bases than we do. These factors may allow our competitions to achieve greater net sales and profits. The significant competition faced by the Company could have a material adverse effect on its business, operating results and financial condition.

 

If we are unable to protect our intellectual property, our business may be adversely affected.

 

There can be no assurance that trade secrets and other intellectual property will not be challenged, invalidated, misappropriated or circumvented by third parties. Currently, our intellectual property includes provisional patents, patent applications, trademarks, trademark applications and know-how related to business, product and technology development. We plan on taking the necessary steps, including but not limited to the filing of additional patents as appropriate. There is no assurance any additional patents will issue or that when they do issue they will include all of the claims currently included in the applications. Even if they do issue, those new patents and our existing patents must be protected against possible infringement. Nonetheless, we currently rely on contractual obligations of our employees and contractors to maintain the confidentiality of our products. To compete effectively, we need to develop and continue to maintain a proprietary position with respect to our technologies, and business. The risks and uncertainties that we face with respect to intellectual property rights principally include the following:

 

  ● Provisional protection may not result in full patents being granted, and any full patent applications that we file may not result in issued patents or may take longer than expected to result in issued patents;
     
  ● we may be subject to interference proceedings;
     
  ● other companies may claim that patents applied for by, assigned or licensed to, us infringe upon their own intellectual property rights;
     
  ● we may be subject to trademark opposition proceedings in the U.S. and in foreign countries;

 

17

 

 

  ● any patents that are issued to us may not provide meaningful protection;
     
  ● we may not be able to develop additional proprietary technologies that are patentable;
     
  ● other companies may challenge patents licensed or issued to us as invalid, unenforceable or not infringed;
     
  ● other companies may independently develop similar or alternative technologies, or duplicate our technologies;
     
  ● other companies may design around technologies that we have licensed or developed;
     
  ● any patents issued to us may expire and competitors may utilize the technology found in such patents to commercialize their own products; and
     
  ● enforcement of patents is complex, uncertain and expensive.

 

It is also possible that others may obtain issued patents that could prevent us from commercializing certain aspects of our products or require us to obtain licenses requiring the payment of significant fees or royalties in order to enable us to conduct our business. If we license patents, our rights will depend on maintaining our obligations to the licensor under the applicable license agreement, and we may be unable to do so. Furthermore, there can be no assurance that the work-for-hire, intellectual property assignment and confidentiality agreements entered into by our employees and consultants, advisors and collaborators will provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use or disclosure of such trade secrets, know- how or other proprietary information. The scope and enforceability of patent claims are not systematically predictable with absolute accuracy. The strength of our own patent rights depends, in part, upon the breadth and scope of protection provided by the patent and the validity of our patents, if any.

 

We operate in an industry with the risk of intellectual property litigation. Claims of infringement against us may hurt our business.

 

Our success depends, in part, upon non-infringement of intellectual property rights owned by others and being able to resolve claims of intellectual property infringement without major financial expenditures or adverse consequences. Participants that own, or claim to own, intellectual property may aggressively assert their rights. From time to time, we may be subject to legal proceedings and claims relating to the intellectual property rights of others. Future litigation may be necessary to defend us or our clients by determining the scope, enforceability, and validity of third-party proprietary rights or to establish its proprietary rights. Some competitors have substantially greater resources and are able to sustain the costs of complex intellectual property litigation to a greater degree and for longer periods of time. In addition, patent holding companies that focus solely on extracting royalties and settlements by enforcing patent rights may target us. Regardless of whether claims that we are infringing patents or other intellectual property rights have any merit, these claims are time-consuming and costly to evaluate and defend and could:

 

  ● adversely affect relationships with future clients;
     
  ● cause delays or stoppages in providing products;
     
  ● divert management’s attention and resources;
     
  ● require technology changes to our platform that would cause our Company to incur substantial cost;
     
  ● subject us to significant liabilities; and
     
  ● require us to cease some or all business activities.

 

18

 

 

In addition to liability for monetary damages, which may be tripled and may include attorneys’ fees, or, in some circumstances, damages against clients, we may be prohibited from developing, commercializing, or continuing to provide some or all of our products unless we obtain licenses from, and pay royalties to, the holders of the patents or other intellectual property rights, which may not be available on commercially favorable terms, or at all.

 

We have limited foreign intellectual property rights and may not be able to protect our intellectual property rights throughout the world.

 

We have limited intellectual property rights outside the United States. Filing, prosecuting and defending patents on devices in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property to the same extent as laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patents to develop their own products and further, may export otherwise infringing products to territories where we have patents, but enforcement is not as strong as that in the United States.

 

Many companies have encountered significant problems in protecting and defending intellectual property in foreign jurisdictions. The legal systems of certain countries, particularly China and certain other developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. To date, we have not sought to enforce any issued patents in these foreign jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. The requirements for patentability may differ in certain countries, particularly developing countries. Certain countries in Europe and developing countries, including China and India, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In those countries, we and our licensors may have limited remedies if patents are infringed or if we or our licensors are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.

 

If we are unable to obtain or defend our patents, our business could be materially adversely affected.

 

Our patent position is highly uncertain and involves complex legal and factual questions. Accordingly, we cannot predict the breadth of claims that may be allowed or enforced under our patents or in third-party patents. For example, we might not have been the first to make the inventions covered by each of our pending patent applications and provisional patents; we might not have been the first to file patent applications for these inventions; others may independently develop similar or alternative technologies or duplicate any of our technologies; it is possible that none of our pending patent applications will result in issued patents; our issued patents may not provide a basis for commercially viable technologies, or may not provide us with any competitive advantages, or may be challenged and invalidated by third parties; and, we may not develop additional proprietary technologies that are patentable.

 

As a result, our owned and licensed patents may not be valid and we may not be able to obtain and enforce patents and to maintain trade secret protection for the full commercial extent of our technology. The extent to which we are unable to do so could materially harm our business.

 

We have applied for and will continue to apply for patents for certain products. Such applications may not result in the issuance of any patents, and any patents now held or that may be issued may not provide us with adequate protection from competition. Furthermore, it is possible that patents issued or licensed to us may be challenged successfully. In that event, if we have a preferred competitive position because of such patents, such preferred position would be lost. If we are unable to secure or to continue to maintain a preferred position, we could become subject to competition from the sale of generic products. Failure to receive, inability to protect, or expiration of our patents would adversely affect our business and operations.

 

19

 

 

Patents issued or licensed to us may be infringed by the products or processes of others. The cost of enforcing our patent rights against infringers, if such enforcement is required, could be significant, and we do not currently have the financial resources to fund such litigation. Further, such litigation can go on for years and the time demands could interfere with our normal operations. We may become a party to patent litigation and other proceedings. The cost to us of any patent litigation, even if resolved in our favor, could be substantial. Many of our competitors may be able to sustain the costs of such litigation more effectively than we can because of their substantially greater financial resources. Litigation may also absorb significant management time.

 

Unpatented trade secrets, improvements, confidential know-how and continuing technological innovation are important to our scientific and commercial success. Although we attempt to and will continue to attempt to protect our proprietary information through reliance on trade secret laws and the use of confidentiality agreements with our partners, collaborators, employees and consultants, as well as through other appropriate means, these measures may not effectively prevent disclosure of our proprietary information, and, in any event, others may develop independently, or obtain access to, the same or similar information.

 

International intellectual property protection is particularly uncertain, and if we are involved in opposition proceedings in foreign countries, we may have to expend substantial sums and management resources.

 

Patent and other intellectual property law outside the United States is more uncertain and is continually undergoing review and revisions in many countries. Further, the laws of some foreign countries may not protect intellectual property rights to the same extent as the laws of the United States. For example, certain countries do not grant patent claims that are directed to business methods and processes. In addition, we may have to participate in opposition proceedings to determine the validity of its foreign patents or its competitors’ foreign patents, which could result in substantial costs and diversion of its efforts and loss of credibility with customers.

 

If we are found to be infringing on patents or trade secrets owned by others, we may be forced to cease or alter our product development efforts, obtain a license to continue the development or sale of our products, and/or pay damages.

 

Our processes and potential products may violate proprietary rights of patents that have been or may be granted to competitors, universities or others, or the trade secrets of those persons and entities. As our industry expands and more patents are issued, the risk increases that our processes and potential products may give rise to claims that they infringe the patents or trade secrets of others. These other persons could bring legal actions against us claiming damages and seeking to enjoin manufacturing and marketing of the affected product or process. If any of these actions are successful, in addition to any potential liability for damages, we could be required to obtain a license in order to continue to manufacture or market the affected product or use the affected process. Required licenses may not be available on acceptable terms, if at all, and the results of litigation are uncertain. If we become involved in litigation or other proceedings, it could consume a substantial portion of our financial resources and the efforts of our personnel.

 

We rely on confidentiality agreements to protect our trade secrets. If these agreements are breached by our employees or other parties, our trade secrets may become known to our competitors.

 

We rely on trade secrets that we seek to protect through confidentiality agreements with our employees and other parties. If these agreements are breached, our competitors may obtain and use our trade secrets to gain a competitive advantage over us. We may not have any remedies against our competitors and any remedies that may be available to us may not be adequate to protect our business or compensate us for the damaging disclosure. In addition, we may have to expend resources to protect our interests from possible infringement by others.

 

20

 

 

We have a limited operating history on which to judge our business prospects and management.

 

Our company was incorporated and commenced operations in 2017. Accordingly, we have only a limited operating history upon which to base an evaluation of our business and prospects. Operating results for future periods are subject to numerous uncertainties and we cannot assure you that we will achieve or sustain profitability. Our prospects must be considered in light of the risks encountered by companies in the early stage of development, particularly companies in new and rapidly evolving markets. Future operating results will depend upon many factors, including increasing the number of affiliates, our success in attracting and retaining motivated and qualified personnel, our ability to establish short term credit lines, our ability to develop and market new products, control costs, and general economic conditions. We cannot assure you that we will successfully address any of these risks.

 

We may not be able to continue as a going concern.

 

The Company has incurred substantial operating losses since its inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As reflected in the financial statements, the Company had an accumulated deficit of approximately $32.8 million at December 31, 2022, a net loss of approximately $12.9 million, and approximately $12.1 million of net cash used in operating activities for the year ended December 31, 2022. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company anticipates incurring additional losses until such time, if ever, that it can obtain marketing approval to sell, and then generate significant sales, of its technology that is currently in development. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is seeking additional financing to support its growth plans. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to currently outstanding common shares.

 

Our management team will be required to devote substantial time to regulatory compliance which may divert our attention from the day-to-day management of our business.

 

Our management team will require substantial attention from our senior management and could divert our attention away from the day-to-day management of our business. Regulatory compliance is increasingly complex and management may not have experience in all areas of public company compliance. The management team will seek assistance from external resources when appropriate for public company regulatory compliance and tax regulatory compliance for applicable jurisdictions.

 

The Company may become subject to litigation, which may have a material adverse effect on the Company’s reputation, business, results from operations, and financial condition.

 

The Company may be named as a defendant in a lawsuit or regulatory action. The Company may also incur uninsured losses for liabilities which arise in the ordinary course of business, or which are unforeseen, including, but not limited to, employment liability and business loss claims. Any such losses could have a material adverse effect on the Company’s business, results of operations, sales, cash flow or financial condition.

 

If the Company is unable to attract and retain key personnel, it may not be able to compete effectively.

 

The Company’s success has depended and continues to depend upon its ability to attract and retain key management, including the Company’s Chief Executive Officer and technical experts. The Company will attempt to enhance its management and technical expertise by continuing to recruit qualified individuals who possess desired skills and experience in certain targeted areas. The Company’s inability to retain employees and attract and retain sufficient additional employees or engineering and technical support resources could have a material adverse effect on the Company’s business, results of operations, sales, cash flow or financial condition. Shortages in qualified personnel or the loss of key personnel could adversely affect the financial condition of the Company, results of operations of the business and could limit the Company’s ability to develop and market its intellectual property. The loss of any of the Company’s senior management or key employees could materially adversely affect the Company’s ability to execute the Company’s business plan and strategy, and the Company may not be able to find adequate replacements on a timely basis, or at all. The Company does not maintain key person life insurance policies on any of the Company’s employees.

 

21

 

 

The size of the Company’s initial target market is difficult to quantify and investors will be reliant on their own estimates on the accuracy of market data.

 

Because high growth crop technology is in an early stage with uncertain boundaries, there is a lack of information about comparable companies available for potential investors to review in deciding about whether to invest in the Company and, few, if any, established companies whose business model the Company can follow or upon whose success the Company can build. Accordingly, investors will have to rely on their own estimates in deciding about whether to invest in the Company. There can be no assurance that the Company’s estimates are accurate or that the market size is sufficiently large for its business to grow as projected, which may negatively impact its financial results. The Company regularly follows market research.

 

The Company’s industry is experiencing rapid growth and consolidation that may cause the Company to lose key relationships and intensify competition.

 

The agriculture industry and various verticals within it are undergoing rapid growth and substantial change, which has resulted in an increase in competitors, consolidation and formation of strategic relationships. Acquisitions or other consolidating transactions could harm the Company in a number of ways, including by losing strategic partners and or customers if they are acquired by or enter into relationships with a competitor, losing customers, revenue and market share, or forcing the Company to expend greater resources to meet new or additional competitive threats, all of which could harm the Company’s operating results. As competitors enter the market and become increasingly sophisticated, competition in the Company’s industry may intensify which could negatively impact its profitability.

 

The Company will be reliant on information technology systems and may be subject to damaging cyberattacks.

 

The Company’s operations depend, in part, on how well it and its suppliers protect networks, equipment, information technology systems and software against damage from a number of threats, including, but not limited to, cable cuts, damage to physical plants, natural disasters, intentional damage and destruction, fire, power loss, hacking, computer viruses, vandalism and theft. The Company’s operations also depend on the timely maintenance, upgrade and replacement of networks, equipment, IT systems and software, as well as pre-emptive expenses to mitigate the risks of failures. Any of these and other events could result in information system failures, delays and/or increase in capital expenses. The failure of information systems or a component of information systems could, depending on the nature of any such failure, adversely impact the Company’s reputation and results of operations.

 

The Company has not experienced any material losses to date relating to cyber-attacks or other information security breaches, but there can be no assurance that the Company will not incur such losses in the future. The Company’s risk and exposure to these matters cannot be fully mitigated because of, among other things, the evolving nature of these threats. As a result, cyber security and the continued development and enhancement of controls, processes and practices designed to protect systems, computers, software, data and networks from attack, damage or unauthorized access is a risk. As cyber threats continue to evolve, the Company may be required to expend additional resources to continue to modify or enhance protective measures or to investigate and remediate any security vulnerabilities.

 

22

 

 

The Company’s officers and directors may be engaged in a range of business activities resulting in conflicts of interest.

 

Although certain officers and board members of the Company are expected to be bound by anti-circumvention agreements limiting their ability to enter into competing and/or conflicting ventures or businesses, the Company may be subject to various potential conflicts of interest because some of its officers and directors may be engaged in a range of business activities. In addition, the Company’s executive officers and directors may devote time to their outside business interests, so long as such activities do not materially or adversely interfere with their duties to the Company. In some cases, the Company’s executive officers and directors may have fiduciary obligations associated with these business interests that interfere with their ability to devote time to the Company’s business and affairs and that could adversely affect the Company’s operations. These business interests could require significant time and attention of the Company’s executive officers and directors.

 

In addition, the Company may also become involved in other transactions which conflict with the interests of its directors and the officers who may from time to time deal with persons, firms, institutions or companies with which the Company may be dealing, or which may be seeking investments similar to those desired by it. The interests of these persons could conflict with those of the Company. In addition, from time to time, these persons may be competing with the Company for available investment opportunities. Conflicts of interest, if any, will be subject to the procedures and remedies provided under applicable laws. In particular, if such a conflict of interest arises at a meeting of the Company’s directors, a director who has such a conflict will abstain from voting for or against the approval of such participation or such terms. In accordance with applicable laws, the directors of the Company are required to act honestly, in good faith and in the best interests of the Company.

 

There is no guarantee that how the Company uses its available funds will yield the expected results or returns which could impact the business and financial condition of the Company.

 

The Company cannot specify with certainty the particular uses of available funds. Management has broad discretion in the application of its proceeds. Accordingly, a holder of shares will have to rely upon the judgment of management with respect to the use of available funds, with only limited information concerning management’s specific intentions. The Company’s management may spend a portion or all of the available funds in ways that the Company’s shareholders might not desire, that might not yield a favorable return and that might not increase the value of a purchaser’s investment. The failure by management to apply these funds effectively could harm the Company’s business. Pending use of such funds, the Company might invest the available funds in a manner that does not produce income or that loses value.

 

Our Articles of incorporation, by-laws and certain Canadian legislation, contain provisions that may have the effect of delaying or preventing a change in control.

 

Certain provisions of our by-laws, together or separately, could discourage potential acquisition proposals, delay or prevent a change in control and limit the price that certain investors may be willing to pay for our common shares. For instance, our by-laws contain provisions that establish certain advance notice procedures for nomination of candidates for election as directors at shareholders’ meetings.

 

The Investment Canada Act requires any person that is non-Canadian (as defined in the Investment Canada Act) who acquires “control” (as defined in the Investment Canada Act) of an existing Canadian business to file either a pre-closing application for review or notification with Innovation, Science and Economic Development Canada. An acquisition of control is a reviewable transaction where prescribed financial thresholds are exceeded. The Investment Canada Act generally prohibits the implementation of a reviewable transaction unless, after review, the relevant Minister is satisfied that the acquisition is likely to be of net benefit to Canada. Under the national security regime in the Investment Canada Act, the federal government may undertake a discretionary review of a broader range of investments by a non-Canadian to determine whether such an investment by a non-Canadian could be “injurious to national security.” Review on national security grounds is at the discretion of the federal government and may occur on a pre- or post-closing basis.

 

23

 

 

Furthermore, limitations on the ability to acquire and hold our common shares may be imposed by the Competition Act (Canada). This legislation permits the Commissioner of Competition to review any acquisition or establishment, directly or indirectly, including through the acquisition of shares, of control over or of a significant interest in us. This legislation grants the Commissioner of Competition jurisdiction, for up to one year, to challenge this type of acquisition before the Canadian Competition Tribunal on the basis that it would, or would be likely to, substantially prevent or lessen competition. This legislation also requires any person who intends to acquire our common shares to file a notification with the Canadian Competition Bureau if (i) that person (and their affiliates) would hold, in the aggregate, more than 20% of all of our outstanding voting shares, (ii) certain financial thresholds are exceeded, and (iii) no exemption applies. Where a person (and their affiliates) already holds, in the aggregate, more than 20% of all of our outstanding voting shares, a notification must be filed if (i) the acquisition of additional shares would bring that person’s (and their affiliates) holdings to over 50%, (ii) certain financial thresholds are exceeded and (iii) no exemption applies. Where a notification is required, the legislation prohibits completion of the acquisition until the expiration of the applicable statutory waiting period, unless compliance with the waiting period has been waived or the Commissioner of Competition provides written notice that he does not intend to challenge the acquisition. The Commissioner of Competition’s review of a notifiable transaction for substantive competition law considerations may take longer than the statutory waiting period.

 

We are governed by the corporate laws of British Columbia, Canada which in some cases have a different effect on shareholders than the corporate laws of the United States.

 

We are incorporated under the Business Corporations Act (British Columbia) (the “BC Act”) and other relevant laws, which may affect the rights of shareholders differently than those of a company governed by the laws of a U.S. jurisdiction, and may, together with our charter documents, have the effect of delaying, deferring or discouraging another party from acquiring control of our company by means of a tender offer, a proxy contest or otherwise, or may affect the price an acquiring party would be willing to offer in such an instance. The material differences between the BC Act and Delaware General Corporation Law (“DGCL”) that may have the greatest such effect include, but are not limited to, the following: (i) for certain corporate transactions (such as mergers and amalgamations or amendments to our articles) the BC Act generally requires the voting threshold to be a special resolution approved by 66 2/3% of shareholders, or as set out in the articles, as applicable, whereas DGCL generally only requires a majority vote; and (ii) under the BC Act a holder of 5% or more of our common shares can requisition a special meeting of shareholders, whereas such right does not exist under the DGCL. We cannot predict whether investors will find our company and our common shares less attractive because we are governed by foreign laws.

 

Risks Related to the Ownership of Our Common Shares

 

New laws, regulations, and standards relating to corporate governance and public disclosure may create uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time consuming.

 

These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, may evolve over time as new guidance is provided by the courts and other bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.

 

As a public company subject to these rules and regulations, we may find it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of our Board of Directors, particularly to serve on its audit committee and compensation committee, and qualified executive officers.

 

24

 

 

The market price of our common shares and Series A Warrants may be volatile, and you may not be able to resell your common shares and Series A Warrants at or above the acquisition price.

 

The market price for our common shares and Series A Warrants may be volatile and subject to wide fluctuations in response to factors including the following:

 

  ● actual or anticipated fluctuations in our quarterly or annual operating results;
     
  ● changes in financial or operational estimates or projections;
     
  ● conditions in markets generally;
     
  ● changes in the economic performance or market valuations of companies similar to ours;
     
  ● general economic or political conditions in the United States or elsewhere;
     
  ● any delay in development of our products or services;
     
  ● failure to comply with regulatory requirements;
     
  ● inability to commercially launch products and services and market and generate sales of our products and services,
     
  ● developments or disputes concerning intellectual property rights;
     
  ● our or our competitors’ technological innovations;
     
  ● general and industry-specific economic conditions that may affect our expenditures;
     
  ● changes in market valuations of similar companies;
     
  ● announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, joint ventures, capital commitments, new technologies, or patents;
     
  ● future sales of our common shares or other securities, including shares issuable upon the exercise of outstanding warrants or convertible securities or otherwise issued pursuant to certain contractual rights;
     
  ● period-to-period fluctuations in our financial results; and
     
  ● low or high trading volume of our common shares due to many factors, including the terms of our financing arrangements.

 

In addition, if we fail to reach an important research, development or commercialization milestone or result by a publicly expected deadline, even if by only a small margin, there could be significant impact on the market price of our common shares. Additionally, as we approach the announcement of anticipated significant information and as we announce such information, we expect the price of our common shares to be particularly volatile and negative results would have a substantial negative impact on the price of our common shares and Series A Warrants.

 

In addition, in recent years, the stock market in general has experienced extreme price and volume fluctuations. This volatility has had a significant effect on the market price of securities issued by many companies, including for reasons unrelated to their operating performance. These broad market fluctuations may adversely affect our stock price, notwithstanding our operating results. The market price of our common shares and Series A Warrants will fluctuate and there can be no assurances about the levels of the market prices for our common shares and Series A Warrants.

 

In some cases, following periods of volatility in the market price of a company’s securities, shareholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our business operations and reputation.

 

25

 

 

As an “emerging growth company” under applicable law, we will be subject to lessened disclosure requirements, which could leave our shareholders without information or rights available to shareholders of more mature companies.

 

For as long as we remain an “emerging growth company” as defined in the JOBS Act, we have elected to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to:

 

  ● not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act;
     
  ● being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced “Management’s Discussion and Analysis of Financial Condition and Results of Operations” disclosure;
     
  ● reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements;
     
  ● taking advantage of an extension of time to comply with new or revised financial accounting standard; and
     
  ● exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

We expect to take advantage of these reporting exemptions until we are no longer an “emerging growth company.” Because of these lessened regulatory requirements, our shareholders would be left without information or rights available to shareholders of more mature companies. We cannot predict whether investors will find our common shares less attractive if we rely on these exemptions. If some investors find our common shares less attractive as a result, there may be a less active trading market for our common shares and our stock price may be more volatile.

 

We are also a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act and have elected to follow certain scaled disclosure requirements available to smaller reporting companies.

 

Because we have elected to use the extended transition period for complying with new or revised accounting standards for an “emerging growth company” our financial statements may not be comparable to companies that comply with public company effective dates.

 

We have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(1) of the JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates and may contain less or more modified disclosure than those public companies. Because our financial statements may not be comparable to companies that comply with public company effective dates, investors may have difficulty evaluating or comparing our business, performance or prospects in comparison to other public companies, which may have a negative impact on the value and liquidity of our common shares.

 

FINRA sales practice requirements may also limit your ability to buy and sell our common shares, which could depress the price of our shares.

 

Financial Industry Regulatory Authority, Inc. (FINRA) rules require broker-dealers to have reasonable grounds for believing that an investment is suitable for a customer before recommending that investment to the customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status and investment objectives, among other things. Under interpretations of these rules, FINRA believes that there is a high probability such speculative low-priced securities will not be suitable for at least some customers. Thus, FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common shares, which may limit your ability to buy and sell our shares, have an adverse effect on the market for our shares, and thereby depress our share price.

 

26

 

 

If research analysts do not publish research about our business or if they issue unfavorable commentary or downgrade our common shares or Series A Warrants, our securities’ price and trading volume could decline.

 

The trading market for our securities may depend in part on the research and reports that research analysts publish about us and our business. If we do not maintain adequate research coverage, or if any of the analysts who cover us downgrade our stock or publish inaccurate or unfavorable research about our business, the price of our common shares and Series A Warrants could decline. If one or more of our research analysts ceases to cover our business or fails to publish reports on us regularly, demand for our securities could decrease, which could cause the price of our common shares and Series A Warrants or trading volume to decline.

 

We may issue additional equity securities, or engage in other transactions that could dilute our book value or relative rights of our common shares, which may adversely affect the market price of our common shares and Series A Warrants.

 

Our Board of Directors may determine from time to time that it needs to raise additional capital by issuing additional shares of our common shares or other securities. Except as otherwise described in this filing, we will not be restricted from issuing additional common shares, including securities that are convertible into or exchangeable for, or that represent the right to receive common shares. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, or nature of any future offerings, or the prices at which such offerings may be affected. Additional equity offerings may dilute the holdings of existing shareholders or reduce the market price of our common shares and Series A Warrants, or all of them. Holders of our securities are not entitled to pre-emptive rights or other protections against dilution. New investors also may have rights, preferences and privileges that are senior to, and that adversely affect, then-current holders of our securities. Additionally, if we raise additional capital by making offerings of debt or preference shares, upon our liquidation, holders of our debt securities and preference shares, and lenders with respect to other borrowings, may receive distributions of its available assets before the holders of our common shares.

 

An investment in our Series A Warrants is speculative in nature and could result in a loss of your investment therein.

 

The Series A Warrants do not confer any rights of common share ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire shares of our common shares at a fixed price for a limited period of time. Specifically, commencing on the date of issuance, holders of the Series A Warrants may exercise their right to acquire the common shares and pay an exercise price of $6.00 per share, prior to three years from the date of issuance, after which date any unexercised Series A Warrants will expire and have no further value. Moreover, the market value of the Series A Warrants is uncertain and there can be no assurance that the market value of the Series A Warrants will equal or exceed their initial price. There can be no assurance that the market price of the common shares will ever equal or exceed the exercise price of the Series A Warrants, and consequently, whether it will ever be profitable for holders of the Series A Warrants to exercise the Series A Warrants.

 

Our Series A Warrants and contain a provision which only permits securities claims to be brought in federal court.

 

Section 11 of our Series A Warrants states in relevant part: “The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan (except for claims brought under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, which must be brought in federal court)”. Therefore any claims with respect to our Series A Warrants brought under the Securities Act of 1933 or the Securities Exchange Act must be brought in federal court while all other claims may be brought in federal or state court. Proceedings in federal court may be more expensive than in state court due to more comprehensive rules on how discovery and motion and trial practice are handled. This provision may have a dampening effect on claims brought under these securities laws or limit the ability of the investor to bring a claim in the jurisdiction it deems more favorable. This provision is likely enforceable as requirements regarding bringing securities claims have been met, but it may have the overall effect of discouraging litigation due to the circumstances described herein.

 

27

 

 

We do not currently intend to pay dividends on our common shares in the foreseeable future, and consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common shares.

 

We have never declared or paid cash dividends on our common shares and do not anticipate paying any cash dividends to holders of our common shares in the foreseeable future. Consequently, investors must rely on sales of their common shares after price appreciation, which may never occur, as the only way to realize any future gains on their investments. There is no guarantee that our common shares will appreciate in value or even maintain the price at which our shareholders have purchased their shares.

 

Item 1B. Unresolved Staff Comments

 

None.

 

Item 2. Properties

 

The Company currently leases office space at 2233 Colombia Street, Suite 300, Vancouver, B.C., V5Y 0M6 as its principal office. The Company believes the offices are in good condition and satisfy its current operational requirements.

 

Item 3. Legal Proceedings

 

We are subject to the legal proceeding and claims described in detail in “Note 17. Commitments and Contingencies” to the audited financial statements included in this Annual Report on Form 10-K. Although the results of litigation and claims cannot be predicted with certainty, as of the date of this Annual Report on Form 10-K, we do not believe the outcome of such legal proceeding and claims, if determined adversely to us, would be reasonably expected to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

28

 

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market information

 

Our common stock is currently quoted on Nasdaq Capital Market under the symbol “AGRI”, and warrants under the symbol “AGRIW”. Trading in our common stock has historically lacked consistent volume, and the market price has been volatile.

 

On March 13, 2023, the closing price for our common stock as reported on the Nasdaq Capital Market was $0.87 per share.

 

Securities outstanding and holders of record

 

On March 13, 2023, there were approximately 305 shareholders of record for our common stock and 18,156,154 shares of our common stock issued and outstanding.

 

Dividend Policy

 

We have never paid any cash dividends on our common shares. However, we have paid common share dividends on our preferred stock. Our preferred stock was retired and there were no preferred shares outstanding after the IPO. We anticipate that we will retain funds and future earnings to support operations and to finance the growth and development of our business. Therefore, we do not expect to pay cash dividends on our common shares in the foreseeable future following this offering. Any future determination to pay cash dividends on our common shares will be at the discretion of our Board of Directors and will depend on our financial condition, results of operations, capital requirements and other factors that our Board of Directors deems relevant. In addition, the terms of any future debt or credit financings may preclude us from paying dividends.

 

Information respecting equity compensation plans

 

The Company adopted a stock option plan originally on December 12, 2018 (the “Option Plan”), as amended, under which the compensation committee of the Board (the “Compensation Committee”) may from time to time in its discretion, recommend changes to the Option Plan to grant to directors, officers, employees and consultants of the Company non-transferable options to purchase common shares (“Options”). The Board of Directors review recommendations and approve changes. As of the date of this filling, the Company has 1,382,629 Options outstanding. The Option Plan was approved by the shareholders of the Company on June 10, 2019.

 

The following table provides information with respect to options outstanding under our Plan as at December 31, 2022:

 

Plan category  Number of securities to be issued upon exercise of outstanding options    

Weighted-

average exercise price of

outstanding options

   Number of securities remaining available for future issuance  
                  
Equity compensation plans approved by security holders   1,382,629   $3.30    431,986 
Equity compensation plans not approved by security holders    -    -    - 
Total   1,382,629   $3.30    431,986 

 

Recent Sales of Unregistered Securities

 

The Company had the following sales of unregistered securities during the year ended December 31, 2022:

 

   # of shares   Amount 
Common shares issued for bonuses and compensation   266,765   $520,230 
Common shares issued for conversion of convertible debt   67,568    131,532 
Common shares issued to consultants   284,767    853,457 
Total common shares issued   619,100   $1,505,219 

 

29

 

 

The Company had the following sales of unregistered securities from January 1, 2023 to March 13, 2023:

 

   # of shares   Amount 
Common shares issued for conversion of vested prefunded warrants   1,637,049   $2,959,108 
Common shares issued for conversion of convertible debt   71,807    1,038,073 
Common shares issued to consultants   12,500    26,000 
Total common shares issued   2,360,356   $4,023,181 

 

Purchases of Equity Securities by the Issuer or Affiliated Purchasers

 

There were no repurchases of shares of common stock made during the year ended December 31, 2022.

 

Item 6. Selected Financial Data

 

As a registrant that qualifies as a smaller reporting company, AgriFORCE™ is not required to provide the information required by this Item.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Prospective investors should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes and other financial information included elsewhere in this Annual Report. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements.” You should review the “Risk Factors” section of this Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

 

30

 

 

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Revenues

 

The Company has not generated any revenue since inception.

 

Operating Expenses

 

Operating expenses primarily consist of wages and salaries, professional fees, consulting, office and administration, investor and public relations, research and development, and share-based compensation. Operating expenses increased in the year ended December 31, 2022 by $6,727,450 as compared to December 31, 2021 primarily due to the following:

 

● Wages and salaries increased by $2,156,838 due to increased headcount for the Company’s expansion of operations including UN(THINK)™.
● Professional fees and consulting increased by $1,786,876 and $1,473,495, respectively due to increased legal and financial consulting services fees incurred for significant M&A activity.
● Office and administrative increased by $547,604 due to increase in operational costs from the Company’s operational growth, increased headcount, and public company insurance and administration costs.
● Investor and public relations expense increased by $159,087 due to increased Company campaigns during 2022 to increase Company awareness and provide information to the public.
● Sales and marketing increased by $387,130 to support the ramp up of UN(THINK)™. Costs include brand development, marketing campaigns, and other miscellaneous marketing costs.
● Share based compensation expense decreased by $375,426 due to previous issued options becoming fully vested during the 2022, decreasing the share based compensation recognized for graded vesting as well as lower market prices for 2022 option issuances.
● Travel and entertainment increased by $211,240 due to increase in international travel for expanded Company operations and M&A activity.
● Lease expense increased by $150,647 due to full year of Vancouver office lease for 2022. Vancouver office lease was entered into July 2021.
● Shareholder and regulatory expense increased by $77,988 due to increased costs for public company regulatory and shareholder expenses for the full 2022 year. The Company completed their listing on July 12, 2021, as such 2021 had increased expense for 6 months of 2021.
●

Other expenditures amount to an additional $151,971 between 2021 and 2022.

 

Research and Development

 

During the year ended December 31, 2022, the Company spent $615,693 as compared to $474,338 for the year ended December 31, 2021 in research and development costs in relation to the license agreement with Radical, the testing, nutrient, and micro analysis for UN(THINK)™ food product development, as well as costs of design and construction for the Coachella land and its future structure. The following represents the breakdown of research and development activities:

 

   December 31, 2022   December 31, 2021 
License agreement  $256,703   $- 
Product development   179,563    296,931 
Design and construction   179,427    177,407 
   $615,693   $474,338 

 

The increase in research and development expenses was due to product development costs for UN(THINK)™ food products.

 

Other (Income) / Expenses

 

Other income for the year ended December 31, 2022 increased due to the following:

 

● Change in fair value of derivative liabilities showed a larger gain by $2,528,486 due to decreased derivative liabilities fair values.
● Issuance cost related to warrants decreased by $374,465 due to no warrant issuance costs incurred during 2022.
● Foreign exchange gain increased by $127,103 due to an increase in USD to CAD foreign exchange rates compared to 2021.
● Gain on debt conversion of $93,973 (nil – 2021) from the conversion of $150,000 of convertible debentures into the Company’s common shares.
● Other income increased by $75,823 from interest earned on cash deposited into savings accounts during the year.
● Offset by an increase of accretion interest on debentures of $2,913,049 from the issuance of $14,025,000 in convertible debentures during the year.

 

31

 

 

Critical Accounting Policies and Estimates

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Fair value can be determined using a market approach, income approach or cost approach. The reversal of impairment losses is prohibited.

 

Equity-linked instruments

 

The fair value of the Company’s warrants is determined in accordance with FASB ASC 820, “Fair Value Measurement,” which establishes a fair value hierarchy that prioritizes the assumptions (inputs) to valuation techniques used to price assets or liabilities that are measured at fair value. The hierarchy, as defined below, gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The guidance for fair value measurements requires that assets and liabilities measured at fair value be classified and disclosed in one of the following categories:

 

● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities.
   
● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
   
● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which provides that if three criteria are met, the Company is required to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which;

 

(a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract;

(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur; and

(c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.”

 

The debenture conversion features are categorized as a Level 3 financial instrument. The Company utilized the Monte Carlo option-pricing for valuing the convertible features.

 

The Debenture Warrants are categorized as a Level 3 financial instrument. The Company utilized the Monte Carlo option-pricing model to value the Debenture Warrants.

 

The most subjective assumptions in such option pricing models include the implied volatility, expected term, risk-free rate and the probability of triggering the down-round provisions.

 

Share Based Compensation

 

The Company generally uses the straight-line method to allocate compensation cost to reporting periods over each optionee’s requisite service period, which is generally the vesting period, and estimates the fair value of stock-based awards to employees and directors using the Black-Scholes option-valuation model (the “Black-Scholes model”). .. This model incorporates certain assumptions for inputs including a risk-free market interest rate, expected dividend yield of the underlying common stock, expected option life, and expected volatility in the market value of the underlying common stock. The Company recognizes any forfeitures as they occur.

 

32
 

 

Income Taxes

 

Current tax expense is the expected tax payable on the taxable income for the period, using tax rates enacted at period-end.

 

Deferred tax assets, including those arising from tax loss carryforwards, requires management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted.

 

The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.

 

Liquidity and Capital Resources

 

The Company’s primary need for liquidity is to fund working capital requirements, capital expenditures, and for general corporate purposes. The Company’s ability to fund operations and make planned capital expenditures and debt service obligations depends on future operating performance and cash flows, which are subject to prevailing economic conditions, financial markets, business and other factors. We have recorded a net loss of $12,873,102 for the year ended December 31, 2022 compared to $6,643,116 for the year ended December 31, 2021; and recorded an accumulated deficit of $32,774,094 as of December 31, 2022 ($19,900,992 – December 31, 2021). Net cash used in operating activities for the year ended December 31, 2022 was $12,079,359 compared to $5,136,947 for year ended December 31, 2021.

 

We had $2,269,320 in cash as at December 31, 2022 as compared to $7,775,290 as at December 31, 2021.

 

Our future capital requirements will depend on many factors, including:

 

● the cost and timing of our regulatory activities, especially the process to obtain regulatory approval for our intellectual properties in the U.S. and foreign countries;
● the costs of R&D activities we undertake to further develop our technology;
● the costs of constructing our grow houses, including any impact of complications, delays, and other unknown events;
● the costs of commercialization activities, including sales, marketing and production;
● the costs of our M&A activity;
● the level of working capital required to support our growth; and
● our need for additional personnel, information technology or other operating infrastructure to support our growth and operations as a public company.

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company is at an early stage of development. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

For the next twelve months from issuance of these financial statements, the Company will seek to obtain additional capital through the sale of debt or equity financings or other arrangements to fund operations; however, there can be no assurance that the Company will be able to raise needed capital under acceptable terms, if at all. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to currently outstanding common shares. Issued debt securities may contain covenants and limit the Company’s ability to pay dividends or make other distributions to shareholders. If the Company is unable to obtain such additional financing, future operations would need to be scaled back or discontinued. Due to the uncertainty in the Company’s ability to raise capital, management believes that there is substantial doubt in the Company’s ability to continue as a going concern for twelve months from the issuance of these financial statements.

 

Cash Flows

 

The net cash used by operating activities for the year ended December 31, 2022 is attributable to a net loss of $12,873,102 due to operating costs which are mentioned above. The net loss was adjusted primarily by the following non-cash expenses:

 

● Amortization of debt issuance costs of $3,057,825 from the issuance of $14,025,000 convertible debentures during the year.
● Share issuances for consulting services and compensation as well as share-based compensation from vesting stock options of $760,162, $520,230 and $420,715, respectively due to increased business consulting and executive compensation.
● This was partially offset by a non-cash change in the fair value of derivative liabilities of $3,719,869 due to decreased securities prices.

 

For the year ended December 31, 2021 net cash used by operating activities was attributable to net loss of $6,643,116 owing to wages, consulting expenses, professional fees, research and development expenses and general administrative expenses. The net loss was adjusted primarily by the following non-cash expenses:

 

● Shared based compensation of $796,141; and
● Shares issued for consulting services amounting to $321,121.

 

33
 

 

During the year ended December 31, 2022, the net cash used in investing activities is related to the payment against acquisition of IP intangible asset of $500,000 and acquisition of equipment and leasehold improvements amounting to $104,986 due to increased staffing and office renovations, respectively. Comparatively, investing activity for the year ended December 31, 2021 mainly included payments for acquisition of IP assets amounting to $225,000 and payments for construction in progress of $744,191.

 

Cash provided by financing activities for the year ended December 31, 2022 represents net proceeds from debentures of $12,750,000. This was partially offset by financing costs of debentures of $1,634,894 and repayments of $2,805,000 as well as payment of $750,000 for the acquisition of an intangible asset. The net cash provided by financing activities for the year ended December 31, 2021 mainly represents cash proceeds from the IPO of $13,360,616, net of underwriting discount and issue costs, proceeds from issuance of senior secured debentures, net of transaction costs of $531,000, proceeds from exercise of warrants of $238,800, as well as proceeds from long-term loan of $15,932, which was offset by repayment of senior secured debentures of $750,000.

 

Recent Financings

 

On June 30, 2022, the Company entered into security purchase agreements with certain accredited investors for the purchase of $14,025,000 in principal amount of convertible debentures due December 31, 2024. On July 7, 2022, $12,750,000 of proceeds were received net of $1,275,000 in original issuance discount, less financing costs of $1,634,894.

 

On January 17 and 18, 2023, the investors purchased additional tranches of convertible debentures for the principal amount of $5,076,923 due July 17 and 18, 2025.

 

Off Balance Sheet Arrangements

 

None.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

 

As a registrant that qualifies as a smaller reporting company, AgriFORCE™ is not required to provide the information required by this Item.

 

34
 

 

Item 8. Financial Statements and Supplementary Data

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

AgriFORCE Growing Systems Ltd.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of AgriFORCE Growing Systems Ltd. (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of comprehensive loss, changes in shareholders’ equity and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Explanatory Paragraph – Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 2, the Company has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Explanatory Paragraph – Change in Accounting Principle

 

As discussed in Note 2 to the financial statements, the Company changed its method of accounting for leases in 2022 due to the adoption of ASU No. 2016-02, Leases (Topic 842), as amended, effective January 1, 2022, using the modified retrospective approach.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Marcum LLP  
Marcum llp  
   
We have served as the Company’s auditor since 2020  

 

Costa Mesa, CA

March 13, 2023

 

F-1

 

 

AGRIFORCE GROWING SYSTEMS LTD.

CONSOLIDATED BALANCE SHEETS

(Expressed in US dollars)

 

   Note   December 31, 2022   December 31, 2021 
             
ASSETS               
                
Current               
Cash        $2,269,320   $7,775,290 
Other receivable        48,941    32,326 
Prepaid expenses and other current assets   4    598,342    309,040 
Total current assets        2,916,603    8,116,656 
                
Non-current               
Property and equipment, net   5    121,672    40,971 
Intangible asset   7    13,089,377    1,477,237 
Operating lease right-of-use asset   16    1,540,748    - 
Lease deposit, non-current        -    50,608 
Construction in progress   6    2,092,533    2,079,914 
Land deposit    4    2,085,960    - 
Total assets       $21,846,893   $11,765,386 
                
LIABILITIES AND SHAREHOLDERS’ EQUITY               
                
Current               
Accounts payable and accrued liabilities   8   $1,147,739   $1,532,312 
Contingent consideration payable   7    -    753,727 
Debentures   9    3,941,916    - 
Lease liability – current   16    271,110    - 
Total current liabilities        5,360,765    2,286,039 
                
Non-current               
Deferred rent        -    12,954 
Lease liability – non-current   16    1,250,060    - 
Derivative liabilities   11    4,649,115    1,418,964 
Long term loan   10    44,300    47,326 
Total liabilities        11,304,240    3,765,283 
Commitments and contingencies   17    -    - 
                
Shareholders’ equity               
Common shares, no par value per share - unlimited shares authorized; 15,795,798 and 15,176,698 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively   12    27,142,762    25,637,543 
Additional paid-in-capital   12    16,816,695    2,203,343 
Obligation to issue shares   12    -    93,295 
Accumulated deficit        (32,774,094)   (19,900,992)
Accumulated other comprehensive loss        (642,710)   (33,086)
Total shareholders’ equity        10,542,653    8,000,103 
                
Total liabilities and shareholders’ equity       $21,846,893   $11,765,386 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-2

 

 

AGRIFORCE GROWING SYSTEMS LTD.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Expressed in US dollars)

For the years ended December 31, 2022 and 2021

 

   Note   2022   2021 
             
OPERATING EXPENSES               
Wages and salaries       $3,923,329   $1,766,491 
Professional fees        2,669,022    882,146 
Consulting        2,561,908    1,088,413 
Office and administrative        1,327,739    780,135 
Investor and public relations        907,436    748,349 
Research and development   15    615,693    474,338 
Share based compensation   12    420,715    796,141 
Sales and marketing        387,130    - 
Lease expense   16    318,962    168,315 
Travel and entertainment        280,838    69,598 
Shareholder and regulatory        221,083    143,095 
Depreciation   5    22,413    11,797 
Operating loss        (13,656,268)   (6,928,818)
                
OTHER EXPENSES / (INCOME)               
Foreign exchange gain        (290,079)   (162,976)
Gain on conversion of convertible debt   9    (93,973)   - 
Change in fair value of derivative liabilities   11    (3,719,869)   (1,191,383)
Accretion of interest on debentures   9    3,396,578    483,529 
Write-off of deposit        -    151,711 
Issuance cost related to warrants        -    374,465 
Loss on extension of debt term        -    58,952 
Other income        (75,823)   - 
                
Net loss        (12,873,102)   (6,643,116)
                
Dividend paid to preferred shareholders        -    735,932 
                
Net loss attributable to common shareholders        (12,873,102)   (7,379,048)
                
Other comprehensive loss               
Foreign currency translation        (609,624)   (152,140)
                
Comprehensive loss attributable to common shareholders       $(13,482,726)  $(7,531,188)
                
Basic and diluted net loss attributed to common share       $(0.71)  $(0.66)
                
Weighted average number of common shares outstanding – basic and diluted        18,080,318    11,164,311 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

AGRIFORCE GROWING SYSTEMS LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Expressed in US dollars, except share numbers)

 

    Note     # of Shares     Amount     # of Shares     Amount     capital     shares     Deficit     income (loss)     Equity  
          Common Shares     Series A Preferred Shares     Additional Paid-in-     Obligation to issue     Accumulated     Accumulated other comprehensive     Total Shareholders’  
    Note     # of Shares     Amount     # of Shares     Amount     capital     shares     Deficit     income (loss)     Equity  
Balance, December 31, 2020             8,441,617     $ 5,696,050       2,258,826     $ 6,717,873     $ 1,297,566     $ 94,885     $ (12,521,944 )   $ 119,054     $ 1,403,484  
Shares issued for cash             3,127,998       13,262,712       -       -       -       -       -       -       13,262,712  
Shares issued for conversion of series A Preferred Stock             2,258,826       6,717,873       (2,258,826 )     (6,717,873 )     -       -       -       -       -  
Shares issued on exercise of warrants             39,800       238,800       -       -       44,644       -       -       -       283,444  
Shares issued on cashless exercise of warrants             36,275       -       -       -       64,992       -       -       -       64,992  
Shares issued on exercise of options             7,018       9,123       -       -       -       -       -       -       9,123  
Shares issued on cashless exercise of options             820,029       -       -       -       -       -       -       -       -  
Shares issued for bonus and compensation             159,775       648,449       -       -       -       -       -       -       648,449  
Shares issued for consulting services             76,364       381,663       -       -       -       (1,590 )     -       -       380,073  
Share issued for settlement of accrued director’s fee             19,992       46,783       -       -       -       -       -       -       46,783  
Shares issued for dividend on Preferred shares             189,004       735,932       -       -       -       -       (735,932 )     -       -  
Share issue costs             -       (2,099,842 )     -       -       -       -       -       -       (2,099,842 )
Share based compensation             -       -       -       -       796,141       -       -       -       796,141  
Net loss             -       -       -       -       -       -       (6,643,116 )     -       (6,643,116  
Foreign currency translation             -       -       -       -       -       -       -       (152,140 )     (152,140 )
Balance, December 31, 2021             15,176,698     $ 25,637,543       -     $ -     $ 2,203,343     $ 93,295     $ (19,900,992 )   $ (33,086 )   $ 8,000,103  
Shares issued for conversion of convertible debt      9 & 12       67,568       131,532                                                       131,532  
Shares issued for bonus and compensation     12       266,765       520,230                                                       520,230  
Shares issued for consulting services     12       284,767       853,457                               (93,295 )                     760,162  
Share issued for settlement of accrued director’s fee                                                                                
Prefunded warrants issued     7                                       14,192,637                               14,192,637  
Share based compensation     12                                       420,715                               420,715  
Net loss                             -        -                        (12,873,102 )             (12,873,102 )
Foreign currency translation                                                                     (609,624 )     (609,624 )
Balance, December 31, 2022             15,795,798     $ 27,142,762       -      $ -      $ 16,816,695     $ -     $ (32,774,094 )   $ (642,710 )   $ 10,542,653  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

AGRIFORCE GROWING SYSTEMS LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Expressed in US Dollars)

For the years ended December 31, 2022 and 2021

 

    Note    2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES                  
Net loss for the year          $(12,873,102)  $(6,643,116)
Adjustments to reconcile net loss to net cash used in operating activities:                  
Depreciation     5     22,413    11,797 
Share based compensation     12     420,715    796,141 
Shares issued for consulting services     12     760,162    321,121 
Shares issued for compensation and bonuses     12     520,230    134,383 
Amortization of debt issuance costs     9     3,057,825    483,529 
Loss on extension of debt term           -    58,952 
Write-off of deposit           -    151,711 
Issuance cost related to warrants           -    374,465 
Change in fair value of derivative liabilities           (3,719,869)   (1,191,383)
Gain on debt conversion           (93,973)   - 
Changes in operating assets and liabilities:                  
Other receivables           (16,615)   (23,353)
Prepaid expenses and other current assets           (274,302)   (235,713)
Accounts payable and accrued liabilities           75,552    662,173 
Right-of-use asset           297,034    - 
Lease liabilities           (255,429)   - 
Lease deposit, non-current           -    (50,608)
Deferred rent           -    12,954 
Net cash used in operating activities           (12,079,359)   (5,136,947)
                   
CASH FLOWS FROM INVESTING ACTIVITIES                  
Acquisition of equipment and leasehold improvements           (104,986)   (25,522)
Payment against acquisition of intangibles     7     (500,000)   (225,000)
Return of deposit on purchase of land           20,000    - 
Deposit for purchase of land           -    (12,000)
Construction in progress           (55,028)   (744,191)
Net cash used in investing activities           (640,014)   (1,006,713)
                   
CASH FLOWS FROM FINANCING ACTIVITIES                  
Proceeds from debentures – net of discount           12,750,000    - 
Repayment of convertible debentures           (2,805,000)   - 
Financing costs of debentures           (1,634,894)   (69,000)
Payment for acquisition of intangible asset    

7

     

(750,000

)   

-

 
Proceeds from initial public offering           -    15,639,990 
Payment of IPO costs           -    (2,279,374)
Proceeds from exercise of warrants           -    238,800 
Proceeds from long term loan           -    15,932 
Proceeds from senior secured debentures - net           -    600,000 
Repayment of senior secured debentures           -    (750,000)
Proceeds from exercise of options           -    9,123 
Net cash provided by financing activities           7,560,106    13,405,471 
                   
Effect of exchange rate changes on cash           (346,703)   (139,931)
Change in cash           (5,505,970)   7,121,880 
Cash, beginning of year           7,775,290    653,410 
Cash, end of year          $2,269,320   $7,775,290 
                   
Supplemental cash flow information:                  
Cash paid during the period for interest         

$

338,753

   $

-

 
                   
Supplemental disclosure of non-cash investing and financing transactions                  
Initial fair value of warrants issued in connection with issuance of debentures          $4,080,958   $- 
Initial fair value of conversion feature of debentures           3,336,535    - 
Prefunded warrants issued related to intangible assets           12,106,677    - 
Prefunded warrants related to land deposit           2,085,960    - 
Shares issued for conversion of convertible debt           131,532    - 
Initial operating lease liability recognized under Topic 842           1,776,599    - 
Initial lease right-of-use asset recognized under Topic 842           1,837,782    - 
Initial fair value of warrants liability           -    374,028 
Preferred stock dividend paid in common shares           -    735,932 
Conversion of Series A preferred stock to common shares           -    6,717,873 
Unpaid amount related to intangible assets included in accrued expenses           -    500,000 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended December 31, 2022 and 2021

(Expressed in US Dollars, except where noted)

 

1. BUSINESS OVERVIEW

 

AgriFORCE Growing Systems Ltd. (“AgriFORCE™” of the “Company”) was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the Business Corporations Act (British Columbia) on December 22, 2017. The Company’s registered and records office address is at 300 – 2233 Columbia Street, Vancouver, British Columbia, Canada, V5Y 0M6.

 

The Company is an innovative agriculture-focused technology company that delivers reliable, financially robust solutions for high value crops through our proprietary facility design and automation Intellectual Property to businesses and enterprises globally through our AgriFORCE™ Solutions division (“Solutions”) and delivers nutritious food products through our AgriFORCE™ Brands division (“Brands”).

 

Solutions intends to operate in the plant based pharmaceutical, nutraceutical, and other high value crop markets using its unique proprietary facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops in a controlled environment(“FORCEGH+™”) The Company has designed FORCEGH+™ facilities to produce in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible whilst substantially eliminating the need for the use of pesticides and/or irradiation.

 

Brands is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and more nutritious solutions. We will market and commercialize both branded consumer product offerings and ingredient supply.

 

2. BASIS OF PREPARATION

 

Basis of Presentation

 

The accompanying consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.

 

Principal of Consolidation

 

Our consolidated financial statements include the accounts of our wholly owned subsidiaries. We consolidate variable interest entities (VIEs) when we have variable interests and are the primary beneficiary.

 

All inter-company balances and transactions have been eliminated on consolidation. These consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries:

 

Name of entity:   Country of Incorporation   Purpose   Date of Incorporation
AgriFORCE Growing Systems Ltd.   Canada   Parent Company   Dec 22, 2017
un(Think) Food Company Canada Ltd.*   Canada   Food Product Manufacturing   Dec 4, 2019
West Pender Holdings, Inc.   United States   Real Estate Holding and Development Company   Sep 1, 2018
AgriFORCE Investments Inc.   United States   Holding Company   Apr 9, 2019
West Pender Management Co.   United States   Management Advisory Services   Jul 9, 2019
AGI IP Co.   United States   Intellectual Property   Mar 5, 2020
un(Think) Food Company   United States   Food Product Manufacturing   June 20, 2022

 

* un(Think) Food Company Canada Ltd. changed its name from Daybreak AG Systems Ltd. on August 19, 2022.

 

F-6

 

 

un(Think) Food Company, a wholly owned subsidiary commenced operations in 2022 and their results are consolidated into the results of the Company.  

 

Functional and Reporting Currency

 

The functional currency for each entity included in these consolidated financial statements is the currency of the primary economic environment in which the entity operates. These consolidated financial statements are presented in United States dollars (“U.S. dollars”). Currency conversion to U.S. dollars is performed in accordance with ASC 830, Foreign Currency Matters.

 

Use of Estimates

 

The preparation of our financial statements in accordance with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Significant estimates reflected in these financial statements include, but are not limited to, accounting for share-based compensation, valuation of derivative liabilities, valuation of embedded conversion feature, going concern, impairment as well as depreciation method. Actual results could differ from these estimates and those differences could be material.

 

Going Concern

 

The Company has incurred substantial operating losses since its inception, and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As reflected in the financial statements, the Company had an accumulated deficit of approximately $32.8 million at December 31, 2022, a net loss of approximately $12.9 million, and approximately $12.1 million of net cash used in operating activities for the year ended December 31, 2022. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company anticipates incurring additional losses until such time, if ever, that it can obtain marketing approval to sell, and then generate significant sales, of its technology that is currently in development. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is seeking additional financing to support its growth plans. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to currently outstanding common shares.

 

F-7

 

 

3. SIGNIFICANT ACCOUNTING POLICIES

 

Cash

 

The Company’s cash consists of cash maintained in checking and interest-bearing accounts. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents. The Company held no cash equivalents as of December 31, 2022 and 2021.

 

Property and Equipment

 

Property and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company’s management. Property, plant and equipment are subsequently measured at cost less accumulated depreciation and impairment losses.

 

Depreciation is recognized on a straight-line basis to write down the cost less estimated residual value of computer equipment and furniture and fixtures. The following useful lives are applied:

 

Computer equipment   3 years
Furniture and fixtures   7 years
Leasehold improvements   Lower of estimated useful life or remaining lease term

 

Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets and are recognized in profit or loss within other income or other expenses.

 

Construction in progress includes construction progress payments, deposits, engineering costs, interest expense for debt financing on long-term construction projects and other costs directly related to the construction of the facilities. Expenditures are capitalized during the construction period and construction in progress is transferred to the relevant class of property and equipment when the assets are available for use, at which point the depreciation of the asset commences.

 

Definite Lived Intangible Asset

 

Definite lived intangible asset consists of a granted patent. Amortization is computed using the straight-line method over the estimated useful lives of the asset. Estimated useful lives of the granted patent is 20 years. Amortization expense is allocated to general and administrative expense. No amortization expense has been taken on the granted patent as it was available for use starting January 2023.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Fair value can be determined using a market approach, income approach or cost approach. The reversal of impairment losses is prohibited.

 

F-8

 

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which provides that if three criteria are met, the Company is required to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which;

 

(a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract;

(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur; and

(c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Leases

 

The Company determines at the inception of a contract if the arrangement is or contains a lease. A contract is or contains a lease if the contract gives the right to control the use of an identified asset for a period of time in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a right-of-use asset and a lease liability on the balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded on the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.

 

The Company’s contracts can contain both lease and non-lease components. The non-lease components may include maintenance, utilities, and other operating costs. The Company combines the lease and non-lease components of fixed costs in its leases as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of right-of-use assets and lease liabilities. These costs are expensed when the event determining the amount of variable consideration to be paid occurs.

 

Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of future lease payments over the expected lease term. The Company determines the present value of future lease payments by using its estimated secured incremental borrowing rate for that lease term as the interest rate implicit in the lease is not readily determinable. The Company estimates its incremental borrowing rate for each lease based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments over a similar term.

 

F-9

 

 

Revenue Recognition

 

The Company has not recorded any revenues since its inception. However, in the future, the Company expects to generate returns from any or all the revenue sources below from its customers:

 

● Rental income from facilities
● Sales revenue from nutritious food products
● Intellectual property income from the license of the facilities
● Management and advisory fees from management service contracts

 

On January 1, 2018, the Company early adopted ASU No. 2014-09, Revenue from Contracts with Customers and all related amendments (“ASC 606” or “the new revenue standard”). ASC 606 is a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new revenue standard is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 provides that an entity should apply the following steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The new revenue standard also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, and costs to obtain or fulfill contracts. The Company will apply ASC 606 prospectively to all contracts.

 

Loss per Common Share

 

The Company presents basic and diluted loss per share data for its common shares. Basic loss per common share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the year. The number of common shares used in the loss per shares calculation includes all outstanding common shares plus all common shares issuable for which there are no conditions to issue other than time. Diluted loss per common share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all potentially dilutive share equivalents, such as stock options and warrants and assumes the receipt of proceeds upon exercise of the dilutive securities to determine the number of shares assumed to be purchased at the average market price during the year.

 

Research and Development

 

Expenditure on research and development activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognized as expense when incurred.

 

Foreign Currency Transactions

 

The financial statements of the Company and its subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, shareholders’ equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries’ accounts are included in “Accumulated other comprehensive income” as equity in the consolidated balance sheets. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the reporting currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within non-operating expenses.

 

Fair value of Financial Instruments

 

The fair value of the Company’s accounts receivable, accounts payable and other current liabilities approximate their carrying amounts due to the relative short maturities of these items.

 

F-10

 

 

As part of the issuance of debentures on March 24, 2021 and June 30, 2022, the Company issued warrants having strike price denominated in U.S. Dollars. This creates an obligation to issue shares for a price that is not denominated in the Company’s functional currency and renders the warrants not indexed to the Company’s stock, and therefore, must be classified as a derivative liability and measured at fair value. On the same basis, the Series A Warrants and the representative warrants issued as part of the IPO are also classified as a derivative liability and measured at fair value.

 

The fair value of the Company’s warrants is determined in accordance with FASB ASC 820, “Fair Value Measurement,” which establishes a fair value hierarchy that prioritizes the assumptions (inputs) to valuation techniques used to price assets or liabilities that are measured at fair value. The hierarchy, as defined below, gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The guidance for fair value measurements requires that assets and liabilities measured at fair value be classified and disclosed in one of the following categories:

 

● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities.
   
● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
   
● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.

 

As of December 31, 2022, the Company’s warrant liability related to IPO warrants and representative’s warrant amounting to $275,115 (December 31, 2021 - $1,418,964) is reported at fair value and categorized as Level 1 inputs. The fair value of derivative liabilities related to the Debenture Warrants and Debenture Convertible Feature that were issued during the year amounted to $4,374,000 (December 31, 2021 - $nil) and were categorized as level 3 inputs. The Bridge Warrants that were issued and exercised in the year ended December 31, 2021 were also categorized as level 3 inputs. (See Note 9 and Note 11)

 

Income Taxes

 

Current tax expense is the expected tax payable on the taxable income for the period, using tax rates enacted at period-end.

 

Deferred tax assets, including those arising from tax loss carryforwards, requires management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted.

 

The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.

 

F-11

 

 

The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.

 

There were no material uncertain tax positions as of December 31, 2022 and 2021.

 

Share Based Compensation

 

The Company generally uses the straight-line method to allocate compensation cost to reporting periods over each optionee’s requisite service period, which is generally the vesting period, and estimates the fair value of stock-based awards to employees and directors using the Black-Scholes option-valuation model (the “Black-Scholes model”). .. This model incorporates certain assumptions for inputs including a risk-free market interest rate, expected dividend yield of the underlying common stock, expected option life, and expected volatility in the market value of the underlying common stock. The Company recognizes any forfeitures as they occur.

 

Recent Accounting Pronouncements

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Start-ups Act of 2012, (the “JOBS Act”). Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, for complying with new or revised accounting standards applicable to public companies. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize leases on balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.

 

The Company adopted ASC 842 as of January 1, 2022 using the optional transition method to apply the standard as of the effective date. Accordingly, previously reported financial statements, including footnote disclosures, have not been recast to reflect the application of the new standard to all comparative periods presented.

 

The new standard also provides practical expedients for an entity’s ongoing accounting as a lessee. The Company elected to utilize the practical expedient to not separate lease and non-lease components for its existing lease. The Company has also elected not to present short-term leases on the consolidated balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because the Company’s lease does not provide an implicit rate of return, it used its incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.

 

Adoption of the new lease standard on January 1, 2022 had a material impact on the Company’s consolidated financial statements. The most significant impacts related to the recognition of ROU assets of $1,776,599 and lease liabilities of $1,837,782 for operating leases on the consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The standard did not materially impact the Company’s consolidated statements of comprehensive loss and consolidated statement of cash flows.

 

In August 2020, the FASB issued ASU 2020-06 “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASU 2020-06”). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted “Earnings per share” under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. ASC 2020-06 is effective for emerging growth companies for fiscal years beginning after December 15, 2023. We are currently assessing the impact this guidance will have on our financial statements.

 

F-12

 

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” The standard, including subsequently issued amendments, requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and requires the modified retrospective approach. Early adoption is permitted. Based on the composition of the Company’s trade receivables and other financial assets, current market conditions, and historical credit loss activity, the Company is currently in the process of evaluating the impact of this guidance on our financial statements.

 

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under ASU 2021-08, an acquirer must recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The guidance is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is currently in the process of evaluating the impact of this guidance on our financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

4. PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT

 

   December 31, 2022   December 31, 2021 
Deposits  $12,000   $32,000 
Legal retainer   24,457    33,692 
Prepaid expenses   436,496    214,445 
Deferred offering costs   100,337    - 
Others   25,052    28,903 
Prepaid expenses, other current assets  $598,342   $309,040 

 

On August 31, 2022, the Company signed a purchase and sale agreement with Stronghold Power Systems, Inc. (“Stronghold”), to purchase approximately seventy acres of land located in the City of Coachella as well as the completion of certain permitting, zoning, and infrastructure work by Stronghold for a total purchase price of $4,300,000. The purchase price consists of:

 

  (i) $1,500,000 in cash due on March 31, 2023.
     
  (ii) A first stock deposit of $1,700,000 in prefunded warrants. The Company issued 695,866 prefunded warrants on September 9, 2022 to Stronghold.
     
  (iii) A second stock deposit $1,100,000 in prefunded warrants. The Company issued 450,266 prefunded warrants on September 9, 2022 to Stronghold.

 

At December 31, 2022 the $2,085,960 of prefunded warrants were recorded under land deposit in relation to the Stronghold agreement. The prefunded warrant issuance may be rescinded and the warrants null and void if Stronghold does not meet all escrow performance conditions by March 31, 2023.

 

5. PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following:

 

   December 31, 2022   December 31, 2021 
Leasehold improvements  $86,979   $- 
Computer equipment   39,112    22,708 
Furniture and fixtures   37,590    39,997 
Total property and equipment   163,681    62,705 
Less: Accumulated depreciation   (42,009)   (21,734)
Property and equipment, net  $121,672   $40,971 

 

Depreciation expense on property and equipment, was $22,413 and $11,797 for the years ended December 31, 2022 and 2021, respectively.

 

F-13

 

 

6. CONSTRUCTION IN PROGRESS

 

The Company engaged outside contractors to begin construction work on its first facility. As of December 31, 2022, $2,092,533 (December 31, 2021 – $2,079,914) represents progress payments related to facility construction.

 

7. INTANGIBLE ASSET

 

Intangible asset represents $13,089,377 (December 31, 2021 - $1,477,237) for intellectual property (“Manna IP”) acquired under an asset purchase agreement with Manna Nutritional Group, LLC (“Manna”) dated September 10, 2021. The Manna IP encompasses patent-pending technologies to naturally process and convert grain, pulses and root vegetables, resulting in low-starch, low-sugar, high-protein, fiber-rich baking flour products, as well as a wide range of breakfast cereals, juices, natural sweeteners and baking enhancers. The Company paid $1,475,000 in cash and issued 7,379,969 prefunded warrants valued at $12,106,677 (the “Purchase Price”) adjusted for foreign exchange differences of $492,300. Subject to a 9.99% stopped and SEC Rule 144 restrictions the prefunded warrants will vest in tranches up until March 10, 2024. When vested the tranches of prefunded warrants will be converted into an equal number of common shares.

 

Subsequent to the year end, Manna satisfied all of its contractual obligations when the patent was approved by the US Patents Office and title was transferred to the Company. The Company issued 1,637,049 shares in relation to this transaction on January 3, 2023.

 

Based on the terms above and in conformity with US GAAP, the Company accounted for purchase as an asset acquisition and has deemed the asset purchased as an in-process research and development. The Company has further deemed the asset to be of indefinite life until the completion of the associated research and development activities. Once completed and commercialized, the asset will be amortized over its useful life.

 

8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

   December 31, 2022   December 31, 2021 
Accounts payable  $498,188   $414,117 
Accrued expenses   365,521    981,027 
Others   284,030    137,168 
 Accounts Payable and Accrued Liabilities  $1,147,739   $1,532,312 

 

Accrued expenses as of December 31, 2021, included $500,000 related to the purchase of the Manna IP.

 

F-14

 

 

9. DEBENTURES

 

On March 24, 2021, the Company entered into a securities purchase agreement with certain investors for the purchase of $750,000 in principal amount ($600,000 subscription amount) of senior secured debentures originally due June 24, 2021 (the “Bridge Loan”). The imputed interest rate is encompassed within the original issue discount of the debentures and no additional cash interest shall be due. Transaction costs of $69,000 have been recorded in connection with the Bridge Loan.

 

On June 24, 2021, the due date was extended, for which the Company paid an extension fee of 10,000 common shares with a fair value of $60,000. The senior secured debentures were repaid in full on July 13, 2021.

 

As part of the bridge loan, the debenture holder was issued warrants (the “Bridge Warrants”) to purchase 93,938 common shares for up to three years of the issuance date with a strike price of $3.99 per share.

 

On June 30, 2022, the Company executed the definitive agreement with certain institutional investors (the “Investors”) for a $14,025,000 principal debentures with a 10% original issue discount (the “Debentures”) for net proceeds of $12,750,000. The interest rates on the Debentures are 5% for the first 12 months, 6% for the subsequent 12 months, and 8% per annum thereafter. Principal repayments will be made in 25 equal monthly installments and began on September 1, 2022. The Debenture may be extended by six months at the election of the Company by paying a sum equal to six months interest on the principal amount outstanding at the end of the 18th month, at the rate of 8% per annum. The Debentures are convertible into common shares at $2.22 per share. The Investors have the right to purchase additional tranches of $5,000,000 each, up to a total additional principal amount of $33,000,000. In addition, the Investors received 4,106,418 warrants at a strike price of $2.442, which expire on December 31, 2025 (the “Debenture Warrants”). The Debenture Warrants and Debentures each have down round provisions whereby the conversion and strike prices will be adjusted downward if the Company issues equity instruments at lower prices. The Debenture Warrants strike price and the Debenture conversion price will be adjusted down to the effective conversion price of the issued equity instruments. Due to the currency of these features being different from the Company’s functional currency the Debenture Warrants and Debentures’ convertible features were classified as derivative liabilities and are further discussed in Note 11. The transaction costs incurred in relation to the Debentures were $1,634,894.

 

The following table summarizes our outstanding debentures as of the dates indicated:

 

   Maturity   Cash Interest Rate  December 31, 2022 
Principal (initial)   12/31/2024   5.00% - 8.00 %  $14,025,000 
Repayments and conversions           (2,955,000)
Debt issuance costs and discounts (Note 9 & 11)           (7,128,084)
Total Debentures (current)          $3,941,916 

 

During the year ended December 31, 2022, the Investors converted $150,000 of convertible debentures into 67,568 shares of the Company resulting in a $93,973 gain on the conversion of convertible debentures.

 

Subsequent to the year end, the Investors purchased an additional tranche of $5,076,923. The convertible debt and warrants were issued with an exercise price of $1.24. The issuance of the additional tranche triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $1.24.

 

F-15

 

 

10. LONG TERM LOAN

 

During the year ended December 31, 2020, the Company entered into a loan agreement with Alterna Bank for a principal amount of $29,533 (December 31, 2021 - $31,417) (CAD$40,000) under the Canada Emergency Business Account Program (the “Program”).

 

The Program, as set out by the Government of Canada, requires that the funds from this loan shall only be used by the Company to pay non-deferrable operating expenses including, without limitation, payroll, rent, utilities, insurance, property tax and regularly scheduled debt service, and may not be used to fund any payments or expenses such as prepayment/refinancing of existing indebtedness, payments of dividends, distributions and increases in management compensation.

 

In April 2021, the Company applied for an additional loan with Alterna Bank under the Program and received $14,767 (CAD$20,000) (December 31, 2021 - $15,909 (CAD $60,000)). The expansion loan is subject to the original terms and conditions of the Program.

 

The loan is interest free for an initial term that ends on December 31, 2023. Repaying the loan balance on or before December 31, 2023 will result in loan forgiveness of up to a third of loan value (up to CAD $20,000). Any outstanding loan after initial term carries an interest rate of 5% per annum, payable monthly during the extended term i.e. January 31, 2024 to December 31, 2025.

 

The balance at December 31, 2022 was $44,300 (CAD $60,000) (December 31, 2021 - $47,326 (CAD $60,000)).

 

11. DERIVATIVE LIABILITIES

 

The Company’s derivative liabilities consist of warrants, denominated in a currency other than the Company’s functional currency (the “Warrant Liabilities”) and conversion rights embedded in the Debentures, see Note 9 (the “Debenture Convertible Features”).

 

Warrant Liabilities

 

As of December 31, 2022, the Warrant Liabilities represent aggregate fair value of publicly traded 3,088,198 Series A warrants (“IPO Warrants”), 135,999 representative’s warrants (“Rep Warrants”) and 4,106,418 Debenture Warrants.

 

The fair value of the IPO Warrants and Rep Warrants amount to $275,115 (December 31, 2021 - $1,418,964) and were categorized as a Level 1 financial instrument. The Rep Warrants are exercisable one year from the effective date of the IPO registration statement and will expire three years after the effective date.

 

The fair value of the Debenture Warrants amounted to $2,917,000 (June 30, 2022 - $4,080,958) and were categorized as a Level 3 financial instrument. As at December 31, 2022 the Company utilized the Monte Carlo option-pricing model (June 30, 2022 – Black-Scholes option-pricing model) to value the Debenture Warrants using the following assumptions: stock price $1.13 (June 30, 2022 - $2.31), dividend yield – nil (June 30, 2022 – nil), expected volatility 95.0% (June 30, 2022 – 58.3%), risk free rate of return 4.22% (June 30, 2022 – 3.14%), and expected term of 3 years (June 30, 2022 – expected term of 3.5 years).

 

The changes in the fair value of the Bridge Warrants ($203,456 – 2021) was charged to the statement of comprehensive loss. The warrants were exercised on October 27, 2021 and accordingly, the warrant liability was extinguished. The fair value of the warrants prior to exercise was estimated at $64,992, determined using the Black-Scholes option pricing model and the following assumptions; stock price $2.16, dividend yield – nil, expected volatility 73%, risk free rate of return 0.94%, expected term of 3 years.

 

Debenture Convertible Features

 

On June 30, 2022, the Company issued Debentures with an equity conversion feature, see Note 9. The fair value of the Debentures’ convertible features was $3,336,535 on the issuance date and $1,457,000 as at December 31, 2022. These conversion features are categorized as a Level 3 financial instrument. As at December 31, 2022 the Company utilized the Monte Carlo option-pricing model (June 30, 2022 – Black-Scholes option-pricing model) for valuing the convertible feature using the following assumptions: stock price $1.13 (June 30, 2022 - $2.31), dividend yield – nil (June 30, 2022 – nil), expected volatility 95.0% (June 30, 2022 – 101.0%), risk free rate of return 4.41% (June 30, 2022 – 3.14%), discount rate 13.65% (June 30, 2022 – not applicable), and expected term of 2 years (June 30, 2022 – 1 year).

 

Changes in the fair value of Company’s Level 1 and 3 financial instruments for the year ended December 31, 2022 were as follows:

 

                        
    Level 1    Level 3   Level 3     
    IPO and Rep Warrants    Debenture Warrants  

Debenture

Convertible

Feature

   Total 
Balance at December 31, 2021   $ 1,418,964    $-   $-   $1,418,964 
Additions     -     4,080,958    3,336,535    7,417,493 
Conversions     -     -    (63,723)   (63,723)
Change in fair value     (1,086,562 )   (966,141)   (1,667,166)   (3,719,869)
Effect of exchange rate changes     (57,287 )   (197,817)   (148,646)   (403,750)
Balance at December 31, 2022   $ 275,115    $2,917,000   $1,457,000   $4,649,115 

 

Due to the expiry date of the warrants and conversion feature being subsequent to December 31, 2023, the liabilities have been classified as non-current.

 

F-16

 

 

12. SHARE CAPITAL

 

  a) Authorized Share Capital 

 

On March 1, 2019, the Company changed its share structure to replace Class – A voting shares with Common voting Shares, eliminated Class-B non-voting shares, and created a new series of Preferred shares with no par value and unlimited number of shares. Holders of Preferred shares shall be entitled to receive distribution ahead of holders of Common shares. In addition, Preferred shareholders are also entitled to a fixed premium (if specifically provided in the special rights and restrictions attached to a specific series of Preferred shares), prior to any distributions to holders of Common shares in the event of dissolution, liquidation or winding-up of the Company.

 

  b) Issued Share Capital

 

The Company had the following common share transactions during the year ended December 31, 2022:

 SCHEDULE OF SHARE CAPITAL

   # of shares   Amount 
Common shares issued for bonuses and compensation   266,765   $520,230 
Common shares issued for conversion of convertible debt   67,568    131,532 
Common shares issued to consultants   284,767    853,457 
Total common shares issued   619,100   $1,505,219 

 

The Company had the following common share transactions during the year ended December 31, 2021:

 

   # of shares   Amount 
Common shares issued for cash   3,127,998   $13,262,712 
Common shares issued for conversion of series A preferred stock   2,258,826    6,717,873 
Common shares issued on exercise of warrants   39,800    238,800 
Common shares issued on cashless exercise of warrants   36,275    - 
Common shares issued on exercise of options   7,018    9,123 
Common shares issued on cashless exercise of options   820,029    - 
Common shares issued for bonus and compensation   159,775    648,449 
Common shares issued for consulting services   76,364    381,663 
Common shares issued for settlement of accrued director’s fee   19,992    46,783 
Common shares issued for dividend on preferred shares   189,004    735,932 
Share issue costs   -    (2,099,842)
Total common shares issued   6,735,081   $19,941,493 

 

  c) Stock Options

 

The Company has adopted a stock option plan (the “Option Plan”) for its directors, officers, employees and consultants to acquire common shares of the Company. The terms and conditions of the stock options are determined by the Board of Directors.

 

On May 28, 2019, at the Company’s annual general meeting, shareholders approved an amendment to the Option Plan to increase the number of authorized shares subject to the Option Plan to 15% of the issued and outstanding shares of the Company (including any unconverted Series A Preferred Shares).

 

For the year ended December 31, 2022, the Company recorded aggregate share-based compensation expense of $420,715 (December 31, 2021 - $796,141) for all stock options on a straight-line basis over the vesting period.

 

F-17

 

 

As of December 31, 2022, 1,382,629 (December 31, 2021 – 717,019) Options were outstanding at a weighted average exercise price of $3.30 (December 31, 2021 - $5.63), of which 414,305 (December 31, 2021 – 280,938) were exercisable.

 

The amounts recognized as share-based payments and stock options are included in share-based compensation on the Statement of Loss and Comprehensive Loss.

 

As of December 31, 2022, there was $538,358 (December 31, 2021 - $634,626) of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted; that cost is expected to be recognized over a period of 2 years (December 31, 2021 – 3 years).

 

The following summarizes stock option activity during the years ended December 31, 2022 and 2021:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Life (years) 
             
Balance at December 31, 2020   1,450,918   $2.01    4.38 
Granted   509,788   $7.00    4.47 
Exercised   (1,120,719)  $3.23    - 
Forfeited   (28,947)  $4.75    - 
Cancelled   (94,021)  $6.70    - 
Balance at December 31, 2021   717,019   $5.63    4.48 
Granted   747,060   $1.14    4.48 
Forfeited   (25,542)  $7.00    - 
Cancelled   (55,908)  $4.27    - 
Balance at December 31, 2022   1,382,629   $3.30    4.24 

 

The Company’s outstanding and exercisable stock options at December 31, 2022 were:

 

   Outstanding Options   Exercisable Options 
Expiry Date  Number   Weighted Average Remaining Life (years)   Weighted Average Exercise Price   Number   Weighted Average Exercise Price 
           $       $ 
June 30, 2026   210,489    3.50    3.51    210,489    3.51 
May 31, 2026   320,351    3.42    7.00    160,176    7.00 
July 15, 2026   55,445    3.54    7.00    23,100    7.00 
September 30, 2026   49,284    3.75    7.00    20,540    7.00 
November 18, 2027   747,060    4.88    1.14    -    - 
Total Share Options   1,382,629    4.24    3.30    414,305    5.23 

 

F-18

 

 

The following table summarizes the Company’s assumptions used in the valuation of options granted during the year ended December 31, 2022 and December 31, 2021:

 

   December 31, 2022   December 31, 2021 
Expected volatility   78.05%   80.00%
Expected term (in years)   3.07    3.31 
Risk-free interest rate   3.35%   0.92%
Fair value of options  $0.60   $2.59 

 

  d) Warrants

 

The Company’s outstanding warrants as of December 31, 2022 were:

 

   Number of warrants   Weighted average exercise price   Expiry Date
       $    
Outstanding, December 31, 2020   2,546,065    7.46    
Granted July 12, 2021   3,263,997    6.00   July 12, 2024
Granted July 28, 2021   93,938    3.99   July 28, 2024
Exercised in 2021   (133,738)   4.59   n/a
Outstanding, December 31, 2021   5,770,262    5.91    
Granted June 30, 2022   4,106,418    2.44a  December 30, 2025
Outstanding, December 31, 2022   9,876,680    4.91    

 

(a) Subsequent to the year end, the issuance of additional tranches of Debentures triggered the down round provision, adjusting the exercise prices of the Debenture Warrants to $1.24 (Note 9).

 

  e) Loss per Common Share

 

Diluted net loss attributable to common shareholders per share does not differ from basic net loss attributable to common shareholders per share for the years ended December 31, 2022 and December 31, 2021, since the effect of the Company’s warrants, stock options and convertible debentures are anti-dilutive.

 

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

           
  

December 31, 2022

  

December 31, 2021

 
Warrants   9,876,680    5,770,262 
Options   1,382,629    717,019 
Prefunded warrants   1,146,132    - 
Convertible debentures   4,986,486    - 
Total anti-dilutive weighted average shares   17,391,927    6,487,281 

 

F-19

 

 

13. INCOME TAXES

 

For the year ended December 31, 2022 and 2021, loss before income tax provision consisted of the following:

 

   December 31, 2022   December 31, 2021 
         
Domestic operations - Canada  $(11,753,662)  $(6,202,837)
Foreign operations - United States   (1,119,440)   (440,279)
Total loss before taxes  $(12,873,102)  $(6,643,116)

 

Income tax expense (benefit) consists of the following for the years ended December 31, 2022 and December 31, 2021:

 

   December 31, 2022   December 31, 2021 
         
Loss before taxes  $(12,873,102)  $(6,643,116)
Statutory tax rate   27.00%   27.00%
Income taxes at the statutory rate  $(3,475,738)  $(1,793,641)
Change in fair value of derivative liabilities   (1,032,824)   (321,674)
Non-deductible accretion interest   747,719    - 
Stock-based compensation   484,035    253,556 
Share issue costs   (108,685)   (112,812)
Foreign currency translation   298,876    - 
Other   63,035    111,874 
Total  $(3,023,582)  $(1,862,697)
           
Change in valuation allowance  $3,023,582   $1,862,697 
Total income tax expense (benefit)  $-   $- 

 

The Company is subject to Canadian federal and provincial tax for the estimated assessable profit for the years ended December 31, 2022 and 2021 at a rate of 27%.

 

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not that we will not realize those tax assets through future operations. Significant components of the Company’s deferred taxes are as follows:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Unused net operating losses carry forward - Canada and United States  $7,572,932   $4,459,457 
Unused capital losses carry forward   

-

    40,962 
Share issue costs   130,732    

174,377

 
Other   (5,286)   - 
Total deferred tax assets   7,698,378    4,674,796 
Valuation allowance   (7,698,378)   (4,674,796)
   $-  

$

- 

 

The Company has non-capital losses of $25.8 million as of December 31, 2022 and $15.7 million as of December 31, 2021, which are due to expire between 2038 and 2042 and which can be used to offset future taxable income in Canada. For foreign operations in United States, aggregate net operating losses are $2.2 million as of December 31, 2022 and $0.9 million as of December 31, 2021 which can be carried forward indefinitely. The Company has no capital losses of as of December 31, 2022 and $0.2 million as of December 31, 2021. Non-Capital Losses in Canada can be carried forward after change of ownership, if the particular business which gave rise to the loss is carried on by the company for profit or with a reasonable expectation of profit. Certain accumulated net operating losses in United States are subject to an annual limitation from equity shifts, which constitute a change of ownership as defined under Internal Revenue Code (“IRC”) Section 382. These rules will limit the utilization of the losses.

 

The Company files income tax returns in Canada and the United States and is subject to examination in these jurisdictions for all years since the Company’s inception in 2017. As at December 31, 2022, no tax authority audits are currently underway.

 

The Company currently has no uncertain tax position and is therefore not reflecting any adjustments.

 

F-20

 

 

14. RELATED PARTY TRANSACTIONS

 

Key management personnel include those persons having the authority and responsibility of planning, directing, and executing the activities of the Company. The Company has determined that its key management personnel consist of the Company’s officers and directors.

 

As of December 31, 2022, $32,500 (December 31, 2021, $47,461) in total was owing to officers and directors or to companies owned by officers and directors of the Company for services and expenses. These amounts owing have been included in accounts payable and accrued liabilities.

 

During the year ended December 31, 2022 and 2021, the Company incurred $79,457 and $66,246, respectively, to our U.S. general counsel firm, DR Welch against legal services, a corporation controlled by a director of the Company. No shares were issued in the year ended December 31, 2022 (an aggregate of 13,158 shares were issued during the year ended December 31, 2021 to David Welch).

 

There were no other payments to related parties for the year ended December 31, 2022 and 2021 other than expense reimbursements in the ordinary course of business.

 

15. RESEARCH AND DEVELOPMENT

 

During the year ended December 31, 2022, the Company spent $615,693 as compared to $474,338 for the year ended December 31, 2021 in research and development costs in relation to the license agreement with Radical Clean Solutions Ltd (“Radical”), the testing, nutrient and micro analysis for UN(THINK)™ food product development as well as costs of design and construction for the Coachella land and its future structure architecture. The following represents the breakdown of research and development activities:

 SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS

   December 31, 2022   December 31, 2021 
License agreement  $

256,703

   $- 
Product development  179,563   296,931 
Design and construction   179,427    177,407 
 Research and development costs  $615,693   $474,338 

 

F-21

 

 

16. LEASES

 

The Company has entered into an operating lease for office space. At December 31, 2022, the remaining lease term is seven years and the discount rate is 7.0%. The Company has no finance leases.

 

The components of lease expenses were as follows:

 

   December 31, 2022 
Operating lease cost  $295,601 
Short-term lease cost   23,361 
Total lease expenses  $318,962 

 

The minimum future payments under the lease for our continuing operations in each of the years ending December 31 is as follows:

 

     
2023  $271,110 
2024   280,409 
2025   296,350 
2026   296,350 
2027   296,350 
Subsequent years   518,613 
Total minimum lease payments   1,959,182 
Less: imputed interest   (438,012)
Total lease liability   1,521,170 
Current portion of lease liability   (271,110)
Non-current portion of lease liability  $1,250,060 

 

17. COMMITMENTS AND CONTINGENCIES

 

Debenture principal repayments

 

The following table summarizes the future principal payments related to our outstanding debt as of December 31, 2022:

 

      
2023  $6,732,000 
2024   4,338,000 
Long Term Debt  $11,070,000 

 

Contingencies

 

As at December 31, 2022, the Company had no contingencies or litigation to disclose.

 

18. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events through March 13, 2023, the date on which these financial statements were available to be issued, to ensure that this filing includes appropriate disclosure of events both recognized in the financial statements as of December 31, 2022, and events which occurred subsequent to December 31, 2022 but were not recognized in the financial statements.

 

On January 17 and 18, 2023, the Investors purchased additional tranches totaling $5,076,923 in convertible debentures and received 2,661,289 warrants. The convertible debentures and warrants were issued with an exercise price of $1.24. The issuance of the additional tranches triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $1.24 (Note 9 & 11). Subsequent to the year ended December 31, 2022, the investors converted $881,400 of convertible debentures into 710,807 shares.

 

Subsequent to the year ended December 31, 2022, the Company issued 1,637,049 shares to Manna upon exercise of their prefunded warrants.

 

Subsequent to the year ended December 31, 2022, the Company issued 12,500 shares to a consultant for services rendered.

 

On January 24, 2023, the Company entered a binding letter of intent (“BP LOI”) to acquire Berry People LLC (“Berry People”), a U.S. based berry business. The BP LOI sets forth a purchase price of $28 million, consisting of $18.2 million in cash and $9.8 million in restricted shares to acquire 70% of Berry People.

 

F-22

 

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a—15(e) and 15d—15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of such date, our disclosure controls and procedures were effective.

 

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including the individuals serving as our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013 Framework). Based on this assessment, our management concluded that, as of December 31, 2022, our internal control over financial reporting was effective based on those criteria.

 

Attestation Report on Internal Control over Financial Reporting.

 

This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm due to the deferral allowed given we are neither an accelerated nor a large accelerated filer.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information

 

None.

 

35
 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

The information required by this Item is incorporated by reference from our definitive proxy statement for our 2022 Annual Meeting of Stockholders (the “Proxy Statement”). The definitive Proxy Statement will be filed with the SEC within 120 days after the close of the fiscal year covered by this Annual Report on Form 10-K.

 

Name     Age   Position   Served Since
Ingo W. Mueller*   57   Chairman, Director, Chief Executive Officer   December 2017
William J. Meekison   58   Director, Audit Committee, Compensation Committee   June 2019
David Welch   41   Director, Nominating and Governance Committee, Compensation Committee   June 2019
Richard Levychin   64   Director, Audit Committee Chair, Nominating and Governance Committee,   July 2021
Amy Griffith   50   Director, Audit Committee, Compensation Committee Chair, Nominating and Governance Committee   July 2021
Richard S. Wong   58   Chief Financial Officer   October 2018
Troy T. McClellan   61   President, AgriFORCE™ Solutions   February 2018
Mauro Pennella   57   Chief Marketing Officer and President AgriFORCE™ Brands division.   July 2021
Dr. Laila Benkrima   60   Chief Scientist   May 2018

 

*Ingo Mueller was appointed as Chairman of the Board effective September 24, 2021.

 

Directors serve until the next annual meeting and until their successors are elected and qualified. Officers are appointed to serve for one year until the meeting of the Board of Directors following the annual meeting of shareholders and until their successors have been elected and qualified.

 

Ingo Wilhelm Mueller – Chairman, Director and Chief Executive Officer

 

Mr. Mueller has been involved in the finance and advisory business for the past 25 years having been involved in the financing of companies and projects. Mr. Mueller is the founder and currently the CEO of the Company since inception and has been responsible for the development of the Company’s intellectual property, business model and financing. He is full time with the Company. He is also currently the CEO of St. George Capital Corp. (since 1998), doing business as Capital Fusion Group, a private financial advisory firm. Mr. Mueller was Chairman and CEO of International Coal Company Ltd. from 2008-2010 before it was sold to London Mining plc, after which Mr. Mueller was named Chairman and CEO of London Mining Colombia Ltd. (2010 to 2012). Mr. Mueller was also the CEO and Chairman of WIGU City Edutainment Centers Plc (2014 to 2017). Mr. Mueller has a Bachelor Commerce (major in Finance and minor in Urban Land Economics) from the University of British Columbia. The Board has determined that Mr. Mueller is suited to serve on the Board due to his long standing involvement in the financial community. Mr. Mueller was appointed as the Chairman of the Board effective September 24, 2021.

 

David Welch, Director, Nominating and Governance Committee

 

Mr. Welch is a founding partner at ENSO LAW, LLP, based in Los Angeles. He has a broad base of experience in representing US, Canadian and Mexican corporate clients in the areas of litigation, intellectual property and government regulatory advisement and defense. Mr. Welch has represented recognizable businesses in the agriculture and food services space in Federal Court, California state courts and before the USPTO.  Mr. Welch has also argued before the California Supreme Court and the US 9th Circuit Court of Appeals on constitutional issues related to preemption and the application of US law to various companies. Mr. Welch obtained his Juris Doctorate degree from Loyola Law School with an emphasis in international trade and has received various accolades for his work in intellectual property and regulatory law, including Top 40 under 40 by the Daily Journal; National Law Journal Intellectual Property Trail Blazer, and Super Lawyers from 2013 until 2023. In his business ventures, Mr. Welch is a registered aquaculturist and farmer focusing on sustainable and regenerative agricultural practices.  He is suited to serve as a director due to his long standing experience in international intellectual property and business.

 

36
 

 

William John Meekison, Director, Audit Committee, Compensation Committee

 

Mr. Meekison is a career Chief Financial Officer and former investment banker. He has spent the last fifteen years serving in a variety of executive management and CFO roles with both private and public companies, currently as the CFO and Director of Exro Technologies Inc. (since October 2017), a technology company that creates energy management system, and CFO and CFO of ArcWest Exploration Inc. (since December 2010), a mining exploration company in British Columbia. He is currently on the board of Telo Genomics Corp. (since July 2018) and Adven Inc. (since April 2021).  Prior to his position at Exro Technologies Inc. and other CFO roles, Mr. Meekison spent fifteen years in corporate finance with a focus on raising equity capital for North American technology companies, including nine years at Haywood Securities Inc. Mr. Meekison received his Bachelor of Arts from the University of British Columbia and is a Chartered Professional Accountant, Professional Logistician and Certified Investment Manager. He is suited to serve as a director due to his long time experience as a CFO.

 

Richard Levychin, Director, Audit Committee Chair, Nominating and Governance Committee, Compensation Committee

 

Richard Levychin, CPA, CGMA, is a Partner in Galleros Robinson’s Commercial Audit and Assurance practice where he focuses on both privately and publicly held companies. Prior to taking this position in October 2018, Richard was the managing partner of KBL, LLP, a PCAOB certified independent registered accounting firm, since 1994. Mr. Levychin has over 25 years of accounting, auditing, business advisory services and tax experience working with both privately owned and public entities in various industries including media, entertainment, real estate, manufacturing, not-for-profit, technology, retail, technology, and professional services. His experience also includes expertise with SEC filings, initial public offerings, and compliance with regulatory bodies. As a business adviser, he advises companies, helping them to identify and define their business and financial objectives, and then provides them with the on-going personal attention necessary to help them achieve their established goals. Mr. Levychin is well suited to serve on our Board due to his decades of experience as the managing partner of a PCAOB certified independent registered accounting firm, which included decades of expertise with SEC filings and initial public offerings.

 

Amy Griffith, Director, Audit Committee, Compensation Committee Chair, Nominating and Governance Committee

 

Ms. Griffith currently serves as Group Director for the North America Operating unit of the Coca-Cola Company, in this capacity she oversees public affairs, government relations, sustainability and communications in Canada and the Northeastern United States.  Previously, she served as Wells Fargo’s State & Local Government Relations Senior Vice President.  She was recruited to Wells Fargo’s Government Relations and Public Policy team in 2019. In this role, Griffith led Wells Fargo’s legislative and political agenda in her region and managed relationships with state and local policymakers and community stakeholders. From 2008-2019, Ms. Griffith led government relations for sixteen states in the Eastern United States for TIAA for over a decade. Prior to that, she worked in the aerospace, high tech, education, private and public sectors, and has managed multiple high-profile political campaigns at the local, state and national level. Griffith is active in her community and has co-chaired The Baldwin School Golf Outing to raise funds for girls’ athletics programs. She is a graduate of Gwynedd-Mercy College and holds a Bachelor of Arts in History. Ms. Griffith is well qualified to serve as a director due to her significant experience in government relations, policy and politics as well as decades of experience working with companies in both the private and public sectors.

 

Richard Wong, Chief Financial Officer

 

Mr. Wong, who works full time for the Company, has over 25 years of experience in both start-up and public companies in the consumer goods, agricultural goods, manufacturing, and forest industries. Prior to joining the Company in 2018, he was a partner in First Choice Capital Advisors from 2008-2016 and a partner in Lighthouse Advisors Ltd. from 2016-2018. Mr. Wong has also served as the CFO of Emerald Harvest Co., Dan-D Foods, Ltd., and was the Director of Finance and CFO of SUGOI Performance Apparel and had served positions at Canfor, Canadian Pacific & other Fortune 1000 companies. Mr. Wong is a Chartered Professional Accountant, and a member since 1999. Mr. Wong has a Diploma in Technology and Financial Management from the British Columbia Institute of Technology.

 

Troy McClellan, President AgriFORCE™ Solutions

 

Mr. McClellan, who works full time for the Company, has focused on innovative design and construction technologies throughout his career. Most recently, he was V.P. of Design and Development at WIGU City from 2015-2018, at which time he joined the Company. Mr. McClellan was the VP Design and Development of MGM Macau. Previously, he was a Project Manager at Wynn Design & Development and a Design Manager at Universal Studios (Japan). Mr. McClellan is a registered professional architect and received his Master’s Degree in Architecture from Montana State University.

 

37
 

 

Mauro Pennella, Chief Marketing Officer and President, AgriFORCE ™ Brands

 

Mr. Pennella, who works full time for the Company, is a consumer products veteran with more than 30 years of experience in the consumer-packaged goods industry. From May 2018 until January 2021, he was Chief Growth & Sustainability Officer at McCain Foods, a Canadian multinational frozen food company. In that role, he was responsible for global marketing, sales, research and development (R&D) and sustainability. From October 2014 to April 2018, Mr. Pennella served as the President, International of Combe Incorporated, a personal care products company where he oversaw the international division, R&D and the internal advertising agency. He was also a member of the Executive Committee at Combe Incorporated, where he was responsible for the P&L - overseeing eight subsidiaries with more than 100 employees around the world. Prior to that, Mr. Pennella led the Retail and International businesses at Conagra’s Lamb Weston division and developed his career at Diageo and Procter & Gamble. Mr. Pennella received a Master of Business from Audencia, a premier European business school, as well as an M.A.B.A. in Marketing and Finance from The Ohio State University Fisher College of Business.

 

Dr. Laila Benkrima, Chief Scientist

 

Dr. Benkrima, who consults part-time for the Company, holds a PhD from the University of Paris in horticulture with a specialization in tissue culture and the hybridization and selection of plant varietals. Her employment history includes Inflazyme Pharmaceuticals, the University of British Columbia, and Celex Laboratory.

 

Corporate Governance

 

The business and affairs of our Company are managed under the direction of the Board of Directors.

 

Director Independence

 

We use the definition of “independence” of The NASDAQ Stock Market to make this determination. We are not yet listed on NASDAQ, and although we use its definition of “independence,” its rules are inapplicable to us until such time as we become listed on NASDAQ. NASDAQ Listing Rule 5605(a)(2) provides that an “independent director” is a person other than an officer or employee of our Company or any other individual having a relationship which, in the opinion of the Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The NASDAQ rules provide that a director cannot be considered independent if:

 

  ● the director is, or at any time during the past three years was, an employee of our Company;
     
  ● the director or a family member of the director accepted any compensation from our Company in excess of $120,000 during any period of 12 consecutive months within the three years preceding the independence determination (subject to certain exclusions, including, among other things, compensation for board or board committee service);
     
  ● a family member of the director is, or at any time during the past three years was, an executive officer of our Company;
     
  ● the director or a family member of the director is a partner in, controlling shareholder of, or an executive officer of an entity to which our Company made, or from which our Company received, payments in the current or any of the past three fiscal years that exceed 5% of the recipient’s consolidated gross revenue for that year or $200,000, whichever is greater (subject to certain exclusions);
     
  ● the director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three years, any of the executive officers of our Company served on the compensation committee of such other entity; or
     
  ● the director or a family member of the director is a current partner of our Company’s outside auditor, or at any time during the past three years was a partner or employee of our Company’s outside auditor, and who worked on our Company’s audit.

 

38
 

 

Under the following three NASDAQ director independence rules a director is not considered independent: (a) NASDAQ Rule 5605(a)(2)(A), a director is not considered to be independent if he or she also is an executive officer or employee of the corporation, (b) NASDAQ Rule 5605(a)(2)(B), a director is not consider independent if he or she accepted any compensation from our Company in excess of $120,000 during any period of twelve consecutive months within the three years preceding the determination of independence, and (c) NASDAQ Rule 5605(a)(2)(D), a director is not considered to be independent if he or she is a partner in, or a controlling shareholder or an executive officer of, any organization to which our Company made, or from which our Company received, payments for property or services in the current or any of the past three fiscal years that exceed 5% of the recipient’s consolidated gross revenues for that year, or $200,000. Under such definitions, we have four independent directors.

 

Family Relationships

 

There are no family relationships among any of the directors and executive officers.

 

Board Committees

 

Our Board has established the following three standing committees: audit committee; compensation committee; and nominating and governance committee, or nominating committee. Our board of directors has adopted written charters for each of these committees. Copies of the charters will be available on our website. Our board of directors may establish other committees as it deems necessary or appropriate from time to time.

 

Audit Committee

 

Our Audit Committee is comprised of at least three individuals, each of whom are independent director and at least one of whom will be an “audit committee financial expert,” as defined in Item 407(d)(5)(ii) of Regulation S-K. Our audit committee is currently comprised of Richard Levychin (Chair), John Meekison and Amy Griffith, who are independent, and Mr. Levychin is our financial expert.

 

Our Audit Committee will oversee our corporate accounting, financial reporting practices and the audits of financial statements. For this purpose, the Audit Committee will have a charter (which will be reviewed annually) and perform several functions. The Audit Committee will:

 

  ● evaluate the independence and performance of, and assess the qualifications of, our independent auditor and engage such independent auditor;
     
  ● approve the plan and fees for the annual audit, quarterly reviews, tax and other audit-related services and approve in advance any non-audit service to be provided by our independent auditor;
     
  ● monitor the independence of our independent auditor and the rotation of partners of the independent auditor on our engagement team as required by law;
     
  ● review the financial statements to be included in our future Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q and review with management and our independent auditor the results of the annual audit and reviews of our quarterly financial statements; and
     
  ● oversee all aspects our systems of internal accounting control and corporate governance functions on behalf of the Board of Directors.

 

39
 

 

Compensation Committee

 

Our Compensation Committee comprises of at least three individuals, each of whom will be an independent director, Our Compensation committee is currently comprised of Amy Griffith (Chair), David Welch and John Meekison and who are independent.

 

The Compensation Committee will review or recommend the compensation arrangements for our management and employees and also assist our Board of Directors in reviewing and approving matters such as company benefit and insurance plans, including monitoring the performance thereof. The Compensation Committee will have a charter (which will be reviewed annually) and perform several functions.

 

The Compensation Committee will have the authority to directly engage, at our expense, any compensation consultants or other advisers as it deems necessary to carry out its responsibilities in determining the amount and form of employee, executive and director compensation.

 

Nominating and Corporate Governance Committee (the “N&CG Committee”)

 

Our N&CG Committee is comprised of at least three individuals, each of whom will be an independent director. Currently Amy Griffith, Richard Levychin and David Welch (Chair) are members of the committee.

 

The NC&G Committee is charged with the responsibility of reviewing our corporate governance policies and with proposing potential director nominees to the Board of Directors for consideration. This committee also has the authority to oversee the hiring of potential executive positions in our Company. The NC&G Committee also has a charter, which is to be reviewed annually.

 

Item 11. Executive Compensation

 

Name & Principal Position  Year   Salary   Bonus   Share-Based Awardsc    Option-Based Awards   All Other Compensation   Total Compensation 
Ingo W. Mueller,   2022    392,464    375,718    359,881    6,866    1,741    1,136,670 
Chief Executive Officer   2021    299,299    282,808    155,668    279,632    14,958    1,032,365 
Richard S. Wong,   2022    295,216     134,696 a   86,456    28,831    1,741    546,940 
Chief Financial Officer   2021    237,582    132,070    37,397    186,422    -    593,471 
Troy T. McClellan,   2022    246,732    69,162 b   76,846    30,132    1,741    424,613 
Vice President Design & Construction   2021    206,280    80,774    35,456    167,778    -    490,288 
Mauro Pennella   2022    268,962    -    115,269    45,593    1,741    431,565 
Chief Marketing Officer, President AgriFORCE™ Brands   2021    128,841    -    55,179    85,693    -    269,713 

 

(a)Bonus was paid out $101,022 in shares and $33,674 in cash.
(b)Bonus was paid out $69,162 in shares
(c)

Some share-based awards were issued net of income taxes. The Company repurchased shares on the issuance date to remit as income taxes to the appropriate government revenue service agencies.

 

40
 

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table sets forth information known to us regarding the beneficial ownership of our common stock as of March 13, 2023 by:

 

● each person known to us to be the beneficial owner of more than 5% of our outstanding common stock;
● each of our executive officers and directors; and
● all of our executive officers and directors as a group.

 

   Common shares  

Options Granted vested

within 60 days of

March 13, 2023

   Warrants   Total   Percentage beneficially owned 
Directors and Officers:                         
Ingo Mueller   1,060,083 a   169,592    -    1,229,675    6.7%
Richard Wong   130,244    77,980    -    208,224    1.1%
Troy McClellan   445,581    64,126    -    509,707    2.8%
Mauro Pennella   56,073    37,141    -    93,214    0.5%
John Meekison   43,208    30,405    -    73,613    0.4%
David Welch   52,450    26,459    -    78,909    0.4%
Amy Griffith   -    16,511    -    16,511    0.1%
Richard Levychin   -    16,511    -    16,511    0.1%
Total all officers and directors (8 persons)*   1,787,639    438,725    

-

    2,226,364    12.1%
                          
5% or Greater Beneficial Owners                         
Ingo Mueller    1,060,083 a    169,592    -    1,229,675    6.7%
Manna Nutritional Group, LLC   1,637,049    -    -    1,637,049    9.0%

 

  (a) Includes (1) 60,757 common shares held by St. George Capital Corp. of which Mr. Mueller is the President, (2) 193,766 common shares held by 1071269 BC Ltd. of which Mr. Mueller is the sole owner, and (3) 14,532 common shares held by 1178196 BC Ltd. of which Mr. Mueller is an affiliate.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

We have adopted a written related-person transactions policy that sets forth our policies and procedures regarding the identification, review, consideration and oversight of “related-party transactions.” For purposes of our policy only, and not for purposes of required disclosure, which will be all related party transactions, even if less than $120,000, a “related-party transaction” is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which we and any “related party” are participants involving an amount that exceeds $120,000.

 

Transactions involving compensation for services provided to us as an employee, consultant or director are not considered related-person transactions under this policy. A related party is any executive officer, director or a holder of more than five percent of our common shares, including any of their immediate family members and any entity owned or controlled by such persons.

 

41
 

 

At present, we have appointed three independent directors to the N&CG Committee. As a result, our Chief Financial Officer, Richard Wong, must present information regarding a proposed related-party transaction to the Nominating and Corporate Governance Committee. Under the policy, where a transaction has been identified as a related-party transaction, Mr. Wong must present information regarding the proposed related-party transaction to our Nominating and Corporate Governance Committee, once the same is established, for review. The presentation must include a description of, among other things, the material facts, the direct and indirect interests of the related parties, the benefits of the transaction to us and whether any alternative transactions are available. To identify related-party transactions in advance, we rely on information supplied by our executive officers, directors and certain significant shareholders. In considering related-party transactions, our Nominating and Corporate Governance Committee takes into account the relevant available facts and circumstances including, but not limited to:

 

  ● whether the transaction was undertaken in the ordinary course of our business;
     
  ● whether the related party transaction was initiated by us or the related party;
     
  ● whether the transaction with the related party is proposed to be, or was, entered into on terms no less favorable to us than terms that could have been reached with an unrelated third party;
     
  ● the purpose of, and the potential benefits to us from the related party transaction;
     
  ● the approximate dollar value of the amount involved in the related party transaction, particularly as it relates to the related party;
     
  ● the related party’s interest in the related party transaction, and
     
  ● any other information regarding the related party transaction or the related party that would be material to investors in light of the circumstances of the particular transaction.

 

The Nominating and Corporate Governance Committee shall then make a recommendation to the Board, which will determine whether or not to approve of the related party transaction, and if so, upon what terms and conditions. In the event a director has an interest in the proposed transaction, the director must recuse himself or herself from the deliberations and approval.

 

Except as set forth below, we have not had any related party transactions, regardless of dollar amount:

 

As of December 31, 2022, $32,500 (December 31, 2021, $47,461) in total was owing to officers and directors or to companies owned by officers and directors of the Company for services and expenses. These amounts owing have been included in accounts payable and accrued liabilities.

 

During the year ended December 31, 2022 and 2021, the Company incurred $79,457 and $66,246, respectively, to our U.S. general counsel firm, D R Welch against legal services, a corporation controlled by a director of the Company. No shares were issued in the year ended December 31, 2022 (an aggregate of 13,158 shares were issued – December 31, 2021) to David Welch as part of the payment.

 

Item 14. Principal Accounting Fees and Services

 

Aggregate fees billed to us by Marcum LLP, the Company’s principal independent accountants, during the last two fiscal years were as follows:

 

   December 31, 2022   December 31, 2021 
Audit Feesa  $170,000   $126,000 
Audit – Related Fees   197,649    83,954 
   $367,649   $209,954 

 

  (a) Amounts represent the contractual fees related to the fiscal year, not the accrued fees incurred during the year.

 

Audit Fees consist of fees billed for professional services rendered for the audit of our consolidated annual financial statements and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by our auditors in connection with statutory and regulatory filings or engagements.

 

Audit-Related Fees consist of services by our independent auditors that, including accounting consultations on transaction related matters including work related to our S-1 fillings, are reasonably related to the performance of the audit or review of our financial statements and are not reported above under Audit Fees.

 

During the years ended December 31, 2022 and 2021, Marcum LLP did not incur fees for any other professional services.

 

42
 

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules

 

Financial Statements

 

The following Consolidated Financial Statements of the Company and the Report of Independent Registered Public Accounting Firm (PCAOB ID: 688) included in Part II, Item 8:

 

Consolidated Balance Sheets as of December 31, 2022 and 2021

 

Consolidated Statements of Comprehensive Loss for the years ended December 31, 2022 and 2021

 

Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2022 and 2021

 

Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021

 

Financial Statement Schedules

 

All schedules have been omitted because they are not required or because the required information is given in the Consolidated Financial Statements or Notes thereto set forth under Item 8.

 

Exhibits

 

The exhibits listed below are filed or incorporated by reference as part of this Annual Report on Form 10-K.

 

Exhibit No.

   Description
3.1   Articles of Incorporation and Bylaws of Issuer*
4.1   Form of Series A Warrant and Representatives Warrant****
4.2   Amended and Restated Stock Option Plan – Form of Stock Option Certificate attached as Schedule A*
4.3   Form of Broker Compensation Warrant Certificate for $1.00 warrants issued to brokers in connection in May 2019 in connection with $1.00 preferred unit financing*
10.1   Vacant Land Purchase Agreement, dated July 13, 2020, between Company and Coachella Properties, Inc.*
10.2   Capital Funding Group-Commercial Loan Terms_Sheet_-_Re Coachella_3837v2*
10.3   Commercial Loan Agreement with Alterna Bank-2020-04-30*
10.4   Vacant Land Offer Extension_of_Time_Addendum_Coachella-IM Signed*
10.5   Employment Agreement - Ingo Mueller********
10.6   Employment Agreement - Richard Wong********
10.7   Employment Agreement - Troy McClellan********
10.8   Employment Agreement – Mauro Pennella********
10.9   Second Vacant Land Offer Extension_of_Time_Addendum_Coachella-IM Signed***
10.10   Warrant Agent Agreement***
10.11   Capital Funding Term Sheet dated February 5, 2021 ****
10.12   Extension of Land Purchase Agreement ****
10.13   Pharmhaus Termination Agreements ******
10.14   Bridge Loan Agreement dated March 24, 2021******
10.15   Bridge Note, dated March 24, 2021******
10.16   Bridge Warrant, dated March 24, 2021******
10.17   Asset Purchase Agreement – Manna Nutritional Group********
10.18   Definitive Agreement with Humboldt Bliss, Ltd********
10.19   Share Purchase Agreement with Delphy Groep B.V.********
10.20   Binding LOI to Acquire Deroose Plants NV********
10.21   License Agreement with Radical Clean Solutions Ltd.********
14.1   Code of Ethics**
21.1   List of Subsidiaries**
23.1   Consent of Marcum, LLP**
31.1   Certification of Chief Executive Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**
31.2   Certification of Chief Financial Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**
32.1   Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2   Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed with our Registration Statement on Form S-1 filed with the Commission on December 16, 2020.

** Filed herewith

*** Filed with Amendment No. 1 to our Registration Statement on Form S-1 filed with the Commission on January 20, 2021.

**** Filed with Amendment No. 2 to our Registration Statement on Form S-1 filed with the Commission on March 3, 2021.

***** Filed with Amendment No. 3 to our Registration Statement on Form S-1 filed with the Commission on March 22, 2021.

****** Filed with Amendment No. 4 to our Registration Statement on Form S-1 filed with the Commission on June 3, 2021.

******* Filed with Amendment No. 5 to our Registration Statement on Form S-1 filed with the Commission on June 14, 2021.

******** Filed with Form 10-K filed with the Commission on March 30, 2022.

 

Item 16. Form 10-K Summary.

 

None.

 

43
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AGRIFORCE GROWING SYSTEMS, LTD.
     
Date: March 13, 2023 By: /s/ Ingo Mueller
  Name: Ingo Mueller
  Title: Chief Executive Officer and Director (Principal Executive Officer)
     
Date: March 13, 2023 By: /s/ Richard Wong
  Name: Richard Wong
  Title: Chief Financial Officer (Principal Financial and Accounting Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Ingo Mueller   Chief Executive Officer,   March 13, 2023
Ingo Mueller   Chairman of the Board of Directors    
         
/s/ Richard Wong   Chief Financial Officer   March 13, 2023
Richard Wong        
         
/s/ John Meekison   Director   March 13, 2023
John Meekison        
         
/s/ Richard Levychin   Director   March 13, 2023
Richard Levychin        
         
/s/ Amy Griffith   Director   March 13, 2023
Amy Griffith        
         
/s/ David Welch   Director   March 13, 2023
David Welch        

 

44

 

 EX-14.1 2 ex14-1.htm

 

Exhibit 14.1

 

2.0 BUSINESS ETHICS

 

2.1 Company Ethics & Conduct

 

The successful business operation and reputation of AgriFORCE™ is built upon the principles of fair dealing and ethical conduct of our employees. Our reputation for integrity and excellence requires careful observance of the spirit and letter of all applicable laws and regulations, as well as the highest regard for standards of conduct and personal integrity.

 

The continued success of AgriFORCE™ is dependent upon our customers’ trust and we are dedicated to preserving that trust. Employees owe a duty to AgriFORCE™ and its customers to act in a way that will merit the continued trust and confidence of our customers and the public in general.

 

AgriFORCE™ will comply with all applicable laws and regulations and expects its directors, officers, and employees to conduct business in accordance with the letter, spirit, and intent of all relevant laws and to refrain from any illegal, dishonest, or unethical conduct.

 

In general, the use of common sense and good judgment, together with our core values, will guide you with respect to lines of acceptable conduct. If a situation arises where it is difficult to determine the proper course of action, the matter should be discussed openly with your immediate supervisor, a member of senior management, or Human Resources for advice and consultation, if necessary.

 

Compliance with this policy of business ethics and conduct is the responsibility of every AgriFORCE™ employee. Disregarding or failing to comply with this standard of business ethics and conduct may lead to disciplinary action, up to and including termination of employment.

 

Employees must report violations of this policy, or any of the policies in the Business Ethics section, to their immediate supervisor, a member of senior management, or Human Resources.

 

2.2 Employment Equity

 

AgriFORCE™ is committed to providing equal employment opportunity for all employees and applicants for employment. The company does not discriminate in employment opportunities or practices on the basis of race, colour, religion, sex, marital status, family status, age, place of origin, ancestry, physical disability, mental disability, political belief, sexual orientation, or any other grounds protected by the laws or regulations of any jurisdiction in which we operate. We base all employment decisions – including recruitment, selection, training, compensation, benefits, discipline, promotions, transfers, terminations, and social/recreational programs – on merit and the principles of equal employment opportunity.

 

 

 

 

Our employees have diverse backgrounds, skills and ideas that collectively contribute to greater opportunities for innovation. Our recruitment strategy is designed to attract a diverse pool of talent so that we may select the best candidates and open doors at all levels of this organization.

 

2.3 Conflict of Interest

 

Everyone working at AgriFORCE™ has an obligation to conduct business within guidelines that prohibit actual or potential conflicts of interest. This policy establishes the framework within which AgriFORCE™ wishes the company to operate. The purpose of these guidelines is to provide general direction so that team members can seek further clarification on issues regarding conflict of interest.

 

An actual or potential conflict of interest occurs when someone on the team is able to influence a decision that may result in a personal gain for that individual or for a relative because of AgriFORCE™’s business dealings. For the purposes of this policy, a relative is any person who is related by blood or marriage or whose relationship with anyone working in the company is like that of persons who are related by blood or marriage.

 

If an employee has any influence on transactions involving purchases, contracts, or leases, it is imperative that they disclose to their supervisor, as soon as possible the existence of any actual or potential conflict of interest so that safeguards can be established to protect all parties.

 

Personal gain may result not only in cases where an employee or relative has a significant ownership or other interests in a business with which AgriFORCE™ does business, but also when an employee or relative receives any kickback, bribe, substantial gift, or special consideration as a result of any transaction or business dealings involving AgriFORCE™.

 

2.4 Gifts

 

AgriFORCE™ employees (or immediate family members) are not permitted to give or accept gifts, services, discounts, favours, loans personal discounts and similar gratuities offered to you because of your position at AgriFORCE™. This applies to or from individuals or companies who are doing business or would like to do business with AgriFORCE™. Items of modest value may be permitted if they are not given or received on a regular or frequent basis, provided that the gift is reported to the CEO or the Chair of the Audit Committee and they do not advise that retaining the gift would be inappropriate. This does not apply to officially approved corporate rebates.

 

2.5 Entertainment

 

You must not encourage or solicit entertainment from any individual or company with whom AgriFORCE™ does business. Entertainment includes, but is not limited to, activities such as dining, attending sporting or other special events, and travel. From time-to-time employees may accept unsolicited entertainment, but only under the following conditions:

 

  1. the entertainment occurs infrequently,
     
  2. it arises out of the ordinary course of business,
     
  3. it involves reasonable expenditures (the amounts involved should be such as employees, officers and Directors are accustomed to normally spending for their own business or personal entertainment) and
     
  4. the entertainment takes place in settings that also are reasonable, appropriate, and fitting to employees, officers and Directors, their hosts, and their business at hand.

 

 

 

 

2.6 Anti-Bribery and Anti-Corruption

 

Part of behaving ethically means that you should never participate in any corrupt activities and that you comply with all applicable Anti-Bribery and Anti-Corruption laws and regulations of each jurisdiction in which AgriFORCE™ conducts business. AgriFORCE™ does not permit providing payments, kickbacks, gifts, or anything else of significant value for the purpose of improperly influencing third parties. Even if the intent is not to influence, you should not provide a payment or benefit to any third party if it could appear to be improper.

 

AgriFORCE™ can be held responsible for improper payments and benefits provided by agents, contractors, suppliers and other third parties acting on its behalf. You must ensure that you only deal with legitimate, reputable parties, and that they understand their obligation not to provide such improper payments or benefits in connection with the business they conduct for AgriFORCE™.

 

2.7 Confidentiality

 

All employees are required to keep all AgriFORCE™’s financial, operational and business information acquired while working at AgriFORCE™; secure and confidential. Business strategies and plans, including technologies and products used, are AgriFORCE™ intellectual property. Employees must not discuss details of AgriFORCE™’s financial, business operations, plans or strategies with any third party including the media, family or friends, or at social or public functions, and should direct all inquiries to the CFO. Any employee who divulges confidential information may be subject to disciplinary action, up to and including termination.

 

2.8 Disclosure, Confidentiality, and Insider Trading

 

At times you may find that you are in possession of material non-public information regarding AgriFORCE™ and/or a competitor or supplier. Material non-public information is any information that could reasonably be expected to alter the value of a company’s security (ies) if it were made public. Securities laws in both Canada and the United States provide that it is illegal to trade on such information or disclose it to others. These laws are extensive and complex, and violation of these laws may lead to civil and criminal actions against you.

 

 

 

 

If you find yourself in possession of such information, you and your immediate family members are prohibited from trading in those securities until such time as the information becomes public or you are notified by your manager that restrictions are no longer in place.

 

The purchase and sale of AgriFORCE™ securities may only be done in accordance with the AgriFORCE™ Insider Trading Policy. The Policy also addresses legal prohibitions against trading with knowledge of undisclosed material information, tipping, market manipulation or fraud and insider trade reporting requirements. Violations of such requirements may also have severe consequences, including fines, imprisonment and civil liability and may subject the individual to disciplinary action by the Corporation, up to and including termination. Employees, Officers, and Directors who engage in insider trading may also be accountable to AgriFORCE™ for any benefit or advantage received as a result.

 

Please refer to the AgriFORCE™ Insider Trading Policy provided as an Appendix to this Handbook for more detailed information on this subject. The AgriFORCE™ Insider Trading Policy requires your signature separate from the Handbook Acknowledgement.

 

2.9 Whistleblower Policy

 

Employees are often the first to have concerns that there may be something wrong or unethical occurring within the organisation in which they work. However, they may feel that their concerns cannot be openly expressed, because it may be disloyal to colleagues; their concerns may not be taken seriously; or it may be easier to ignore their concern.

 

As a means of reinforcing AgriFORCE™’s commitment to the highest standards, this ‘Whistle-blowing Procedure’ serves to help build the commitment of all employees, by providing a means of identifying and eliminating unethical practices within the workplace. The ‘Whistle-blowing Procedure’ provides an effective mechanism for employees to report potential concerns (confidentially and anonymously, if required), in the knowledge that genuine concerns will be appropriately investigated and resolved, without fear of discrimination or victimisation.

 

Please refer to the separate Whistleblower Policy document for more detail.

 

2.10 Anti-Retaliation Provisions

 

Retaliation against any employee, who in good faith seeks advice, raises a concern, reports misconduct, or provides information in an investigation will not be tolerated and will itself be considered a violation of AgriFORCE™ Business Ethics. Some examples of retaliation include denial of benefits, termination, demotion, suspension, threats, harassment, or discrimination. If any individual retaliates against an employee who has truthfully and in good faith reported a potential violation, AgriFORCE™ will take appropriate action. However, if an individual has intentionally made a false report, the Company will respond accordingly. For more details, please refer to the AgriFORCE™ Whistleblower Policy.

 

 

 

 

If you believe that you or another employee has been retaliated against for (in good faith) seeking advice, raising a concern, reporting misconduct, or providing information in an investigation, please advise your immediate manager, Human Resources, the AgriFORCE™ CEO or the Chairman of the Audit Committee of the AgriFORCE™ Board. All reports will be handled promptly and confidentially.

 

2.11 Outside Employment

 

While not encouraged, should employees wish to engage in outside employment, in addition to their full-time position at AgriFORCE™, we request that:

 

  ● such outside employment does not interfere in any way with the employee’s work performance or hours of employment with the Company;

 

  ● such employment is non-competitive with the business activities of the Company; and

 

  ● such employment has no possible conflict of interest with the employee’s position at the Company.

 

All employees are reminded that they have signed an agreement which legally prohibits them from passing on the Company’s ideas and work methods to other organizations. Employees may not use Company property, equipment, facilities, or time in connection with outside employment.

 

If it is deemed that, because of outside employment, an employee is repeatedly late, unable to work overtime, or unable to successfully fulfill the obligations of their position at AgriFORCE™, it may result in disciplinary action, up to and including termination.

 

2.12 Off Duty Conduct Policy

 

In general, how employees decide to lead their lives when they are off duty is a private matter. However, the way in which employees conduct and present themselves off-duty can also have a significant impact on AgriFORCE™ its business, reputation, products, customer relations and workplace environment. Accordingly, while the Company respects your personal freedoms, it also has a legitimate interest in establishing standards of off duty conduct and holding workers accountable for following those standards, including using discipline where necessary.

 

Off-duty conduct will be considered a work-related matter subject to discipline if it:

 

  ● harms the Company’s reputation or products;
     
  ● has consequences that render you unable to perform your job or any part of your job effectively;
     
  ● leads other workers to refuse, be reluctant to or unable to work with you;
     
  ● makes you guilty of a serious breach of the Criminal Code of Canada/Title 18 of the United States Code or;
     
  ● makes it difficult for the Company to manage its operations and/or direct its workforce efficiently.

 

 

 

 

Violations of the Company’s off-duty standards of conduct that meet the above criteria will be treated like a disciplinary infraction committed on-duty and subject to discipline up to and including termination.

 

You must report to your supervisor as soon as possible if you are arrested, detained, or charged with a violation under the Criminal Code of Canada/Title 18 of the United States Code or other Canadian/US laws related to your official duties.

 

2.13 Board Participation and Involvement with Other Companies

 

For any employee who wishes to participate on a for-profit, or not-for-profit board, these involvements must be approved by the CEO. All Directors should notify the Chair of the Audit Committee of all other board engagements and seek approval before assuming additional Board roles. You may not be a Director, officer, partner or consultant of an organization (other than an organization in which AgriFORCE™ holds an interest or in which AgriFORCE™ has the right to nominate a Director, officer, partner or consultant) doing or seeking to do business with AgriFORCE™, nor may you permit your name to be used in any way indicating a business connection with such an organization, without appropriate prior written approval of the AgriFORCE™ CEO, in the case of an employee, and of the Chair of the Governance and Nominating Committee in the case of an officer or Director of AgriFORCE™.

 

2.14 AgriFORCE™ Property

 

Employees are responsible for and are expected to take proper care of all AgriFORCE™ property, materials, or written information issued to them or in their possession or control.

 

Upon request of the Company or upon termination or expiration of employment, the employee will turn over to the Company all property belonging to the Company including all confidential information belonging to the Company, including but not limited to, all documents, plans, specifications, disks, or other computer media, as well as any duplicates or backups made of that Confidential Information in whatever form or media, in the possession or control of the employee that:

 

  ● may contain or be derived from ideas, concepts, creations, or trade secrets and other proprietary and confidential information; or

 

  ● is connected with or derived from the employee’s employment with AgriFORCE Growing Systems Ltd.

 

 

 

 

2.15 Copyright and Protection of Intellectual Property

 

Employees are not entitled to any copyright or moral right in or arising from any work they produce in the course of their employment with AgriFORCE™. This includes any program, strategy, design, or system they develop during their employment with the Company. Any copyright or merchandising rights in such work shall be the sole and exclusive property of AgriFORCE™ in accordance with the Canadian and International Copyright Acts.

 

2.16 Public Reporting and Retention of Records

 

Depending on your position with AgriFORCE™, you may be called upon to provide necessary information to ensure that the Company’s public reports are complete, fair and understandable. AgriFORCE™ expects you to take this responsibility very seriously and to provide prompt accurate answers to inquiries related to AgriFORCE™ public disclosure requirements.

 

Employees are required to ensure that all records are kept confidential and meet regulatory and legal requirements in the jurisdiction in which they are created and/or maintained. Destruction of records can only take place if they are not required for any pending legal matters. If you are unclear on what documents may be discarded, contact company legal counsel, or speak to your manager.

 

2.17 Non-Solicitation

 

During the employee’s term of employment with AgriFORCE™ and for a period of twelve (12) months after the end of that term, the employee will not in any way, directly or indirectly:

 

  ● induce or attempt to induce any employee or contractor of the Employer to quit employment or retainer with AgriFORCE™;
     
  ● otherwise interfere with or disrupt AgriFORCE™’s relationship with its employees and contractors;
     
  ● discuss employment opportunities or provide information about competitive employment to any of AgriFORCE™’s employees or contractors; or
     
  ● solicit, entice, or hire away any employee or contractor of AgriFORCE™ for the purpose of an employment opportunity that is in competition with AgriFORCE™.

 

This non-solicitation obligation as described above will be limited to employees or contractors who were employees or contractors of AgriFORCE™ during the period that the employee was employed by AgriFORCE™.

 

During the term of the employee’s active employment with AgriFORCE™, and for one (1) year thereafter, the employee will not divert or attempt to divert from AgriFORCE™ any business AgriFORCE™ had enjoyed, solicited, or attempted to solicit, from its customers, prior to termination or expiration, as the case may be, of the employee’s employment with AgriFORCE™.

 

2.18 Contract Binding Authority

 

Unless authorized in writing by AgriFORCE™, employees do not have the authority to enter any contracts or commitments for or on the behalf of the Company. AgriFORCE™ will maintain a list of delegated authorities in this regard.

 

 

 

 EX-21.1 3 ex21-1.htm

 

Exhibit 21.1

 

AgriFORCE Growing Systems Ltd. LIST OF SUBSIDIARIES:

 

un(Think) Food Company Canada Ltd.

 

AgriFORCE Investments Inc.

 

West Pender Holdings Inc.

 

AGI IP Co.

 

West Pender Management Co.

 

un(Think) Food Company

 

 

 

 EX-23.1 4 ex23-1.htm

 

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in the Registration Statements of AgriFORCE Growing Systems Ltd. on Form S-3 (File No. 333-266722) and Form S-8 (File No. 333-259052) of our report dated March 13, 2023, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of AgriFORCE Growing Systems Ltd. as of December 31, 2022 and 2021 and for the years ended December 31, 2022 and 2021, which report is included in this Annual Report on Form 10-K of AgriFORCE Growing Systems Ltd. for the year ended December 31, 2022.

 

Our report on the consolidated financial statements refers to a change in the method of accounting for leases effective January 1, 2022.

 

/s/ Marcum LLP

 

Marcum LLP

Costa Mesa, California

March 13, 2023

 

 

 

 EX-31.1 5 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14 and 15d-14

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Ingo Mueller, Chief Executive Officer, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of AgriFORCE Growing Systems Ltd.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 13, 2023  
   
/s/ Ingo Mueller  
Ingo Mueller  
Chief Executive Officer and Chairman of the Board  
(Principal Executive Officer)  

 

 

 

 EX-31.2 6 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14 and 15d-14

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Wong, Chief Financial Officer, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of AgriFORCE Growing Systems Ltd.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 13, 2023  
   
/s/ Richard Wong  
Richard Wong  
Chief Financial Officer  
(Principal Financial Officer)  

 

 

 

 EX-32.1 7 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of AgriFORCE Growing Systems Ltd. (the “Company”) for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, the undersigned, Ingo Mueller, as the Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 13, 2023  
   
/s/ Ingo Mueller  
Ingo Mueller  
Chief Executive Officer and Chairman of the Board  
(Principal Executive Officer)  

 

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-K or as a separate disclosure document.

 

 

 

 EX-32.2 8 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of AgriFORCE Growing Systems Ltd. (the “Company”) for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, the undersigned, Richard Wong, as the Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 13, 2023  
   
/s/ Richard Wong  
Richard Wong  
Chief Financial Officer  
(Principal Financial Officer)  

 

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-K or as a separate disclosure document.

 

 

 

 GRAPHIC 9 form10-k_001.jpg begin 644 form10-k_001.jpg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end EX-101.SCH 10 agri-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - BUSINESS OVERVIEW link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - BASIS OF PREPARATION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - CONSTRUCTION IN PROGRESS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INTANGIBLE ASSET link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - DEBENTURES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - LONG TERM LOAN link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - DERIVATIVE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - RESEARCH AND DEVELOPMENT link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - BASIS OF PREPARATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - DEBENTURES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - DERIVATIVE LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - RESEARCH AND DEVELOPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - BASIS OF PREPARATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - CONSTRUCTION IN PROGRESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - INTANGIBLE ASSET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF OUTSTANDING DEBENTURES (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - DEBENTURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - LONG TERM LOAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - DERIVATIVE LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SHARE CAPITAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SUMMARY OF INCOME TAX PROVISION (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - RESEARCH AND DEVELOPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF LEASE EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SCHEDULE OF FUTURE PAYMENTS UNDER LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 agri-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 12 agri-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 13 agri-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Shares Series A Warrants Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Series A Preferred Stock [Member] Additional Paid-in Capital [Member] Obligation To Issue Shares [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Legal Entity [Axis] AgriFORCE Growing Systems Ltd. [Member] Un Food Company Canada Ltd [Member] West Pender Holdings, Inc. [Member] AgriFORCE Investments Inc.[Member] West Pender Management Co. [Member] AGI IP Co. [Member] Un Food Company Canada [Member] Statistical Measurement [Axis] Minimum [Member] Financial Instrument [Axis] IPO Warrant [Member] Long-Lived Tangible Asset [Axis] Computer Equipment [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Land Purchase And Sale Agreement [Member] Related Party [Axis] Stronghold Power System [Member] Scenario [Axis] Forecast [Member] Investment Type [Axis] First Stock Deposits [Member] Second Stock Deposits [Member] Land Purchase Agreement [Member] Asset Purchase Agreement [Member] Manna Nutritional Group LLC [Member] Finite-Lived Intangible Assets by Major Class [Axis] Prefunded Warrants [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Title of Individual [Axis] Accredited Investors [Member] Securities Purchase Agreement [Member] Bridge Warrant [Member] Definitive Agreement [Member] Investors [Member] First 12 Months [Member] Subsequent 12 Months [Member] Thereafter [Member] Debt Instrument [Axis] Additional Tranches [Member] Vesting [Axis] Tranche [Member] Short-Term Debt, Type [Axis] Convertible Debt [Member] Maximum [Member] Alterna Bank [Member] Loan Agreement [Member] Series A Warrants [Member] Warrant [Member] Debenture Warrants [Member] Sale of Stock [Axis] IPO [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 3 [Member] Measurement Input Type [Axis] Measurement Input, Share Price [Member] Measurement Input, Expected Dividend Rate [Member] Measurement Input, Price Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Debenture Convertible [Member] Measurement Input, Discount Rate [Member] Liability Class [Axis] IPO And Representative Warrants [Member] Debenture Convertible Feature [Member] Plan Name [Axis] Option Plan [Member] Reverse Split [Member] Stock Option One [Member] Stock Option Two [Member] Stock Option Three [Member] Stock Option Four [Member] Stock Option Five [Member] Warrants Granted One [Member] Warrants Granted Two [Member] Warrants Exercised One [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Convertible Debt Securities [Member] Tax Credit Carryforward [Axis] Non Capital Losses Carryforward [Member] Geographical [Axis] CANADA Capital Loss Carryforward [Member] UNITED STATES Balance Sheet Location [Axis] Accounts Payable and Accrued Liabilities [Member] David Welch [Member] Class of Warrant or Right [Axis] Consultant [Member] Business Acquisition [Axis] Berry People LLC [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Location Auditor Firm ID Statement of Financial Position [Abstract] ASSETS Current Cash Other receivable Prepaid expenses and other current assets Total current assets Non-current Property and equipment, net Intangible asset Operating lease right-of-use asset Lease deposit, non-current Construction in progress Land deposit Total assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current Accounts payable and accrued liabilities Contingent consideration payable Debentures Lease liability – current Total current liabilities Non-current Deferred rent Lease liability – non-current Derivative liabilities Long term loan Total liabilities Commitments and contingencies Shareholders’ equity Common shares, no par value per share - unlimited shares authorized; 15,795,798 and 15,176,698 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively Additional paid-in-capital Obligation to issue shares Accumulated deficit Accumulated other comprehensive loss Total shareholders’ equity Total liabilities and shareholders’ equity Common stock, no par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] OPERATING EXPENSES Wages and salaries Professional fees Consulting Office and administrative Investor and public relations Research and development Share based compensation Sales and marketing Lease expense Travel and entertainment Shareholder and regulatory Depreciation Operating loss OTHER EXPENSES / (INCOME) Foreign exchange gain Gain on conversion of convertible debt Change in fair value of derivative liabilities Accretion of interest on debentures Write-off of deposit Issuance cost related to warrants Loss on extension of debt term Other income Net loss Dividend paid to preferred shareholders Net loss attributable to common shareholders Other comprehensive loss Foreign currency translation Comprehensive loss attributable to common shareholders Basic and diluted net loss attributed to common share Weighted average number of common shares outstanding – basic and diluted Balance, value Balance, shares Shares issued for cash Shares issued for cash, shares Shares issued for conversion of series A Preferred Stock Shares issued for conversion of series A Preferred Stock, shares Shares issued on exercise of warrants Shares issued on exercise of warrants, shares Shares issued on cashless exercise of warrants Shares issued on cashless exercise of warrants, shares Shares issued on exercise of options Shares issued on exercise of options, shares Shares issued on cashless exercise of options Shares issued on cashless exercise of options, shares Shares issued for bonus and compensation Shares issued for bonus and compensation, shares Shares issued for consulting services Shares issued for consulting services, shares Share issued for settlement of accrued director’s fee Share issued for settlement of accrued director's fee, shares Shares issued for dividend on Preferred shares Shares issued for dividend on Preferred Shares, shares Share issue costs Share based compensation Net loss Shares issued for conversion of convertible debt Shares issued for conversion of convertible debt, shares Prefunded warrants issued Balance, value Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss for the year Adjustments to reconcile net loss to net cash used in operating activities: Shares issued for consulting services Shares issued for compensation and bonuses Amortization of debt issuance costs Loss on extension of debt term Gain on debt conversion Changes in operating assets and liabilities: Other receivables Prepaid expenses and other current assets Accounts payable and accrued liabilities Right-of-use asset Lease liabilities Lease deposit, non-current Deferred rent Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Acquisition of equipment and leasehold improvements Payment against acquisition of intangibles Return of deposit on purchase of land Deposit for purchase of land Construction in progress Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from debentures – net of discount Repayment of convertible debentures Financing costs of debentures Payment for acquisition of intangible asset Proceeds from initial public offering Payment of IPO costs Proceeds from exercise of warrants Proceeds from long term loan Proceeds from senior secured debentures - net Repayment of senior secured debentures Proceeds from exercise of options Net cash provided by financing activities Effect of exchange rate changes on cash Change in cash Cash, beginning of year Cash, end of year Supplemental cash flow information: Cash paid during the period for interest Supplemental disclosure of non-cash investing and financing transactions Initial fair value of warrants issued in connection with issuance of debentures Initial fair value of conversion feature of debentures Prefunded warrants issued related to intangible assets Prefunded warrants related to land deposit Shares issued for conversion of convertible debt Initial operating lease liability recognized under Topic 842 Initial lease right-of-use asset recognized under Topic 842 Initial fair value of warrants liability Preferred stock dividend paid in common shares Conversion of Series A preferred stock to common shares Unpaid amount related to intangible assets included in accrued expenses Accounting Policies [Abstract] BUSINESS OVERVIEW Organization, Consolidation and Presentation of Financial Statements [Abstract] BASIS OF PREPARATION SIGNIFICANT ACCOUNTING POLICIES Prepaid Expenses And Other Current Assets And Land Deposit PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Construction In Progress CONSTRUCTION IN PROGRESS Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSET Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Debt Disclosure [Abstract] DEBENTURES LONG TERM LOAN Derivative Instruments and Hedging Activities Disclosure [Abstract] DERIVATIVE LIABILITIES Equity [Abstract] SHARE CAPITAL Income Tax Disclosure [Abstract] INCOME TAXES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Research and Development [Abstract] RESEARCH AND DEVELOPMENT Leases LEASES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Cash Property and Equipment Definite Lived Intangible Asset Impairment of Long-Lived Assets Convertible Instruments Leases Revenue Recognition Loss per Common Share Research and Development Foreign Currency Transactions Fair value of Financial Instruments Income Taxes Share Based Compensation Recent Accounting Pronouncements SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES SCHEDULE OF OUTSTANDING DEBENTURES SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS SCHEDULE OF SHARE CAPITAL SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS SCHEDULE OF OUTSTANDING WARRANTS ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE SUMMARY OF INCOME TAX PROVISION SCHEDULE OF COMPONENTS OF INCOME TAX SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS SCHEDULE OF LEASE EXPENSES SCHEDULE OF FUTURE PAYMENTS UNDER LEASE SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING Country of Incorporation Purpose Date of Incorporation Accumulated deficit Net loss Net cash used in operating activities Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property plant and equipment useful life Property plant and equipment estimated useful lives Cash equivalents Estimated useful lives Lessor operating lease term of contract Warrant liability Derivative assets liabilities at fair value net Right of use assets Lease liabilities Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Deposits Legal retainer Prepaid expenses Deferred offering costs Others Prepaid expenses, other current assets Cash Warrants issued Payments to acquire land Land deposits Total property and equipment Less: Accumulated depreciation Depreciation expense Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Intangible Assets, Net (Excluding Goodwill) Number of shares issued Stock issued during period value new issues Adjusted for foreign exchange adjustments Foreign currency exchange rate Accounts payable Accrued expenses Others  Accounts Payable and Accrued Liabilities Accounts payable Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Maturity Date Cash Interest Rate Debentures (gross) Repayments and conversions Debt issuance costs and debt discounts Total debentures (current) Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Debt principal amount Subscription amount Debt, maturity date Transaction costs Stock issued during period, shares Stock issued during period, value Investors received warrants Warrant strike price Original issue discount percentage Gross proceeds of debt Debt instrument interest rate percentage Convertible into common shares per share Purchase of additional tranches Warrants expire date Debentures transaction costs incurred Debt instrument converted value Debt instrument converted shares Loss on conversion of convertible debentures Convertible debt Exercise price Proceeds from loan Debt instrument, forgiveness Debt instrument, interest rate Debt, maturity date description Long term loans payable Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Balance at December 31, 2021 Additions Conversions Change in fair value Effect of exchange rate changes Balance at December 31, 2022 Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Class of warrant or right number of securities called by warrants or rights Fair value of warrant Class of warrant or right exercise price of warrants or rights Warrants and rights outstanding measurement input Expected term Exercise of warrants Fair value of debentures convertible Stock price Debenture convertible measurement input Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Common shares issued for bonus and compensation, shares Common shares issued for bonus and compensation , value Common shares issued for conversion of convertible debt, shares Common shares issued for conversion of convertible debt, value Common shares issued for consulting services, shares Common shares issued for consulting services, value Total common shares issued, shares Total common shares issued, value Common shares issued for conversion of convertible debt, shares Common shares issued for conversion of convertible debt, value Common shares issued on exercise of warrants, shares Common shares issued on exercise of warrants, value Common shares issued on cashless exercise of warrants, shares Common shares issued on cashless exercise of warrants, value Common shares issued on exercise of options, shares Common shares issued on exercise of options, value Common shares issued on cashless exercise of options, shares Common shares issued on cashless exercise of options, value Common shares issued for settlement of accrued director's fee, shares Common shares issued for settlement of accrued director's fee, value Common shares issued for dividend on preferred shares, shares Common shares issued for dividend on preferred shares, shares Share issue costs, shares Share issue costs, value Number of Options, beginning balance Weighted average exercise price, beginning balance Weighted average remaining life, ending balance Number of options, granted Weighted average exercise price, granted Weighted average remaining life, granted Number of options, exercised Weighted average exercise price, exercised Number of options forfeited Weighted average exercise price, forfeited Number of options, cancelled Weighted average exercise price, cancelled Number of Options, ending balance Weighted average exercise price, ending balance Outstanding Options, Expiry Date Outstanding Options, Number Outstanding Options, Weighted Average Remaining Life (years) Outstanding Options, Weighted Average Exercise Price Exercisable Options, Number Exercisable Options, Weighted Average Exercise Price Expected volatility Expected Term (in years) Risk-free interest rate Fair value of options Number of warrants, beginning balance Weighted average exercise price, beginning balance Number of warrants, beginning balance Weighted average exercise price, beginning balance Expiry Date Number of warrants, beginning balance Weighted average exercise price, beginning balance Number of warrants, beginning balance Weighted average exercise price, beginning balance Share price Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total anti-dilutive weighted average shares Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Increase the number of authorized shares percentage Share-based compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Unrecognized compensation cost Recognized over a period Domestic operations - Canada Foreign operations - United States Total loss before taxes Loss before taxes Statutory tax rate Income taxes at the statutory rate Change in fair value of derivative liabilities Non-deductible accretion interest Stock-based compensation Share issue costs Foreign currency translation Others permanent differences Total Change in valuation Allowance Total income tax expense (benefit) Unused net operating losses carry forward - Canada and United States Unused capital losses carry forward Share issue costs Other Total deferred tax assets Valuation allowance Tax Credit Carryforward [Table] Tax Credit Carryforward [Line Items] Effective income tax rate reconciliation at federal statutory income tax rate Capital losses Income Tax Examination, Description Due to officers and directors Legal expense License agreement Product development Design and construction  Research and development costs Research and development expense Schedule Of Lease Expenses Operating lease cost Short-term lease cost Total lease expenses Schedule Of Future Payments Under Lease 2023 2024 2025 2026 2027 Subsequent years Total minimum lease payments Less: imputed interest Total lease liability Current portion of lease liability Non-current portion of lease liability Operating lease for office remaining lease term Operating lease discount rate Finance leases 2023 2024 Long Term Debt Subsequent Event [Table] Subsequent Event [Line Items] Conversion of stock, shares issued Number of shares issued upon exercise of warrants Number of shares issued for services Business acquisition, description Series Warrants [Member] Common Shares [Member] Lease Deposit NonCurrent. Construction in progress. Land deposit assets Obligation to issue shares. Consulting. Investor and public relations. Shareholder and regulatory. Change in fair value of derivative liabilities Issuance cost related to warrants. Loss on extension of debt term. Write off of deposit. Series A Warrants [Member] Debenture Warrants [Member] Obligation To Issue Shares [Member] Debenture Convertible [Member] Debenture Convertible Feature [Member] Effect of exchange rate changes. Shares issued on exercise of warrants. Shares issued on cashless exercise of warrants Shares issued on cashless exercise of options shares. Shares issued on cashless exercise of options. Share issued for settlement of accrued directors fee. Share issued for settlement of accrued directors fee shares. Shares Issued On Cashless Exercise Of Warrants Shares Shares issued on exercise of warrants shares. Accretion of interest on senior secured debentures. Gain loss on extension of debt term. Increase the number of authorized shares percentage. Reverse Split [Member]. Increase decrease in right of use asset. Increase Decrease In Lease Deposit Increase Decrease In Deferred Rent Number of options, cancelled. Proceeds from repayments of debentures net of issuance costs. Interest paid on convertible debentures. Prefunded warrants issued related to intangible assets. Prefunded warrants issued related to land deposit. shares issued for conversion of convertible debt. Initial operating lease liability. Initial lease right of use asset. Unpaid amount related to intangible assets Preferred stock dividend paid in common shares. Weighted averave exercise price options, cancelled Sharebased compensation arrangement by sharebased paymentaward options grants in period weighted average remaining contractual term. Increase decrease in contingent consideration payable. Schedule Of Outstanding And Exercisable Stock Options [Table Text Block] Stock Option One [Member]. Stock Option Two [Member]. Stock Option Three [Member]. Stock Option Four [Member]. Stock Option Five [Member]. Sharebased compensation arrangement by Sharebased payment award fair value assumptions fair value. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price Country of Incorporation. AgriFORCE Growing Systems Ltd [Member] Canivate Growing Solutions Ltd. [Member] West Pender Holdings, Inc. [Member] AgriFORCE Investments Inc.[Member] West Pender Management Co. [Member] AGI IP Co. [Member] Class Of Warrant Or Right Expiry Date. Un Food Company Canada Ltd [Member] Un Food Company Canada [Member] Purpose. Permanent differences Share issue costs. Income Tax Expense Benefit Gross. Deferred Tax Assets Share Issue Costs The given value refers to working capital. Non Capital Losses Carryforward [Member] David Welch [Member] Schedule Of Research And Development Costs [Table Text Block] Product development. Design and construction. Technology and Attendant Intellectua lProperty Rights [Member] Consulting Services [Member] HydroHaus Horticulture Inc [Member] Licensing Agreement [Member] Schedule Of Estimated Residual Value Of Computer Equipment And Furniture And Fixtures [Table Text Block] IPO Warrant [Member] Legal retainer. Land Purchase Agreement [Member] Land Purchase And Sale Agreement [Member] Stronghold Power System [Member] First Stock Deposits [Member] Second Stock Deposits [Member] Construction In Progress [Text Block] Asset Purchase Agreement [Member] Manna Nutritional Group LLC [Member] Agreement Description. Cash Payable For Agreement Description. Intellectuals Property [Member] Accredited Investors [Member] Securities Purchase Agreement [Member] Definitive Agreement [Member] Investors [Member] First Twelve Months [Member] Subsequent Twelve Months [Member] Purchase of additional tranches. Additional Tranches [Member] Repayments and conversions. Alterna Bank [Member] Loan Agreement [Member] Bridge Warrant [Member] Thereafter [Member] Post Closing Shares [Member] Stock issued during peirod, shares total. Stock issued during peirod, value total. Shares issued for compensation and bonus. Warrants Granted One [Member] Warrants Granted Two [Member] Warrants Exercised One [Member] Accretion interest on debentures. Initial fair value of warrants issued in connection with issuance of debentures. Initial fair value of conversion feature of debentures. Initial fair value of warrants liability. Prefunded Warrants [Member] Prepaid Expenses And Other Current Assets [Text Block] Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block] IPO And Representative Warrants [Member] Option Plan [Member] Income tax reconciliation income tax expense benefit at change in fair value of derivative liabilities. Deferred tax assets lease liability. Deferred tax assets right of use assets. License agreement. Berry People LLC [Member] Tranche [Member] Payment for acquisition of intangible asset. Travel and entertainment. Number of shares issued upon exercise of warrants. Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Foreign Currency Transaction Gain (Loss), before Tax ChangeInFairValueOfDerivativeLiabilities Other Nonoperating Income Net Income (Loss) Available to Common Stockholders, Basic Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Issuance of Stock and Warrants for Services or Claims GainLossOnExtensionOfDebtTerm Increase (Decrease) in Other Receivables Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities IncreaseDecreaseInLeaseDeposit IncreaseDecreaseInDeferredRent Net Cash Provided by (Used in) Operating Activities Payments to Acquire Machinery and Equipment Payments to Acquire Intangible Assets Payments for Construction in Process Net Cash Provided by (Used in) Investing Activities Repayments of Convertible Debt Payments of Financing Costs PaymentForAcquisitionOfIntangibleAsset Payments for Repurchase of Initial Public Offering Repayments of Long-Term Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations SharesIssuedForConversionOfConvertibleDebt Cash and Cash Equivalents, Policy [Policy Text Block] Lessor, Leases [Policy Text Block] Cash [Default Label] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accounts Payable and Other Accrued Liabilities Accrued Liabilities Debt Instrument, Unamortized Discount Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice Share issue costs. Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount Income Tax Expense Benefit Gross. Income Tax Expense (Benefit) DeferredTaxAssetsShareIssueCosts Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Lease, Cost Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Long-Term Debt, Maturity, Year One Long-Term Debt, Maturity, Year Two Long-Term Debt EX-101.PRE 14 agri-20221231_pre.xml XBRL PRESENTATION FILE XML 15 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 13, 2023
Jun. 30, 2022
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-40578    
Entity Registrant Name AGRIFORCE GROWING SYSTEMS LTD.    
Entity Central Index Key 0001826397    
Entity Incorporation, State or Country Code A1    
Entity Address, Address Line One 300 – 2233 Columbia Street    
Entity Address, City or Town Vancouver    
Entity Address, State or Province BC    
Entity Address, Country CA    
Entity Address, Postal Zip Code V5Y 0M6    
City Area Code (604)    
Local Phone Number 757-0952    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 28,755,938
Entity Common Stock, Shares Outstanding   18,156,154  
Documents Incorporated by Reference [Text Block] List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424(b) or (c) under the Securities Act of 1933. The listed documents should be clearly described for identification purposes (e.g., annual report to security holders for fiscal year ended December 24, 1980).    
Auditor Name Marcum LLP    
Auditor Location Costa Mesa, CA    
Auditor Firm ID 688    
Common Shares      
Title of 12(b) Security Common Shares    
Trading Symbol AGRI    
Security Exchange Name NASDAQ    
Series A Warrants      
Title of 12(b) Security Series A Warrants    
Trading Symbol AGRIW    
Security Exchange Name NASDAQ    
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Current    
Cash $ 2,269,320 $ 7,775,290
Other receivable 48,941 32,326
Prepaid expenses and other current assets 598,342 309,040
Total current assets 2,916,603 8,116,656
Non-current    
Property and equipment, net 121,672 40,971
Intangible asset 13,089,377 1,477,237
Operating lease right-of-use asset 1,540,748
Lease deposit, non-current 50,608
Construction in progress 2,092,533 2,079,914
Land deposit 2,085,960
Total assets 21,846,893 11,765,386
Current    
Accounts payable and accrued liabilities 1,147,739 1,532,312
Contingent consideration payable 753,727
Debentures 3,941,916
Lease liability – current 271,110
Total current liabilities 5,360,765 2,286,039
Non-current    
Deferred rent 12,954
Lease liability – non-current 1,250,060
Derivative liabilities 4,649,115 1,418,964
Long term loan 44,300 47,326
Total liabilities 11,304,240 3,765,283
Commitments and contingencies
Shareholders’ equity    
Common shares, no par value per share - unlimited shares authorized; 15,795,798 and 15,176,698 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively 27,142,762 25,637,543
Additional paid-in-capital 16,816,695 2,203,343
Obligation to issue shares 93,295
Accumulated deficit (32,774,094) (19,900,992)
Accumulated other comprehensive loss (642,710) (33,086)
Total shareholders’ equity 10,542,653 8,000,103
Total liabilities and shareholders’ equity $ 21,846,893 $ 11,765,386
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Common stock, no par value $ 0 $ 0
Common stock, shares authorized Unlimited Unlimited
Common stock, shares issued 15,795,798 15,176,698
Common stock, shares outstanding 15,795,798 15,176,698
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
OPERATING EXPENSES    
Wages and salaries $ 3,923,329 $ 1,766,491
Professional fees 2,669,022 882,146
Consulting 2,561,908 1,088,413
Office and administrative 1,327,739 780,135
Investor and public relations 907,436 748,349
Research and development 615,693 474,338
Share based compensation 420,715 796,141
Sales and marketing 387,130
Lease expense 318,962 168,315
Travel and entertainment 280,838 69,598
Shareholder and regulatory 221,083 143,095
Depreciation 22,413 11,797
Operating loss (13,656,268) (6,928,818)
OTHER EXPENSES / (INCOME)    
Foreign exchange gain (290,079) (162,976)
Gain on conversion of convertible debt (93,973)
Change in fair value of derivative liabilities (3,719,869) (1,191,383)
Accretion of interest on debentures 3,396,578 483,529
Write-off of deposit 151,711
Issuance cost related to warrants 374,465
Loss on extension of debt term 58,952
Other income (75,823)
Net loss (12,873,102) (6,643,116)
Dividend paid to preferred shareholders 735,932
Net loss attributable to common shareholders (12,873,102) (7,379,048)
Other comprehensive loss    
Foreign currency translation (609,624) (152,140)
Comprehensive loss attributable to common shareholders $ (13,482,726) $ (7,531,188)
Basic and diluted net loss attributed to common share $ (0.71) $ (0.66)
Weighted average number of common shares outstanding – basic and diluted 18,080,318 11,164,311
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Additional Paid-in Capital [Member]
Obligation To Issue Shares [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance, value at Dec. 31, 2020 $ 5,696,050 $ 6,717,873 $ 1,297,566 $ 94,885 $ (12,521,944) $ 119,054 $ 1,403,484
Balance, shares at Dec. 31, 2020 8,441,617 2,258,826          
Shares issued for cash $ 13,262,712 13,262,712
Shares issued for cash, shares 3,127,998            
Shares issued for conversion of series A Preferred Stock $ 6,717,873 $ (6,717,873)
Shares issued for conversion of series A Preferred Stock, shares 2,258,826 (2,258,826)          
Shares issued on exercise of warrants $ 238,800 44,644 283,444
Shares issued on exercise of warrants, shares 39,800            
Shares issued on cashless exercise of warrants 64,992 64,992
Shares issued on cashless exercise of warrants, shares 36,275            
Shares issued on exercise of options $ 9,123 $ 9,123
Shares issued on exercise of options, shares 7,018           1,120,719
Shares issued on cashless exercise of options
Shares issued on cashless exercise of options, shares 820,029            
Shares issued for bonus and compensation $ 648,449 648,449
Shares issued for bonus and compensation, shares 159,775            
Shares issued for consulting services $ 381,663 (1,590) 380,073
Shares issued for consulting services, shares 76,364            
Share issued for settlement of accrued director’s fee $ 46,783 46,783
Share issued for settlement of accrued director's fee, shares 19,992            
Shares issued for dividend on Preferred shares $ 735,932 (735,932)
Shares issued for dividend on Preferred Shares, shares 189,004            
Share issue costs $ (2,099,842) (2,099,842)
Share based compensation 796,141 796,141
Net loss (6,643,116) (6,643,116)
Foreign currency translation (152,140) (152,140)
Balance, value at Dec. 31, 2021 $ 25,637,543 2,203,343 93,295 (19,900,992) (33,086) 8,000,103
Balance, shares at Dec. 31, 2021 15,176,698          
Shares issued for bonus and compensation $ 520,230           520,230
Shares issued for bonus and compensation, shares 266,765            
Shares issued for consulting services $ 853,457     (93,295)     760,162
Shares issued for consulting services, shares 284,767            
Share based compensation     420,715       420,715
Net loss       (12,873,102)   (12,873,102)
Foreign currency translation           (609,624) (609,624)
Shares issued for conversion of convertible debt $ 131,532           131,532
Shares issued for conversion of convertible debt, shares 67,568            
Prefunded warrants issued     14,192,637       14,192,637
Balance, value at Dec. 31, 2022 $ 27,142,762 $ 16,816,695 $ (32,774,094) $ (642,710) $ 10,542,653
Balance, shares at Dec. 31, 2022 15,795,798          
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss for the year $ (12,873,102) $ (6,643,116)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 22,413 11,797
Share based compensation 420,715 796,141
Shares issued for consulting services 760,162 321,121
Shares issued for compensation and bonuses 520,230 134,383
Amortization of debt issuance costs 3,057,825 483,529
Loss on extension of debt term 58,952
Write-off of deposit 151,711
Issuance cost related to warrants 374,465
Change in fair value of derivative liabilities (3,719,869) (1,191,383)
Gain on debt conversion (93,973)
Changes in operating assets and liabilities:    
Other receivables (16,615) (23,353)
Prepaid expenses and other current assets (274,302) (235,713)
Accounts payable and accrued liabilities 75,552 662,173
Right-of-use asset 297,034
Lease liabilities (255,429)
Lease deposit, non-current (50,608)
Deferred rent 12,954
Net cash used in operating activities (12,079,359) (5,136,947)
CASH FLOWS FROM INVESTING ACTIVITIES    
Acquisition of equipment and leasehold improvements (104,986) (25,522)
Payment against acquisition of intangibles (500,000) (225,000)
Return of deposit on purchase of land 20,000
Deposit for purchase of land (12,000)
Construction in progress (55,028) (744,191)
Net cash used in investing activities (640,014) (1,006,713)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from debentures – net of discount 12,750,000
Repayment of convertible debentures (2,805,000)
Financing costs of debentures (1,634,894) (69,000)
Payment for acquisition of intangible asset (750,000)
Proceeds from initial public offering 15,639,990
Payment of IPO costs (2,279,374)
Proceeds from exercise of warrants 238,800
Proceeds from long term loan 15,932
Proceeds from senior secured debentures - net 600,000
Repayment of senior secured debentures (750,000)
Proceeds from exercise of options 9,123
Net cash provided by financing activities 7,560,106 13,405,471
Effect of exchange rate changes on cash (346,703) (139,931)
Change in cash (5,505,970) 7,121,880
Cash, beginning of year 7,775,290 653,410
Cash, end of year 2,269,320 7,775,290
Supplemental cash flow information:    
Cash paid during the period for interest 338,753
Supplemental disclosure of non-cash investing and financing transactions    
Initial fair value of warrants issued in connection with issuance of debentures 4,080,958
Initial fair value of conversion feature of debentures 3,336,535
Prefunded warrants issued related to intangible assets 12,106,677
Prefunded warrants related to land deposit 2,085,960
Shares issued for conversion of convertible debt 131,532
Initial operating lease liability recognized under Topic 842 1,776,599
Initial lease right-of-use asset recognized under Topic 842 1,837,782
Initial fair value of warrants liability 374,028
Preferred stock dividend paid in common shares 735,932
Conversion of Series A preferred stock to common shares 6,717,873
Unpaid amount related to intangible assets included in accrued expenses $ 500,000
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.4
BUSINESS OVERVIEW
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
BUSINESS OVERVIEW

1. BUSINESS OVERVIEW

 

AgriFORCE Growing Systems Ltd. (“AgriFORCE™” of the “Company”) was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the Business Corporations Act (British Columbia) on December 22, 2017. The Company’s registered and records office address is at 300 – 2233 Columbia Street, Vancouver, British Columbia, Canada, V5Y 0M6.

 

The Company is an innovative agriculture-focused technology company that delivers reliable, financially robust solutions for high value crops through our proprietary facility design and automation Intellectual Property to businesses and enterprises globally through our AgriFORCE™ Solutions division (“Solutions”) and delivers nutritious food products through our AgriFORCE™ Brands division (“Brands”).

 

Solutions intends to operate in the plant based pharmaceutical, nutraceutical, and other high value crop markets using its unique proprietary facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops in a controlled environment(“FORCEGH+™”) The Company has designed FORCEGH+™ facilities to produce in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible whilst substantially eliminating the need for the use of pesticides and/or irradiation.

 

Brands is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and more nutritious solutions. We will market and commercialize both branded consumer product offerings and ingredient supply.

 
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
BASIS OF PREPARATION
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PREPARATION

2. BASIS OF PREPARATION

 

Basis of Presentation

 

The accompanying consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.

 

Principal of Consolidation

 

Our consolidated financial statements include the accounts of our wholly owned subsidiaries. We consolidate variable interest entities (VIEs) when we have variable interests and are the primary beneficiary.

 

All inter-company balances and transactions have been eliminated on consolidation. These consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries:

 

Name of entity:   Country of Incorporation   Purpose   Date of Incorporation
AgriFORCE Growing Systems Ltd.   Canada   Parent Company   Dec 22, 2017
un(Think) Food Company Canada Ltd.*   Canada   Food Product Manufacturing   Dec 4, 2019
West Pender Holdings, Inc.   United States   Real Estate Holding and Development Company   Sep 1, 2018
AgriFORCE Investments Inc.   United States   Holding Company   Apr 9, 2019
West Pender Management Co.   United States   Management Advisory Services   Jul 9, 2019
AGI IP Co.   United States   Intellectual Property   Mar 5, 2020
un(Think) Food Company   United States   Food Product Manufacturing   June 20, 2022

 

* un(Think) Food Company Canada Ltd. changed its name from Daybreak AG Systems Ltd. on August 19, 2022.

 

 

un(Think) Food Company, a wholly owned subsidiary commenced operations in 2022 and their results are consolidated into the results of the Company.  

 

Functional and Reporting Currency

 

The functional currency for each entity included in these consolidated financial statements is the currency of the primary economic environment in which the entity operates. These consolidated financial statements are presented in United States dollars (“U.S. dollars”). Currency conversion to U.S. dollars is performed in accordance with ASC 830, Foreign Currency Matters.

 

Use of Estimates

 

The preparation of our financial statements in accordance with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Significant estimates reflected in these financial statements include, but are not limited to, accounting for share-based compensation, valuation of derivative liabilities, valuation of embedded conversion feature, going concern, impairment as well as depreciation method. Actual results could differ from these estimates and those differences could be material.

 

Going Concern

 

The Company has incurred substantial operating losses since its inception, and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As reflected in the financial statements, the Company had an accumulated deficit of approximately $32.8 million at December 31, 2022, a net loss of approximately $12.9 million, and approximately $12.1 million of net cash used in operating activities for the year ended December 31, 2022. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company anticipates incurring additional losses until such time, if ever, that it can obtain marketing approval to sell, and then generate significant sales, of its technology that is currently in development. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is seeking additional financing to support its growth plans. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to currently outstanding common shares.

 

 
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.4
SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES

3. SIGNIFICANT ACCOUNTING POLICIES

 

Cash

 

The Company’s cash consists of cash maintained in checking and interest-bearing accounts. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents. The Company held no cash equivalents as of December 31, 2022 and 2021.

 

Property and Equipment

 

Property and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company’s management. Property, plant and equipment are subsequently measured at cost less accumulated depreciation and impairment losses.

 

Depreciation is recognized on a straight-line basis to write down the cost less estimated residual value of computer equipment and furniture and fixtures. The following useful lives are applied:

 

Computer equipment   3 years
Furniture and fixtures   7 years
Leasehold improvements   Lower of estimated useful life or remaining lease term

 

Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets and are recognized in profit or loss within other income or other expenses.

 

Construction in progress includes construction progress payments, deposits, engineering costs, interest expense for debt financing on long-term construction projects and other costs directly related to the construction of the facilities. Expenditures are capitalized during the construction period and construction in progress is transferred to the relevant class of property and equipment when the assets are available for use, at which point the depreciation of the asset commences.

 

Definite Lived Intangible Asset

 

Definite lived intangible asset consists of a granted patent. Amortization is computed using the straight-line method over the estimated useful lives of the asset. Estimated useful lives of the granted patent is 20 years. Amortization expense is allocated to general and administrative expense. No amortization expense has been taken on the granted patent as it was available for use starting January 2023.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Fair value can be determined using a market approach, income approach or cost approach. The reversal of impairment losses is prohibited.

 

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which provides that if three criteria are met, the Company is required to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which;

 

(a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract;

(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur; and

(c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Leases

 

The Company determines at the inception of a contract if the arrangement is or contains a lease. A contract is or contains a lease if the contract gives the right to control the use of an identified asset for a period of time in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a right-of-use asset and a lease liability on the balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded on the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.

 

The Company’s contracts can contain both lease and non-lease components. The non-lease components may include maintenance, utilities, and other operating costs. The Company combines the lease and non-lease components of fixed costs in its leases as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of right-of-use assets and lease liabilities. These costs are expensed when the event determining the amount of variable consideration to be paid occurs.

 

Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of future lease payments over the expected lease term. The Company determines the present value of future lease payments by using its estimated secured incremental borrowing rate for that lease term as the interest rate implicit in the lease is not readily determinable. The Company estimates its incremental borrowing rate for each lease based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments over a similar term.

 

 

Revenue Recognition

 

The Company has not recorded any revenues since its inception. However, in the future, the Company expects to generate returns from any or all the revenue sources below from its customers:

 

● Rental income from facilities
● Sales revenue from nutritious food products
● Intellectual property income from the license of the facilities
● Management and advisory fees from management service contracts

 

On January 1, 2018, the Company early adopted ASU No. 2014-09, Revenue from Contracts with Customers and all related amendments (“ASC 606” or “the new revenue standard”). ASC 606 is a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new revenue standard is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 provides that an entity should apply the following steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The new revenue standard also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, and costs to obtain or fulfill contracts. The Company will apply ASC 606 prospectively to all contracts.

 

Loss per Common Share

 

The Company presents basic and diluted loss per share data for its common shares. Basic loss per common share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the year. The number of common shares used in the loss per shares calculation includes all outstanding common shares plus all common shares issuable for which there are no conditions to issue other than time. Diluted loss per common share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all potentially dilutive share equivalents, such as stock options and warrants and assumes the receipt of proceeds upon exercise of the dilutive securities to determine the number of shares assumed to be purchased at the average market price during the year.

 

Research and Development

 

Expenditure on research and development activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognized as expense when incurred.

 

Foreign Currency Transactions

 

The financial statements of the Company and its subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, shareholders’ equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries’ accounts are included in “Accumulated other comprehensive income” as equity in the consolidated balance sheets. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the reporting currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within non-operating expenses.

 

Fair value of Financial Instruments

 

The fair value of the Company’s accounts receivable, accounts payable and other current liabilities approximate their carrying amounts due to the relative short maturities of these items.

 

 

As part of the issuance of debentures on March 24, 2021 and June 30, 2022, the Company issued warrants having strike price denominated in U.S. Dollars. This creates an obligation to issue shares for a price that is not denominated in the Company’s functional currency and renders the warrants not indexed to the Company’s stock, and therefore, must be classified as a derivative liability and measured at fair value. On the same basis, the Series A Warrants and the representative warrants issued as part of the IPO are also classified as a derivative liability and measured at fair value.

 

The fair value of the Company’s warrants is determined in accordance with FASB ASC 820, “Fair Value Measurement,” which establishes a fair value hierarchy that prioritizes the assumptions (inputs) to valuation techniques used to price assets or liabilities that are measured at fair value. The hierarchy, as defined below, gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The guidance for fair value measurements requires that assets and liabilities measured at fair value be classified and disclosed in one of the following categories:

 

● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities.
   
● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
   
● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.

 

As of December 31, 2022, the Company’s warrant liability related to IPO warrants and representative’s warrant amounting to $275,115 (December 31, 2021 - $1,418,964) is reported at fair value and categorized as Level 1 inputs. The fair value of derivative liabilities related to the Debenture Warrants and Debenture Convertible Feature that were issued during the year amounted to $4,374,000 (December 31, 2021 - $nil) and were categorized as level 3 inputs. The Bridge Warrants that were issued and exercised in the year ended December 31, 2021 were also categorized as level 3 inputs. (See Note 9 and Note 11)

 

Income Taxes

 

Current tax expense is the expected tax payable on the taxable income for the period, using tax rates enacted at period-end.

 

Deferred tax assets, including those arising from tax loss carryforwards, requires management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted.

 

The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.

 

 

The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.

 

There were no material uncertain tax positions as of December 31, 2022 and 2021.

 

Share Based Compensation

 

The Company generally uses the straight-line method to allocate compensation cost to reporting periods over each optionee’s requisite service period, which is generally the vesting period, and estimates the fair value of stock-based awards to employees and directors using the Black-Scholes option-valuation model (the “Black-Scholes model”). .. This model incorporates certain assumptions for inputs including a risk-free market interest rate, expected dividend yield of the underlying common stock, expected option life, and expected volatility in the market value of the underlying common stock. The Company recognizes any forfeitures as they occur.

 

Recent Accounting Pronouncements

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Start-ups Act of 2012, (the “JOBS Act”). Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, for complying with new or revised accounting standards applicable to public companies. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize leases on balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.

 

The Company adopted ASC 842 as of January 1, 2022 using the optional transition method to apply the standard as of the effective date. Accordingly, previously reported financial statements, including footnote disclosures, have not been recast to reflect the application of the new standard to all comparative periods presented.

 

The new standard also provides practical expedients for an entity’s ongoing accounting as a lessee. The Company elected to utilize the practical expedient to not separate lease and non-lease components for its existing lease. The Company has also elected not to present short-term leases on the consolidated balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because the Company’s lease does not provide an implicit rate of return, it used its incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.

 

Adoption of the new lease standard on January 1, 2022 had a material impact on the Company’s consolidated financial statements. The most significant impacts related to the recognition of ROU assets of $1,776,599 and lease liabilities of $1,837,782 for operating leases on the consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The standard did not materially impact the Company’s consolidated statements of comprehensive loss and consolidated statement of cash flows.

 

In August 2020, the FASB issued ASU 2020-06 “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASU 2020-06”). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted “Earnings per share” under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. ASC 2020-06 is effective for emerging growth companies for fiscal years beginning after December 15, 2023. We are currently assessing the impact this guidance will have on our financial statements.

 

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” The standard, including subsequently issued amendments, requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and requires the modified retrospective approach. Early adoption is permitted. Based on the composition of the Company’s trade receivables and other financial assets, current market conditions, and historical credit loss activity, the Company is currently in the process of evaluating the impact of this guidance on our financial statements.

 

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under ASU 2021-08, an acquirer must recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The guidance is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is currently in the process of evaluating the impact of this guidance on our financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT
 12 Months Ended
Dec. 31, 2022
Prepaid Expenses And Other Current Assets And Land Deposit  
PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT

4. PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT

 

   December 31, 2022   December 31, 2021 
Deposits  $12,000   $32,000 
Legal retainer   24,457    33,692 
Prepaid expenses   436,496    214,445 
Deferred offering costs   100,337    - 
Others   25,052    28,903 
Prepaid expenses, other current assets  $598,342   $309,040 

 

On August 31, 2022, the Company signed a purchase and sale agreement with Stronghold Power Systems, Inc. (“Stronghold”), to purchase approximately seventy acres of land located in the City of Coachella as well as the completion of certain permitting, zoning, and infrastructure work by Stronghold for a total purchase price of $4,300,000. The purchase price consists of:

 

  (i) $1,500,000 in cash due on March 31, 2023.
     
  (ii) A first stock deposit of $1,700,000 in prefunded warrants. The Company issued 695,866 prefunded warrants on September 9, 2022 to Stronghold.
     
  (iii) A second stock deposit $1,100,000 in prefunded warrants. The Company issued 450,266 prefunded warrants on September 9, 2022 to Stronghold.

 

At December 31, 2022 the $2,085,960 of prefunded warrants were recorded under land deposit in relation to the Stronghold agreement. The prefunded warrant issuance may be rescinded and the warrants null and void if Stronghold does not meet all escrow performance conditions by March 31, 2023.

 
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.22.4
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

5. PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following:

 

   December 31, 2022   December 31, 2021 
Leasehold improvements  $86,979   $- 
Computer equipment   39,112    22,708 
Furniture and fixtures   37,590    39,997 
Total property and equipment   163,681    62,705 
Less: Accumulated depreciation   (42,009)   (21,734)
Property and equipment, net  $121,672   $40,971 

 

Depreciation expense on property and equipment, was $22,413 and $11,797 for the years ended December 31, 2022 and 2021, respectively.

 

 
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.22.4
CONSTRUCTION IN PROGRESS
 12 Months Ended
Dec. 31, 2022
Construction In Progress  
CONSTRUCTION IN PROGRESS

6. CONSTRUCTION IN PROGRESS

 

The Company engaged outside contractors to begin construction work on its first facility. As of December 31, 2022, $2,092,533 (December 31, 2021 – $2,079,914) represents progress payments related to facility construction.

 
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.22.4
INTANGIBLE ASSET
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSET

7. INTANGIBLE ASSET

 

Intangible asset represents $13,089,377 (December 31, 2021 - $1,477,237) for intellectual property (“Manna IP”) acquired under an asset purchase agreement with Manna Nutritional Group, LLC (“Manna”) dated September 10, 2021. The Manna IP encompasses patent-pending technologies to naturally process and convert grain, pulses and root vegetables, resulting in low-starch, low-sugar, high-protein, fiber-rich baking flour products, as well as a wide range of breakfast cereals, juices, natural sweeteners and baking enhancers. The Company paid $1,475,000 in cash and issued 7,379,969 prefunded warrants valued at $12,106,677 (the “Purchase Price”) adjusted for foreign exchange differences of $492,300. Subject to a 9.99% stopped and SEC Rule 144 restrictions the prefunded warrants will vest in tranches up until March 10, 2024. When vested the tranches of prefunded warrants will be converted into an equal number of common shares.

 

Subsequent to the year end, Manna satisfied all of its contractual obligations when the patent was approved by the US Patents Office and title was transferred to the Company. The Company issued 1,637,049 shares in relation to this transaction on January 3, 2023.

 

Based on the terms above and in conformity with US GAAP, the Company accounted for purchase as an asset acquisition and has deemed the asset purchased as an in-process research and development. The Company has further deemed the asset to be of indefinite life until the completion of the associated research and development activities. Once completed and commercialized, the asset will be amortized over its useful life.

 
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.22.4
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

   December 31, 2022   December 31, 2021 
Accounts payable  $498,188   $414,117 
Accrued expenses   365,521    981,027 
Others   284,030    137,168 
 Accounts Payable and Accrued Liabilities  $1,147,739   $1,532,312 

 

Accrued expenses as of December 31, 2021, included $500,000 related to the purchase of the Manna IP.

 

 
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.22.4
DEBENTURES
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
DEBENTURES

9. DEBENTURES

 

On March 24, 2021, the Company entered into a securities purchase agreement with certain investors for the purchase of $750,000 in principal amount ($600,000 subscription amount) of senior secured debentures originally due June 24, 2021 (the “Bridge Loan”). The imputed interest rate is encompassed within the original issue discount of the debentures and no additional cash interest shall be due. Transaction costs of $69,000 have been recorded in connection with the Bridge Loan.

 

On June 24, 2021, the due date was extended, for which the Company paid an extension fee of 10,000 common shares with a fair value of $60,000. The senior secured debentures were repaid in full on July 13, 2021.

 

As part of the bridge loan, the debenture holder was issued warrants (the “Bridge Warrants”) to purchase 93,938 common shares for up to three years of the issuance date with a strike price of $3.99 per share.

 

On June 30, 2022, the Company executed the definitive agreement with certain institutional investors (the “Investors”) for a $14,025,000 principal debentures with a 10% original issue discount (the “Debentures”) for net proceeds of $12,750,000. The interest rates on the Debentures are 5% for the first 12 months, 6% for the subsequent 12 months, and 8% per annum thereafter. Principal repayments will be made in 25 equal monthly installments and began on September 1, 2022. The Debenture may be extended by six months at the election of the Company by paying a sum equal to six months interest on the principal amount outstanding at the end of the 18th month, at the rate of 8% per annum. The Debentures are convertible into common shares at $2.22 per share. The Investors have the right to purchase additional tranches of $5,000,000 each, up to a total additional principal amount of $33,000,000. In addition, the Investors received 4,106,418 warrants at a strike price of $2.442, which expire on December 31, 2025 (the “Debenture Warrants”). The Debenture Warrants and Debentures each have down round provisions whereby the conversion and strike prices will be adjusted downward if the Company issues equity instruments at lower prices. The Debenture Warrants strike price and the Debenture conversion price will be adjusted down to the effective conversion price of the issued equity instruments. Due to the currency of these features being different from the Company’s functional currency the Debenture Warrants and Debentures’ convertible features were classified as derivative liabilities and are further discussed in Note 11. The transaction costs incurred in relation to the Debentures were $1,634,894.

 

The following table summarizes our outstanding debentures as of the dates indicated:

 

   Maturity   Cash Interest Rate  December 31, 2022 
Principal (initial)   12/31/2024   5.00% - 8.00 %  $14,025,000 
Repayments and conversions           (2,955,000)
Debt issuance costs and discounts (Note 9 & 11)           (7,128,084)
Total Debentures (current)          $3,941,916 

 

During the year ended December 31, 2022, the Investors converted $150,000 of convertible debentures into 67,568 shares of the Company resulting in a $93,973 gain on the conversion of convertible debentures.

 

Subsequent to the year end, the Investors purchased an additional tranche of $5,076,923. The convertible debt and warrants were issued with an exercise price of $1.24. The issuance of the additional tranche triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $1.24.

 

 
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.22.4
LONG TERM LOAN
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
LONG TERM LOAN

10. LONG TERM LOAN

 

During the year ended December 31, 2020, the Company entered into a loan agreement with Alterna Bank for a principal amount of $29,533 (December 31, 2021 - $31,417) (CAD$40,000) under the Canada Emergency Business Account Program (the “Program”).

 

The Program, as set out by the Government of Canada, requires that the funds from this loan shall only be used by the Company to pay non-deferrable operating expenses including, without limitation, payroll, rent, utilities, insurance, property tax and regularly scheduled debt service, and may not be used to fund any payments or expenses such as prepayment/refinancing of existing indebtedness, payments of dividends, distributions and increases in management compensation.

 

In April 2021, the Company applied for an additional loan with Alterna Bank under the Program and received $14,767 (CAD$20,000) (December 31, 2021 - $15,909 (CAD $60,000)). The expansion loan is subject to the original terms and conditions of the Program.

 

The loan is interest free for an initial term that ends on December 31, 2023. Repaying the loan balance on or before December 31, 2023 will result in loan forgiveness of up to a third of loan value (up to CAD $20,000). Any outstanding loan after initial term carries an interest rate of 5% per annum, payable monthly during the extended term i.e. January 31, 2024 to December 31, 2025.

 

The balance at December 31, 2022 was $44,300 (CAD $60,000) (December 31, 2021 - $47,326 (CAD $60,000)).

 
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.22.4
DERIVATIVE LIABILITIES
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITIES

11. DERIVATIVE LIABILITIES

 

The Company’s derivative liabilities consist of warrants, denominated in a currency other than the Company’s functional currency (the “Warrant Liabilities”) and conversion rights embedded in the Debentures, see Note 9 (the “Debenture Convertible Features”).

 

Warrant Liabilities

 

As of December 31, 2022, the Warrant Liabilities represent aggregate fair value of publicly traded 3,088,198 Series A warrants (“IPO Warrants”), 135,999 representative’s warrants (“Rep Warrants”) and 4,106,418 Debenture Warrants.

 

The fair value of the IPO Warrants and Rep Warrants amount to $275,115 (December 31, 2021 - $1,418,964) and were categorized as a Level 1 financial instrument. The Rep Warrants are exercisable one year from the effective date of the IPO registration statement and will expire three years after the effective date.

 

The fair value of the Debenture Warrants amounted to $2,917,000 (June 30, 2022 - $4,080,958) and were categorized as a Level 3 financial instrument. As at December 31, 2022 the Company utilized the Monte Carlo option-pricing model (June 30, 2022 – Black-Scholes option-pricing model) to value the Debenture Warrants using the following assumptions: stock price $1.13 (June 30, 2022 - $2.31), dividend yield – nil (June 30, 2022 – nil), expected volatility 95.0% (June 30, 2022 – 58.3%), risk free rate of return 4.22% (June 30, 2022 – 3.14%), and expected term of 3 years (June 30, 2022 – expected term of 3.5 years).

 

The changes in the fair value of the Bridge Warrants ($203,456 – 2021) was charged to the statement of comprehensive loss. The warrants were exercised on October 27, 2021 and accordingly, the warrant liability was extinguished. The fair value of the warrants prior to exercise was estimated at $64,992, determined using the Black-Scholes option pricing model and the following assumptions; stock price $2.16, dividend yield – nil, expected volatility 73%, risk free rate of return 0.94%, expected term of 3 years.

 

Debenture Convertible Features

 

On June 30, 2022, the Company issued Debentures with an equity conversion feature, see Note 9. The fair value of the Debentures’ convertible features was $3,336,535 on the issuance date and $1,457,000 as at December 31, 2022. These conversion features are categorized as a Level 3 financial instrument. As at December 31, 2022 the Company utilized the Monte Carlo option-pricing model (June 30, 2022 – Black-Scholes option-pricing model) for valuing the convertible feature using the following assumptions: stock price $1.13 (June 30, 2022 - $2.31), dividend yield – nil (June 30, 2022 – nil), expected volatility 95.0% (June 30, 2022 – 101.0%), risk free rate of return 4.41% (June 30, 2022 – 3.14%), discount rate 13.65% (June 30, 2022 – not applicable), and expected term of 2 years (June 30, 2022 – 1 year).

 

Changes in the fair value of Company’s Level 1 and 3 financial instruments for the year ended December 31, 2022 were as follows:

 

                        
    Level 1    Level 3   Level 3     
    IPO and Rep Warrants    Debenture Warrants  

Debenture

Convertible

Feature

   Total 
Balance at December 31, 2021   $ 1,418,964    $-   $-   $1,418,964 
Additions     -     4,080,958    3,336,535    7,417,493 
Conversions     -     -    (63,723)   (63,723)
Change in fair value     (1,086,562 )   (966,141)   (1,667,166)   (3,719,869)
Effect of exchange rate changes     (57,287 )   (197,817)   (148,646)   (403,750)
Balance at December 31, 2022   $ 275,115    $2,917,000   $1,457,000   $4,649,115 

 

Due to the expiry date of the warrants and conversion feature being subsequent to December 31, 2023, the liabilities have been classified as non-current.

 

 
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE CAPITAL
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
SHARE CAPITAL

12. SHARE CAPITAL

 

  a) Authorized Share Capital 

 

On March 1, 2019, the Company changed its share structure to replace Class – A voting shares with Common voting Shares, eliminated Class-B non-voting shares, and created a new series of Preferred shares with no par value and unlimited number of shares. Holders of Preferred shares shall be entitled to receive distribution ahead of holders of Common shares. In addition, Preferred shareholders are also entitled to a fixed premium (if specifically provided in the special rights and restrictions attached to a specific series of Preferred shares), prior to any distributions to holders of Common shares in the event of dissolution, liquidation or winding-up of the Company.

 

  b) Issued Share Capital

 

The Company had the following common share transactions during the year ended December 31, 2022:

 SCHEDULE OF SHARE CAPITAL

   # of shares   Amount 
Common shares issued for bonuses and compensation   266,765   $520,230 
Common shares issued for conversion of convertible debt   67,568    131,532 
Common shares issued to consultants   284,767    853,457 
Total common shares issued   619,100   $1,505,219 

 

The Company had the following common share transactions during the year ended December 31, 2021:

 

   # of shares   Amount 
Common shares issued for cash   3,127,998   $13,262,712 
Common shares issued for conversion of series A preferred stock   2,258,826    6,717,873 
Common shares issued on exercise of warrants   39,800    238,800 
Common shares issued on cashless exercise of warrants   36,275    - 
Common shares issued on exercise of options   7,018    9,123 
Common shares issued on cashless exercise of options   820,029    - 
Common shares issued for bonus and compensation   159,775    648,449 
Common shares issued for consulting services   76,364    381,663 
Common shares issued for settlement of accrued director’s fee   19,992    46,783 
Common shares issued for dividend on preferred shares   189,004    735,932 
Share issue costs   -    (2,099,842)
Total common shares issued   6,735,081   $19,941,493 

 

  c) Stock Options

 

The Company has adopted a stock option plan (the “Option Plan”) for its directors, officers, employees and consultants to acquire common shares of the Company. The terms and conditions of the stock options are determined by the Board of Directors.

 

On May 28, 2019, at the Company’s annual general meeting, shareholders approved an amendment to the Option Plan to increase the number of authorized shares subject to the Option Plan to 15% of the issued and outstanding shares of the Company (including any unconverted Series A Preferred Shares).

 

For the year ended December 31, 2022, the Company recorded aggregate share-based compensation expense of $420,715 (December 31, 2021 - $796,141) for all stock options on a straight-line basis over the vesting period.

 

 

As of December 31, 2022, 1,382,629 (December 31, 2021 – 717,019) Options were outstanding at a weighted average exercise price of $3.30 (December 31, 2021 - $5.63), of which 414,305 (December 31, 2021 – 280,938) were exercisable.

 

The amounts recognized as share-based payments and stock options are included in share-based compensation on the Statement of Loss and Comprehensive Loss.

 

As of December 31, 2022, there was $538,358 (December 31, 2021 - $634,626) of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted; that cost is expected to be recognized over a period of 2 years (December 31, 2021 – 3 years).

 

The following summarizes stock option activity during the years ended December 31, 2022 and 2021:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Life (years) 
             
Balance at December 31, 2020   1,450,918   $2.01    4.38 
Granted   509,788   $7.00    4.47 
Exercised   (1,120,719)  $3.23    - 
Forfeited   (28,947)  $4.75    - 
Cancelled   (94,021)  $6.70    - 
Balance at December 31, 2021   717,019   $5.63    4.48 
Granted   747,060   $1.14    4.48 
Forfeited   (25,542)  $7.00    - 
Cancelled   (55,908)  $4.27    - 
Balance at December 31, 2022   1,382,629   $3.30    4.24 

 

The Company’s outstanding and exercisable stock options at December 31, 2022 were:

 

   Outstanding Options   Exercisable Options 
Expiry Date  Number   Weighted Average Remaining Life (years)   Weighted Average Exercise Price   Number   Weighted Average Exercise Price 
           $       $ 
June 30, 2026   210,489    3.50    3.51    210,489    3.51 
May 31, 2026   320,351    3.42    7.00    160,176    7.00 
July 15, 2026   55,445    3.54    7.00    23,100    7.00 
September 30, 2026   49,284    3.75    7.00    20,540    7.00 
November 18, 2027   747,060    4.88    1.14    -    - 
Total Share Options   1,382,629    4.24    3.30    414,305    5.23 

 

 

The following table summarizes the Company’s assumptions used in the valuation of options granted during the year ended December 31, 2022 and December 31, 2021:

 

   December 31, 2022   December 31, 2021 
Expected volatility   78.05%   80.00%
Expected term (in years)   3.07    3.31 
Risk-free interest rate   3.35%   0.92%
Fair value of options  $0.60   $2.59 

 

  d) Warrants

 

The Company’s outstanding warrants as of December 31, 2022 were:

 

   Number of warrants   Weighted average exercise price   Expiry Date
       $    
Outstanding, December 31, 2020   2,546,065    7.46    
Granted July 12, 2021   3,263,997    6.00   July 12, 2024
Granted July 28, 2021   93,938    3.99   July 28, 2024
Exercised in 2021   (133,738)   4.59   n/a
Outstanding, December 31, 2021   5,770,262    5.91    
Granted June 30, 2022   4,106,418    2.44a  December 30, 2025
Outstanding, December 31, 2022   9,876,680    4.91    

 

(a) Subsequent to the year end, the issuance of additional tranches of Debentures triggered the down round provision, adjusting the exercise prices of the Debenture Warrants to $1.24 (Note 9).

 

  e) Loss per Common Share

 

Diluted net loss attributable to common shareholders per share does not differ from basic net loss attributable to common shareholders per share for the years ended December 31, 2022 and December 31, 2021, since the effect of the Company’s warrants, stock options and convertible debentures are anti-dilutive.

 

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

           
  

December 31, 2022

  

December 31, 2021

 
Warrants   9,876,680    5,770,262 
Options   1,382,629    717,019 
Prefunded warrants   1,146,132    - 
Convertible debentures   4,986,486    - 
Total anti-dilutive weighted average shares   17,391,927    6,487,281 

 

 
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

13. INCOME TAXES

 

For the year ended December 31, 2022 and 2021, loss before income tax provision consisted of the following:

 

   December 31, 2022   December 31, 2021 
         
Domestic operations - Canada  $(11,753,662)  $(6,202,837)
Foreign operations - United States   (1,119,440)   (440,279)
Total loss before taxes  $(12,873,102)  $(6,643,116)

 

Income tax expense (benefit) consists of the following for the years ended December 31, 2022 and December 31, 2021:

 

   December 31, 2022   December 31, 2021 
         
Loss before taxes  $(12,873,102)  $(6,643,116)
Statutory tax rate   27.00%   27.00%
Income taxes at the statutory rate  $(3,475,738)  $(1,793,641)
Change in fair value of derivative liabilities   (1,032,824)   (321,674)
Non-deductible accretion interest   747,719    - 
Stock-based compensation   484,035    253,556 
Share issue costs   (108,685)   (112,812)
Foreign currency translation   298,876    - 
Other   63,035    111,874 
Total  $(3,023,582)  $(1,862,697)
           
Change in valuation allowance  $3,023,582   $1,862,697 
Total income tax expense (benefit)  $-   $- 

 

The Company is subject to Canadian federal and provincial tax for the estimated assessable profit for the years ended December 31, 2022 and 2021 at a rate of 27%.

 

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not that we will not realize those tax assets through future operations. Significant components of the Company’s deferred taxes are as follows:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Unused net operating losses carry forward - Canada and United States  $7,572,932   $4,459,457 
Unused capital losses carry forward   

-

    40,962 
Share issue costs   130,732    

174,377

 
Other   (5,286)   - 
Total deferred tax assets   7,698,378    4,674,796 
Valuation allowance   (7,698,378)   (4,674,796)
   $-  

$

- 

 

The Company has non-capital losses of $25.8 million as of December 31, 2022 and $15.7 million as of December 31, 2021, which are due to expire between 2038 and 2042 and which can be used to offset future taxable income in Canada. For foreign operations in United States, aggregate net operating losses are $2.2 million as of December 31, 2022 and $0.9 million as of December 31, 2021 which can be carried forward indefinitely. The Company has no capital losses of as of December 31, 2022 and $0.2 million as of December 31, 2021. Non-Capital Losses in Canada can be carried forward after change of ownership, if the particular business which gave rise to the loss is carried on by the company for profit or with a reasonable expectation of profit. Certain accumulated net operating losses in United States are subject to an annual limitation from equity shifts, which constitute a change of ownership as defined under Internal Revenue Code (“IRC”) Section 382. These rules will limit the utilization of the losses.

 

The Company files income tax returns in Canada and the United States and is subject to examination in these jurisdictions for all years since the Company’s inception in 2017. As at December 31, 2022, no tax authority audits are currently underway.

 

The Company currently has no uncertain tax position and is therefore not reflecting any adjustments.

 

 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.22.4
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

14. RELATED PARTY TRANSACTIONS

 

Key management personnel include those persons having the authority and responsibility of planning, directing, and executing the activities of the Company. The Company has determined that its key management personnel consist of the Company’s officers and directors.

 

As of December 31, 2022, $32,500 (December 31, 2021, $47,461) in total was owing to officers and directors or to companies owned by officers and directors of the Company for services and expenses. These amounts owing have been included in accounts payable and accrued liabilities.

 

During the year ended December 31, 2022 and 2021, the Company incurred $79,457 and $66,246, respectively, to our U.S. general counsel firm, DR Welch against legal services, a corporation controlled by a director of the Company. No shares were issued in the year ended December 31, 2022 (an aggregate of 13,158 shares were issued during the year ended December 31, 2021 to David Welch).

 

There were no other payments to related parties for the year ended December 31, 2022 and 2021 other than expense reimbursements in the ordinary course of business.

 
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.22.4
RESEARCH AND DEVELOPMENT
 12 Months Ended
Dec. 31, 2022
Research and Development [Abstract]  
RESEARCH AND DEVELOPMENT

15. RESEARCH AND DEVELOPMENT

 

During the year ended December 31, 2022, the Company spent $615,693 as compared to $474,338 for the year ended December 31, 2021 in research and development costs in relation to the license agreement with Radical Clean Solutions Ltd (“Radical”), the testing, nutrient and micro analysis for UN(THINK)™ food product development as well as costs of design and construction for the Coachella land and its future structure architecture. The following represents the breakdown of research and development activities:

 SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS

   December 31, 2022   December 31, 2021 
License agreement  $

256,703

   $- 
Product development  179,563   296,931 
Design and construction   179,427    177,407 
 Research and development costs  $615,693   $474,338 

 

 
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES
 12 Months Ended
Dec. 31, 2022
Leases  
LEASES

16. LEASES

 

The Company has entered into an operating lease for office space. At December 31, 2022, the remaining lease term is seven years and the discount rate is 7.0%. The Company has no finance leases.

 

The components of lease expenses were as follows:

 

   December 31, 2022 
Operating lease cost  $295,601 
Short-term lease cost   23,361 
Total lease expenses  $318,962 

 

The minimum future payments under the lease for our continuing operations in each of the years ending December 31 is as follows:

 

     
2023  $271,110 
2024   280,409 
2025   296,350 
2026   296,350 
2027   296,350 
Subsequent years   518,613 
Total minimum lease payments   1,959,182 
Less: imputed interest   (438,012)
Total lease liability   1,521,170 
Current portion of lease liability   (271,110)
Non-current portion of lease liability  $1,250,060 

 
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.22.4
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

17. COMMITMENTS AND CONTINGENCIES

 

Debenture principal repayments

 

The following table summarizes the future principal payments related to our outstanding debt as of December 31, 2022:

 

      
2023  $6,732,000 
2024   4,338,000 
Long Term Debt  $11,070,000 

 

Contingencies

 

As at December 31, 2022, the Company had no contingencies or litigation to disclose.

 
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.22.4
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

18. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events through March 13, 2023, the date on which these financial statements were available to be issued, to ensure that this filing includes appropriate disclosure of events both recognized in the financial statements as of December 31, 2022, and events which occurred subsequent to December 31, 2022 but were not recognized in the financial statements.

 

On January 17 and 18, 2023, the Investors purchased additional tranches totaling $5,076,923 in convertible debentures and received 2,661,289 warrants. The convertible debentures and warrants were issued with an exercise price of $1.24. The issuance of the additional tranches triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $1.24 (Note 9 & 11). Subsequent to the year ended December 31, 2022, the investors converted $881,400 of convertible debentures into 710,807 shares.

 

Subsequent to the year ended December 31, 2022, the Company issued 1,637,049 shares to Manna upon exercise of their prefunded warrants.

 

Subsequent to the year ended December 31, 2022, the Company issued 12,500 shares to a consultant for services rendered.

 

On January 24, 2023, the Company entered a binding letter of intent (“BP LOI”) to acquire Berry People LLC (“Berry People”), a U.S. based berry business. The BP LOI sets forth a purchase price of $28 million, consisting of $18.2 million in cash and $9.8 million in restricted shares to acquire 70% of Berry People.
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.22.4
SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Cash

Cash

 

The Company’s cash consists of cash maintained in checking and interest-bearing accounts. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents. The Company held no cash equivalents as of December 31, 2022 and 2021.

 
Property and Equipment

Property and Equipment

 

Property and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company’s management. Property, plant and equipment are subsequently measured at cost less accumulated depreciation and impairment losses.

 

Depreciation is recognized on a straight-line basis to write down the cost less estimated residual value of computer equipment and furniture and fixtures. The following useful lives are applied:

 

Computer equipment   3 years
Furniture and fixtures   7 years
Leasehold improvements   Lower of estimated useful life or remaining lease term

 

Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets and are recognized in profit or loss within other income or other expenses.

 

Construction in progress includes construction progress payments, deposits, engineering costs, interest expense for debt financing on long-term construction projects and other costs directly related to the construction of the facilities. Expenditures are capitalized during the construction period and construction in progress is transferred to the relevant class of property and equipment when the assets are available for use, at which point the depreciation of the asset commences.

 
Definite Lived Intangible Asset

Definite Lived Intangible Asset

 

Definite lived intangible asset consists of a granted patent. Amortization is computed using the straight-line method over the estimated useful lives of the asset. Estimated useful lives of the granted patent is 20 years. Amortization expense is allocated to general and administrative expense. No amortization expense has been taken on the granted patent as it was available for use starting January 2023.

 
Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Fair value can be determined using a market approach, income approach or cost approach. The reversal of impairment losses is prohibited.

 

 
Convertible Instruments

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which provides that if three criteria are met, the Company is required to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which;

 

(a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract;

(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur; and

(c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 
Leases

Leases

 

The Company determines at the inception of a contract if the arrangement is or contains a lease. A contract is or contains a lease if the contract gives the right to control the use of an identified asset for a period of time in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a right-of-use asset and a lease liability on the balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded on the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.

 

The Company’s contracts can contain both lease and non-lease components. The non-lease components may include maintenance, utilities, and other operating costs. The Company combines the lease and non-lease components of fixed costs in its leases as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of right-of-use assets and lease liabilities. These costs are expensed when the event determining the amount of variable consideration to be paid occurs.

 

Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of future lease payments over the expected lease term. The Company determines the present value of future lease payments by using its estimated secured incremental borrowing rate for that lease term as the interest rate implicit in the lease is not readily determinable. The Company estimates its incremental borrowing rate for each lease based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments over a similar term.

 

 
Revenue Recognition

Revenue Recognition

 

The Company has not recorded any revenues since its inception. However, in the future, the Company expects to generate returns from any or all the revenue sources below from its customers:

 

● Rental income from facilities
● Sales revenue from nutritious food products
● Intellectual property income from the license of the facilities
● Management and advisory fees from management service contracts

 

On January 1, 2018, the Company early adopted ASU No. 2014-09, Revenue from Contracts with Customers and all related amendments (“ASC 606” or “the new revenue standard”). ASC 606 is a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new revenue standard is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 provides that an entity should apply the following steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The new revenue standard also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, and costs to obtain or fulfill contracts. The Company will apply ASC 606 prospectively to all contracts.

 
Loss per Common Share

Loss per Common Share

 

The Company presents basic and diluted loss per share data for its common shares. Basic loss per common share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the year. The number of common shares used in the loss per shares calculation includes all outstanding common shares plus all common shares issuable for which there are no conditions to issue other than time. Diluted loss per common share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all potentially dilutive share equivalents, such as stock options and warrants and assumes the receipt of proceeds upon exercise of the dilutive securities to determine the number of shares assumed to be purchased at the average market price during the year.

 
Research and Development

Research and Development

 

Expenditure on research and development activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognized as expense when incurred.

 
Foreign Currency Transactions

Foreign Currency Transactions

 

The financial statements of the Company and its subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, shareholders’ equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries’ accounts are included in “Accumulated other comprehensive income” as equity in the consolidated balance sheets. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the reporting currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within non-operating expenses.

 
Fair value of Financial Instruments

Fair value of Financial Instruments

 

The fair value of the Company’s accounts receivable, accounts payable and other current liabilities approximate their carrying amounts due to the relative short maturities of these items.

 

 

As part of the issuance of debentures on March 24, 2021 and June 30, 2022, the Company issued warrants having strike price denominated in U.S. Dollars. This creates an obligation to issue shares for a price that is not denominated in the Company’s functional currency and renders the warrants not indexed to the Company’s stock, and therefore, must be classified as a derivative liability and measured at fair value. On the same basis, the Series A Warrants and the representative warrants issued as part of the IPO are also classified as a derivative liability and measured at fair value.

 

The fair value of the Company’s warrants is determined in accordance with FASB ASC 820, “Fair Value Measurement,” which establishes a fair value hierarchy that prioritizes the assumptions (inputs) to valuation techniques used to price assets or liabilities that are measured at fair value. The hierarchy, as defined below, gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The guidance for fair value measurements requires that assets and liabilities measured at fair value be classified and disclosed in one of the following categories:

 

● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities.
   
● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
   
● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.

 

As of December 31, 2022, the Company’s warrant liability related to IPO warrants and representative’s warrant amounting to $275,115 (December 31, 2021 - $1,418,964) is reported at fair value and categorized as Level 1 inputs. The fair value of derivative liabilities related to the Debenture Warrants and Debenture Convertible Feature that were issued during the year amounted to $4,374,000 (December 31, 2021 - $nil) and were categorized as level 3 inputs. The Bridge Warrants that were issued and exercised in the year ended December 31, 2021 were also categorized as level 3 inputs. (See Note 9 and Note 11)

 
Income Taxes

Income Taxes

 

Current tax expense is the expected tax payable on the taxable income for the period, using tax rates enacted at period-end.

 

Deferred tax assets, including those arising from tax loss carryforwards, requires management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted.

 

The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.

 

 

The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.

 

There were no material uncertain tax positions as of December 31, 2022 and 2021.

 
Share Based Compensation

Share Based Compensation

 

The Company generally uses the straight-line method to allocate compensation cost to reporting periods over each optionee’s requisite service period, which is generally the vesting period, and estimates the fair value of stock-based awards to employees and directors using the Black-Scholes option-valuation model (the “Black-Scholes model”). .. This model incorporates certain assumptions for inputs including a risk-free market interest rate, expected dividend yield of the underlying common stock, expected option life, and expected volatility in the market value of the underlying common stock. The Company recognizes any forfeitures as they occur.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Start-ups Act of 2012, (the “JOBS Act”). Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, for complying with new or revised accounting standards applicable to public companies. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize leases on balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.

 

The Company adopted ASC 842 as of January 1, 2022 using the optional transition method to apply the standard as of the effective date. Accordingly, previously reported financial statements, including footnote disclosures, have not been recast to reflect the application of the new standard to all comparative periods presented.

 

The new standard also provides practical expedients for an entity’s ongoing accounting as a lessee. The Company elected to utilize the practical expedient to not separate lease and non-lease components for its existing lease. The Company has also elected not to present short-term leases on the consolidated balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because the Company’s lease does not provide an implicit rate of return, it used its incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.

 

Adoption of the new lease standard on January 1, 2022 had a material impact on the Company’s consolidated financial statements. The most significant impacts related to the recognition of ROU assets of $1,776,599 and lease liabilities of $1,837,782 for operating leases on the consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The standard did not materially impact the Company’s consolidated statements of comprehensive loss and consolidated statement of cash flows.

 

In August 2020, the FASB issued ASU 2020-06 “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASU 2020-06”). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted “Earnings per share” under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. ASC 2020-06 is effective for emerging growth companies for fiscal years beginning after December 15, 2023. We are currently assessing the impact this guidance will have on our financial statements.

 

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” The standard, including subsequently issued amendments, requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and requires the modified retrospective approach. Early adoption is permitted. Based on the composition of the Company’s trade receivables and other financial assets, current market conditions, and historical credit loss activity, the Company is currently in the process of evaluating the impact of this guidance on our financial statements.

 

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under ASU 2021-08, an acquirer must recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The guidance is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is currently in the process of evaluating the impact of this guidance on our financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.22.4
BASIS OF PREPARATION (Tables)
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS

 

Name of entity:   Country of Incorporation   Purpose   Date of Incorporation
AgriFORCE Growing Systems Ltd.   Canada   Parent Company   Dec 22, 2017
un(Think) Food Company Canada Ltd.*   Canada   Food Product Manufacturing   Dec 4, 2019
West Pender Holdings, Inc.   United States   Real Estate Holding and Development Company   Sep 1, 2018
AgriFORCE Investments Inc.   United States   Holding Company   Apr 9, 2019
West Pender Management Co.   United States   Management Advisory Services   Jul 9, 2019
AGI IP Co.   United States   Intellectual Property   Mar 5, 2020
un(Think) Food Company   United States   Food Product Manufacturing   June 20, 2022

 

* un(Think) Food Company Canada Ltd. changed its name from Daybreak AG Systems Ltd. on August 19, 2022.
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.22.4
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES

Depreciation is recognized on a straight-line basis to write down the cost less estimated residual value of computer equipment and furniture and fixtures. The following useful lives are applied:

 

Computer equipment   3 years
Furniture and fixtures   7 years
Leasehold improvements   Lower of estimated useful life or remaining lease term
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Tables)
 12 Months Ended
Dec. 31, 2022
Prepaid Expenses And Other Current Assets And Land Deposit  
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

   December 31, 2022   December 31, 2021 
Deposits  $12,000   $32,000 
Legal retainer   24,457    33,692 
Prepaid expenses   436,496    214,445 
Deferred offering costs   100,337    - 
Others   25,052    28,903 
Prepaid expenses, other current assets  $598,342   $309,040 

 

On August 31, 2022, the Company signed a purchase and sale agreement with Stronghold Power Systems, Inc. (“Stronghold”), to purchase approximately seventy acres of land located in the City of Coachella as well as the completion of certain permitting, zoning, and infrastructure work by Stronghold for a total purchase price of $4,300,000. The purchase price consists of:

 

  (i) $1,500,000 in cash due on March 31, 2023.
     
  (ii) A first stock deposit of $1,700,000 in prefunded warrants. The Company issued 695,866 prefunded warrants on September 9, 2022 to Stronghold.
     
  (iii) A second stock deposit $1,100,000 in prefunded warrants. The Company issued 450,266 prefunded warrants on September 9, 2022 to Stronghold.

 

At December 31, 2022 the $2,085,960 of prefunded warrants were recorded under land deposit in relation to the Stronghold agreement. The prefunded warrant issuance may be rescinded and the warrants null and void if Stronghold does not meet all escrow performance conditions by March 31, 2023.

 
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.22.4
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT

Property and equipment consist of the following:

 

   December 31, 2022   December 31, 2021 
Leasehold improvements  $86,979   $- 
Computer equipment   39,112    22,708 
Furniture and fixtures   37,590    39,997 
Total property and equipment   163,681    62,705 
Less: Accumulated depreciation   (42,009)   (21,734)
Property and equipment, net  $121,672   $40,971 
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.22.4
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

   December 31, 2022   December 31, 2021 
Accounts payable  $498,188   $414,117 
Accrued expenses   365,521    981,027 
Others   284,030    137,168 
 Accounts Payable and Accrued Liabilities  $1,147,739   $1,532,312 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.4
DEBENTURES (Tables)
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
SCHEDULE OF OUTSTANDING DEBENTURES

The following table summarizes our outstanding debentures as of the dates indicated:

 

   Maturity   Cash Interest Rate  December 31, 2022 
Principal (initial)   12/31/2024   5.00% - 8.00 %  $14,025,000 
Repayments and conversions           (2,955,000)
Debt issuance costs and discounts (Note 9 & 11)           (7,128,084)
Total Debentures (current)          $3,941,916 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.22.4
DERIVATIVE LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS

Changes in the fair value of Company’s Level 1 and 3 financial instruments for the year ended December 31, 2022 were as follows:

 

                        
    Level 1    Level 3   Level 3     
    IPO and Rep Warrants    Debenture Warrants  

Debenture

Convertible

Feature

   Total 
Balance at December 31, 2021   $ 1,418,964    $-   $-   $1,418,964 
Additions     -     4,080,958    3,336,535    7,417,493 
Conversions     -     -    (63,723)   (63,723)
Change in fair value     (1,086,562 )   (966,141)   (1,667,166)   (3,719,869)
Effect of exchange rate changes     (57,287 )   (197,817)   (148,646)   (403,750)
Balance at December 31, 2022   $ 275,115    $2,917,000   $1,457,000   $4,649,115 
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE CAPITAL (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
SCHEDULE OF SHARE CAPITAL

The Company had the following common share transactions during the year ended December 31, 2022:

 SCHEDULE OF SHARE CAPITAL

   # of shares   Amount 
Common shares issued for bonuses and compensation   266,765   $520,230 
Common shares issued for conversion of convertible debt   67,568    131,532 
Common shares issued to consultants   284,767    853,457 
Total common shares issued   619,100   $1,505,219 

 

The Company had the following common share transactions during the year ended December 31, 2021:

 

   # of shares   Amount 
Common shares issued for cash   3,127,998   $13,262,712 
Common shares issued for conversion of series A preferred stock   2,258,826    6,717,873 
Common shares issued on exercise of warrants   39,800    238,800 
Common shares issued on cashless exercise of warrants   36,275    - 
Common shares issued on exercise of options   7,018    9,123 
Common shares issued on cashless exercise of options   820,029    - 
Common shares issued for bonus and compensation   159,775    648,449 
Common shares issued for consulting services   76,364    381,663 
Common shares issued for settlement of accrued director’s fee   19,992    46,783 
Common shares issued for dividend on preferred shares   189,004    735,932 
Share issue costs   -    (2,099,842)
Total common shares issued   6,735,081   $19,941,493 
SCHEDULE OF STOCK OPTION ACTIVITY

The following summarizes stock option activity during the years ended December 31, 2022 and 2021:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Life (years) 
             
Balance at December 31, 2020   1,450,918   $2.01    4.38 
Granted   509,788   $7.00    4.47 
Exercised   (1,120,719)  $3.23    - 
Forfeited   (28,947)  $4.75    - 
Cancelled   (94,021)  $6.70    - 
Balance at December 31, 2021   717,019   $5.63    4.48 
Granted   747,060   $1.14    4.48 
Forfeited   (25,542)  $7.00    - 
Cancelled   (55,908)  $4.27    - 
Balance at December 31, 2022   1,382,629   $3.30    4.24 
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS

The Company’s outstanding and exercisable stock options at December 31, 2022 were:

 

   Outstanding Options   Exercisable Options 
Expiry Date  Number   Weighted Average Remaining Life (years)   Weighted Average Exercise Price   Number   Weighted Average Exercise Price 
           $       $ 
June 30, 2026   210,489    3.50    3.51    210,489    3.51 
May 31, 2026   320,351    3.42    7.00    160,176    7.00 
July 15, 2026   55,445    3.54    7.00    23,100    7.00 
September 30, 2026   49,284    3.75    7.00    20,540    7.00 
November 18, 2027   747,060    4.88    1.14    -    - 
Total Share Options   1,382,629    4.24    3.30    414,305    5.23 
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS

The following table summarizes the Company’s assumptions used in the valuation of options granted during the year ended December 31, 2022 and December 31, 2021:

 

   December 31, 2022   December 31, 2021 
Expected volatility   78.05%   80.00%
Expected term (in years)   3.07    3.31 
Risk-free interest rate   3.35%   0.92%
Fair value of options  $0.60   $2.59 
SCHEDULE OF OUTSTANDING WARRANTS

The Company’s outstanding warrants as of December 31, 2022 were:

 

   Number of warrants   Weighted average exercise price   Expiry Date
       $    
Outstanding, December 31, 2020   2,546,065    7.46    
Granted July 12, 2021   3,263,997    6.00   July 12, 2024
Granted July 28, 2021   93,938    3.99   July 28, 2024
Exercised in 2021   (133,738)   4.59   n/a
Outstanding, December 31, 2021   5,770,262    5.91    
Granted June 30, 2022   4,106,418    2.44a  December 30, 2025
Outstanding, December 31, 2022   9,876,680    4.91    

 

(a) Subsequent to the year end, the issuance of additional tranches of Debentures triggered the down round provision, adjusting the exercise prices of the Debenture Warrants to $1.24 (Note 9).
ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

           
  

December 31, 2022

  

December 31, 2021

 
Warrants   9,876,680    5,770,262 
Options   1,382,629    717,019 
Prefunded warrants   1,146,132    - 
Convertible debentures   4,986,486    - 
Total anti-dilutive weighted average shares   17,391,927    6,487,281 

 

 
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
SUMMARY OF INCOME TAX PROVISION

For the year ended December 31, 2022 and 2021, loss before income tax provision consisted of the following:

 

   December 31, 2022   December 31, 2021 
         
Domestic operations - Canada  $(11,753,662)  $(6,202,837)
Foreign operations - United States   (1,119,440)   (440,279)
Total loss before taxes  $(12,873,102)  $(6,643,116)
SCHEDULE OF COMPONENTS OF INCOME TAX

Income tax expense (benefit) consists of the following for the years ended December 31, 2022 and December 31, 2021:

 

   December 31, 2022   December 31, 2021 
         
Loss before taxes  $(12,873,102)  $(6,643,116)
Statutory tax rate   27.00%   27.00%
Income taxes at the statutory rate  $(3,475,738)  $(1,793,641)
Change in fair value of derivative liabilities   (1,032,824)   (321,674)
Non-deductible accretion interest   747,719    - 
Stock-based compensation   484,035    253,556 
Share issue costs   (108,685)   (112,812)
Foreign currency translation   298,876    - 
Other   63,035    111,874 
Total  $(3,023,582)  $(1,862,697)
           
Change in valuation allowance  $3,023,582   $1,862,697 
Total income tax expense (benefit)  $-   $- 
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not that we will not realize those tax assets through future operations. Significant components of the Company’s deferred taxes are as follows:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Unused net operating losses carry forward - Canada and United States  $7,572,932   $4,459,457 
Unused capital losses carry forward   

-

    40,962 
Share issue costs   130,732    

174,377

 
Other   (5,286)   - 
Total deferred tax assets   7,698,378    4,674,796 
Valuation allowance   (7,698,378)   (4,674,796)
   $-  

$

- 
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.22.4
RESEARCH AND DEVELOPMENT (Tables)
 12 Months Ended
Dec. 31, 2022
Research and Development [Abstract]  
SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS

 SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS

   December 31, 2022   December 31, 2021 
License agreement  $

256,703

   $- 
Product development  179,563   296,931 
Design and construction   179,427    177,407 
 Research and development costs  $615,693   $474,338 
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Tables)
 12 Months Ended
Dec. 31, 2022
Leases  
SCHEDULE OF LEASE EXPENSES

The components of lease expenses were as follows:

 

   December 31, 2022 
Operating lease cost  $295,601 
Short-term lease cost   23,361 
Total lease expenses  $318,962 
SCHEDULE OF FUTURE PAYMENTS UNDER LEASE

The minimum future payments under the lease for our continuing operations in each of the years ending December 31 is as follows:

 

     
2023  $271,110 
2024   280,409 
2025   296,350 
2026   296,350 
2027   296,350 
Subsequent years   518,613 
Total minimum lease payments   1,959,182 
Less: imputed interest   (438,012)
Total lease liability   1,521,170 
Current portion of lease liability   (271,110)
Non-current portion of lease liability  $1,250,060 
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.22.4
COMMITMENTS AND CONTINGENCIES (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING

The following table summarizes the future principal payments related to our outstanding debt as of December 31, 2022:

 

      
2023  $6,732,000 
2024   4,338,000 
Long Term Debt  $11,070,000 
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS (Details)
 12 Months Ended
Dec. 31, 2022
AgriFORCE Growing Systems Ltd. [Member]  
Country of Incorporation Canada
Purpose Parent Company
Date of Incorporation Dec. 22, 2017
Un Food Company Canada Ltd [Member]  
Country of Incorporation Canada
Purpose Food Product Manufacturing
Date of Incorporation Dec. 04, 2019
West Pender Holdings, Inc. [Member]  
Country of Incorporation United States
Purpose Real Estate Holding and Development Company
Date of Incorporation Sep. 01, 2018
AgriFORCE Investments Inc.[Member]  
Country of Incorporation United States
Purpose Holding Company
Date of Incorporation Apr. 09, 2019
West Pender Management Co. [Member]  
Country of Incorporation United States
Purpose Management Advisory Services
Date of Incorporation Jul. 09, 2019
AGI IP Co. [Member]  
Country of Incorporation United States
Purpose Intellectual Property
Date of Incorporation Mar. 05, 2020
Un Food Company Canada [Member]  
Country of Incorporation United States
Purpose Food Product Manufacturing
Date of Incorporation Jun. 20, 2022
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.22.4
BASIS OF PREPARATION (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 32,774,094 $ 19,900,992
Net loss 12,873,102 6,643,116
Net cash used in operating activities $ 12,079,359 $ 5,136,947
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES (Details)
 12 Months Ended
Dec. 31, 2022
Computer Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 3 years
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 7 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment estimated useful lives Lower of estimated useful life or remaining lease term
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.22.4
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Jan. 02, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]      
Cash equivalents $ 0   $ 0
Estimated useful lives 20 years    
Lessor operating lease term of contract 12 months    
Right of use assets $ 1,540,748 $ 1,776,599
Lease liabilities 1,250,060 $ 1,837,782
IPO Warrant [Member]      
Property, Plant and Equipment [Line Items]      
Warrant liability 275,115   1,418,964
Derivative assets liabilities at fair value net $ 4,374,000  
Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Lessor operating lease term of contract 12 months    
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Sep. 09, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Deposits   $ 12,000   $ 32,000
Legal retainer   24,457   33,692
Prepaid expenses   436,496   214,445
Deferred offering costs   100,337  
Others   25,052   28,903
Prepaid expenses, other current assets   $ 598,342   $ 309,040
Land Purchase And Sale Agreement [Member] | Stronghold Power System [Member] | First Stock Deposits [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Deposits     $ 1,700,000  
Warrants issued     695,866  
Land Purchase And Sale Agreement [Member] | Stronghold Power System [Member] | Second Stock Deposits [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Deposits     $ 1,100,000  
Land Purchase And Sale Agreement [Member] | Stronghold Power System [Member] | Forecast [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Cash $ 1,500,000      
Land Purchase Agreement [Member] | Stronghold Power System [Member] | Second Stock Deposits [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Warrants issued     450,266  
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Details Narrative) - USD ($)
 12 Months Ended
Aug. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Payments to acquire land   $ 12,000
Land deposits   2,085,960
Land Purchase And Sale Agreement [Member] | Stronghold Power System [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Payments to acquire land $ 4,300,000    
Land deposits   $ 2,085,960  
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 163,681 $ 62,705
Less: Accumulated depreciation (42,009) (21,734)
Property and equipment, net 121,672 40,971
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 86,979
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 39,112 22,708
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 37,590 $ 39,997
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.22.4
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 22,413 $ 11,797
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.22.4
CONSTRUCTION IN PROGRESS (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Construction In Progress    
Construction in progress $ 2,092,533 $ 2,079,914
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.22.4
INTANGIBLE ASSET (Details Narrative)
 12 Months Ended
Jan. 03, 2023
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Finite-Lived Intangible Assets [Line Items]      
Intangible Assets, Net (Excluding Goodwill)   $ 13,089,377 $ 1,477,237
Stock issued during period value new issues     13,262,712
Adjusted for foreign exchange adjustments   (609,624) (152,140)
Subsequent Event [Member]      
Finite-Lived Intangible Assets [Line Items]      
Number of shares issued | shares 1,637,049    
Prefunded Warrants [Member]      
Finite-Lived Intangible Assets [Line Items]      
Cash   $ 1,475,000  
Number of shares issued | shares   7,379,969  
Stock issued during period value new issues   $ 12,106,677  
Adjusted for foreign exchange adjustments   $ 492,300  
Foreign currency exchange rate   0.0999  
Asset Purchase Agreement [Member] | Manna Nutritional Group LLC [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible Assets, Net (Excluding Goodwill)   $ 13,089,377 $ 1,477,237
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accounts payable $ 498,188 $ 414,117
Accrued expenses 365,521 981,027
Others 284,030 137,168
 Accounts Payable and Accrued Liabilities $ 1,147,739 $ 1,532,312
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.22.4
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative)
Dec. 31, 2021
USD ($)
Payables and Accruals [Abstract]  
Accounts payable $ 500,000
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF OUTSTANDING DEBENTURES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Maturity Date Dec. 31, 2024  
Debentures (gross) $ 14,025,000  
Repayments and conversions (2,955,000)  
Debt issuance costs and debt discounts (7,128,084)  
Total debentures (current) $ 3,941,916
Minimum [Member]    
Debt Instrument [Line Items]    
Cash Interest Rate 5.00%  
Maximum [Member]    
Debt Instrument [Line Items]    
Cash Interest Rate 8.00%  
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.22.4
DEBENTURES (Details Narrative) - USD ($)
 12 Months Ended
Jan. 03, 2023
Jun. 30, 2022
Jun. 24, 2021
Mar. 24, 2021
Dec. 31, 2022
Dec. 31, 2021
Mar. 10, 2023
Jan. 18, 2023
Jan. 17, 2023
Short-Term Debt [Line Items]                  
Subscription amount         $ 600,000      
Debt, maturity date         Dec. 31, 2024        
Stock issued during period, value           13,262,712      
Debentures transaction costs incurred         $ 3,941,916      
Loss on conversion of convertible debentures         93,973      
Subsequent Event [Member]                  
Short-Term Debt [Line Items]                  
Stock issued during period, shares 1,637,049                
Subsequent Event [Member] | Convertible Debt [Member]                  
Short-Term Debt [Line Items]                  
Exercise price             $ 1.24    
Subsequent Event [Member] | Tranche [Member]                  
Short-Term Debt [Line Items]                  
Convertible debt             $ 5,076,923    
Bridge Warrant [Member]                  
Short-Term Debt [Line Items]                  
Investors received warrants     93,938            
Warrant strike price     $ 3.99            
Accredited Investors [Member]                  
Short-Term Debt [Line Items]                  
Stock issued during period, shares     10,000            
Stock issued during period, value     $ 60,000            
Accredited Investors [Member] | Securities Purchase Agreement [Member]                  
Short-Term Debt [Line Items]                  
Debt principal amount       $ 750,000          
Subscription amount       $ 600,000          
Debt, maturity date       Jun. 24, 2021          
Transaction costs       $ 69,000          
Investors [Member]                  
Short-Term Debt [Line Items]                  
Debt instrument converted value         $ 150,000        
Debt instrument converted shares         67,568        
Loss on conversion of convertible debentures         $ 93,973        
Investors [Member] | Subsequent Event [Member]                  
Short-Term Debt [Line Items]                  
Investors received warrants               2,661,289 2,661,289
Warrant strike price               $ 1.24 $ 1.24
Purchase of additional tranches               $ 5,076,923 $ 5,076,923
Convertible debt               $ 881,400  
Investors [Member] | Definitive Agreement [Member]                  
Short-Term Debt [Line Items]                  
Debt principal amount   $ 14,025,000              
Investors received warrants   4,106,418              
Warrant strike price   $ 2.442              
Original issue discount percentage   10.00%              
Gross proceeds of debt   $ 12,750,000              
Debt instrument interest rate percentage   8.00%              
Convertible into common shares per share   $ 2.22              
Purchase of additional tranches   $ 5,000,000              
Warrants expire date   Dec. 31, 2025              
Debentures transaction costs incurred   $ 1,634,894              
Investors [Member] | Definitive Agreement [Member] | Additional Tranches [Member]                  
Short-Term Debt [Line Items]                  
Debt principal amount   $ 33,000,000              
Investors [Member] | Definitive Agreement [Member] | First 12 Months [Member]                  
Short-Term Debt [Line Items]                  
Debt instrument interest rate percentage   5.00%              
Investors [Member] | Definitive Agreement [Member] | Subsequent 12 Months [Member]                  
Short-Term Debt [Line Items]                  
Debt instrument interest rate percentage   6.00%              
Investors [Member] | Definitive Agreement [Member] | Thereafter [Member]                  
Short-Term Debt [Line Items]                  
Debt instrument interest rate percentage   8.00%              
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.22.4
LONG TERM LOAN (Details Narrative)
 1 Months Ended 12 Months Ended
Apr. 30, 2021
USD ($)
Apr. 30, 2021
CAD ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CAD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2020
CAD ($)
Debt, maturity date     Dec. 31, 2024              
Long term loans payable       $ 47,326   $ 44,300 $ 60,000 $ 60,000    
Alterna Bank [Member] | Loan Agreement [Member]                    
Debt principal amount       31,417         $ 29,533 $ 40,000
Proceeds from loan $ 14,767 $ 20,000   $ 15,909 $ 60,000          
Debt, maturity date     Dec. 31, 2023              
Debt instrument, forgiveness     $ 20,000              
Debt instrument, interest rate           5.00% 5.00%      
Debt, maturity date description     January 31, 2024 to December 31, 2025.              
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Balance at December 31, 2021 $ 1,418,964
Additions 7,417,493
Conversions (63,723)
Change in fair value (3,719,869)
Effect of exchange rate changes (403,750)
Balance at December 31, 2022 4,649,115
IPO And Representative Warrants [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Balance at December 31, 2021 1,418,964
Additions
Conversions
Change in fair value (1,086,562)
Effect of exchange rate changes (57,287)
Balance at December 31, 2022 275,115
Debenture Warrants [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Balance at December 31, 2021
Additions 4,080,958
Conversions
Change in fair value (966,141)
Effect of exchange rate changes (197,817)
Balance at December 31, 2022 2,917,000
Debenture Convertible Feature [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Balance at December 31, 2021
Additions 3,336,535
Conversions (63,723)
Change in fair value (1,667,166)
Effect of exchange rate changes (148,646)
Balance at December 31, 2022 $ 1,457,000
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.22.4
DERIVATIVE LIABILITIES (Details Narrative)
 6 Months Ended 12 Months Ended
Oct. 27, 2021
USD ($)
$ / shares
Jun. 30, 2022
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
Jun. 24, 2021
$ / shares
shares
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Exercise of warrants       $ 64,992  
Debenture Warrants [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Fair value of warrant   $ 4,080,958      
Debenture Convertible [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Stock price | $ / shares   $ 2.31 $ 1.13    
Debenture Convertible [Member] | Measurement Input, Expected Dividend Rate [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Debenture convertible measurement input      
Debenture Convertible [Member] | Measurement Input, Price Volatility [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Debenture convertible measurement input   101.0 95.0    
Debenture Convertible [Member] | Measurement Input, Risk Free Interest Rate [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Debenture convertible measurement input   3.14 4.41    
Debenture Convertible [Member] | Measurement Input, Expected Term [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Expected term   1 year 2 years    
Debenture Convertible [Member] | Measurement Input, Discount Rate [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Debenture convertible measurement input     13.65    
Fair Value, Inputs, Level 3 [Member] | Debenture Warrants [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Fair value of warrant     $ 2,917,000    
Fair Value, Inputs, Level 3 [Member] | Debenture Convertible [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Fair value of debentures convertible   $ 3,336,535 1,457,000    
IPO [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Fair value of warrant       $ 1,418,964  
IPO [Member] | Fair Value, Inputs, Level 1 [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Fair value of warrant     $ 275,115    
Series A Warrants [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Class of warrant or right number of securities called by warrants or rights | shares     3,088,198    
Warrant [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Class of warrant or right number of securities called by warrants or rights | shares     135,999    
Debenture Warrants [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Class of warrant or right number of securities called by warrants or rights | shares     4,106,418    
Debenture Warrants [Member] | Measurement Input, Share Price [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Class of warrant or right exercise price of warrants or rights | $ / shares   $ 2.31 $ 1.13    
Debenture Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Warrants and rights outstanding measurement input      
Debenture Warrants [Member] | Measurement Input, Price Volatility [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Warrants and rights outstanding measurement input   58.3 95.0    
Debenture Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Warrants and rights outstanding measurement input   3.14 4.22    
Debenture Warrants [Member] | Measurement Input, Expected Term [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Expected term   3 years 6 months 3 years    
Bridge Warrant [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Class of warrant or right number of securities called by warrants or rights | shares         93,938
Fair value of warrant $ 203,456        
Class of warrant or right exercise price of warrants or rights | $ / shares         $ 3.99
Exercise of warrants $ 64,992        
Bridge Warrant [Member] | Measurement Input, Share Price [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Warrants and rights outstanding measurement input | $ / shares 2.16        
Bridge Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Warrants and rights outstanding measurement input 0.94        
Bridge Warrant [Member] | Measurement Input, Expected Term [Member]          
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]          
Warrants and rights outstanding measurement input 73        
Expected term 3 years        
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF SHARE CAPITAL (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Common shares issued for bonus and compensation , value $ 520,230 $ 648,449
Common shares issued for conversion of convertible debt, value 131,532  
Common shares issued for consulting services, value $ 760,162 380,073
Shares issued for cash   13,262,712
Common shares issued for conversion of convertible debt, value  
Common shares issued on exercise of warrants, value   283,444
Common shares issued on cashless exercise of warrants, value   $ 64,992
Common shares issued on exercise of options, shares   1,120,719
Common shares issued on exercise of options, value   $ 9,123
Common shares issued on cashless exercise of options, value  
Common shares issued for settlement of accrued director's fee, value   46,783
Common shares issued for dividend on preferred shares, shares  
Share issue costs, value   $ (2,099,842)
Common Stock [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Common shares issued for bonus and compensation, shares 266,765 159,775
Common shares issued for bonus and compensation , value $ 520,230 $ 648,449
Common shares issued for conversion of convertible debt, shares 67,568  
Common shares issued for conversion of convertible debt, value $ 131,532  
Common shares issued for consulting services, shares 284,767 76,364
Common shares issued for consulting services, value $ 853,457 $ 381,663
Total common shares issued, shares 619,100 6,735,081
Total common shares issued, value $ 1,505,219 $ 19,941,493
Shares issued for cash, shares   3,127,998
Shares issued for cash   $ 13,262,712
Common shares issued for conversion of convertible debt, shares   2,258,826
Common shares issued for conversion of convertible debt, value   $ 6,717,873
Common shares issued on exercise of warrants, shares   39,800
Common shares issued on exercise of warrants, value   $ 238,800
Common shares issued on cashless exercise of warrants, shares   36,275
Common shares issued on cashless exercise of warrants, value  
Common shares issued on exercise of options, shares   7,018
Common shares issued on exercise of options, value   $ 9,123
Common shares issued on cashless exercise of options, shares   820,029
Common shares issued on cashless exercise of options, value  
Common shares issued for settlement of accrued director's fee, shares   19,992
Common shares issued for settlement of accrued director's fee, value   $ 46,783
Common shares issued for dividend on preferred shares, shares   189,004
Common shares issued for dividend on preferred shares, shares   $ 735,932
Share issue costs, shares  
Share issue costs, value   $ (2,099,842)
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF STOCK OPTION ACTIVITY (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity [Abstract]      
Number of Options, beginning balance 717,019 1,450,918  
Weighted average exercise price, beginning balance $ 5.63 $ 2.01  
Weighted average remaining life, ending balance 4 years 2 months 26 days 4 years 5 months 23 days 4 years 4 months 17 days
Number of options, granted 747,060 509,788  
Weighted average exercise price, granted $ 1.14 $ 7.00  
Weighted average remaining life, granted 4 years 5 months 23 days 4 years 5 months 19 days  
Number of options, exercised   (1,120,719)  
Weighted average exercise price, exercised   $ 3.23  
Number of options forfeited (25,542) (28,947)  
Weighted average exercise price, forfeited $ 7.00 $ 4.75  
Number of options, cancelled (55,908) (94,021)  
Weighted average exercise price, cancelled $ 4.27 $ 6.70  
Number of Options, ending balance 1,382,629 717,019 1,450,918
Weighted average exercise price, ending balance $ 3.30 $ 5.63 $ 2.01
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Outstanding Options, Number 1,382,629 717,019 1,450,918
Outstanding Options, Weighted Average Remaining Life (years) 4 years 2 months 26 days 4 years 5 months 23 days 4 years 4 months 17 days
Outstanding Options, Weighted Average Exercise Price $ 3.30 $ 5.63 $ 2.01
Exercisable Options, Number 414,305 280,938  
Exercisable Options, Weighted Average Exercise Price $ 5.23    
Stock Option One [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Outstanding Options, Expiry Date Jun. 30, 2026    
Outstanding Options, Number 210,489    
Outstanding Options, Weighted Average Remaining Life (years) 3 years 6 months    
Outstanding Options, Weighted Average Exercise Price $ 3.51    
Exercisable Options, Number 210,489    
Exercisable Options, Weighted Average Exercise Price $ 3.51    
Stock Option Two [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Outstanding Options, Expiry Date May 31, 2026    
Outstanding Options, Number 320,351    
Outstanding Options, Weighted Average Remaining Life (years) 3 years 5 months 1 day    
Outstanding Options, Weighted Average Exercise Price $ 7.00    
Exercisable Options, Number 160,176    
Exercisable Options, Weighted Average Exercise Price $ 7.00    
Stock Option Three [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Outstanding Options, Expiry Date Jul. 15, 2026    
Outstanding Options, Number 55,445    
Outstanding Options, Weighted Average Remaining Life (years) 3 years 6 months 14 days    
Outstanding Options, Weighted Average Exercise Price $ 7.00    
Exercisable Options, Number 23,100    
Exercisable Options, Weighted Average Exercise Price $ 7.00    
Stock Option Four [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Outstanding Options, Expiry Date Sep. 30, 2026    
Outstanding Options, Number 49,284    
Outstanding Options, Weighted Average Remaining Life (years) 3 years 9 months    
Outstanding Options, Weighted Average Exercise Price $ 7.00    
Exercisable Options, Number 20,540    
Exercisable Options, Weighted Average Exercise Price $ 7.00    
Stock Option Five [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Outstanding Options, Expiry Date Nov. 18, 2027    
Outstanding Options, Number 747,060    
Outstanding Options, Weighted Average Remaining Life (years) 4 years 10 months 17 days    
Outstanding Options, Weighted Average Exercise Price $ 1.14    
Exercisable Options, Number    
Exercisable Options, Weighted Average Exercise Price    
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Expected volatility 78.05% 80.00%
Expected Term (in years) 3 years 25 days 3 years 3 months 21 days
Risk-free interest rate 3.35% 0.92%
Fair value of options $ 0.60 $ 2.59
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF OUTSTANDING WARRANTS (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of warrants, beginning balance 5,770,262 2,546,065
Weighted average exercise price, beginning balance $ 5.91 $ 7.46
Number of warrants, beginning balance 9,876,680 5,770,262
Weighted average exercise price, beginning balance $ 4.91 $ 5.91
Warrants Granted One [Member]    
Number of warrants, beginning balance 4,106,418 3,263,997
Weighted average exercise price, beginning balance $ 2.44 $ 6.00
Expiry Date Dec. 30, 2025 Jul. 12, 2024
Warrants Granted Two [Member]    
Number of warrants, beginning balance   93,938
Weighted average exercise price, beginning balance   $ 3.99
Expiry Date   Jul. 28, 2024
Warrants Exercised One [Member]    
Number of warrants, beginning balance   (133,738)
Weighted average exercise price, beginning balance   $ 4.59
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical)
Mar. 10, 2023
$ / shares
Convertible Debt [Member] | Subsequent Event [Member]  
Short-Term Debt [Line Items]  
Share price $ 1.24
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.22.4
ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total anti-dilutive weighted average shares 17,391,927 6,487,281
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total anti-dilutive weighted average shares 9,876,680 5,770,262
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total anti-dilutive weighted average shares 1,382,629 717,019
Prefunded Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total anti-dilutive weighted average shares 1,146,132
Convertible Debt Securities [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total anti-dilutive weighted average shares 4,986,486
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE CAPITAL (Details Narrative) - USD ($)
 12 Months Ended
May 28, 2019
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share-based compensation expense   $ 420,715 $ 796,141  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   1,382,629 717,019 1,450,918
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price   $ 3.30 $ 5.63 $ 2.01
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number   414,305 280,938  
Unrecognized compensation cost   $ 538,358 $ 634,626  
Recognized over a period   2 years 3 years  
Reverse Split [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price     $ 5.63  
Option Plan [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Increase the number of authorized shares percentage 15.00%      
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF INCOME TAX PROVISION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Domestic operations - Canada $ (11,753,662) $ (6,202,837)
Foreign operations - United States (1,119,440) (440,279)
Total loss before taxes $ (12,873,102) $ (6,643,116)
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF COMPONENTS OF INCOME TAX (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Loss before taxes $ (12,873,102) $ (6,643,116)
Statutory tax rate 27.00% 27.00%
Income taxes at the statutory rate $ (3,475,738) $ (1,793,641)
Change in fair value of derivative liabilities (1,032,824) (321,674)
Non-deductible accretion interest 747,719
Stock-based compensation 484,035 253,556
Share issue costs (108,685) (112,812)
Foreign currency translation 298,876
Others permanent differences 63,035 111,874
Total (3,023,582) (1,862,697)
Change in valuation Allowance 3,023,582 1,862,697
Total income tax expense (benefit)
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Unused net operating losses carry forward - Canada and United States $ 7,572,932 $ 4,459,457
Unused capital losses carry forward 40,962
Share issue costs 130,732 174,377
Other (5,286)
Total deferred tax assets 7,698,378 4,674,796
Valuation allowance $ (7,698,378) $ (4,674,796)
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Tax Credit Carryforward [Line Items]    
Effective income tax rate reconciliation at federal statutory income tax rate 27.00% 27.00%
Capital losses $ 2,200,000 $ 900,000
Non Capital Losses Carryforward [Member] | CANADA    
Tax Credit Carryforward [Line Items]    
Capital losses $ 25,800,000 15,700,000
Income Tax Examination, Description expire between 2038 and 2042  
Capital Loss Carryforward [Member] | UNITED STATES    
Tax Credit Carryforward [Line Items]    
Capital losses $ 0 $ 200,000
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.22.4
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
David Welch [Member]    
Legal expense $ 79,457 $ 66,246
Shares issued for cash, shares 0 13,158
Accounts Payable and Accrued Liabilities [Member]    
Due to officers and directors $ 32,500 $ 47,461
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Research and Development [Abstract]    
License agreement $ 256,703
Product development 179,563 296,931
Design and construction 179,427 177,407
 Research and development costs $ 615,693 $ 474,338
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.22.4
RESEARCH AND DEVELOPMENT (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Research and Development [Abstract]    
Research and development expense $ 615,693 $ 474,338
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF LEASE EXPENSES (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
Leases  
Operating lease cost $ 295,601
Short-term lease cost 23,361
Total lease expenses $ 318,962
XML 85 R71.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF FUTURE PAYMENTS UNDER LEASE (Details) - USD ($)
Dec. 31, 2022
Jan. 02, 2022
Dec. 31, 2021
Leases      
2023 $ 271,110    
2024 280,409    
2025 296,350    
2026 296,350    
2027 296,350    
Subsequent years 518,613    
Total minimum lease payments 1,959,182    
Less: imputed interest (438,012)    
Total lease liability 1,521,170    
Current portion of lease liability (271,110)  
Non-current portion of lease liability $ 1,250,060 $ 1,837,782
XML 86 R72.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Details Narrative)
Dec. 31, 2022
USD ($)
Leases  
Operating lease for office remaining lease term 7 years
Operating lease discount rate 7.00%
Finance leases $ 0
XML 87 R73.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING (Details)
Dec. 31, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2023 $ 6,732,000
2024 4,338,000
Long Term Debt $ 11,070,000
XML 88 R74.htm IDEA: XBRL DOCUMENT v3.22.4
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)
 2 Months Ended
Jan. 24, 2023
Jan. 18, 2023
Mar. 13, 2023
Jan. 17, 2023
Berry People LLC [Member]        
Subsequent Event [Line Items]        
Business acquisition, description The BP LOI sets forth a purchase price of $28 million, consisting of $18.2 million in cash and $9.8 million in restricted shares to acquire 70% of Berry People.      
Consultant [Member]        
Subsequent Event [Line Items]        
Number of shares issued for services     12,500  
Prefunded Warrants [Member] | Manna Nutritional Group LLC [Member]        
Subsequent Event [Line Items]        
Number of shares issued upon exercise of warrants     1,637,049  
Investors [Member]        
Subsequent Event [Line Items]        
Purchase of additional tranches   $ 5,076,923   $ 5,076,923
Investors received warrants   2,661,289   2,661,289
Warrant strike price   $ 1.24   $ 1.24
Convertible debt   $ 881,400    
Conversion of stock, shares issued   710,807    
XML 89 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001826397 2022-01-01 2022-12-31 0001826397 AGRI:CommonSharesMember 2022-01-01 2022-12-31 0001826397 AGRI:SeriesWarrantsMember 2022-01-01 2022-12-31 0001826397 2022-06-30 0001826397 2023-03-13 0001826397 2022-12-31 0001826397 2021-12-31 0001826397 2021-01-01 2021-12-31 0001826397 us-gaap:CommonStockMember 2020-12-31 0001826397 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2020-12-31 0001826397 us-gaap:RetainedEarningsMember 2020-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001826397 2020-12-31 0001826397 us-gaap:CommonStockMember 2021-12-31 0001826397 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2021-12-31 0001826397 us-gaap:RetainedEarningsMember 2021-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001826397 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001826397 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2021-01-01 2021-12-31 0001826397 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001826397 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001826397 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2022-01-01 2022-12-31 0001826397 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001826397 us-gaap:CommonStockMember 2022-12-31 0001826397 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001826397 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001826397 AGRI:ObligationToIssueSharesMember 2022-12-31 0001826397 us-gaap:RetainedEarningsMember 2022-12-31 0001826397 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001826397 AGRI:AgriFORCEGrowingSystemsLtdMember 2022-01-01 2022-12-31 0001826397 AGRI:UnFoodCompanyCanadaLtdMember 2022-01-01 2022-12-31 0001826397 AGRI:WestPenderHoldingsIncMember 2022-01-01 2022-12-31 0001826397 AGRI:AgriFORCEInvestmentsIncMember 2022-01-01 2022-12-31 0001826397 AGRI:WestPenderManagementCoMember 2022-01-01 2022-12-31 0001826397 AGRI:AGIIPCoMember 2022-01-01 2022-12-31 0001826397 AGRI:UnFoodCompanyCanadaMember 2022-01-01 2022-12-31 0001826397 srt:MinimumMember 2022-12-31 0001826397 AGRI:IPOWarrantMember 2022-12-31 0001826397 AGRI:IPOWarrantMember 2021-12-31 0001826397 2022-01-02 0001826397 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001826397 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001826397 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001826397 srt:ScenarioForecastMember AGRI:StrongholdPowerSystemMember AGRI:LandPurchaseAndSaleAgreementMember 2023-03-31 0001826397 AGRI:FirstStockDepositsMember AGRI:StrongholdPowerSystemMember AGRI:LandPurchaseAndSaleAgreementMember 2022-09-09 0001826397 AGRI:SecondStockDepositsMember AGRI:StrongholdPowerSystemMember AGRI:LandPurchaseAndSaleAgreementMember 2022-09-09 0001826397 AGRI:SecondStockDepositsMember AGRI:StrongholdPowerSystemMember AGRI:LandPurchaseAgreementMember 2022-09-09 0001826397 AGRI:StrongholdPowerSystemMember AGRI:LandPurchaseAndSaleAgreementMember 2022-08-31 2022-08-31 0001826397 AGRI:StrongholdPowerSystemMember AGRI:LandPurchaseAndSaleAgreementMember 2022-12-31 0001826397 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001826397 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001826397 us-gaap:ComputerEquipmentMember 2022-12-31 0001826397 us-gaap:ComputerEquipmentMember 2021-12-31 0001826397 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001826397 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001826397 AGRI:AssetPurchaseAgreementMember AGRI:MannaNutritionalGroupLLCMember 2022-12-31 0001826397 AGRI:AssetPurchaseAgreementMember AGRI:MannaNutritionalGroupLLCMember 2021-12-31 0001826397 AGRI:PrefundedWarrantsMember 2022-12-31 0001826397 AGRI:PrefundedWarrantsMember 2022-01-01 2022-12-31 0001826397 us-gaap:SubsequentEventMember 2023-01-02 2023-01-03 0001826397 AGRI:AccreditedInvestorsMember AGRI:SecuritiesPurchaseAgreementMember 2021-03-24 0001826397 AGRI:AccreditedInvestorsMember AGRI:SecuritiesPurchaseAgreementMember 2021-03-23 2021-03-24 0001826397 AGRI:AccreditedInvestorsMember 2021-06-23 2021-06-24 0001826397 AGRI:BridgeWarrantMember 2021-06-24 0001826397 AGRI:InvestorsMember AGRI:DefinitiveAgreementMember 2022-06-30 0001826397 AGRI:InvestorsMember AGRI:DefinitiveAgreementMember 2022-06-29 2022-06-30 0001826397 AGRI:FirstTwelveMonthsMember AGRI:InvestorsMember AGRI:DefinitiveAgreementMember 2022-06-30 0001826397 AGRI:SubsequentTwelveMonthsMember AGRI:InvestorsMember AGRI:DefinitiveAgreementMember 2022-06-30 0001826397 AGRI:ThereafterMember AGRI:InvestorsMember AGRI:DefinitiveAgreementMember 2022-06-30 0001826397 AGRI:InvestorsMember AGRI:AdditionalTranchesMember AGRI:DefinitiveAgreementMember 2022-06-30 0001826397 AGRI:InvestorsMember 2022-01-01 2022-12-31 0001826397 us-gaap:SubsequentEventMember AGRI:TrancheMember 2023-03-10 0001826397 us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2023-03-10 0001826397 srt:MinimumMember 2022-01-01 2022-12-31 0001826397 srt:MaximumMember 2022-01-01 2022-12-31 0001826397 AGRI:LoanAgreementMember AGRI:AlternaBankMember 2020-12-31 0001826397 AGRI:LoanAgreementMember AGRI:AlternaBankMember 2021-12-31 0001826397 AGRI:LoanAgreementMember AGRI:AlternaBankMember 2021-04-01 2021-04-30 0001826397 AGRI:LoanAgreementMember AGRI:AlternaBankMember 2021-01-01 2021-12-31 0001826397 AGRI:LoanAgreementMember AGRI:AlternaBankMember 2022-01-01 2022-12-31 0001826397 AGRI:LoanAgreementMember AGRI:AlternaBankMember 2022-12-31 0001826397 AGRI:SeriesAWarrantsMember 2022-12-31 0001826397 us-gaap:WarrantMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-12-31 0001826397 us-gaap:FairValueInputsLevel1Member us-gaap:IPOMember 2022-01-01 2022-12-31 0001826397 us-gaap:IPOMember 2021-01-01 2021-12-31 0001826397 AGRI:DebentureWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-01-01 2022-06-30 0001826397 us-gaap:MeasurementInputSharePriceMember AGRI:DebentureWarrantsMember 2022-12-31 0001826397 us-gaap:MeasurementInputSharePriceMember AGRI:DebentureWarrantsMember 2022-06-30 0001826397 us-gaap:MeasurementInputExpectedDividendRateMember AGRI:DebentureWarrantsMember 2022-12-31 0001826397 us-gaap:MeasurementInputExpectedDividendRateMember AGRI:DebentureWarrantsMember 2022-06-30 0001826397 us-gaap:MeasurementInputPriceVolatilityMember AGRI:DebentureWarrantsMember 2022-12-31 0001826397 us-gaap:MeasurementInputPriceVolatilityMember AGRI:DebentureWarrantsMember 2022-06-30 0001826397 us-gaap:MeasurementInputRiskFreeInterestRateMember AGRI:DebentureWarrantsMember 2022-12-31 0001826397 us-gaap:MeasurementInputRiskFreeInterestRateMember AGRI:DebentureWarrantsMember 2022-06-30 0001826397 us-gaap:MeasurementInputExpectedTermMember AGRI:DebentureWarrantsMember 2022-12-31 0001826397 us-gaap:MeasurementInputExpectedTermMember AGRI:DebentureWarrantsMember 2022-06-30 0001826397 AGRI:BridgeWarrantMember 2021-10-26 2021-10-27 0001826397 us-gaap:MeasurementInputSharePriceMember AGRI:BridgeWarrantMember 2021-10-27 0001826397 us-gaap:MeasurementInputExpectedTermMember AGRI:BridgeWarrantMember 2021-10-27 0001826397 us-gaap:MeasurementInputRiskFreeInterestRateMember AGRI:BridgeWarrantMember 2021-10-27 0001826397 AGRI:DebentureConvertibleMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001826397 AGRI:DebentureConvertibleMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputPriceVolatilityMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-06-30 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001826397 AGRI:DebentureConvertibleMember us-gaap:MeasurementInputExpectedTermMember 2022-06-30 0001826397 AGRI:IPOAndRepresentativeWarrantsMember 2021-12-31 0001826397 AGRI:DebentureWarrantsMember 2021-12-31 0001826397 AGRI:DebentureConvertibleFeatureMember 2021-12-31 0001826397 AGRI:IPOAndRepresentativeWarrantsMember 2022-01-01 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-01-01 2022-12-31 0001826397 AGRI:DebentureConvertibleFeatureMember 2022-01-01 2022-12-31 0001826397 AGRI:IPOAndRepresentativeWarrantsMember 2022-12-31 0001826397 AGRI:DebentureWarrantsMember 2022-12-31 0001826397 AGRI:DebentureConvertibleFeatureMember 2022-12-31 0001826397 AGRI:OptionPlanMember 2019-05-27 2019-05-28 0001826397 AGRI:ReverseSplitMember 2021-12-31 0001826397 2020-01-01 2020-12-31 0001826397 AGRI:StockOptionOneMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionOneMember 2022-12-31 0001826397 AGRI:StockOptionTwoMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionTwoMember 2022-12-31 0001826397 AGRI:StockOptionThreeMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionThreeMember 2022-12-31 0001826397 AGRI:StockOptionFourMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionFourMember 2022-12-31 0001826397 AGRI:StockOptionFiveMember 2022-01-01 2022-12-31 0001826397 AGRI:StockOptionFiveMember 2022-12-31 0001826397 AGRI:WarrantsGrantedOneMember 2021-01-01 2021-12-31 0001826397 AGRI:WarrantsGrantedTwoMember 2021-01-01 2021-12-31 0001826397 AGRI:WarrantsExercisedOneMember 2021-01-01 2021-12-31 0001826397 AGRI:WarrantsGrantedOneMember 2022-01-01 2022-12-31 0001826397 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001826397 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001826397 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001826397 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001826397 AGRI:PrefundedWarrantsMember 2022-01-01 2022-12-31 0001826397 AGRI:PrefundedWarrantsMember 2021-01-01 2021-12-31 0001826397 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001826397 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-12-31 0001826397 country:CA AGRI:NonCapitalLossesCarryforwardMember 2022-12-31 0001826397 country:CA AGRI:NonCapitalLossesCarryforwardMember 2021-12-31 0001826397 country:CA AGRI:NonCapitalLossesCarryforwardMember 2022-01-01 2022-12-31 0001826397 country:US us-gaap:CapitalLossCarryforwardMember 2022-12-31 0001826397 country:US us-gaap:CapitalLossCarryforwardMember 2021-12-31 0001826397 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2022-12-31 0001826397 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2021-12-31 0001826397 AGRI:DavidWelchMember 2022-01-01 2022-12-31 0001826397 AGRI:DavidWelchMember 2021-01-01 2021-12-31 0001826397 AGRI:InvestorsMember us-gaap:SubsequentEventMember 2023-01-17 0001826397 AGRI:InvestorsMember us-gaap:SubsequentEventMember 2023-01-18 0001826397 AGRI:InvestorsMember us-gaap:SubsequentEventMember 2023-01-17 2023-01-18 0001826397 AGRI:PrefundedWarrantsMember us-gaap:SubsequentEventMember AGRI:MannaNutritionalGroupLLCMember 2023-01-01 2023-03-13 0001826397 AGRI:ConsultantMember us-gaap:SubsequentEventMember 2023-01-01 2023-03-13 0001826397 AGRI:BerryPeopleLLCMember us-gaap:SubsequentEventMember 2023-01-23 2023-01-24 iso4217:USD shares iso4217:USD shares iso4217:CAD pure iso4217:CAD shares AGRI:CADP 0001826397 false FY A1 Unlimited Unlimited 10-K true 2022-12-31 --12-31 2022 false 001-40578 AGRIFORCE GROWING SYSTEMS LTD. 300 – 2233 Columbia Street Vancouver BC CA V5Y 0M6 (604) 757-0952 Common Shares AGRI NASDAQ Series A Warrants AGRIW NASDAQ No No Yes Yes Non-accelerated Filer true true false false 28755938 18156154 List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424(b) or (c) under the Securities Act of 1933. The listed documents should be clearly described for identification purposes (e.g., annual report to security holders for fiscal year ended December 24, 1980). Marcum LLP Costa Mesa, CA 2269320 7775290 48941 32326 598342 309040 2916603 8116656 121672 40971 13089377 1477237 1540748 50608 2092533 2079914 2085960 21846893 11765386 1147739 1532312 753727 3941916 271110 5360765 2286039 12954 1250060 4649115 1418964 44300 47326 11304240 3765283 0 0 15795798 15795798 15176698 15176698 27142762 25637543 16816695 2203343 93295 -32774094 -19900992 -642710 -33086 10542653 8000103 21846893 11765386 3923329 1766491 2669022 882146 2561908 1088413 1327739 780135 907436 748349 615693 474338 420715 796141 387130 318962 168315 280838 69598 221083 143095 22413 11797 -13656268 -6928818 290079 162976 93973 3719869 1191383 3396578 483529 151711 374465 58952 75823 -12873102 -6643116 735932 -12873102 -7379048 -609624 -152140 -13482726 -7531188 -0.71 -0.66 18080318 11164311 8441617 5696050 2258826 6717873 1297566 94885 -12521944 119054 1403484 3127998 13262712 13262712 2258826 6717873 -2258826 -6717873 39800 238800 44644 283444 36275 64992 64992 7018 9123 9123 820029 159775 648449 648449 76364 381663 -1590 380073 19992 46783 46783 189004 735932 -735932 -2099842 -2099842 796141 796141 -6643116 -6643116 -152140 -152140 15176698 25637543 2203343 93295 -19900992 -33086 8000103 15176698 25637543 2203343 93295 -19900992 -33086 8000103 67568 131532 131532 266765 520230 520230 284767 853457 -93295 760162 14192637 14192637 420715 420715 -12873102 -12873102 -609624 -609624 15795798 27142762 16816695 -32774094 -642710 10542653 15795798 27142762 16816695 -32774094 -642710 10542653 -12873102 -6643116 22413 11797 420715 796141 760162 321121 520230 134383 3057825 483529 58952 151711 374465 3719869 1191383 93973 16615 23353 274302 235713 75552 662173 297034 -255429 50608 12954 -12079359 -5136947 104986 25522 500000 225000 20000 12000 55028 744191 -640014 -1006713 12750000 2805000 1634894 69000 750000 15639990 2279374 238800 15932 600000 750000 9123 7560106 13405471 -346703 -139931 -5505970 7121880 7775290 653410 2269320 7775290 338753 4080958 3336535 12106677 2085960 131532 1776599 1837782 374028 735932 6717873 500000 <p id="xdx_80C_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_z804sgO0Q5Z8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_82C_z13muItMcdz3">BUSINESS OVERVIEW</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">AgriFORCE Growing Systems Ltd. (“AgriFORCE™” of the “Company”) was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the <i>Business Corporations Act (British Columbia)</i> on December 22, 2017. The Company’s registered and records office address is at 300 – 2233 Columbia Street, Vancouver, British Columbia, Canada, V5Y 0M6.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company is an innovative agriculture-focused technology company that delivers reliable, financially robust solutions for high value crops through our proprietary facility design and automation Intellectual Property to businesses and enterprises globally through our AgriFORCE™ Solutions division (“Solutions”) and delivers nutritious food products through our AgriFORCE™ Brands division (“Brands”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Solutions intends to operate in the plant based pharmaceutical, nutraceutical, and other high value crop markets using its unique proprietary facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops in a controlled environment(“FORCEGH+™”) The Company has designed FORCEGH+™ facilities to produce in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible whilst substantially eliminating the need for the use of pesticides and/or irradiation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Brands is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and more nutritious solutions. We will market and commercialize both branded consumer product offerings and ingredient supply.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_806_eus-gaap--BasisOfAccounting_zDrQ6RDEEaNd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_zSA8gIJ6OBJ7">BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principal of Consolidation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements include the accounts of our wholly owned subsidiaries. We consolidate variable interest entities (VIEs) when we have variable interests and are the primary beneficiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All inter-company balances and transactions have been eliminated on consolidation. These consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries:</span></p> <p id="xdx_89F_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zhRDM5s80S2c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyovosdGeCyf" style="display: none">SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of entity:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country of Incorporation</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of Incorporation</span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Growing Systems Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_z6ovFuMtdpNj" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_zMj5GbfhzaM6" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_zsWJzxYNcIP" title="Date of Incorporation">Dec 22, 2017</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F4D_zRX6uOaGv0r3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company Canada Ltd.*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___z8Vlh7OUXRol" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___zbtqFQGTZPE" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Food Product Manufacturing</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___zNWfGwXctWB3" title="Date of Incorporation">Dec 4, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Pender Holdings, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zWGJlyAMx0uc" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zv8bO25h2J4a" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real Estate Holding and Development Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zfP19SO43F03" title="Date of Incorporation">Sep 1, 2018</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Investments Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_zGuWFqx0WBL3" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_z8RzBB0UCUq3" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holding Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_z8JNYUyFaMy9" title="Date of Incorporation">Apr 9, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Pender Management Co.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_zw94cY8wnusj" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_z3E4UhP0eCXh" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management Advisory Services</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_zaTh7GYJC9Q" title="Date of Incorporation">Jul 9, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGI IP Co.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_zXmMq9fV1Al7" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_z3MpknKbzqv7" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual Property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_zShZjKDyLoKj" title="Date of Incorporation">Mar 5, 2020</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zLDvBZ4dJg71" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zPRRoOAIZdJl" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Food Product Manufacturing</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zX07CXmG3Q5" title="Date of Incorporation">June 20, 2022</span></span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0C_zZ4Xm9dcY2Yc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zcMukSJW7Qf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company Canada Ltd. changed its name from Daybreak AG Systems Ltd. on August 19, 2022. </span></td></tr> </table> <p id="xdx_8A8_ziAOir3N4PP4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company, a wholly owned subsidiary commenced operations in 2022 and their results are consolidated into the results of the Company.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Functional and Reporting Currency</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currency for each entity included in these consolidated financial statements is the currency of the primary economic environment in which the entity operates. These consolidated financial statements are presented in United States dollars (“U.S. dollars”). Currency conversion to U.S. dollars is performed in accordance with ASC 830, Foreign Currency Matters.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The preparation of our financial statements in accordance with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Significant estimates reflected in these financial statements include, but are not limited to, accounting for share-based compensation, valuation of derivative liabilities, valuation of embedded conversion feature, going concern, impairment as well as depreciation method. Actual results could differ from these estimates and those differences could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred substantial operating losses since its inception, and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As reflected in the financial statements, the Company had an accumulated deficit of approximately $<span id="xdx_90A_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20221231_zew2JyDi7Xeh" title="Accumulated deficit">32.8</span> million at December 31, 2022, a net loss of approximately $<span id="xdx_903_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20220101__20221231_ze2OImKFF9I9" title="Net loss">12.9 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, and approximately $<span id="xdx_908_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20220101__20221231_zd5utG6ZRat6" title="Net cash used in operating activities">12.1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of net cash used in operating activities for the year ended December 31, 2022. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company anticipates incurring additional losses until such time, if ever, that it can obtain marketing approval to sell, and then generate significant sales, of its technology that is currently in development. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is seeking additional financing to support its growth plans. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to currently outstanding common shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89F_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zhRDM5s80S2c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyovosdGeCyf" style="display: none">SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of entity:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country of Incorporation</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of Incorporation</span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Growing Systems Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_z6ovFuMtdpNj" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_zMj5GbfhzaM6" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_zsWJzxYNcIP" title="Date of Incorporation">Dec 22, 2017</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F4D_zRX6uOaGv0r3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company Canada Ltd.*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___z8Vlh7OUXRol" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___zbtqFQGTZPE" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Food Product Manufacturing</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___zNWfGwXctWB3" title="Date of Incorporation">Dec 4, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Pender Holdings, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zWGJlyAMx0uc" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zv8bO25h2J4a" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real Estate Holding and Development Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zfP19SO43F03" title="Date of Incorporation">Sep 1, 2018</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Investments Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_zGuWFqx0WBL3" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_z8RzBB0UCUq3" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holding Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_z8JNYUyFaMy9" title="Date of Incorporation">Apr 9, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Pender Management Co.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_zw94cY8wnusj" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_z3E4UhP0eCXh" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management Advisory Services</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_zaTh7GYJC9Q" title="Date of Incorporation">Jul 9, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGI IP Co.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_zXmMq9fV1Al7" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_z3MpknKbzqv7" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual Property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_zShZjKDyLoKj" title="Date of Incorporation">Mar 5, 2020</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zLDvBZ4dJg71" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zPRRoOAIZdJl" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Food Product Manufacturing</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zX07CXmG3Q5" title="Date of Incorporation">June 20, 2022</span></span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0C_zZ4Xm9dcY2Yc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zcMukSJW7Qf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company Canada Ltd. changed its name from Daybreak AG Systems Ltd. on August 19, 2022. </span></td></tr> </table> Canada Parent Company 2017-12-22 Canada Food Product Manufacturing 2019-12-04 United States Real Estate Holding and Development Company 2018-09-01 United States Holding Company 2019-04-09 United States Management Advisory Services 2019-07-09 United States Intellectual Property 2020-03-05 United States Food Product Manufacturing 2022-06-20 -32800000 -12900000 -12100000 <p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_zMVALAutqmu1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zCqeLz6kb5I4">SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zkQ6OUU3nnR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z4mM4z7iTuzh">Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash consists of cash maintained in checking and interest-bearing accounts. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents. The Company held <span id="xdx_900_eus-gaap--CashEquivalentsAtCarryingValue_iI_pdp0_do_c20211231_z1YoOic6Os0h" title="Cash equivalents"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_pdp0_do_c20221231_zWv5zHb22RI3" title="Cash equivalents">no</span></span> cash equivalents as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zY9iA7A85J6j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zmVqcYTG3wl1">Property and Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company’s management. Property, plant and equipment are subsequently measured at cost less accumulated depreciation and impairment losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock_zHYM1TSRSrbj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is recognized on a straight-line basis to write down the cost less estimated residual value of computer equipment and furniture and fixtures. The following useful lives are applied:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zihWSiFvId1" style="display: none">SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zKeaNplSHDTh" title="Property plant and equipment useful life">3</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zIHVzGy00862" title="Property plant and equipment useful life">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zCBdKCHA8Iu5" title="Property plant and equipment estimated useful lives">Lower of estimated useful life or remaining lease term</span></span></td></tr> </table> <p id="xdx_8A1_zScj6aXO26N4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets and are recognized in profit or loss within other income or other expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction in progress includes construction progress payments, deposits, engineering costs, interest expense for debt financing on long-term construction projects and other costs directly related to the construction of the facilities. Expenditures are capitalized during the construction period and construction in progress is transferred to the relevant class of property and equipment when the assets are available for use, at which point the depreciation of the asset commences.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zDK6RgDdB9ll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zzh1aJ5BxXre">Definite Lived Intangible Asset</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite lived intangible asset consists of a granted patent. Amortization is computed using the straight-line method over the estimated useful lives of the asset. Estimated useful lives of the granted patent is <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231_zfyPBKuBxsa9" title="Estimated useful lives">20</span> years. Amortization expense is allocated to general and administrative expense. No amortization expense has been taken on the granted patent as it was available for use starting January 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zyykzmHQ0lCg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z9wwYtbfMRW3">Impairment of Long-Lived Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Fair value can be determined using a market approach, income approach or cost approach. The reversal of impairment losses is prohibited.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--DebtPolicyTextBlock_zQAQNbr74xm1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zgPwxi3lCyse">Convertible Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which provides that if three criteria are met, the Company is required to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--LessorLeasesPolicyTextBlock_zj8r91H4IGXc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zNKzHk27tud">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines at the inception of a contract if the arrangement is or contains a lease. A contract is or contains a lease if the contract gives the right to control the use of an identified asset for a period of time in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a right-of-use asset and a lease liability on the balance sheet for all leases with an initial lease term of greater than <span id="xdx_90F_eus-gaap--LessorOperatingLeaseTermOfContract_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zHqfgstiqgMl" title="Lessor operating lease term of contract">12 months</span>. Leases with an initial term of <span id="xdx_90E_eus-gaap--LessorOperatingLeaseTermOfContract_iI_c20221231_zetdyGJxivQ2" title="Lessor operating lease term of contract">12 months</span> or less are not recorded on the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s contracts can contain both lease and non-lease components. The non-lease components may include maintenance, utilities, and other operating costs. The Company combines the lease and non-lease components of fixed costs in its leases as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of right-of-use assets and lease liabilities. These costs are expensed when the event determining the amount of variable consideration to be paid occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of future lease payments over the expected lease term. The Company determines the present value of future lease payments by using its estimated secured incremental borrowing rate for that lease term as the interest rate implicit in the lease is not readily determinable. The Company estimates its incremental borrowing rate for each lease based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments over a similar term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zZseMSiJLMTg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zmKaZ9UgpRy5">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not recorded any revenues since its inception. However, in the future, the Company expects to generate returns from any or all the revenue sources below from its customers:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental income from facilities</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales revenue from nutritious food products</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property income from the license of the facilities</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management and advisory fees from management service contracts</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, the Company early adopted ASU No. 2014-09, <i>Revenue from Contracts with Customers</i> and all related amendments (“ASC 606” or “the new revenue standard”). ASC 606 is a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new revenue standard is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 provides that an entity should apply the following steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The new revenue standard also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, and costs to obtain or fulfill contracts. The Company will apply ASC 606 prospectively to all contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZ6vB3Hj5wg5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zIsdhFljeqZf">Loss per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company presents basic and diluted loss per share data for its common shares. Basic loss per common share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the year. The number of common shares used in the loss per shares calculation includes all outstanding common shares plus all common shares issuable for which there are no conditions to issue other than time. Diluted loss per common share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all potentially dilutive share equivalents, such as stock options and warrants and assumes the receipt of proceeds upon exercise of the dilutive securities to determine the number of shares assumed to be purchased at the average market price during the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zqLYr8snZMR" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_znNNxrLGlUC6">Research and Development</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure on research and development activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognized as expense when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zzFDoVeeadVf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zlmSHdv40lK9">Foreign Currency Transactions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements of the Company and its subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, shareholders’ equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries’ accounts are included in “Accumulated other comprehensive income” as equity in the consolidated balance sheets. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the reporting currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within non-operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOwDeUGaTFFc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_znh5SiM5qldh">Fair value of Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s accounts receivable, accounts payable and other current liabilities approximate their carrying amounts due to the relative short maturities of these items.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the issuance of debentures on March 24, 2021 and June 30, 2022, the Company issued warrants having strike price denominated in U.S. Dollars. This creates an obligation to issue shares for a price that is not denominated in the Company’s functional currency and renders the warrants not indexed to the Company’s stock, and therefore, must be classified as a derivative liability and measured at fair value. On the same basis, the Series A Warrants and the representative warrants issued as part of the IPO are also classified as a derivative liability and measured at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s warrants is determined in accordance with FASB ASC 820, “Fair Value Measurement,” which establishes a fair value hierarchy that prioritizes the assumptions (inputs) to valuation techniques used to price assets or liabilities that are measured at fair value. The hierarchy, as defined below, gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The guidance for fair value measurements requires that assets and liabilities measured at fair value be classified and disclosed in one of the following categories:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company’s warrant liability related to IPO warrants and representative’s warrant amounting to $<span title="Warrant liability"><span id="xdx_90F_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zDZ0s5z0MYz" title="Warrant liability">275,115</span></span> (December 31, 2021 - $<span id="xdx_90D_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zWyYlZBCHOg" title="Warrant liability">1,418,964</span>) is reported at fair value and categorized as Level 1 inputs. The fair value of derivative liabilities related to the Debenture Warrants and Debenture Convertible Feature that were issued during the year amounted to $<span id="xdx_908_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zETst3y8btvk" title="Derivative assets liabilities at fair value net">4,374,000</span> (December 31, 2021 - $<span id="xdx_902_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iI_dxL_c20211231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zIPm9whQgeL4" title="Derivative assets liabilities at fair value net::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0817">nil</span></span>) and were categorized as level 3 inputs. The Bridge Warrants that were issued and exercised in the year ended December 31, 2021 were also categorized as level 3 inputs. (See Note 9 and Note 11)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zOWElaHsvTpd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zlHqVHspYRa4">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current tax expense is the expected tax payable on the taxable income for the period, using tax rates enacted at period-end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets, including those arising from tax loss carryforwards, requires management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no material uncertain tax positions as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zyp1xRSrARs1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zoOt5IoJE1gg">Share Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company generally uses the straight-line method to allocate compensation cost to reporting periods over each optionee’s requisite service period, which is generally the vesting period, and estimates the fair value of stock-based awards to employees and directors using the Black-Scholes option-valuation model (the “Black-Scholes model”). .. This model incorporates certain assumptions for inputs including a risk-free market interest rate, expected dividend yield of the underlying common stock, expected option life, and expected volatility in the market value of the underlying common stock. The Company recognizes any forfeitures as they occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuBDKVvsXCwh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zkF2EP56xLwa">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Start-ups Act of 2012, (the “JOBS Act”). Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, for complying with new or revised accounting standards applicable to public companies. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize leases on balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC 842 as of January 1, 2022 using the optional transition method to apply the standard as of the effective date. Accordingly, previously reported financial statements, including footnote disclosures, have not been recast to reflect the application of the new standard to all comparative periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The new standard also provides practical expedients for an entity’s ongoing accounting as a lessee. The Company elected to utilize the practical expedient to not separate lease and non-lease components for its existing lease. The Company has also elected not to present short-term leases on the consolidated balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because the Company’s lease does not provide an implicit rate of return, it used its incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adoption of the new lease standard on January 1, 2022 had a material impact on the Company’s consolidated financial statements. The most significant impacts related to the recognition of ROU assets of $<span id="xdx_903_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220102_z99xNAUeS4Qc" title="Right of use assets">1,776,599</span> and lease liabilities of $<span id="xdx_902_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20220102_zuziKUFayhVg" title="Lease liabilities">1,837,782</span> for operating leases on the consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The standard did not materially impact the Company’s consolidated statements of comprehensive loss and consolidated statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06 “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASU 2020-06”). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted “Earnings per share” under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. ASC 2020-06 is effective for emerging growth companies for fiscal years beginning after December 15, 2023. We are currently assessing the impact this guidance will have on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” The standard, including subsequently issued amendments, requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and requires the modified retrospective approach. Early adoption is permitted. Based on the composition of the Company’s trade receivables and other financial assets, current market conditions, and historical credit loss activity, the Company is currently in the process of evaluating the impact of this guidance on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under ASU 2021-08, an acquirer must recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The guidance is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is currently in the process of evaluating the impact of this guidance on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_85C_zFCUlXVJ1p9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zkQ6OUU3nnR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z4mM4z7iTuzh">Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash consists of cash maintained in checking and interest-bearing accounts. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents. The Company held <span id="xdx_900_eus-gaap--CashEquivalentsAtCarryingValue_iI_pdp0_do_c20211231_z1YoOic6Os0h" title="Cash equivalents"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_pdp0_do_c20221231_zWv5zHb22RI3" title="Cash equivalents">no</span></span> cash equivalents as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zY9iA7A85J6j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zmVqcYTG3wl1">Property and Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company’s management. Property, plant and equipment are subsequently measured at cost less accumulated depreciation and impairment losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock_zHYM1TSRSrbj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is recognized on a straight-line basis to write down the cost less estimated residual value of computer equipment and furniture and fixtures. The following useful lives are applied:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zihWSiFvId1" style="display: none">SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zKeaNplSHDTh" title="Property plant and equipment useful life">3</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zIHVzGy00862" title="Property plant and equipment useful life">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zCBdKCHA8Iu5" title="Property plant and equipment estimated useful lives">Lower of estimated useful life or remaining lease term</span></span></td></tr> </table> <p id="xdx_8A1_zScj6aXO26N4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets and are recognized in profit or loss within other income or other expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction in progress includes construction progress payments, deposits, engineering costs, interest expense for debt financing on long-term construction projects and other costs directly related to the construction of the facilities. Expenditures are capitalized during the construction period and construction in progress is transferred to the relevant class of property and equipment when the assets are available for use, at which point the depreciation of the asset commences.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock_zHYM1TSRSrbj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is recognized on a straight-line basis to write down the cost less estimated residual value of computer equipment and furniture and fixtures. The following useful lives are applied:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zihWSiFvId1" style="display: none">SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zKeaNplSHDTh" title="Property plant and equipment useful life">3</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zIHVzGy00862" title="Property plant and equipment useful life">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zCBdKCHA8Iu5" title="Property plant and equipment estimated useful lives">Lower of estimated useful life or remaining lease term</span></span></td></tr> </table> P3Y P7Y Lower of estimated useful life or remaining lease term <p id="xdx_846_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zDK6RgDdB9ll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zzh1aJ5BxXre">Definite Lived Intangible Asset</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite lived intangible asset consists of a granted patent. Amortization is computed using the straight-line method over the estimated useful lives of the asset. Estimated useful lives of the granted patent is <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231_zfyPBKuBxsa9" title="Estimated useful lives">20</span> years. Amortization expense is allocated to general and administrative expense. No amortization expense has been taken on the granted patent as it was available for use starting January 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P20Y <p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zyykzmHQ0lCg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z9wwYtbfMRW3">Impairment of Long-Lived Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Fair value can be determined using a market approach, income approach or cost approach. The reversal of impairment losses is prohibited.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--DebtPolicyTextBlock_zQAQNbr74xm1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zgPwxi3lCyse">Convertible Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which provides that if three criteria are met, the Company is required to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--LessorLeasesPolicyTextBlock_zj8r91H4IGXc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zNKzHk27tud">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines at the inception of a contract if the arrangement is or contains a lease. A contract is or contains a lease if the contract gives the right to control the use of an identified asset for a period of time in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a right-of-use asset and a lease liability on the balance sheet for all leases with an initial lease term of greater than <span id="xdx_90F_eus-gaap--LessorOperatingLeaseTermOfContract_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zHqfgstiqgMl" title="Lessor operating lease term of contract">12 months</span>. Leases with an initial term of <span id="xdx_90E_eus-gaap--LessorOperatingLeaseTermOfContract_iI_c20221231_zetdyGJxivQ2" title="Lessor operating lease term of contract">12 months</span> or less are not recorded on the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s contracts can contain both lease and non-lease components. The non-lease components may include maintenance, utilities, and other operating costs. The Company combines the lease and non-lease components of fixed costs in its leases as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of right-of-use assets and lease liabilities. These costs are expensed when the event determining the amount of variable consideration to be paid occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of future lease payments over the expected lease term. The Company determines the present value of future lease payments by using its estimated secured incremental borrowing rate for that lease term as the interest rate implicit in the lease is not readily determinable. The Company estimates its incremental borrowing rate for each lease based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments over a similar term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> P12M P12M <p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zZseMSiJLMTg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zmKaZ9UgpRy5">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not recorded any revenues since its inception. However, in the future, the Company expects to generate returns from any or all the revenue sources below from its customers:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental income from facilities</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales revenue from nutritious food products</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property income from the license of the facilities</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management and advisory fees from management service contracts</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, the Company early adopted ASU No. 2014-09, <i>Revenue from Contracts with Customers</i> and all related amendments (“ASC 606” or “the new revenue standard”). ASC 606 is a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new revenue standard is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 provides that an entity should apply the following steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The new revenue standard also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, and costs to obtain or fulfill contracts. The Company will apply ASC 606 prospectively to all contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZ6vB3Hj5wg5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zIsdhFljeqZf">Loss per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company presents basic and diluted loss per share data for its common shares. Basic loss per common share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the year. The number of common shares used in the loss per shares calculation includes all outstanding common shares plus all common shares issuable for which there are no conditions to issue other than time. Diluted loss per common share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all potentially dilutive share equivalents, such as stock options and warrants and assumes the receipt of proceeds upon exercise of the dilutive securities to determine the number of shares assumed to be purchased at the average market price during the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zqLYr8snZMR" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_znNNxrLGlUC6">Research and Development</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure on research and development activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognized as expense when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zzFDoVeeadVf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zlmSHdv40lK9">Foreign Currency Transactions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements of the Company and its subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, shareholders’ equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries’ accounts are included in “Accumulated other comprehensive income” as equity in the consolidated balance sheets. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the reporting currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within non-operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOwDeUGaTFFc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_znh5SiM5qldh">Fair value of Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s accounts receivable, accounts payable and other current liabilities approximate their carrying amounts due to the relative short maturities of these items.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the issuance of debentures on March 24, 2021 and June 30, 2022, the Company issued warrants having strike price denominated in U.S. Dollars. This creates an obligation to issue shares for a price that is not denominated in the Company’s functional currency and renders the warrants not indexed to the Company’s stock, and therefore, must be classified as a derivative liability and measured at fair value. On the same basis, the Series A Warrants and the representative warrants issued as part of the IPO are also classified as a derivative liability and measured at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s warrants is determined in accordance with FASB ASC 820, “Fair Value Measurement,” which establishes a fair value hierarchy that prioritizes the assumptions (inputs) to valuation techniques used to price assets or liabilities that are measured at fair value. The hierarchy, as defined below, gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The guidance for fair value measurements requires that assets and liabilities measured at fair value be classified and disclosed in one of the following categories:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company’s warrant liability related to IPO warrants and representative’s warrant amounting to $<span title="Warrant liability"><span id="xdx_90F_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zDZ0s5z0MYz" title="Warrant liability">275,115</span></span> (December 31, 2021 - $<span id="xdx_90D_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zWyYlZBCHOg" title="Warrant liability">1,418,964</span>) is reported at fair value and categorized as Level 1 inputs. The fair value of derivative liabilities related to the Debenture Warrants and Debenture Convertible Feature that were issued during the year amounted to $<span id="xdx_908_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zETst3y8btvk" title="Derivative assets liabilities at fair value net">4,374,000</span> (December 31, 2021 - $<span id="xdx_902_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iI_dxL_c20211231__us-gaap--FinancialInstrumentAxis__custom--IPOWarrantMember_zIPm9whQgeL4" title="Derivative assets liabilities at fair value net::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0817">nil</span></span>) and were categorized as level 3 inputs. The Bridge Warrants that were issued and exercised in the year ended December 31, 2021 were also categorized as level 3 inputs. (See Note 9 and Note 11)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 275115 1418964 4374000 <p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zOWElaHsvTpd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zlHqVHspYRa4">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current tax expense is the expected tax payable on the taxable income for the period, using tax rates enacted at period-end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets, including those arising from tax loss carryforwards, requires management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no material uncertain tax positions as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zyp1xRSrARs1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zoOt5IoJE1gg">Share Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company generally uses the straight-line method to allocate compensation cost to reporting periods over each optionee’s requisite service period, which is generally the vesting period, and estimates the fair value of stock-based awards to employees and directors using the Black-Scholes option-valuation model (the “Black-Scholes model”). .. This model incorporates certain assumptions for inputs including a risk-free market interest rate, expected dividend yield of the underlying common stock, expected option life, and expected volatility in the market value of the underlying common stock. The Company recognizes any forfeitures as they occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuBDKVvsXCwh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zkF2EP56xLwa">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Start-ups Act of 2012, (the “JOBS Act”). Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, for complying with new or revised accounting standards applicable to public companies. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize leases on balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC 842 as of January 1, 2022 using the optional transition method to apply the standard as of the effective date. Accordingly, previously reported financial statements, including footnote disclosures, have not been recast to reflect the application of the new standard to all comparative periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The new standard also provides practical expedients for an entity’s ongoing accounting as a lessee. The Company elected to utilize the practical expedient to not separate lease and non-lease components for its existing lease. The Company has also elected not to present short-term leases on the consolidated balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because the Company’s lease does not provide an implicit rate of return, it used its incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adoption of the new lease standard on January 1, 2022 had a material impact on the Company’s consolidated financial statements. The most significant impacts related to the recognition of ROU assets of $<span id="xdx_903_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220102_z99xNAUeS4Qc" title="Right of use assets">1,776,599</span> and lease liabilities of $<span id="xdx_902_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20220102_zuziKUFayhVg" title="Lease liabilities">1,837,782</span> for operating leases on the consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The standard did not materially impact the Company’s consolidated statements of comprehensive loss and consolidated statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06 “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASU 2020-06”). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted “Earnings per share” under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. ASC 2020-06 is effective for emerging growth companies for fiscal years beginning after December 15, 2023. We are currently assessing the impact this guidance will have on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” The standard, including subsequently issued amendments, requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, and requires the modified retrospective approach. Early adoption is permitted. Based on the composition of the Company’s trade receivables and other financial assets, current market conditions, and historical credit loss activity, the Company is currently in the process of evaluating the impact of this guidance on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under ASU 2021-08, an acquirer must recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The guidance is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is currently in the process of evaluating the impact of this guidance on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> 1776599 1837782 <p id="xdx_804_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zCqCJ8B7PLYa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_82B_zsoLNjU0Sjw5">PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT</span></span></b></span></p> <p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_zwumfYRhwsS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span style="display: none"><span><span id="xdx_8BA_zwDJhHb1Mvxd" style="display: none">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></span></span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zF2pgivTD5ja" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zcHcRTdE9Oyc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--DepositAssets_iI_maPEAOAzL9l_zpuPU3sQ4kw4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">32,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--LegalRetainer_iI_maPEAOAzL9l_zXee6axu7wX5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Legal retainer</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,692</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PrepaidExpenseCurrent_iI_maPEAOAzL9l_zCbqazlouQja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">436,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">214,445</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredOfferingCosts_iI_maPEAOAzL9l_zPNPKFZJLjM3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred offering costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,337</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0843">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherAssets_iI_maPEAOAzL9l_zppx8YfxY9qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,052</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,903</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzL9l_zx09HUplIez5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses, other current assets</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">598,342</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,040</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 31, 2022, the Company signed a purchase and sale agreement with Stronghold Power Systems, Inc. (“Stronghold”), to purchase approximately seventy acres of land located in the City of Coachella as well as the completion of certain permitting, zoning, and infrastructure work by Stronghold for a total purchase price of $<span id="xdx_90C_eus-gaap--PaymentsToAcquireLand_c20220831__20220831__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember_zpe5QpdmF1Gb" title="Payments to acquire land">4,300,000</span>. The purchase price consists of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--Cash_iI_c20230331__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zJCbJYYwwKEe" title="Cash">1,500,000</span> in cash due on March 31, 2023. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A first stock deposit of $<span id="xdx_90C_eus-gaap--DepositAssets_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--FirstStockDepositsMember_zcAhNtsK40bj" title="Deposits">1,700,000</span> in prefunded warrants. The Company issued <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--FirstStockDepositsMember_zcBnxBpj9iM5" title="Warrants issued">695,866</span> prefunded warrants on September 9, 2022 to Stronghold. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A second stock deposit $<span id="xdx_90E_eus-gaap--DepositAssets_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--SecondStockDepositsMember_zPE9EIeWXand" title="Deposits">1,100,000</span> in prefunded warrants. The Company issued <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--SecondStockDepositsMember_zkU4NnIYlzPg" title="Warrants issued">450,266</span> prefunded warrants on September 9, 2022 to Stronghold.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022 the $<span id="xdx_90F_ecustom--LandDepositAssets_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember_zufXIWTndkc7" title="Land deposits">2,085,960</span> of prefunded warrants were recorded under land deposit in relation to the Stronghold agreement. The prefunded warrant issuance may be rescinded and the warrants null and void if Stronghold does not meet all escrow performance conditions by March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_zwumfYRhwsS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span style="display: none"><span><span id="xdx_8BA_zwDJhHb1Mvxd" style="display: none">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></span></span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zF2pgivTD5ja" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zcHcRTdE9Oyc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--DepositAssets_iI_maPEAOAzL9l_zpuPU3sQ4kw4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">32,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--LegalRetainer_iI_maPEAOAzL9l_zXee6axu7wX5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Legal retainer</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,692</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PrepaidExpenseCurrent_iI_maPEAOAzL9l_zCbqazlouQja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">436,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">214,445</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredOfferingCosts_iI_maPEAOAzL9l_zPNPKFZJLjM3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred offering costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,337</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0843">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherAssets_iI_maPEAOAzL9l_zppx8YfxY9qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,052</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,903</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzL9l_zx09HUplIez5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses, other current assets</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">598,342</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,040</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 31, 2022, the Company signed a purchase and sale agreement with Stronghold Power Systems, Inc. (“Stronghold”), to purchase approximately seventy acres of land located in the City of Coachella as well as the completion of certain permitting, zoning, and infrastructure work by Stronghold for a total purchase price of $<span id="xdx_90C_eus-gaap--PaymentsToAcquireLand_c20220831__20220831__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember_zpe5QpdmF1Gb" title="Payments to acquire land">4,300,000</span>. The purchase price consists of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--Cash_iI_c20230331__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zJCbJYYwwKEe" title="Cash">1,500,000</span> in cash due on March 31, 2023. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A first stock deposit of $<span id="xdx_90C_eus-gaap--DepositAssets_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--FirstStockDepositsMember_zcAhNtsK40bj" title="Deposits">1,700,000</span> in prefunded warrants. The Company issued <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--FirstStockDepositsMember_zcBnxBpj9iM5" title="Warrants issued">695,866</span> prefunded warrants on September 9, 2022 to Stronghold. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A second stock deposit $<span id="xdx_90E_eus-gaap--DepositAssets_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--SecondStockDepositsMember_zPE9EIeWXand" title="Deposits">1,100,000</span> in prefunded warrants. The Company issued <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220909__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember__us-gaap--InvestmentTypeAxis__custom--SecondStockDepositsMember_zkU4NnIYlzPg" title="Warrants issued">450,266</span> prefunded warrants on September 9, 2022 to Stronghold.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022 the $<span id="xdx_90F_ecustom--LandDepositAssets_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--LandPurchaseAndSaleAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StrongholdPowerSystemMember_zufXIWTndkc7" title="Land deposits">2,085,960</span> of prefunded warrants were recorded under land deposit in relation to the Stronghold agreement. The prefunded warrant issuance may be rescinded and the warrants null and void if Stronghold does not meet all escrow performance conditions by March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 12000 32000 24457 33692 436496 214445 100337 25052 28903 598342 309040 4300000 1500000 1700000 695866 1100000 450266 2085960 <p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z8qnwLD2iuG5" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_zmlkNDgmDWxd">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_z3Fg3Ffs5l28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zsd9ROmxlg7e" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwrAUx5DxSzd" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,979</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zYBkdHCjPfYe" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0871">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zAj1bcQbZQc3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,112</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z4WVmlUBp4eb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,708</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzKWMwQebGoc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,590</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zA8MHqlkzeyj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zb1bhyeGd3x7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163,681</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zOAxTPL1lXvd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,705</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zTRvTzVtPQaa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42,009</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zoEnCBKB1p73" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,734</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zB9NsY0OAJm3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,672</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zthQik5qEHKg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,971</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zljL5CEZ5zD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense on property and equipment, was $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20220101__20221231_z2brGBZUe9Qk" title="Depreciation expense">22,413</span> and $<span id="xdx_901_eus-gaap--DepreciationAndAmortization_pp0p0_c20210101__20211231_zj0RfKAqf5gg" title="Depreciation expense">11,797</span> for the years ended December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_z3Fg3Ffs5l28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zsd9ROmxlg7e" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwrAUx5DxSzd" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,979</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zYBkdHCjPfYe" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0871">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zAj1bcQbZQc3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,112</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z4WVmlUBp4eb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,708</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzKWMwQebGoc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,590</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zA8MHqlkzeyj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zb1bhyeGd3x7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163,681</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zOAxTPL1lXvd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total property and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,705</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zTRvTzVtPQaa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42,009</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zoEnCBKB1p73" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,734</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zB9NsY0OAJm3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,672</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zthQik5qEHKg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,971</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 86979 39112 22708 37590 39997 163681 62705 42009 21734 121672 40971 22413 11797 <p id="xdx_80E_ecustom--ConstructionInProgressTextBlock_zw8zhPn1Wh86" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_827_zMEi8Yhyobcb">CONSTRUCTION IN PROGRESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company engaged outside contractors to begin construction work on its first facility. As of December 31, 2022, $<span id="xdx_900_ecustom--ConstructionInProgress_iI_pp0p0_c20221231_zWuRGwBwAHy7" title="Construction in progress">2,092,533</span> (December 31, 2021 – $<span id="xdx_90B_ecustom--ConstructionInProgress_iI_pp0p0_c20211231_zWT7J43jM1k7" title="Construction in progress">2,079,914</span>) represents progress payments related to facility construction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2092533 2079914 <p id="xdx_80D_eus-gaap--IntangibleAssetsDisclosureTextBlock_zycIUpofeQL4" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_za8gtLNqK31d">INTANGIBLE ASSET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible asset represents $<span id="xdx_907_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--MannaNutritionalGroupLLCMember_z6ekvamwCPcf">13,089,377 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December 31, 2021 - $<span id="xdx_90F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--MannaNutritionalGroupLLCMember_z4Hip2ckocm4">1,477,237</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) for intellectual property (“Manna IP”) acquired under an asset purchase agreement with Manna Nutritional Group, LLC (“Manna”) dated September 10, 2021. The Manna IP encompasses patent-pending technologies to naturally process and convert grain, pulses and root vegetables, resulting in low-starch, low-sugar, high-protein, fiber-rich baking flour products, as well as a wide range of breakfast cereals, juices, natural sweeteners and baking enhancers. The Company paid $<span id="xdx_902_eus-gaap--Cash_iI_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PrefundedWarrantsMember_zhM14MgPxt3k" title="Cash">1,475,000</span> in cash and issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PrefundedWarrantsMember_zcoh8Sr0cXm6" title="Stock issued during period shares new issues">7,379,969</span> prefunded warrants valued at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PrefundedWarrantsMember_zYBkBCiSHBwe" title="Stock issued during period value new issues">12,106,677</span> (the “Purchase Price”) adjusted for foreign exchange differences of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PrefundedWarrantsMember_zmWVgVcKdTuj" title="Adjusted for foreign exchange adjustments">492,300</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Subject to a <span id="xdx_901_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_dp_uPure_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PrefundedWarrantsMember_zkpDHLd4qTS3" title="Foreign currency exchange rate">9.99</span>% stopped and SEC Rule 144 restrictions the prefunded warrants will vest in tranches up until March 10, 2024. When vested the tranches of prefunded warrants will be converted into an equal number of common shares. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Subsequent to the year end, Manna satisfied all of its contractual obligations when the patent was approved by the US Patents Office and title was transferred to the Company. The Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230102__20230103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zucP42zX1LAh" title="Number of shares issued">1,637,049</span> shares in relation to this transaction on January 3, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the terms above and in conformity with US GAAP, the Company accounted for purchase as an asset acquisition and has deemed the asset purchased as an in-process research and development. The Company has further deemed the asset to be of indefinite life until the completion of the associated research and development activities. Once completed and commercialized, the asset will be amortized over its useful life.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 13089377 1477237 1475000 7379969 12106677 492300 0.0999 1637049 <p id="xdx_80D_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_ziyJA4d9K6J3" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_znBeE1K7yqRd">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zmOpaWPYZTPe" style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zhMrlK8g96A8" style="display: none">SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zpHVOlyou7ll" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20211231_zC24XzY457v8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzXis_zBrXuZ23eFNa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">498,188</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414,117</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzXis_zI3m0cFdhJof" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365,521</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">981,027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maAPAALzXis_zemEdIxOBEP1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">284,030</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137,168</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzXis_zNGmOpwALuIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Payable and Accrued Liabilities</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,147,739</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,532,312</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_ziFxJTeGRE1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses as of December 31, 2021, included $<span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zireyB4oZaI5" title="Accounts payable">500,000</span> related to the purchase of the Manna IP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zmOpaWPYZTPe" style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zhMrlK8g96A8" style="display: none">SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zpHVOlyou7ll" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20211231_zC24XzY457v8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzXis_zBrXuZ23eFNa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">498,188</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414,117</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzXis_zI3m0cFdhJof" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365,521</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">981,027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maAPAALzXis_zemEdIxOBEP1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">284,030</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137,168</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzXis_zNGmOpwALuIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Payable and Accrued Liabilities</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,147,739</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,532,312</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 498188 414117 365521 981027 284030 137168 1147739 1532312 500000 <p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zm638rDHu0M" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_z0CNZX0POJGa">DEBENTURES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 24, 2021, the Company entered into a securities purchase agreement with certain investors for the purchase of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20210324__srt--TitleOfIndividualAxis__custom--AccreditedInvestorsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zedq1P21mv87" title="Debt principal amount">750,000</span> in principal amount ($<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pp0p0_c20210323__20210324__srt--TitleOfIndividualAxis__custom--AccreditedInvestorsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zcR7eQJfrJF7" title="Subscription amount">600,000</span> subscription amount) of senior secured debentures originally due <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20210323__20210324__srt--TitleOfIndividualAxis__custom--AccreditedInvestorsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zJkradw2bT75" title="Debt, maturity date">June 24, 2021</span> (the “Bridge Loan”). The imputed interest rate is encompassed within the original issue discount of the debentures and no additional cash interest shall be due. Transaction costs of $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210323__20210324__srt--TitleOfIndividualAxis__custom--AccreditedInvestorsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBP2iim2lPnd" title="Transaction costs">69,000</span> have been recorded in connection with the Bridge Loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 24, 2021, the due date was extended, for which the Company paid an extension fee of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210623__20210624__srt--TitleOfIndividualAxis__custom--AccreditedInvestorsMember_zr3JcxBFmI2a" title="Stock issued during period, shares">10,000</span> common shares with a fair value of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210623__20210624__srt--TitleOfIndividualAxis__custom--AccreditedInvestorsMember_zvKZhUVgO3P4" title="Stock issued during period, value">60,000</span>. The senior secured debentures were repaid in full on July 13, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the bridge loan, the debenture holder was issued warrants (the “Bridge Warrants”) to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210624__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember_z8GYo9bCbw46">93,938 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares for up to three years of the issuance date with a strike price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210624__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember_zLYIsuTs4mU8">3.99 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2022, the Company executed the definitive agreement with certain institutional investors (the “Investors”) for a $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zCsIboSFz5pc" title="Debt principal amount">14,025,000</span> principal debentures with a <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z0vvluq1YVxb" title="Original issue discount percentage">10</span>% original issue discount (the “Debentures”) for net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_c20220629__20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zEmUByfRHl61" title="Gross proceeds of debt">12,750,000</span>. The interest rates on the Debentures are <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__srt--StatementScenarioAxis__custom--FirstTwelveMonthsMember_zTHCUjkE8N77" title="Debt instrument interest rate percentage">5</span>% for the first 12 months, <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__srt--StatementScenarioAxis__custom--SubsequentTwelveMonthsMember_z12MkX0fuvNl" title="Debt instrument interest rate percentage">6</span>% for the subsequent 12 months, and <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__srt--StatementScenarioAxis__custom--ThereafterMember_zeAjd79wtt5l" title="Debt instrument interest rate percentage">8</span>% per annum thereafter. Principal repayments will be made in 25 equal monthly installments and began on September 1, 2022. The Debenture may be extended by six months at the election of the Company by paying a sum equal to six months interest on the principal amount outstanding at the end of the 18<sup>th</sup> month, at the rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z5v8LLzgn624" title="Debt instrument interest rate percentage">8</span>% per annum. The Debentures are convertible into common shares at $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zPgdCUnPQmMb" title="Convertible into common shares per share">2.22</span> per share. The Investors have the right to purchase additional tranches of $<span id="xdx_906_ecustom--PurchaseOfAdditionalTranches_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zQKNvIZ5r5h" title="Purchase of additional tranches">5,000,000</span> each, up to a total additional principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--DebtInstrumentAxis__custom--AdditionalTranchesMember_zrZdVvoAhkv5" title="Debt principal amount">33,000,000</span>. In addition, the Investors received <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zhceUMANgeGd" title="Investors received warrants">4,106,418</span> warrants at a strike price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zKtzVyi0n2Lg" title="Warrant strike price">2.442</span>, which expire on <span id="xdx_902_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20220629__20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_znU8bNI2puei" title="Warrants expire date">December 31, 2025</span> (the “Debenture Warrants”). The Debenture Warrants and Debentures each have down round provisions whereby the conversion and strike prices will be adjusted downward if the Company issues equity instruments at lower prices. The Debenture Warrants strike price and the Debenture conversion price will be adjusted down to the effective conversion price of the issued equity instruments. Due to the currency of these features being different from the Company’s functional currency the Debenture Warrants and Debentures’ convertible features were classified as derivative liabilities and are further discussed in Note 11. The transaction costs incurred in relation to the Debentures were $<span id="xdx_902_eus-gaap--SecuredDebtCurrent_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z8stkcjAfMB" title="Debentures transaction costs incurred">1,634,894</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDebtTableTextBlock_zymSzYdbJn2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes our outstanding debentures as of the dates indicated:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zKpXzZFmU7E3" style="display: none">SCHEDULE OF OUTSTANDING DEBENTURES</span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash Interest Rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal (initial)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20220101__20221231_zzlabH3xfB56" title="Maturity Date">12/31/2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zh3FuoHvkJ9" title="Cash Interest Rate">5.00</span>% - <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zXAiWF8lk7jl" title="Cash Interest Rate">8.00</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DebtInstrumentCarryingAmount_iI_c20221231_zh2fZ2Xxzui8" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Debentures (gross)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,025,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayments and conversions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--RepaymentsAndConversions_iI_c20221231_zltzF8qSd2i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Repayments and conversions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,955,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt issuance costs and discounts (Note 9 &amp; 11)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20221231_zEIBY735fb16" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt issuance costs and debt discounts"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,128,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Debentures (current)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--SecuredDebtCurrent_iI_c20221231_z38rSkAZSkkh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total debentures (current)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,941,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_ziSiOHuwriK9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Investors converted $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220101__20221231__srt--TitleOfIndividualAxis__custom--InvestorsMember_zjULmmYlbEBa" title="Debt instrument converted value">150,000</span> of convertible debentures into <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20221231__srt--TitleOfIndividualAxis__custom--InvestorsMember_zs4VuIOtXOWj" title="Debt instrument converted shares">67,568</span> shares of the Company resulting in a $<span id="xdx_907_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20220101__20221231__srt--TitleOfIndividualAxis__custom--InvestorsMember_z21flXiuvsz7" title="Loss on conversion of convertible debentures">93,973</span> gain on the conversion of convertible debentures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Subsequent to the year end, the Investors purchased an additional tranche of $<span id="xdx_908_eus-gaap--ConvertibleDebt_iI_c20230310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--VestingAxis__custom--TrancheMember_zPcvhn33Qxz" title="Convertible debt">5,076,923</span>. The convertible debt and warrants were issued with an exercise price of $<span id="xdx_904_eus-gaap--SharePrice_iI_c20230310__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3tEKJfAj3o7" title="Exercise price">1.24</span>. The issuance of the additional tranche triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $<span id="xdx_904_eus-gaap--SharePrice_iI_c20230310__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zOV6J5Gtlfw3" title="Exercise price">1.24</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 750000 600000 2021-06-24 69000 10000 60000 93938 3.99 14025000 0.10 12750000 0.05 0.06 0.08 0.08 2.22 5000000 33000000 4106418 2.442 2025-12-31 1634894 <p id="xdx_891_eus-gaap--ScheduleOfDebtTableTextBlock_zymSzYdbJn2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes our outstanding debentures as of the dates indicated:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zKpXzZFmU7E3" style="display: none">SCHEDULE OF OUTSTANDING DEBENTURES</span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash Interest Rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal (initial)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20220101__20221231_zzlabH3xfB56" title="Maturity Date">12/31/2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zh3FuoHvkJ9" title="Cash Interest Rate">5.00</span>% - <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zXAiWF8lk7jl" title="Cash Interest Rate">8.00</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DebtInstrumentCarryingAmount_iI_c20221231_zh2fZ2Xxzui8" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Debentures (gross)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,025,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayments and conversions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--RepaymentsAndConversions_iI_c20221231_zltzF8qSd2i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Repayments and conversions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,955,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt issuance costs and discounts (Note 9 &amp; 11)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20221231_zEIBY735fb16" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt issuance costs and debt discounts"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,128,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Debentures (current)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--SecuredDebtCurrent_iI_c20221231_z38rSkAZSkkh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total debentures (current)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,941,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2024-12-31 0.0500 0.0800 14025000 -2955000 7128084 3941916 150000 67568 93973 5076923 1.24 1.24 <p id="xdx_802_eus-gaap--LongTermDebtTextBlock_zd3RmQhMF89g" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_827_zpgKRPdOhFHc">LONG TERM LOAN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, the Company entered into a loan agreement with Alterna Bank for a principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20201231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zNEe8eWwVI19" title="Debt principal amount">29,533</span> (December 31, 2021 - $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20211231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zNlYGcz3VUla" title="Debt principal amount">31,417</span>) (CAD$<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_uCAD_c20201231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zk69jFCbH8Kf" title="Debt principal amount">40,000</span>) under the Canada Emergency Business Account Program (the “Program”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Program, as set out by the Government of Canada, requires that the funds from this loan shall only be used by the Company to pay non-deferrable operating expenses including, without limitation, payroll, rent, utilities, insurance, property tax and regularly scheduled debt service, and may not be used to fund any payments or expenses such as prepayment/refinancing of existing indebtedness, payments of dividends, distributions and increases in management compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2021, the Company applied for an additional loan with Alterna Bank under the Program and received $<span id="xdx_90B_eus-gaap--ProceedsFromLoans_c20210401__20210430__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zPSnp2N9mN53" title="Proceeds from loan">14,767</span> (CAD$<span id="xdx_90E_eus-gaap--ProceedsFromLoans_uCAD_c20210401__20210430__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zYGZ8sbdPPo4" title="Proceeds from loan">20,000</span>) (December 31, 2021 - $<span id="xdx_909_eus-gaap--ProceedsFromLoans_c20210101__20211231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zf729KrQ8u3h" title="Proceeds from loan">15,909</span> (CAD $<span id="xdx_90A_eus-gaap--ProceedsFromLoans_uCAD_c20210101__20211231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zRu1XcLjLXUi" title="Proceeds from loan">60,000</span>)). The expansion loan is subject to the original terms and conditions of the Program.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loan is interest free for an initial term that ends on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z5TALBqHeAb5" title="Debt, maturity date">December 31, 2023</span>. Repaying the loan balance on or before December 31, 2023 will result in loan forgiveness of up to a third of loan value (up to CAD $<span id="xdx_909_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_uCAD_c20220101__20221231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zmfAR8MOG8h5" title="Debt instrument, forgiveness">20,000</span>). Any outstanding loan after initial term carries an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zHNPhiXPXhx6" title="Debt instrument, interest rate">5</span>% per annum, payable monthly during the extended term i.e. <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20221231__dei--LegalEntityAxis__custom--AlternaBankMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zrW8Bd26ve2h" title="Debt, maturity date description">January 31, 2024 to December 31, 2025.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The balance at December 31, 2022 was $<span id="xdx_90B_eus-gaap--LongTermLoansPayable_iI_c20221231_zMsCoycWdK2b" title="Long term loans payable">44,300</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (CAD $<span id="xdx_90C_eus-gaap--LongTermLoansPayable_iI_uCAD_c20221231_zRuSrKIxbUik" title="Long term loans payable">60,000</span>) (December 31, 2021 - $<span id="xdx_908_eus-gaap--LongTermLoansPayable_iI_c20211231_zXUuSG5HUByc" title="Long term loans payable">47,326</span> (CAD $<span id="xdx_908_eus-gaap--LongTermLoansPayable_iI_uCAD_c20211231_zNmqAI8AkGH3" title="Long term loans payable">60,000</span>)). </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 29533 31417 40000 14767 20000 15909 60000 2023-12-31 20000 0.05 January 31, 2024 to December 31, 2025. 44300 60000 47326 60000 <p id="xdx_80E_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zP5AzrShSKC9" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zQnl8cht64Ri">DERIVATIVE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s derivative liabilities consist of warrants, denominated in a currency other than the Company’s functional currency (the “Warrant Liabilities”) and conversion rights embedded in the Debentures, see Note 9 (the “Debenture Convertible Features”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant Liabilities</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Warrant Liabilities represent aggregate fair value of publicly traded <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantsMember_zRqRCrsW2xKf" title="Class of warrant or right number of securities called by warrants or rights">3,088,198</span> Series A warrants (“IPO Warrants”), <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zt9HkPqKnHFb" title="Class of warrant or right number of securities called by warrants or rights">135,999</span> representative’s warrants (“Rep Warrants”) and <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember_zQBHSYa6AP92" title="Class of warrant or right number of securities called by warrants or rights">4,106,418</span> Debenture Warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the IPO Warrants and Rep Warrants amount to $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvJqIh8mcXJc">275,115 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December 31, 2021 - $<span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20210101__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3741rRaYANl">1,418,964</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) and were categorized as a Level 1 financial instrument. The Rep Warrants are exercisable one year from the effective date of the IPO registration statement and will expire three years after the effective date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Debenture Warrants amounted to $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--DebentureWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3Nx7LBuihm4" title="Fair value adjustment of warrants">2,917,000</span> (June 30, 2022 - $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--DebentureWarrantsMember_zvne1xTJpdW1" title="Fair value adjustment of warrants">4,080,958</span>) and were categorized as a Level 3 financial instrument. As at December 31, 2022 the Company utilized the Monte Carlo option-pricing model (June 30, 2022 – Black-Scholes option-pricing model) to value the Debenture Warrants using the following assumptions: stock price $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zikhm88griUf" title="Class of warrant or right exercise price of warrants or rights">1.13</span> (June 30, 2022 - $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z93mmwBt0LX8" title="Class of warrant or right exercise price of warrants or rights">2.31</span>), dividend yield – <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dxL_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zWfW7DoDIBGh" title="Class of warrant or right exercise price of warrants or rights::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1059">nil</span></span> (June 30, 2022 – <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dxL_uPure_c20220630__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zYATpS2PLvx7" title="Class of warrant or right exercise price of warrants or rights::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1061">nil</span></span>), expected volatility <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z1pezAhGkl3c" title="Warrants and rights outstanding measurement input">95.0</span>% (June 30, 2022 – <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220630__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z5zvGFyxEyp3" title="Warrants and rights outstanding measurement input">58.3</span>%), risk free rate of return <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zp4Rk6KzsNVe" title="Warrants and rights outstanding measurement input">4.22</span>% (June 30, 2022 – <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220630__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z3yO5b4EjV1c" title="Warrants and rights outstanding measurement input">3.14</span>%), and expected term of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zZGlrf22vLc8" title="Warrants and rights outstanding term">3 </span>years (June 30, 2022 – expected term of <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--StatementEquityComponentsAxis__custom--DebentureWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_ztCC8Ad7VH2a" title="Warrants and rights outstanding term">3.5</span> years).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The changes in the fair value of the Bridge Warrants ($<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20211026__20211027__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember_zL9h0h3BWte2" title="Fair value of warrant">203,456</span> – 2021) was charged to the statement of comprehensive loss. The warrants were exercised on October 27, 2021 and accordingly, the warrant liability was extinguished. The fair value of the warrants prior to exercise was estimated at $<span id="xdx_90C_ecustom--SharesIssuedOnCashlessExerciseOfWarrants_c20211026__20211027__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember_zXK0y5YJgw54" title="Exercise of warrants">64,992</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, determined using the Black-Scholes option pricing model and the following assumptions; stock price $<span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20211027__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zV8TZLlM9hih">2.16</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, dividend yield – <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dxL_uPure_c20211027__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zvGlUFKlZMfb">nil</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, expected volatility <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211027__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zvXuiEmQcpud">73</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, risk free rate of return <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211027__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_znq4HMc7LLc2">0.94</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, expected term of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211027__us-gaap--StatementEquityComponentsAxis__custom--BridgeWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zYDrzlj998fa">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Debenture Convertible Features</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2022, the Company issued Debentures with an equity conversion feature, see Note 9. The fair value of the Debentures’ convertible features was $<span id="xdx_909_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4bgCQoTGWbd" title="Fair value of debentures convertible">3,336,535</span> on the issuance date and $<span id="xdx_90D_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20221231__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPvmFB26Bcj2" title="Fair value of debentures convertible">1,457,000</span> as at December 31, 2022. These conversion features are categorized as a Level 3 financial instrument. As at December 31, 2022 the Company utilized the Monte Carlo option-pricing model (June 30, 2022 – Black-Scholes option-pricing model) for valuing the convertible feature using the following assumptions: stock price $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20221231__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember_zw4DDGFumMF1" title="Stock price">1.13</span> (June 30, 2022 - $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220630__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember_zK6DhE4aQlYf" title="Stock price">2.31</span>), dividend yield – <span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_dxL_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z9rxl2XnBazg" title="Dividend yield::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1092">nil</span></span> (June 30, 2022 – <span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_dxL_uPure_c20220630__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zJbaI2WxSVj9" title="Dividend yield::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1094">nil</span></span>), expected volatility <span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z3ZtQWOe7PC7" title="Expected volatility">95.0</span>% (June 30, 2022 –<span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zY8ZzHVLHSzk" title="Expected volatility"> 101.0</span>%), risk free rate of return <span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zDrxfwaelPCg" title="Debenture convertible measurement input">4.41</span>% (June 30, 2022 – <span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zdGjkqaxK8j7" title="Debenture convertible measurement input">3.14</span>%), discount rate <span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8gr6nai3ea6" title="Debenture convertible measurement input">13.65</span>% (June 30, 2022 – not applicable), and expected term of <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zTJv8jDJzZM8" title="Expected term">2</span> years (June 30, 2022 – <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--DebtInstrumentAxis__custom--DebentureConvertibleMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zRtgufzRrylc" title="Expected term">1</span> year).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zUzhBGN8rBAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in the fair value of Company’s Level 1 and 3 financial instruments for the year ended December 31, 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zdRFz4cXSjS5" style="display: none">SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td id="xdx_491_20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__custom--IPOAndRepresentativeWarrantsMember_zH0VUH1Ivc75"> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__custom--DebentureWarrantsMember_zpSleXj9zWxa" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__custom--DebentureConvertibleFeatureMember_zWlDSxsNWMxf" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zOadfUplojm5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><b> </b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Level 1</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>IPO and Rep Warrants</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Debenture Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Debenture</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Feature</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_zKw4NR2ekYz8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at December 31, 2021</td> <td> </td> <td>$</td> <td style="text-align: right">1,418,964</td> <td> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1113">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,418,964</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_zJ86GmEB6Yli" style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: justify">Additions</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 12%"><span style="-sec-ix-hidden: xdx2ixbrl1117">-</span></td> <td style="width: 1%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">4,080,958</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">3,336,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">7,417,493</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_zVnuXGxSVHt8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Conversions</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(63,723</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(63,723</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_z1OPJsj5jmPj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Change in fair value</td> <td> </td> <td> </td> <td style="text-align: right">(1,086,562</td> <td>)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(966,141</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,667,166</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,719,869</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges_z6Ms3877u5Z8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of exchange rate changes</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(57,287</td> <td style="padding-bottom: 1.5pt">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(197,817</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(148,646</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(403,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_zrnLztP5qNgh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance at December 31, 2022</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">275,115</td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,917,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,457,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,649,115</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zqMtBnTuQITh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Due to the expiry date of the warrants and conversion feature being subsequent to December 31, 2023, the liabilities have been classified as non-current.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3088198 135999 4106418 275115 1418964 2917000 4080958 1.13 2.31 95.0 58.3 4.22 3.14 P3Y P3Y6M 203456 64992 2.16 73 0.94 P3Y 3336535 1457000 1.13 2.31 95.0 101.0 4.41 3.14 13.65 P2Y P1Y <p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zUzhBGN8rBAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in the fair value of Company’s Level 1 and 3 financial instruments for the year ended December 31, 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zdRFz4cXSjS5" style="display: none">SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td id="xdx_491_20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__custom--IPOAndRepresentativeWarrantsMember_zH0VUH1Ivc75"> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__custom--DebentureWarrantsMember_zpSleXj9zWxa" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__custom--DebentureConvertibleFeatureMember_zWlDSxsNWMxf" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zOadfUplojm5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><b> </b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Level 1</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>IPO and Rep Warrants</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Debenture Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Debenture</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Feature</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_zKw4NR2ekYz8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at December 31, 2021</td> <td> </td> <td>$</td> <td style="text-align: right">1,418,964</td> <td> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1113">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,418,964</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_zJ86GmEB6Yli" style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: justify">Additions</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 12%"><span style="-sec-ix-hidden: xdx2ixbrl1117">-</span></td> <td style="width: 1%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">4,080,958</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">3,336,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">7,417,493</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_zVnuXGxSVHt8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Conversions</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(63,723</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(63,723</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_z1OPJsj5jmPj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Change in fair value</td> <td> </td> <td> </td> <td style="text-align: right">(1,086,562</td> <td>)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(966,141</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,667,166</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,719,869</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges_z6Ms3877u5Z8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of exchange rate changes</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(57,287</td> <td style="padding-bottom: 1.5pt">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(197,817</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(148,646</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(403,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_zrnLztP5qNgh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance at December 31, 2022</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">275,115</td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,917,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,457,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,649,115</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1418964 1418964 4080958 3336535 7417493 -63723 -63723 -1086562 -966141 -1667166 -3719869 -57287 -197817 -148646 -403750 275115 2917000 1457000 4649115 <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z2VYKfHPAWy" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zEyF72qCH6oj">SHARE CAPITAL</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>a)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Authorized Share Capital</i> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On March 1, 2019, the Company changed its share structure to replace Class – A voting shares with Common voting Shares, eliminated Class-B non-voting shares, and created a new series of Preferred shares with no par value and unlimited number of shares. Holders of Preferred shares shall be entitled to receive distribution ahead of holders of Common shares. In addition, Preferred shareholders are also entitled to a fixed premium (if specifically provided in the special rights and restrictions attached to a specific series of Preferred shares), prior to any distributions to holders of Common shares in the event of dissolution, liquidation or winding-up of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>b)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issued Share Capital</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zTgpekao5QJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the following common share transactions during the year ended December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8B8_zWWFxmy5G8V">SCHEDULE OF SHARE CAPITAL</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"># of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Common shares issued for bonuses and compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqlMhv9SzwA1" style="width: 16%; text-align: right" title="Common shares issued for bonuses and compensation, shares">266,765</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcz68hekgECh" style="width: 16%; text-align: right" title="Common shares issued for bonuses and compensation, value">520,230</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for conversion of convertible debt</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVt2dCfXrZVg" style="text-align: right" title="Common shares issued for conversion of convertible debt, shares">67,568</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfrJmEEydI0j" style="text-align: right" title="Common shares issued for conversion of convertible debt, value">131,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common shares issued to consultants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zx8jyzJtE4n8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common shares issued to consultants, shares">284,767</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7nMcb0eAbn" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common shares issued to consultants, value">853,457</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total common shares issued</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesTotal_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUTcy5jj6cOe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, shares">619,100</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueTotal_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbRfWtab9pEd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, value">1,505,219</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the following common share transactions during the year ended December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"># of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Common shares issued for cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z797fxQkSPkj" style="width: 16%; text-align: right" title="Common shares issued for cash, shares">3,127,998</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzWltVw1WIU4" style="width: 16%; text-align: right" title="Common shares issued for cash, value">13,262,712</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for conversion of series A preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdptvoNf2oOh" style="text-align: right" title="Common shares issued for conversion of convertible debt, shares">2,258,826</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0dZZCJY9eml" style="text-align: right" title="Common shares issued for conversion of convertible debt, value">6,717,873</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common shares issued on exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--SharesIssuedOnExerciseOfWarrantsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVtjnUtmE6Ek" style="text-align: right" title="Common shares issued on exercise of warrants, shares">39,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharesIssuedOnExerciseOfWarrants_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zG3sQwvD1qg3" style="text-align: right" title="Common shares issued on exercise of warrants, value">238,800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued on cashless exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharesIssuedOnCashlessExerciseOfWarrantsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4FfyQYG5VQ8" style="text-align: right" title="Common shares issued on cashless exercise of warrants, shares">36,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharesIssuedOnCashlessExerciseOfWarrants_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaxxXd0IvUEc" style="text-align: right" title="Common shares issued on cashless exercise of warrants, value"><span style="-sec-ix-hidden: xdx2ixbrl1176">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common shares issued on exercise of options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSqFrRdwGRQj" style="text-align: right" title="Common shares issued on exercise of options, shares">7,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzFI40eb3FF9" style="text-align: right" title="Common shares issued on exercise of options, value">9,123</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued on cashless exercise of options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--SharesIssuedOnCashlessExerciseOfOptionsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHH9E2ZKzkSi" style="text-align: right" title="Common shares issued on cashless exercise of options, shares">820,029</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--SharesIssuedOnCashlessExerciseOfOptions_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zccbDR0O5uw9" style="text-align: right" title="Common shares issued on cashless exercise of options, value"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common shares issued for bonus and compensation</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zw2ywSE41uE1" style="text-align: right" title="Common shares issued for bonus and compensation, shares">159,775</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5VMvCS9rk06" style="text-align: right" title="Common shares issued for bonus and compensation , value">648,449</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for consulting services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgncxTJb8Tzl" style="text-align: right" title="Common shares issued for consulting services, shares">76,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpjHcEsj0zf" style="text-align: right" title="Common shares issued for consulting services, value">381,663</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common shares issued for settlement of accrued director’s fee</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareIssuedForSettlementOfAccruedDirectorsFeeShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxwNB3X0vzZ1" style="text-align: right" title="Common shares issued for settlement of accrued director's fee, shares">19,992</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareIssuedForSettlementOfAccruedDirectorsFee_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z46ary2h93u1" style="text-align: right" title="Common shares issued for settlement of accrued director's fee, value">46,783</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for dividend on preferred shares</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockDividendsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5yDTHaVpZg7" style="text-align: right" title="Common shares issued for dividend on preferred shares, shares">189,004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueStockDividend_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoU5kiOii61j" style="text-align: right" title="Common shares issued for dividend on preferred shares, shares">735,932</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Share issue costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOfGjPnBHa6h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share issue costs, shares"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv64b0DQFCx2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share issue costs, value">(2,099,842</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total common shares issued</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesTotal_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkcGu5t5dVFa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, shares">6,735,081</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodValueTotal_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1MtChHUseP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, value">19,941,493</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zsAdw5mtu1Of" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>c)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Options</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted a stock option plan (the “Option Plan”) for its directors, officers, employees and consultants to acquire common shares of the Company. The terms and conditions of the stock options are determined by the Board of Directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2019, at the Company’s annual general meeting, shareholders approved an amendment to the Option Plan to increase the number of authorized shares subject to the Option Plan to <span id="xdx_906_ecustom--IncreaseNumberOfAuthorizedSharesPercentage_pid_dp_uPure_c20190527__20190528__us-gaap--PlanNameAxis__custom--OptionPlanMember_zRjZsMtnZU52" title="Increase the number of authorized shares percentage">15</span>% of the issued and outstanding shares of the Company (including any unconverted Series A Preferred Shares).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, the Company recorded aggregate share-based compensation expense of $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20220101__20221231_z6QkgKy5reF1" title="Share based compensation">420,715</span> (December 31, 2021 - $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231_zMkrtetax778" title="Share-based compensation expense">796,141</span>) for all stock options on a straight-line basis over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231_zaAlCY7kao0k">1,382,629 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December 31, 2021 – <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231_z3JDtdaiUxg7">717,019</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) Options were outstanding at a weighted average exercise price of $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231_znrcZ6WgxULa">3.30 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December 31, 2021 - $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20211231__srt--StatementScenarioAxis__custom--ReverseSplitMember_znXVUYebE9m6">5.63), of which </span></span><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231_zSkxjaqQvJsk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414,305 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December 31, 2021 – <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20211231_zEbhQB4QKs2b">280,938</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) were exercisable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts recognized as share-based payments and stock options are included in share-based compensation on the Statement of Loss and Comprehensive Loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, there was $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20221231_zRueKTVdohGj" title="Unrecognized compensation cost">538,358</span> (December 31, 2021 - $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20211231_zbQT0ehvlJa2" title="Unrecognized compensation cost">634,626</span>) of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted; that cost is expected to be recognized over a period of <span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20221231_z9durHADmAIl" title="Recognized over a period">2</span> years (December 31, 2021 – <span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20210101__20211231_ztof89yEmZdf" title="Recognized over a period">3</span> years).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zD82BBFhtTEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes stock option activity during the years ended December 31, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zk9wNY2ytNua" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Options</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted Average Exercise Price</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted Average Remaining Life (years)</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 46%; font-weight: bold">Balance at December 31, 2020</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231_zw0MuaJCuRtb" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Number of options, beginning balance">1,450,918</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zUosS0ruYJcg" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted average exercise price, beginning balance">2.01</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_zm7BIaLfsZ42" title="Weighted average remaining life, beginning balance">4.38</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231_zzPfXjONtGBj" style="text-align: right" title="Number of options, granted">509,788</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zEqsfVDbOKDk" style="text-align: right" title="Weighted average exercise price, granted">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_z4xUt7PS2OH8" title="Weighted average remaining life, granted">4.47</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231_zwxDjOPB51k3" style="text-align: right" title="Number of options, exercised">(1,120,719</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z57HbuOKzj35" style="text-align: right" title="Weighted average exercise price, exercised">3.23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20210101__20211231_zbIHSFWKhOE3" style="text-align: right" title="Number of options forfeited">(28,947</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zQdYc4okOi27" style="text-align: right" title="Weighted average exercise price, forfeited">4.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled_iN_pid_di_c20210101__20211231_zFn1waU915I7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, cancelled">(94,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zX4lQr1PwFV" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, cancelled">6.70</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Balance at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_z9PSop5ZuDw7" style="text-align: right" title="Number of Options, beginning balance">717,019</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zIIPwJlRwVT9" style="text-align: right" title="Weighted average exercise price, beginning balance">5.63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z1tKoJXRgdKg" title="Weighted average remaining life, beginning balance">4.48</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_zmAxSd2rXhpd" style="text-align: right" title="Number of options, granted">747,060</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zIR8PyuoJnf4" style="text-align: right" title="Weighted average exercise price, granted">1.14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_dtY_c20220101__20221231_zMme1Vg0yZU3" title="Weighted average remaining life, granted">4.48</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20220101__20221231_zg1BLbwUg727" style="text-align: right" title="Number of options forfeited">(25,542</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zKPXqRm7t6r" style="text-align: right" title="Weighted average exercise price, forfeited">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled_iN_pid_di_c20220101__20221231_zfTFBS4hCm1e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, cancelled">(55,908</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zUJL25wY8IYa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, cancelled">4.27</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold">Balance at December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_zz4taB5LTKVl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, ending balance">1,382,629</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zkdltGELpMrc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, ending balance">3.30</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z2f0UgtBp32k" title="Weighted average remaining life, ending balance">4.24</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_z5dzCatyDFqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_ecustom--ScheduleOfOutstandingAndExercisableStockOptionsTableTextBlock_zUj19yGXOrGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s outstanding and exercisable stock options at December 31, 2022 were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zsVdblxU9b8f" style="display: none">SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Outstanding Options</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Exercisable Options</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Life (years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_z9menPbIoC3f" title="Outstanding Options, Expiry Date">June 30, 2026</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_z1AchmUQq8K" title="Outstanding Options, Number">210,489</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_zl9rONZIkMYc" title="Outstanding Options, Weighted Average Remaining Life (years)">3.50</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_zMsWQyNY5zEb" title="Outstanding Options, Weighted Average Exercise Price">3.51</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_z8qXtk6fDTc" title="Exercisable Options, Number">210,489</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_zf0UZTaS8KRk" title="Exercisable Options, Weighted Average Exercise Price">3.51</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zHr2Ki7W5Ruh" title="Outstanding Options, Expiry Date">May 31, 2026</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zpLQIVXfunL9" title="Outstanding Options, Number">320,351</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zWVlcb5C5Po6" title="Outstanding Options, Weighted Average Remaining Life (years)">3.42</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zzL326w06Mt8" title="Outstanding Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zHgmimkkE9eg" title="Exercisable Options, Number">160,176</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_ze3KHEa81AS9" title="Exercisable Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zAudTHQ1WWQj" title="Outstanding Options, Expiry Date">July 15, 2026</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zy2ueokUhMMb" title="Outstanding Options, Number">55,445</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zUhWdlR5AJo2" title="Outstanding Options, Weighted Average Remaining Life (years)">3.54</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zOXbQwzz5Ogh" title="Outstanding Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zkzmSmBdop0k" title="Exercisable Options, Number">23,100</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zx93oT2Iksr5" title="Exercisable Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_z0FspTwfgMml" title="Outstanding Options, Expiry Date">September 30, 2026</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zDmUQAJicG7j" title="Outstanding Options, Number">49,284</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zyOhlhWlyMz3" title="Outstanding Options, Weighted Average Remaining Life (years)">3.75</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zaugF8eTpoGi" title="Outstanding Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zeNRiZJvFpg4" title="Exercisable Options, Number">20,540</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zgTjW0iQytf5" title="Exercisable Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_z2qrpLvlFqBj" title="Outstanding Options, Expiry Date">November 18, 2027</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zuQT5uJyHCz3" title="Outstanding Options, Number">747,060</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zPOTB9BNGV49" title="Outstanding Options, Weighted Average Remaining Life (years)">4.88</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zPcTGcrJ4cAd" title="Outstanding Options, Weighted Average Exercise Price">1.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zgICWC8Vo1L3" title="Exercisable Options, Number"><span style="-sec-ix-hidden: xdx2ixbrl1340">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_z7JJwWkFyXSa" title="Exercisable Options, Weighted Average Exercise Price"><span style="-sec-ix-hidden: xdx2ixbrl1342">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total Share Options</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231_zYQ2KgsV1pFf" title="Outstanding Options, Number">1,382,629</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zIF7Fnej2yoj" title="Outstanding Options, Weighted Average Remaining Life (years)">4.24</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231_zBwNz7KupMWf" title="Outstanding Options, Weighted Average Exercise Price">3.30</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231_zFl84vxvvGJk" title="Exercisable Options, Number">414,305</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231_ztgwV2ToWvv8" title="Exercisable Options, Weighted Average Exercise Price">5.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zI9KUxlYCDY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zw8GFybJRLCc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s assumptions used in the valuation of options granted during the year ended December 31, 2022 and December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zS2Jir9jdJJ1" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231_znwNDtG9CQd7" style="width: 16%; text-align: right" title="Expected volatility">78.05</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20211231_z5ZV2HQUhIc4" style="width: 16%; text-align: right" title="Expected volatility">80.00</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zaEu4ZNV6Wxl" title="Expected Term (in years)">3.07</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zY27f1J7uwth" title="Expected Term (in years)">3.31</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231_zSys3ZUClC7b" style="text-align: right" title="Risk-free interest rate">3.35</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231_zhtU0NJMLW5l" style="text-align: right" title="Risk-free interest rate">0.92</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Fair value of options</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_iI_pid_c20221231_z1Jay06NyyG9" style="text-align: right" title="Fair value of options">0.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_iI_pid_c20211231_zH91Zd7S4Vn8" style="text-align: right" title="Fair value of options">2.59</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zVAPMDdC2pPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>d)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z2znFLaK5qm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s outstanding warrants as of December 31, 2022 were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zAjHSn70k9F7" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted average exercise price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">Outstanding, December 31, 2020</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_zZIvlcNpTJu1" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of warrants, beginning balance">2,546,065</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_zskKmKhllY2" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average exercise price, beginning balance">7.46</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="width: 18%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted July 12, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zbCmDxjBeQSf" style="text-align: right" title="Number of warrants, beginning balance">3,263,997</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_z8ptQpwmJw98" style="text-align: right" title="Weighted average exercise price, beginning balance">6.00</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90D_ecustom--ClassOfWarrantOrRightExpiryDate_dd_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zdJzGwSEfnnb" title="Expiry Date">July 12, 2024</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted July 28, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedTwoMember_zA145Oeg8CNj" style="text-align: right" title="Number of warrants, beginning balance">93,938</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedTwoMember_zUKLkjqVdss6" style="text-align: right" title="Weighted average exercise price, beginning balance">3.99</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_900_ecustom--ClassOfWarrantOrRightExpiryDate_dd_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedTwoMember_zIrtw3jbl0D7" title="Expiry Date">July 28, 2024</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Exercised in 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsExercisedOneMember_zQkmvyikeuKf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, beginning balance">(133,738</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsExercisedOneMember_zbt1UJ8n3ZK" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, beginning balance">4.59</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">n/a</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zU6e4edtTq9" style="text-align: right" title="Number of warrants, beginning balance">5,770,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_fKg_____zESVOSi0uMh1" style="text-align: right" title="Weighted average exercise price, beginning balance">5.91</td><td style="text-align: left"> </td><td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted June 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zuT4ZfIaDOJ2" style="text-align: right" title="Number of warrants, beginning balance">4,106,418</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zNg1jatu7RIl" style="text-align: right" title="Weighted average exercise price, beginning balance">2.44</td><td style="text-align: left"><sup id="xdx_F2E_zyC9tSM6t4z5">a</sup></td><td> </td> <td><span id="xdx_90B_ecustom--ClassOfWarrantOrRightExpiryDate_dd_c20220101__20221231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zN5iHU3DfO66" title="Expiry Date">December 30, 2025</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding, December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_zPOnO1uUwjbk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, beginning balance">9,876,680</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zMV0yPTIS2o5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, beginning balance">4.91</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">(a) Subsequent to the year end, the issuance of additional tranches of Debentures triggered the down round provision, adjusting the exercise prices of the Debenture Warrants to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--SharePrice_iI_c20230310__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2LUmZ7RcBp5" title="Share price">1.24</span> (Note 9).</p> <p id="xdx_8A4_zfl0k973RXm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: top; text-align: left"> <td style="width: 0.5in"><i> </i></td> <td style="width: 0.5in"><i>e)</i></td> <td><i>Loss per Common Share</i></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Diluted net loss attributable to common shareholders per share does not differ from basic net loss attributable to common shareholders per share for the years ended December 31, 2022 and December 31, 2021, since the effect of the Company’s warrants, stock options and convertible debentures are anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9ip6Ja3i2ci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zlVohxHlnyue" style="display: none">ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_494_20220101__20221231_z0IHZTI2PwOf" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49E_20210101__20211231_zHcvkRVdo9V5" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2022</b></p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2021</b></p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zFvebWD0lqK2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt">Warrants</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 16%; font-size: 10pt; text-align: right">9,876,680</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 16%; font-size: 10pt; text-align: right">5,770,262</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zT2TTvQmEaZk" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Options</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,382,629</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">717,019</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PrefundedWarrantsMember_zEQb2jTNnif4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Prefunded warrants</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,146,132</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1419">-</span></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zHmu00Z3n2jh" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Convertible debentures</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">4,986,486</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1422">-</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zJwnVWQn2oX" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total anti-dilutive weighted average shares</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,391,927</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,487,281</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zTgpekao5QJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the following common share transactions during the year ended December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8B8_zWWFxmy5G8V">SCHEDULE OF SHARE CAPITAL</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"># of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Common shares issued for bonuses and compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqlMhv9SzwA1" style="width: 16%; text-align: right" title="Common shares issued for bonuses and compensation, shares">266,765</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcz68hekgECh" style="width: 16%; text-align: right" title="Common shares issued for bonuses and compensation, value">520,230</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for conversion of convertible debt</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVt2dCfXrZVg" style="text-align: right" title="Common shares issued for conversion of convertible debt, shares">67,568</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfrJmEEydI0j" style="text-align: right" title="Common shares issued for conversion of convertible debt, value">131,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common shares issued to consultants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zx8jyzJtE4n8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common shares issued to consultants, shares">284,767</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7nMcb0eAbn" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common shares issued to consultants, value">853,457</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total common shares issued</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesTotal_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUTcy5jj6cOe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, shares">619,100</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueTotal_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbRfWtab9pEd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, value">1,505,219</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the following common share transactions during the year ended December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"># of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Common shares issued for cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z797fxQkSPkj" style="width: 16%; text-align: right" title="Common shares issued for cash, shares">3,127,998</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzWltVw1WIU4" style="width: 16%; text-align: right" title="Common shares issued for cash, value">13,262,712</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for conversion of series A preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdptvoNf2oOh" style="text-align: right" title="Common shares issued for conversion of convertible debt, shares">2,258,826</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0dZZCJY9eml" style="text-align: right" title="Common shares issued for conversion of convertible debt, value">6,717,873</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common shares issued on exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--SharesIssuedOnExerciseOfWarrantsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVtjnUtmE6Ek" style="text-align: right" title="Common shares issued on exercise of warrants, shares">39,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharesIssuedOnExerciseOfWarrants_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zG3sQwvD1qg3" style="text-align: right" title="Common shares issued on exercise of warrants, value">238,800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued on cashless exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharesIssuedOnCashlessExerciseOfWarrantsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4FfyQYG5VQ8" style="text-align: right" title="Common shares issued on cashless exercise of warrants, shares">36,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharesIssuedOnCashlessExerciseOfWarrants_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaxxXd0IvUEc" style="text-align: right" title="Common shares issued on cashless exercise of warrants, value"><span style="-sec-ix-hidden: xdx2ixbrl1176">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common shares issued on exercise of options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSqFrRdwGRQj" style="text-align: right" title="Common shares issued on exercise of options, shares">7,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzFI40eb3FF9" style="text-align: right" title="Common shares issued on exercise of options, value">9,123</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued on cashless exercise of options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--SharesIssuedOnCashlessExerciseOfOptionsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHH9E2ZKzkSi" style="text-align: right" title="Common shares issued on cashless exercise of options, shares">820,029</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--SharesIssuedOnCashlessExerciseOfOptions_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zccbDR0O5uw9" style="text-align: right" title="Common shares issued on cashless exercise of options, value"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common shares issued for bonus and compensation</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zw2ywSE41uE1" style="text-align: right" title="Common shares issued for bonus and compensation, shares">159,775</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5VMvCS9rk06" style="text-align: right" title="Common shares issued for bonus and compensation , value">648,449</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for consulting services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgncxTJb8Tzl" style="text-align: right" title="Common shares issued for consulting services, shares">76,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpjHcEsj0zf" style="text-align: right" title="Common shares issued for consulting services, value">381,663</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common shares issued for settlement of accrued director’s fee</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareIssuedForSettlementOfAccruedDirectorsFeeShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxwNB3X0vzZ1" style="text-align: right" title="Common shares issued for settlement of accrued director's fee, shares">19,992</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareIssuedForSettlementOfAccruedDirectorsFee_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z46ary2h93u1" style="text-align: right" title="Common shares issued for settlement of accrued director's fee, value">46,783</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for dividend on preferred shares</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockDividendsShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5yDTHaVpZg7" style="text-align: right" title="Common shares issued for dividend on preferred shares, shares">189,004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueStockDividend_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoU5kiOii61j" style="text-align: right" title="Common shares issued for dividend on preferred shares, shares">735,932</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Share issue costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOfGjPnBHa6h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share issue costs, shares"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv64b0DQFCx2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share issue costs, value">(2,099,842</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total common shares issued</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesTotal_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkcGu5t5dVFa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, shares">6,735,081</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodValueTotal_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1MtChHUseP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total common shares issued, value">19,941,493</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 266765 520230 67568 131532 284767 853457 619100 1505219 3127998 13262712 2258826 6717873 39800 238800 36275 7018 9123 820029 159775 648449 76364 381663 19992 46783 189004 735932 -2099842 6735081 19941493 0.15 420715 796141 1382629 717019 3.30 5.63 414305 280938 538358 634626 P2Y P3Y <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zD82BBFhtTEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes stock option activity during the years ended December 31, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zk9wNY2ytNua" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Options</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted Average Exercise Price</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted Average Remaining Life (years)</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 46%; font-weight: bold">Balance at December 31, 2020</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231_zw0MuaJCuRtb" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Number of options, beginning balance">1,450,918</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zUosS0ruYJcg" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted average exercise price, beginning balance">2.01</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_zm7BIaLfsZ42" title="Weighted average remaining life, beginning balance">4.38</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231_zzPfXjONtGBj" style="text-align: right" title="Number of options, granted">509,788</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zEqsfVDbOKDk" style="text-align: right" title="Weighted average exercise price, granted">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_z4xUt7PS2OH8" title="Weighted average remaining life, granted">4.47</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231_zwxDjOPB51k3" style="text-align: right" title="Number of options, exercised">(1,120,719</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z57HbuOKzj35" style="text-align: right" title="Weighted average exercise price, exercised">3.23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20210101__20211231_zbIHSFWKhOE3" style="text-align: right" title="Number of options forfeited">(28,947</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zQdYc4okOi27" style="text-align: right" title="Weighted average exercise price, forfeited">4.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled_iN_pid_di_c20210101__20211231_zFn1waU915I7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, cancelled">(94,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zX4lQr1PwFV" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, cancelled">6.70</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Balance at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_z9PSop5ZuDw7" style="text-align: right" title="Number of Options, beginning balance">717,019</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zIIPwJlRwVT9" style="text-align: right" title="Weighted average exercise price, beginning balance">5.63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z1tKoJXRgdKg" title="Weighted average remaining life, beginning balance">4.48</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_zmAxSd2rXhpd" style="text-align: right" title="Number of options, granted">747,060</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zIR8PyuoJnf4" style="text-align: right" title="Weighted average exercise price, granted">1.14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_dtY_c20220101__20221231_zMme1Vg0yZU3" title="Weighted average remaining life, granted">4.48</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20220101__20221231_zg1BLbwUg727" style="text-align: right" title="Number of options forfeited">(25,542</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zKPXqRm7t6r" style="text-align: right" title="Weighted average exercise price, forfeited">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled_iN_pid_di_c20220101__20221231_zfTFBS4hCm1e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, cancelled">(55,908</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zUJL25wY8IYa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, cancelled">4.27</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold">Balance at December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_zz4taB5LTKVl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, ending balance">1,382,629</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zkdltGELpMrc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, ending balance">3.30</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z2f0UgtBp32k" title="Weighted average remaining life, ending balance">4.24</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 1450918 2.01 P4Y4M17D 509788 7.00 P4Y5M19D 1120719 3.23 28947 4.75 94021 6.70 717019 5.63 P4Y5M23D 747060 1.14 P4Y5M23D 25542 7.00 55908 4.27 1382629 3.30 P4Y2M26D <p id="xdx_89E_ecustom--ScheduleOfOutstandingAndExercisableStockOptionsTableTextBlock_zUj19yGXOrGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s outstanding and exercisable stock options at December 31, 2022 were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zsVdblxU9b8f" style="display: none">SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Outstanding Options</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Exercisable Options</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Life (years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_z9menPbIoC3f" title="Outstanding Options, Expiry Date">June 30, 2026</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_z1AchmUQq8K" title="Outstanding Options, Number">210,489</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_zl9rONZIkMYc" title="Outstanding Options, Weighted Average Remaining Life (years)">3.50</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_zMsWQyNY5zEb" title="Outstanding Options, Weighted Average Exercise Price">3.51</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_z8qXtk6fDTc" title="Exercisable Options, Number">210,489</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionOneMember_zf0UZTaS8KRk" title="Exercisable Options, Weighted Average Exercise Price">3.51</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zHr2Ki7W5Ruh" title="Outstanding Options, Expiry Date">May 31, 2026</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zpLQIVXfunL9" title="Outstanding Options, Number">320,351</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zWVlcb5C5Po6" title="Outstanding Options, Weighted Average Remaining Life (years)">3.42</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zzL326w06Mt8" title="Outstanding Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_zHgmimkkE9eg" title="Exercisable Options, Number">160,176</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionTwoMember_ze3KHEa81AS9" title="Exercisable Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zAudTHQ1WWQj" title="Outstanding Options, Expiry Date">July 15, 2026</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zy2ueokUhMMb" title="Outstanding Options, Number">55,445</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zUhWdlR5AJo2" title="Outstanding Options, Weighted Average Remaining Life (years)">3.54</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zOXbQwzz5Ogh" title="Outstanding Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zkzmSmBdop0k" title="Exercisable Options, Number">23,100</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionThreeMember_zx93oT2Iksr5" title="Exercisable Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_z0FspTwfgMml" title="Outstanding Options, Expiry Date">September 30, 2026</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zDmUQAJicG7j" title="Outstanding Options, Number">49,284</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zyOhlhWlyMz3" title="Outstanding Options, Weighted Average Remaining Life (years)">3.75</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zaugF8eTpoGi" title="Outstanding Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zeNRiZJvFpg4" title="Exercisable Options, Number">20,540</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFourMember_zgTjW0iQytf5" title="Exercisable Options, Weighted Average Exercise Price">7.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_z2qrpLvlFqBj" title="Outstanding Options, Expiry Date">November 18, 2027</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zuQT5uJyHCz3" title="Outstanding Options, Number">747,060</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zPOTB9BNGV49" title="Outstanding Options, Weighted Average Remaining Life (years)">4.88</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zPcTGcrJ4cAd" title="Outstanding Options, Weighted Average Exercise Price">1.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_zgICWC8Vo1L3" title="Exercisable Options, Number"><span style="-sec-ix-hidden: xdx2ixbrl1340">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--StockOptionFiveMember_z7JJwWkFyXSa" title="Exercisable Options, Weighted Average Exercise Price"><span style="-sec-ix-hidden: xdx2ixbrl1342">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total Share Options</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231_zYQ2KgsV1pFf" title="Outstanding Options, Number">1,382,629</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zIF7Fnej2yoj" title="Outstanding Options, Weighted Average Remaining Life (years)">4.24</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231_zBwNz7KupMWf" title="Outstanding Options, Weighted Average Exercise Price">3.30</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231_zFl84vxvvGJk" title="Exercisable Options, Number">414,305</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231_ztgwV2ToWvv8" title="Exercisable Options, Weighted Average Exercise Price">5.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 2026-06-30 210489 P3Y6M 3.51 210489 3.51 2026-05-31 320351 P3Y5M1D 7.00 160176 7.00 2026-07-15 55445 P3Y6M14D 7.00 23100 7.00 2026-09-30 49284 P3Y9M 7.00 20540 7.00 2027-11-18 747060 P4Y10M17D 1.14 1382629 P4Y2M26D 3.30 414305 5.23 <p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zw8GFybJRLCc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s assumptions used in the valuation of options granted during the year ended December 31, 2022 and December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zS2Jir9jdJJ1" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231_znwNDtG9CQd7" style="width: 16%; text-align: right" title="Expected volatility">78.05</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20211231_z5ZV2HQUhIc4" style="width: 16%; text-align: right" title="Expected volatility">80.00</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zaEu4ZNV6Wxl" title="Expected Term (in years)">3.07</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zY27f1J7uwth" title="Expected Term (in years)">3.31</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231_zSys3ZUClC7b" style="text-align: right" title="Risk-free interest rate">3.35</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231_zhtU0NJMLW5l" style="text-align: right" title="Risk-free interest rate">0.92</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Fair value of options</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_iI_pid_c20221231_z1Jay06NyyG9" style="text-align: right" title="Fair value of options">0.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_iI_pid_c20211231_zH91Zd7S4Vn8" style="text-align: right" title="Fair value of options">2.59</td><td style="text-align: left"> </td></tr> </table> 0.7805 0.8000 P3Y25D P3Y3M21D 0.0335 0.0092 0.60 2.59 <p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z2znFLaK5qm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s outstanding warrants as of December 31, 2022 were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zAjHSn70k9F7" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted average exercise price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">Outstanding, December 31, 2020</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_zZIvlcNpTJu1" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of warrants, beginning balance">2,546,065</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_zskKmKhllY2" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average exercise price, beginning balance">7.46</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="width: 18%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted July 12, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zbCmDxjBeQSf" style="text-align: right" title="Number of warrants, beginning balance">3,263,997</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_z8ptQpwmJw98" style="text-align: right" title="Weighted average exercise price, beginning balance">6.00</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90D_ecustom--ClassOfWarrantOrRightExpiryDate_dd_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zdJzGwSEfnnb" title="Expiry Date">July 12, 2024</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted July 28, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedTwoMember_zA145Oeg8CNj" style="text-align: right" title="Number of warrants, beginning balance">93,938</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedTwoMember_zUKLkjqVdss6" style="text-align: right" title="Weighted average exercise price, beginning balance">3.99</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_900_ecustom--ClassOfWarrantOrRightExpiryDate_dd_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsGrantedTwoMember_zIrtw3jbl0D7" title="Expiry Date">July 28, 2024</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Exercised in 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsExercisedOneMember_zQkmvyikeuKf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, beginning balance">(133,738</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231__srt--StatementScenarioAxis__custom--WarrantsExercisedOneMember_zbt1UJ8n3ZK" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, beginning balance">4.59</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">n/a</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zU6e4edtTq9" style="text-align: right" title="Number of warrants, beginning balance">5,770,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_fKg_____zESVOSi0uMh1" style="text-align: right" title="Weighted average exercise price, beginning balance">5.91</td><td style="text-align: left"> </td><td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted June 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zuT4ZfIaDOJ2" style="text-align: right" title="Number of warrants, beginning balance">4,106,418</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zNg1jatu7RIl" style="text-align: right" title="Weighted average exercise price, beginning balance">2.44</td><td style="text-align: left"><sup id="xdx_F2E_zyC9tSM6t4z5">a</sup></td><td> </td> <td><span id="xdx_90B_ecustom--ClassOfWarrantOrRightExpiryDate_dd_c20220101__20221231__srt--StatementScenarioAxis__custom--WarrantsGrantedOneMember_zN5iHU3DfO66" title="Expiry Date">December 30, 2025</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding, December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_zPOnO1uUwjbk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, beginning balance">9,876,680</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zMV0yPTIS2o5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, beginning balance">4.91</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">(a) Subsequent to the year end, the issuance of additional tranches of Debentures triggered the down round provision, adjusting the exercise prices of the Debenture Warrants to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--SharePrice_iI_c20230310__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2LUmZ7RcBp5" title="Share price">1.24</span> (Note 9).</p> 2546065 7.46 3263997 6.00 2024-07-12 93938 3.99 2024-07-28 133738 4.59 5770262 5.91 4106418 2.44 2025-12-30 9876680 4.91 1.24 <p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9ip6Ja3i2ci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zlVohxHlnyue" style="display: none">ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_494_20220101__20221231_z0IHZTI2PwOf" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49E_20210101__20211231_zHcvkRVdo9V5" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2022</b></p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2021</b></p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zFvebWD0lqK2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt">Warrants</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 16%; font-size: 10pt; text-align: right">9,876,680</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 16%; font-size: 10pt; text-align: right">5,770,262</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zT2TTvQmEaZk" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Options</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,382,629</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">717,019</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PrefundedWarrantsMember_zEQb2jTNnif4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Prefunded warrants</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,146,132</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1419">-</span></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zHmu00Z3n2jh" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Convertible debentures</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">4,986,486</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1422">-</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zJwnVWQn2oX" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total anti-dilutive weighted average shares</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,391,927</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,487,281</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 9876680 5770262 1382629 717019 1146132 4986486 17391927 6487281 <p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zcsn9i1M6fV1" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_826_z4uzmZZD5Jsf">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--SummaryOfIncomeTaxExaminationsTextBlock_z1lJTPwar6f4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, loss before income tax provision consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z6woJjmY76F9" style="display: none">SUMMARY OF INCOME TAX PROVISION</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20220101__20221231_zB7LvqpSXWc8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20210101__20211231_zjEJAyzFcO5c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_zhwPUgiSFx01" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domestic operations - Canada</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,753,662</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,202,837</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--ForeignIncomeTaxExpenseBenefitContinuingOperations_zCfxajy7IY83" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign operations - United States</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,119,440</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(440,279</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zXb5fpvwbapa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total loss before taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,873,102</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,643,116</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p id="xdx_8AC_z4wgLpN1Jeu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <p id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zg2yzPPxUHt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense (benefit) consists of the following for the years ended December 31, 2022 and December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zBZdgm4t3X89" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before taxes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231_zaGrOEIfXl4l" style="width: 16%; text-align: right" title="Loss before taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,873,102</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231_zmM99L70zePl" style="width: 16%; text-align: right" title="Loss before taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,643,116</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statutory tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220101__20221231_zReHPjRwLyW" style="text-align: right" title="Statutory tax rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231_zuOqapVltA31" style="text-align: right" title="Statutory tax rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes at the statutory rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zfmg5OkgoMla" style="text-align: right" title="Income taxes at the statutory rate">(3,475,738</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20210101__20211231_z7Qc6mywJQ2d" style="text-align: right" title="Income taxes at the statutory rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,793,641</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of derivative liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities_c20220101__20221231_zmM179PbFHXl" style="text-align: right" title="Change in fair value of derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,032,824</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities_c20210101__20211231_zE9wZXm5DpCh" style="text-align: right" title="Change in fair value of derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(321,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible accretion interest</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_c20220101__20221231_zAKkXfnNvMI7" style="text-align: right" title="Non-deductible accretion interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">747,719</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_c20210101__20211231_zoLscnvbU5xa" style="text-align: right" title="Non-deductible accretion interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c20220101__20221231_zeg9RTQ9gctg" style="text-align: right" title="Stock-based compensation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">484,035</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c20210101__20211231_ztKYE64S47Gl" style="text-align: right" title="Stock-based compensation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,556</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--ShareIssueCosts_c20220101__20221231_zsY7wVNQ0Jo8" style="text-align: right" title="Share issue costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(108,685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--ShareIssueCosts_c20210101__20211231_zvn3p2KaSic6" style="text-align: right" title="Share issue costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(112,812</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Foreign currency translation</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationRepatriationOfForeignEarnings_c20220101__20221231_zqjKpWglwNFc" style="text-align: right" title="Foreign currency translation">298,876</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxReconciliationRepatriationOfForeignEarnings_c20210101__20211231_zBv8veUdHsHl" style="text-align: right" title="Foreign currency translation"><span style="-sec-ix-hidden: xdx2ixbrl1472">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_c20220101__20221231_zyRy0viK7nd7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Others permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,035</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationOtherAdjustments_c20210101__20211231_zX8amu0Q6OY9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Others permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,874</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--IncomeTaxExpenseBenefitGross_iT_c20220101__20221231_zdjzV7yDc4Fa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">(3,023,582</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--IncomeTaxExpenseBenefitGross_iT_c20210101__20211231_zsled55SCFG9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,862,697</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20221231_zRqcSMsauGga" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in valuation Allowance">3,023,582</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20210101__20211231_z4ax2bRU1I85" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in valuation Allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,862,697</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax expense (benefit)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_iT_c20220101__20221231_z7c94ZHyoJP2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total income tax expense (benefit)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1486">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_iT_c20210101__20211231_zVBldkVtAjwc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total income tax expense (benefit)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A7_zZNGiwHQ6mJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to Canadian federal and provincial tax for the estimated assessable profit for the years ended December 31, 2022 and 2021 at a rate of <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220101__20221231_zxzxoxhLBOSd" title="Effective income tax rate reconciliation at federal statutory income tax rate"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231_z6wRlCEKF4q1" title="Effective income tax rate reconciliation at federal statutory income tax rate">27</span></span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zLY06dR5saij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not that we will not realize those tax assets through future operations. Significant components of the Company’s deferred taxes are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zz9vuPI8O2zk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20221231_z4mGxepnvza5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20211231_zn1SaVuo6Ydg" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_z8oe9F098nyj" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unused net operating losses carry forward - Canada and United States</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right">7,572,932</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,459,457</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zAxMvbo9u6Ch" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unused capital losses carry forward</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1499">-</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,962</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--DeferredTaxAssetsShareIssueCosts_iI_z8uadj8NJUV3" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><p style="margin: 0pt 0pt 0pt 0">174,377</p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_iI_zLLm7v71Bzx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,286</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1506">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_iTI_z1dzB57GICRa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"> </td><td style="text-align: right">7,698,378</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,674,796</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zvgOJ2MySIke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,698,378</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,674,796</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">$</p></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zMFuzeQpaVM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has non-capital losses of $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20221231__us-gaap--TaxCreditCarryforwardAxis__custom--NonCapitalLossesCarryforwardMember__srt--StatementGeographicalAxis__country--CA_zpX1z5bfaEWj" title="Non-capital losses">25.8 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million as of December 31, 2022 and $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20211231__us-gaap--TaxCreditCarryforwardAxis__custom--NonCapitalLossesCarryforwardMember__srt--StatementGeographicalAxis__country--CA_zYIYbMpoRZ58" title="Non-capital losses">15.7 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million as of December 31, 2021, which are due to <span id="xdx_904_eus-gaap--IncomeTaxExaminationDescription_c20220101__20221231__us-gaap--TaxCreditCarryforwardAxis__custom--NonCapitalLossesCarryforwardMember__srt--StatementGeographicalAxis__country--CA_zKGB3560t1cb">expire between 2038 and 2042 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and which can be used to offset future taxable income in Canada. For foreign operations in United States, aggregate net operating losses are $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20221231_zs5DvTXEmIc2" title="Net operating losses">2.2 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million as of December 31, 2022 and $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20211231_zoXXEQ40jVV5" title="Net operating losses">0.9 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million as of December 31, 2021 which can be carried forward indefinitely. The Company has <span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_do_c20221231__us-gaap--TaxCreditCarryforwardAxis__us-gaap--CapitalLossCarryforwardMember__srt--StatementGeographicalAxis__country--US_zNtdCh06TB1c" title="Capital losses">no</span> capital losses of as of December 31, 2022 and $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20211231__us-gaap--TaxCreditCarryforwardAxis__us-gaap--CapitalLossCarryforwardMember__srt--StatementGeographicalAxis__country--US_zvuTjWGo1tj9" title="Capital losses">0.2 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million as of December 31, 2021. Non-Capital Losses in Canada can be carried forward after change of ownership, if the particular business which gave rise to the loss is carried on by the company for profit or with a reasonable expectation of profit. Certain accumulated net operating losses in United States are subject to an annual limitation from equity shifts, which constitute a change of ownership as defined under Internal Revenue Code (“IRC”) Section 382. These rules will limit the utilization of the losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files income tax returns in Canada and the United States and is subject to examination in these jurisdictions for all years since the Company’s inception in 2017. As at December 31, 2022, no tax authority audits are currently underway.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently has no uncertain tax position and is therefore not reflecting any adjustments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--SummaryOfIncomeTaxExaminationsTextBlock_z1lJTPwar6f4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022 and 2021, loss before income tax provision consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z6woJjmY76F9" style="display: none">SUMMARY OF INCOME TAX PROVISION</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20220101__20221231_zB7LvqpSXWc8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20210101__20211231_zjEJAyzFcO5c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_zhwPUgiSFx01" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domestic operations - Canada</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,753,662</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,202,837</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--ForeignIncomeTaxExpenseBenefitContinuingOperations_zCfxajy7IY83" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign operations - United States</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,119,440</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(440,279</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zXb5fpvwbapa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total loss before taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,873,102</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,643,116</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> -11753662 -6202837 -1119440 -440279 -12873102 -6643116 <p id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zg2yzPPxUHt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense (benefit) consists of the following for the years ended December 31, 2022 and December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zBZdgm4t3X89" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before taxes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231_zaGrOEIfXl4l" style="width: 16%; text-align: right" title="Loss before taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,873,102</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231_zmM99L70zePl" style="width: 16%; text-align: right" title="Loss before taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,643,116</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statutory tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220101__20221231_zReHPjRwLyW" style="text-align: right" title="Statutory tax rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231_zuOqapVltA31" style="text-align: right" title="Statutory tax rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes at the statutory rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zfmg5OkgoMla" style="text-align: right" title="Income taxes at the statutory rate">(3,475,738</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20210101__20211231_z7Qc6mywJQ2d" style="text-align: right" title="Income taxes at the statutory rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,793,641</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of derivative liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities_c20220101__20221231_zmM179PbFHXl" style="text-align: right" title="Change in fair value of derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,032,824</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities_c20210101__20211231_zE9wZXm5DpCh" style="text-align: right" title="Change in fair value of derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(321,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible accretion interest</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_c20220101__20221231_zAKkXfnNvMI7" style="text-align: right" title="Non-deductible accretion interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">747,719</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_c20210101__20211231_zoLscnvbU5xa" style="text-align: right" title="Non-deductible accretion interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c20220101__20221231_zeg9RTQ9gctg" style="text-align: right" title="Stock-based compensation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">484,035</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c20210101__20211231_ztKYE64S47Gl" style="text-align: right" title="Stock-based compensation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,556</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--ShareIssueCosts_c20220101__20221231_zsY7wVNQ0Jo8" style="text-align: right" title="Share issue costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(108,685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--ShareIssueCosts_c20210101__20211231_zvn3p2KaSic6" style="text-align: right" title="Share issue costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(112,812</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Foreign currency translation</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationRepatriationOfForeignEarnings_c20220101__20221231_zqjKpWglwNFc" style="text-align: right" title="Foreign currency translation">298,876</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxReconciliationRepatriationOfForeignEarnings_c20210101__20211231_zBv8veUdHsHl" style="text-align: right" title="Foreign currency translation"><span style="-sec-ix-hidden: xdx2ixbrl1472">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_c20220101__20221231_zyRy0viK7nd7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Others permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,035</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationOtherAdjustments_c20210101__20211231_zX8amu0Q6OY9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Others permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,874</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--IncomeTaxExpenseBenefitGross_iT_c20220101__20221231_zdjzV7yDc4Fa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">(3,023,582</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--IncomeTaxExpenseBenefitGross_iT_c20210101__20211231_zsled55SCFG9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,862,697</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20221231_zRqcSMsauGga" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in valuation Allowance">3,023,582</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20210101__20211231_z4ax2bRU1I85" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in valuation Allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,862,697</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax expense (benefit)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_iT_c20220101__20221231_z7c94ZHyoJP2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total income tax expense (benefit)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1486">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_iT_c20210101__20211231_zVBldkVtAjwc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total income tax expense (benefit)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> -12873102 -6643116 0.2700 0.2700 -3475738 -1793641 -1032824 -321674 747719 484035 253556 -108685 -112812 298876 63035 111874 -3023582 -1862697 3023582 1862697 0.27 0.27 <p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zLY06dR5saij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not that we will not realize those tax assets through future operations. Significant components of the Company’s deferred taxes are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zz9vuPI8O2zk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20221231_z4mGxepnvza5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20211231_zn1SaVuo6Ydg" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_z8oe9F098nyj" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unused net operating losses carry forward - Canada and United States</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right">7,572,932</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,459,457</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zAxMvbo9u6Ch" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unused capital losses carry forward</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1499">-</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,962</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--DeferredTaxAssetsShareIssueCosts_iI_z8uadj8NJUV3" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><p style="margin: 0pt 0pt 0pt 0">174,377</p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_iI_zLLm7v71Bzx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,286</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1506">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_iTI_z1dzB57GICRa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"> </td><td style="text-align: right">7,698,378</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,674,796</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zvgOJ2MySIke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,698,378</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,674,796</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">$</p></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 7572932 4459457 40962 130732 174377 -5286 7698378 4674796 7698378 4674796 25800000 15700000 expire between 2038 and 2042 2200000 900000 0 200000 <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zZOMhjlPb784" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zLlg3CNThdug">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management personnel include those persons having the authority and responsibility of planning, directing, and executing the activities of the Company. The Company has determined that its key management personnel consist of the Company’s officers and directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, $<span id="xdx_902_eus-gaap--DueToOfficersOrStockholdersNoncurrent_iI_pp0p0_c20221231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_zqUYfhKKVGPa" title="Due to officers and directors">32,500</span> (December 31, 2021, $<span id="xdx_908_eus-gaap--DueToOfficersOrStockholdersNoncurrent_iI_pp0p0_c20211231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_zYOVm5cbfHTe" title="Due to officers and directors">47,461</span>) in total was owing to officers and directors or to companies owned by officers and directors of the Company for services and expenses. These amounts owing have been included in accounts payable and accrued liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022 and 2021, the Company incurred $<span id="xdx_90F_eus-gaap--LegalFees_pp0p0_c20220101__20221231__srt--TitleOfIndividualAxis__custom--DavidWelchMember_zWPLG8rI4wM5" title="Legal expense">79,457</span> and $<span id="xdx_904_eus-gaap--LegalFees_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DavidWelchMember_zhmNPYV4Ynj8" title="Legal expense">66,246</span>, respectively, to our U.S. general counsel firm, DR Welch against legal services, a corporation controlled by a director of the Company. <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_do_c20220101__20221231__srt--TitleOfIndividualAxis__custom--DavidWelchMember_zWuCecbz3wp" title="Share issued during period, shares">No</span> shares were issued in the year ended December 31, 2022 (an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DavidWelchMember_zl7YbgxhiH4k" title="Share issued during period, shares">13,158</span> shares were issued during the year ended December 31, 2021 to David Welch).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no other payments to related parties for the year ended December 31, 2022 and 2021 other than expense reimbursements in the ordinary course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 32500 47461 79457 66246 0 13158 <p id="xdx_80B_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_zODmHm4fvib3" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zaz1vnSHMxYd">RESEARCH AND DEVELOPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company spent $<span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20220101__20221231_zBtw22feH8Zi" title="Research and development expense">615,693</span> as compared to $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20210101__20211231_zIzQ8VD0Og06" title="Research and development expense">474,338</span> for the year ended </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021 in research and development costs in relation to the license agreement with Radical Clean Solutions Ltd (“Radical”), the testing, nutrient and micro analysis for UN(THINK)™ food product development as well as costs of design and construction for the Coachella land and its future structure architecture. The following represents the breakdown of research and development activities:</span></p> <p id="xdx_896_ecustom--ScheduleOfResearchAndDevelopmentCostsTableTextBlock_zjKq926kLVM" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8B4_zAIhVgrdCrU4">SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231_zvSLHfdmoTLc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20210101__20211231_ziRkjFfewuGj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--LicenseAgreement_maRADEzsUT_zb2SbIm2y1Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">License agreement</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">256,703</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1550">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ProductDevelopment_maRADEzsUT_z6zq1WkZUZU8" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Product development</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 16%; text-align: right">179,563</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 16%; text-align: right">296,931</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--DesignAndConstruction_maRADEzsUT_zqT16CvxK1La" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Design and construction</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">179,427</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">177,407</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ResearchAndDevelopmentExpense_iT_pp0p0_mtRADEzsUT_zBzgoT7xSVW2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">615,693</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">474,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zdgNkbNS5Zib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 615693 474338 <p id="xdx_896_ecustom--ScheduleOfResearchAndDevelopmentCostsTableTextBlock_zjKq926kLVM" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8B4_zAIhVgrdCrU4">SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231_zvSLHfdmoTLc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20210101__20211231_ziRkjFfewuGj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--LicenseAgreement_maRADEzsUT_zb2SbIm2y1Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">License agreement</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">256,703</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1550">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ProductDevelopment_maRADEzsUT_z6zq1WkZUZU8" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Product development</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 16%; text-align: right">179,563</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 16%; text-align: right">296,931</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--DesignAndConstruction_maRADEzsUT_zqT16CvxK1La" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Design and construction</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">179,427</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">177,407</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ResearchAndDevelopmentExpense_iT_pp0p0_mtRADEzsUT_zBzgoT7xSVW2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">615,693</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">474,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 256703 179563 296931 179427 177407 615693 474338 <p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zcy45clD5ud8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zEOmxadOUpM7">LEASES</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into an operating lease for office space. At December 31, 2022, the remaining lease term is <span id="xdx_90D_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dc_c20221231_znwJSTsnWl82" title="Operating lease for office remaining lease term">seven years</span> and the discount rate is <span id="xdx_903_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_uPure_c20221231_zKKE31a6PiJ6" title="Operating lease discount rate">7.0</span>%. The Company has <span id="xdx_90F_eus-gaap--FinanceLeaseLiability_iI_do_c20221231_zJeUrGDPSzp4" title="Finance leases">no</span> finance leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zsAnHhyRfKNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of lease expenses were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zbKj2KHu1Qu6" style="display: none">SCHEDULE OF LEASE EXPENSES</span></b></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20221231_zZBigjmHIfMb" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseCost_maLCzMxP_zFec4MMF3XA7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">295,601</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCzMxP_zhjCqkD3nyj8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Short-term lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,361</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LeaseCost_iT_mtLCzMxP_zTAOurXjaySb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">318,962</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zbrjcWrPDBBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zXzIad1kATmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The minimum future payments under the lease for our continuing operations in each of the years ending December 31 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_z2hx94Vl7mvb" style="display: none">SCHEDULE OF FUTURE PAYMENTS UNDER LEASE</span></span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" id="xdx_49E_20221231_zVcBd7UXEBu9" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzXIa_zr3aLmbZbGh6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">271,110</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzXIa_zF0cIhfzkGii" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">280,409</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzXIa_zg3c0JWITtn4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzXIa_zxRRtPDV3UIe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzXIa_zkekMdtwcNtb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzXIa_znaxdxWv8P07" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Subsequent years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">518,613</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzXIa_zuOeAaR59aJi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,959,182</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zWgqcfvqOdQd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(438,012</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zOv20rdSKtX2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,521,170</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_zzly0faBmMHe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Current portion of lease liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(271,110</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_z4nRuYHhXEd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Non-current portion of lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,060</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zAil3nRtfD1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P7Y 0.070 0 <p id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zsAnHhyRfKNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of lease expenses were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zbKj2KHu1Qu6" style="display: none">SCHEDULE OF LEASE EXPENSES</span></b></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20221231_zZBigjmHIfMb" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseCost_maLCzMxP_zFec4MMF3XA7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">295,601</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCzMxP_zhjCqkD3nyj8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Short-term lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,361</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LeaseCost_iT_mtLCzMxP_zTAOurXjaySb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">318,962</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 295601 23361 318962 <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zXzIad1kATmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The minimum future payments under the lease for our continuing operations in each of the years ending December 31 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_z2hx94Vl7mvb" style="display: none">SCHEDULE OF FUTURE PAYMENTS UNDER LEASE</span></span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" id="xdx_49E_20221231_zVcBd7UXEBu9" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzXIa_zr3aLmbZbGh6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">271,110</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzXIa_zF0cIhfzkGii" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">280,409</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzXIa_zg3c0JWITtn4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzXIa_zxRRtPDV3UIe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzXIa_zkekMdtwcNtb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">296,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzXIa_znaxdxWv8P07" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Subsequent years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">518,613</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzXIa_zuOeAaR59aJi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,959,182</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zWgqcfvqOdQd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(438,012</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zOv20rdSKtX2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,521,170</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_zzly0faBmMHe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Current portion of lease liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(271,110</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_z4nRuYHhXEd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Non-current portion of lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,060</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 271110 280409 296350 296350 296350 518613 1959182 438012 1521170 271110 1250060 <p id="xdx_807_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zvYtquj1UTGi" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zEF7YLGaJUsb">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Debenture principal repayments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_896_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zkdLQIiDloNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the future principal payments related to our outstanding debt as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: normal"> <span id="xdx_8BE_znSL0ow8SNV3" style="display: none">SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_zXiVsNRBUIRk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maLTDzaXv_zAy3MeNssbPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,732,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maLTDzaXv_zWoFU7YZoiqb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,338,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebt_iTI_mtLTDzaXv_z3S5ARDQg8n4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Long Term Debt</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,070,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zrp4XMBfQn8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contingencies</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As at December 31, 2022, the Company had no contingencies or litigation to disclose.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zkdLQIiDloNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the future principal payments related to our outstanding debt as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: normal"> <span id="xdx_8BE_znSL0ow8SNV3" style="display: none">SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_zXiVsNRBUIRk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maLTDzaXv_zAy3MeNssbPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,732,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maLTDzaXv_zWoFU7YZoiqb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,338,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebt_iTI_mtLTDzaXv_z3S5ARDQg8n4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Long Term Debt</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,070,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6732000 4338000 11070000 <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zzvPuxiUjJhi" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_zwX9KU5mu1Te">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated subsequent events through March 13, 2023, the date on which these financial statements were available to be issued, to ensure that this filing includes appropriate disclosure of events both recognized in the financial statements as of December 31, 2022, and events which occurred subsequent to December 31, 2022 but were not recognized in the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On January 17 and 18, 2023, the Investors purchased additional tranches totaling $<span id="xdx_908_ecustom--PurchaseOfAdditionalTranches_iI_c20230117__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztZYsM7gzGpd" title="Purchase of additional tranches"><span id="xdx_901_ecustom--PurchaseOfAdditionalTranches_iI_c20230118__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIeU8GkrwIHh" title="Purchase of additional tranches">5,076,923</span></span> in convertible debentures and received <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230117__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXqLBZwP9KD6" title="Investors received warrants"><span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230118__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJvaQhCyAgbi" title="Investors received warrants">2,661,289</span></span> warrants. The convertible debentures and warrants were issued with an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230117__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z46Y1tQypYzd" title="Warrant strike price"><span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230118__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEU35zmf9qR5" title="Warrant strike price">1.24</span></span>. The issuance of the additional tranches triggered the down round provision, adjusting the exercise prices of the Debentures and the Debenture Warrants to $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230117__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zywhyhFJyWWd" title="Warrant strike price"><span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230118__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZXRecQ969rg" title="Warrant strike price">1.24</span></span> (Note 9 &amp; 11). Subsequent to the year ended December 31, 2022, the investors converted $<span id="xdx_90B_eus-gaap--ConvertibleDebt_iI_c20230118__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3LB4F99epU1" title="Convertible debt">881,400</span> of convertible debentures into <span id="xdx_907_eus-gaap--ConversionOfStockSharesIssued1_c20230117__20230118__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2YOU89tHzw4" title="Conversion of stock, shares issued">710,807</span> shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Subsequent to the year ended December 31, 2022, the Company issued <span id="xdx_900_ecustom--NumberOfSharesIssuedUponExerciseOfWarrants_c20230101__20230313__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember__dei--LegalEntityAxis__custom--MannaNutritionalGroupLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zoc2lTRbRnx6" title="Number of shares issued upon exercise of warrants">1,637,049</span> shares to Manna upon exercise of their prefunded warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Subsequent to the year ended December 31, 2022, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20230101__20230313__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9MLEyKQfpwd" title="Number of shares issued for services">12,500</span> shares to a consultant for services rendered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On January 24, 2023, the Company entered a binding letter of intent (“BP LOI”) to acquire Berry People LLC (“Berry People”), a U.S. based berry business. <span id="xdx_908_eus-gaap--BusinessAcquisitionNameOfAcquiredEntity_c20230123__20230124__us-gaap--BusinessAcquisitionAxis__custom--BerryPeopleLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYdl3YqZMRrg" title="Business acquisition, description">The BP LOI sets forth a purchase price of $28 million, consisting of $18.2 million in cash and $9.8 million in restricted shares to acquire 70% of Berry People.</span></p> 5076923 5076923 2661289 2661289 1.24 1.24 1.24 1.24 881400 710807 1637049 12500 The BP LOI sets forth a purchase price of $28 million, consisting of $18.2 million in cash and $9.8 million in restricted shares to acquire 70% of Berry People. 688 EXCEL 90 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 92 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 93 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 174 359 1 false 85 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://agriforcegs.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://agriforcegs.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://agriforcegs.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://agriforcegs.com/role/StatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://agriforcegs.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - BUSINESS OVERVIEW Sheet http://agriforcegs.com/role/BusinessOverview BUSINESS OVERVIEW Notes 7 false false R8.htm 00000008 - Disclosure - BASIS OF PREPARATION Sheet http://agriforcegs.com/role/BasisOfPreparation BASIS OF PREPARATION Notes 8 false false R9.htm 00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://agriforcegs.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT Sheet http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDeposit PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT Notes 10 false false R11.htm 00000011 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://agriforcegs.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 11 false false R12.htm 00000012 - Disclosure - CONSTRUCTION IN PROGRESS Sheet http://agriforcegs.com/role/ConstructionInProgress CONSTRUCTION IN PROGRESS Notes 12 false false R13.htm 00000013 - Disclosure - INTANGIBLE ASSET Sheet http://agriforcegs.com/role/IntangibleAsset INTANGIBLE ASSET Notes 13 false false R14.htm 00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Sheet http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilities ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Notes 14 false false R15.htm 00000015 - Disclosure - DEBENTURES Sheet http://agriforcegs.com/role/Debentures DEBENTURES Notes 15 false false R16.htm 00000016 - Disclosure - LONG TERM LOAN Sheet http://agriforcegs.com/role/LongTermLoan LONG TERM LOAN Notes 16 false false R17.htm 00000017 - Disclosure - DERIVATIVE LIABILITIES Sheet http://agriforcegs.com/role/DerivativeLiabilities DERIVATIVE LIABILITIES Notes 17 false false R18.htm 00000018 - Disclosure - SHARE CAPITAL Sheet http://agriforcegs.com/role/ShareCapital SHARE CAPITAL Notes 18 false false R19.htm 00000019 - Disclosure - INCOME TAXES Sheet http://agriforcegs.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 00000020 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://agriforcegs.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 20 false false R21.htm 00000021 - Disclosure - RESEARCH AND DEVELOPMENT Sheet http://agriforcegs.com/role/ResearchAndDevelopment RESEARCH AND DEVELOPMENT Notes 21 false false R22.htm 00000022 - Disclosure - LEASES Sheet http://agriforcegs.com/role/Leases LEASES Notes 22 false false R23.htm 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://agriforcegs.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 23 false false R24.htm 00000024 - Disclosure - SUBSEQUENT EVENTS Sheet http://agriforcegs.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 00000025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 00000026 - Disclosure - BASIS OF PREPARATION (Tables) Sheet http://agriforcegs.com/role/BasisOfPreparationTables BASIS OF PREPARATION (Tables) Tables http://agriforcegs.com/role/BasisOfPreparation 26 false false R27.htm 00000027 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://agriforcegs.com/role/SignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://agriforcegs.com/role/SignificantAccountingPolicies 27 false false R28.htm 00000028 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Tables) Sheet http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositTables PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Tables) Tables http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDeposit 28 false false R29.htm 00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://agriforcegs.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://agriforcegs.com/role/PropertyAndEquipment 29 false false R30.htm 00000030 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Sheet http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilitiesTables ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Tables http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilities 30 false false R31.htm 00000031 - Disclosure - DEBENTURES (Tables) Sheet http://agriforcegs.com/role/DebenturesTables DEBENTURES (Tables) Tables http://agriforcegs.com/role/Debentures 31 false false R32.htm 00000032 - Disclosure - DERIVATIVE LIABILITIES (Tables) Sheet http://agriforcegs.com/role/DerivativeLiabilitiesTables DERIVATIVE LIABILITIES (Tables) Tables http://agriforcegs.com/role/DerivativeLiabilities 32 false false R33.htm 00000033 - Disclosure - SHARE CAPITAL (Tables) Sheet http://agriforcegs.com/role/ShareCapitalTables SHARE CAPITAL (Tables) Tables http://agriforcegs.com/role/ShareCapital 33 false false R34.htm 00000034 - Disclosure - INCOME TAXES (Tables) Sheet http://agriforcegs.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://agriforcegs.com/role/IncomeTaxes 34 false false R35.htm 00000035 - Disclosure - RESEARCH AND DEVELOPMENT (Tables) Sheet http://agriforcegs.com/role/ResearchAndDevelopmentTables RESEARCH AND DEVELOPMENT (Tables) Tables http://agriforcegs.com/role/ResearchAndDevelopment 35 false false R36.htm 00000036 - Disclosure - LEASES (Tables) Sheet http://agriforcegs.com/role/LeasesTables LEASES (Tables) Tables http://agriforcegs.com/role/Leases 36 false false R37.htm 00000037 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://agriforcegs.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://agriforcegs.com/role/CommitmentsAndContingencies 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS (Details) Sheet http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS (Details) Details 38 false false R39.htm 00000039 - Disclosure - BASIS OF PREPARATION (Details Narrative) Sheet http://agriforcegs.com/role/BasisOfPreparationDetailsNarrative BASIS OF PREPARATION (Details Narrative) Details http://agriforcegs.com/role/BasisOfPreparationTables 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES (Details) Sheet http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES (Details) Details 40 false false R41.htm 00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://agriforcegs.com/role/SignificantAccountingPoliciesTables 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) Sheet http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) Details 42 false false R43.htm 00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Details Narrative) Sheet http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Details Narrative) Details http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositTables 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 44 false false R45.htm 00000045 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://agriforcegs.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://agriforcegs.com/role/PropertyAndEquipmentTables 45 false false R46.htm 00000046 - Disclosure - CONSTRUCTION IN PROGRESS (Details Narrative) Sheet http://agriforcegs.com/role/ConstructionInProgressDetailsNarrative CONSTRUCTION IN PROGRESS (Details Narrative) Details http://agriforcegs.com/role/ConstructionInProgress 46 false false R47.htm 00000047 - Disclosure - INTANGIBLE ASSET (Details Narrative) Sheet http://agriforcegs.com/role/IntangibleAssetDetailsNarrative INTANGIBLE ASSET (Details Narrative) Details http://agriforcegs.com/role/IntangibleAsset 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) Sheet http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) Details 48 false false R49.htm 00000049 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative) Sheet http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative) Details http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilitiesTables 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF OUTSTANDING DEBENTURES (Details) Sheet http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails SCHEDULE OF OUTSTANDING DEBENTURES (Details) Details 50 false false R51.htm 00000051 - Disclosure - DEBENTURES (Details Narrative) Sheet http://agriforcegs.com/role/DebenturesDetailsNarrative DEBENTURES (Details Narrative) Details http://agriforcegs.com/role/DebenturesTables 51 false false R52.htm 00000052 - Disclosure - LONG TERM LOAN (Details Narrative) Sheet http://agriforcegs.com/role/LongTermLoanDetailsNarrative LONG TERM LOAN (Details Narrative) Details http://agriforcegs.com/role/LongTermLoan 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS (Details) Sheet http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS (Details) Details 53 false false R54.htm 00000054 - Disclosure - DERIVATIVE LIABILITIES (Details Narrative) Sheet http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative DERIVATIVE LIABILITIES (Details Narrative) Details http://agriforcegs.com/role/DerivativeLiabilitiesTables 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) Sheet http://agriforcegs.com/role/ScheduleOfShareCapitalDetails SCHEDULE OF SHARE CAPITAL (Details) Details 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details) Sheet http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails SCHEDULE OF STOCK OPTION ACTIVITY (Details) Details 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS (Details) Sheet http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS (Details) Details 57 false false R58.htm 00000058 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) Sheet http://agriforcegs.com/role/ScheduleOfWeightedAverageAssumptionsDetails SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) Details 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) Sheet http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails SCHEDULE OF OUTSTANDING WARRANTS (Details) Details 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical) Sheet http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical) Details 60 false false R61.htm 00000061 - Disclosure - ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) Sheet http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) Details 61 false false R62.htm 00000062 - Disclosure - SHARE CAPITAL (Details Narrative) Sheet http://agriforcegs.com/role/ShareCapitalDetailsNarrative SHARE CAPITAL (Details Narrative) Details http://agriforcegs.com/role/ShareCapitalTables 62 false false R63.htm 00000063 - Disclosure - SUMMARY OF INCOME TAX PROVISION (Details) Sheet http://agriforcegs.com/role/SummaryOfIncomeTaxProvisionDetails SUMMARY OF INCOME TAX PROVISION (Details) Details 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX (Details) Sheet http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails SCHEDULE OF COMPONENTS OF INCOME TAX (Details) Details 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 65 false false R66.htm 00000066 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://agriforcegs.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://agriforcegs.com/role/IncomeTaxesTables 66 false false R67.htm 00000067 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://agriforcegs.com/role/RelatedPartyTransactions 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS (Details) Sheet http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS (Details) Details 68 false false R69.htm 00000069 - Disclosure - RESEARCH AND DEVELOPMENT (Details Narrative) Sheet http://agriforcegs.com/role/ResearchAndDevelopmentDetailsNarrative RESEARCH AND DEVELOPMENT (Details Narrative) Details http://agriforcegs.com/role/ResearchAndDevelopmentTables 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF LEASE EXPENSES (Details) Sheet http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails SCHEDULE OF LEASE EXPENSES (Details) Details 70 false false R71.htm 00000071 - Disclosure - SCHEDULE OF FUTURE PAYMENTS UNDER LEASE (Details) Sheet http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails SCHEDULE OF FUTURE PAYMENTS UNDER LEASE (Details) Details 71 false false R72.htm 00000072 - Disclosure - LEASES (Details Narrative) Sheet http://agriforcegs.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://agriforcegs.com/role/LeasesTables 72 false false R73.htm 00000073 - Disclosure - SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING (Details) Sheet http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING (Details) Details 73 false false R74.htm 00000074 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://agriforcegs.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://agriforcegs.com/role/SubsequentEvents 74 false false All Reports Book All Reports [dq-0547-EntityTaxIdentificationNumber-Missing] Submission type 10-K should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. form10-k.htm [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityIncorporationStateCountryCode - form10-k.htm 28 form10-k.htm agri-20221231.xsd agri-20221231_cal.xml agri-20221231_def.xml agri-20221231_lab.xml agri-20221231_pre.xml ex14-1.htm ex21-1.htm ex23-1.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm form10-k_001.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 96 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 27, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 708, "http://xbrl.sec.gov/dei/2022": 47 }, "contextCount": 174, "dts": { "calculationLink": { "local": [ "agri-20221231_cal.xml" ] }, "definitionLink": { "local": [ "agri-20221231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "agri-20221231_lab.xml" ] }, "presentationLink": { "local": [ "agri-20221231_pre.xml" ] }, "schema": { "local": [ "agri-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 581, "entityCount": 1, "hidden": { "http://agriforcegs.com/20221231": 48, "http://fasb.org/us-gaap/2022": 111, "http://xbrl.sec.gov/dei/2022": 4, "total": 163 }, "keyCustom": 69, "keyStandard": 290, "memberCustom": 50, "memberStandard": 30, "nsprefix": "AGRI", "nsuri": "http://agriforcegs.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://agriforcegs.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT", "menuCat": "Notes", "order": "10", "role": "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDeposit", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - PROPERTY AND EQUIPMENT", "menuCat": "Notes", "order": "11", "role": "http://agriforcegs.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ConstructionInProgressTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - CONSTRUCTION IN PROGRESS", "menuCat": "Notes", "order": "12", "role": "http://agriforcegs.com/role/ConstructionInProgress", "shortName": "CONSTRUCTION IN PROGRESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ConstructionInProgressTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INTANGIBLE ASSET", "menuCat": "Notes", "order": "13", "role": "http://agriforcegs.com/role/IntangibleAsset", "shortName": "INTANGIBLE ASSET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "menuCat": "Notes", "order": "14", "role": "http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilities", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - DEBENTURES", "menuCat": "Notes", "order": "15", "role": "http://agriforcegs.com/role/Debentures", "shortName": "DEBENTURES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - LONG TERM LOAN", "menuCat": "Notes", "order": "16", "role": "http://agriforcegs.com/role/LongTermLoan", "shortName": "LONG TERM LOAN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - DERIVATIVE LIABILITIES", "menuCat": "Notes", "order": "17", "role": "http://agriforcegs.com/role/DerivativeLiabilities", "shortName": "DERIVATIVE LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SHARE CAPITAL", "menuCat": "Notes", "order": "18", "role": "http://agriforcegs.com/role/ShareCapital", "shortName": "SHARE CAPITAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "19", "role": "http://agriforcegs.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://agriforcegs.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "20", "role": "http://agriforcegs.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - RESEARCH AND DEVELOPMENT", "menuCat": "Notes", "order": "21", "role": "http://agriforcegs.com/role/ResearchAndDevelopment", "shortName": "RESEARCH AND DEVELOPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - LEASES", "menuCat": "Notes", "order": "22", "role": "http://agriforcegs.com/role/Leases", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "23", "role": "http://agriforcegs.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "24", "role": "http://agriforcegs.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "25", "role": "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfAccounting", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - BASIS OF PREPARATION (Tables)", "menuCat": "Tables", "order": "26", "role": "http://agriforcegs.com/role/BasisOfPreparationTables", "shortName": "BASIS OF PREPARATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfAccounting", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "27", "role": "http://agriforcegs.com/role/SignificantAccountingPoliciesTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "AGRI:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Tables)", "menuCat": "Tables", "order": "28", "role": "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositTables", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AGRI:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "29", "role": "http://agriforcegs.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockNoParValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://agriforcegs.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockNoParValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "menuCat": "Tables", "order": "30", "role": "http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilitiesTables", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - DEBENTURES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://agriforcegs.com/role/DebenturesTables", "shortName": "DEBENTURES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - DERIVATIVE LIABILITIES (Tables)", "menuCat": "Tables", "order": "32", "role": "http://agriforcegs.com/role/DerivativeLiabilitiesTables", "shortName": "DERIVATIVE LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - SHARE CAPITAL (Tables)", "menuCat": "Tables", "order": "33", "role": "http://agriforcegs.com/role/ShareCapitalTables", "shortName": "SHARE CAPITAL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfIncomeTaxExaminationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://agriforcegs.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfIncomeTaxExaminationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ScheduleOfResearchAndDevelopmentCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - RESEARCH AND DEVELOPMENT (Tables)", "menuCat": "Tables", "order": "35", "role": "http://agriforcegs.com/role/ResearchAndDevelopmentTables", "shortName": "RESEARCH AND DEVELOPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:ScheduleOfResearchAndDevelopmentCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "36", "role": "http://agriforcegs.com/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "menuCat": "Tables", "order": "37", "role": "http://agriforcegs.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "us-gaap:BasisOfAccounting", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_AgriFORCEGrowingSystemsLtdMember", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:CountryOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS (Details)", "menuCat": "Details", "order": "38", "role": "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails", "shortName": "SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "us-gaap:BasisOfAccounting", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_AgriFORCEGrowingSystemsLtdMember", "decimals": null, "first": true, "lang": "en-US", "name": "AGRI:CountryOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - BASIS OF PREPARATION (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://agriforcegs.com/role/BasisOfPreparationDetailsNarrative", "shortName": "BASIS OF PREPARATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Comprehensive Loss", "menuCat": "Statements", "order": "4", "role": "http://agriforcegs.com/role/StatementsOfComprehensiveLoss", "shortName": "Consolidated Statements of Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AGRI:ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES (Details)", "menuCat": "Details", "order": "40", "role": "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "shortName": "SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AGRI:ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AGRI:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "AGRI:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepositAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)", "menuCat": "Details", "order": "42", "role": "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "shortName": "SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AGRI:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "AGRI:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepositAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireLand", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "AGRI:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "AGRI:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-08-312022-08-31_custom_LandPurchaseAndSaleAgreementMember_custom_StrongholdPowerSystemMember", "decimals": "0", "lang": null, "name": "us-gaap:PaymentsToAcquireLand", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "menuCat": "Details", "order": "44", "role": "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://agriforcegs.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "AGRI:ConstructionInProgress", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - CONSTRUCTION IN PROGRESS (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://agriforcegs.com/role/ConstructionInProgressDetailsNarrative", "shortName": "CONSTRUCTION IN PROGRESS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - INTANGIBLE ASSET (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "shortName": "INTANGIBLE ASSET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_PrefundedWarrantsMember", "decimals": "0", "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)", "menuCat": "Details", "order": "48", "role": "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails", "shortName": "SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDate", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF OUTSTANDING DEBENTURES (Details)", "menuCat": "Details", "order": "50", "role": "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails", "shortName": "SCHEDULE OF OUTSTANDING DEBENTURES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfSecuredDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - DEBENTURES (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://agriforcegs.com/role/DebenturesDetailsNarrative", "shortName": "DEBENTURES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-10_us-gaap_SubsequentEventMember_custom_TrancheMember", "decimals": "0", "lang": null, "name": "us-gaap:ConvertibleDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDate", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - LONG TERM LOAN (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "shortName": "LONG TERM LOAN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:LongTermLoansPayable", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS (Details)", "menuCat": "Details", "order": "53", "role": "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails", "shortName": "SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AGRI:SharesIssuedOnCashlessExerciseOfWarrants", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - DERIVATIVE LIABILITIES (Details Narrative)", "menuCat": "Details", "order": "54", "role": "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative", "shortName": "DERIVATIVE LIABILITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-06-30_custom_DebentureWarrantsMember", "decimals": "0", "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details)", "menuCat": "Details", "order": "55", "role": "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "shortName": "SCHEDULE OF SHARE CAPITAL (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_CommonStockMember", "decimals": "INF", "lang": null, "name": "AGRI:StockIssuedDuringPeriodSharesTotal", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)", "menuCat": "Details", "order": "56", "role": "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails", "shortName": "SCHEDULE OF STOCK OPTION ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS (Details)", "menuCat": "Details", "order": "57", "role": "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "shortName": "SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AGRI:ScheduleOfOutstandingAndExercisableStockOptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)", "menuCat": "Details", "order": "58", "role": "http://agriforcegs.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details)", "menuCat": "Details", "order": "59", "role": "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails", "shortName": "SCHEDULE OF OUTSTANDING WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://agriforcegs.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-10_us-gaap_ConvertibleDebtMember_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical)", "menuCat": "Details", "order": "60", "role": "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "shortName": "SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "menuCat": "Details", "order": "61", "role": "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "shortName": "ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - SHARE CAPITAL (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://agriforcegs.com/role/ShareCapitalDetailsNarrative", "shortName": "SHARE CAPITAL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxExaminationsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SUMMARY OF INCOME TAX PROVISION (Details)", "menuCat": "Details", "order": "63", "role": "http://agriforcegs.com/role/SummaryOfIncomeTaxProvisionDetails", "shortName": "SUMMARY OF INCOME TAX PROVISION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxExaminationsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxExaminationsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX (Details)", "menuCat": "Details", "order": "64", "role": "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "menuCat": "Details", "order": "65", "role": "http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "66", "role": "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_DavidWelchMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LegalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "67", "role": "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_DavidWelchMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LegalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "AGRI:ScheduleOfResearchAndDevelopmentCostsTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "AGRI:LicenseAgreement", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS (Details)", "menuCat": "Details", "order": "68", "role": "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails", "shortName": "SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "AGRI:ScheduleOfResearchAndDevelopmentCostsTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "AGRI:LicenseAgreement", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - RESEARCH AND DEVELOPMENT (Details Narrative)", "menuCat": "Details", "order": "69", "role": "http://agriforcegs.com/role/ResearchAndDevelopmentDetailsNarrative", "shortName": "RESEARCH AND DEVELOPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - BUSINESS OVERVIEW", "menuCat": "Notes", "order": "7", "role": "http://agriforcegs.com/role/BusinessOverview", "shortName": "BUSINESS OVERVIEW", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - SCHEDULE OF LEASE EXPENSES (Details)", "menuCat": "Details", "order": "70", "role": "http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails", "shortName": "SCHEDULE OF LEASE EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SCHEDULE OF FUTURE PAYMENTS UNDER LEASE (Details)", "menuCat": "Details", "order": "71", "role": "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails", "shortName": "SCHEDULE OF FUTURE PAYMENTS UNDER LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - LEASES (Details Narrative)", "menuCat": "Details", "order": "72", "role": "http://agriforcegs.com/role/LeasesDetailsNarrative", "shortName": "LEASES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING (Details)", "menuCat": "Details", "order": "73", "role": "http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails", "shortName": "SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-01-232023-01-24_custom_BerryPeopleLLCMember_us-gaap_SubsequentEventMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionNameOfAcquiredEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "74", "role": "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-01-232023-01-24_custom_BerryPeopleLLCMember_us-gaap_SubsequentEventMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionNameOfAcquiredEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccounting", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - BASIS OF PREPARATION", "menuCat": "Notes", "order": "8", "role": "http://agriforcegs.com/role/BasisOfPreparation", "shortName": "BASIS OF PREPARATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccounting", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://agriforcegs.com/role/SignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 85, "tag": { "AGRI_AGIIPCoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AGI IP Co. [Member]", "label": "AGI IP Co. [Member]" } } }, "localname": "AGIIPCoMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "AGRI_AccreditedInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accredited Investors [Member]", "label": "Accredited Investors [Member]" } } }, "localname": "AccreditedInvestorsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_AccretionInterestOnDebentures": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion interest on debentures.", "label": "Accretion of interest on debentures" } } }, "localname": "AccretionInterestOnDebentures", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_AdditionalTranchesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Tranches [Member]", "label": "Additional Tranches [Member]" } } }, "localname": "AdditionalTranchesMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_AgriFORCEGrowingSystemsLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AgriFORCE Growing Systems Ltd [Member]", "label": "AgriFORCE Growing Systems Ltd. [Member]" } } }, "localname": "AgriFORCEGrowingSystemsLtdMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "AGRI_AgriFORCEInvestmentsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AgriFORCE Investments Inc.[Member]", "label": "AgriFORCE Investments Inc.[Member]" } } }, "localname": "AgriFORCEInvestmentsIncMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "AGRI_AlternaBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alterna Bank [Member]", "label": "Alterna Bank [Member]" } } }, "localname": "AlternaBankMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_AssetPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Purchase Agreement [Member]", "label": "Asset Purchase Agreement [Member]" } } }, "localname": "AssetPurchaseAgreementMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_BerryPeopleLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Berry People LLC [Member]", "label": "Berry People LLC [Member]" } } }, "localname": "BerryPeopleLLCMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_BridgeWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridge Warrant [Member]", "label": "Bridge Warrant [Member]" } } }, "localname": "BridgeWarrantMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_ChangeInFairValueOfDerivativeLiabilities": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of derivative liabilities", "label": "ChangeInFairValueOfDerivativeLiabilities", "negatedLabel": "Change in fair value of derivative liabilities" } } }, "localname": "ChangeInFairValueOfDerivativeLiabilities", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_ClassOfWarrantOrRightExpiryDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right Expiry Date.", "label": "Expiry Date" } } }, "localname": "ClassOfWarrantOrRightExpiryDate", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "dateItemType" }, "AGRI_CommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Shares [Member]", "label": "Common Shares" } } }, "localname": "CommonSharesMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "domainItemType" }, "AGRI_ConstructionInProgress": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Construction in progress.", "label": "Construction in progress" } } }, "localname": "ConstructionInProgress", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/ConstructionInProgressDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AGRI_ConstructionInProgressTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Construction In Progress [Text Block]", "label": "CONSTRUCTION IN PROGRESS" } } }, "localname": "ConstructionInProgressTextBlock", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ConstructionInProgress" ], "xbrltype": "textBlockItemType" }, "AGRI_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consultant [Member]" } } }, "localname": "ConsultantMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_Consulting": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting.", "label": "Consulting" } } }, "localname": "Consulting", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_CountryOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Country of Incorporation.", "label": "Country of Incorporation" } } }, "localname": "CountryOfIncorporation", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "AGRI_DavidWelchMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "David Welch [Member]", "label": "David Welch [Member]" } } }, "localname": "DavidWelchMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_DebentureConvertibleFeatureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debenture Convertible Feature [Member]", "label": "Debenture Convertible Feature [Member]" } } }, "localname": "DebentureConvertibleFeatureMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "AGRI_DebentureConvertibleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debenture Convertible [Member]", "label": "Debenture Convertible [Member]" } } }, "localname": "DebentureConvertibleMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_DebentureWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debenture Warrants [Member]", "label": "Debenture Warrants [Member]" } } }, "localname": "DebentureWarrantsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "AGRI_DeferredTaxAssetsShareIssueCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Share Issue Costs", "label": "DeferredTaxAssetsShareIssueCosts", "verboseLabel": "Share issue costs" } } }, "localname": "DeferredTaxAssetsShareIssueCosts", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_DefinitiveAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Definitive Agreement [Member]", "label": "Definitive Agreement [Member]" } } }, "localname": "DefinitiveAgreementMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_DesignAndConstruction": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails": { "order": 3.0, "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Design and construction.", "label": "Design and construction" } } }, "localname": "DesignAndConstruction", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_DisclosureConstructionInProgressAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Construction In Progress" } } }, "localname": "DisclosureConstructionInProgressAbstract", "nsuri": "http://agriforcegs.com/20221231", "xbrltype": "stringItemType" }, "AGRI_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Future Payments Under Lease", "verboseLabel": "Schedule Of Lease Expenses" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://agriforcegs.com/20221231", "xbrltype": "stringItemType" }, "AGRI_DisclosurePrepaidExpensesAndOtherCurrentAssetsAndLandDepositAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expenses And Other Current Assets And Land Deposit" } } }, "localname": "DisclosurePrepaidExpensesAndOtherCurrentAssetsAndLandDepositAbstract", "nsuri": "http://agriforcegs.com/20221231", "xbrltype": "stringItemType" }, "AGRI_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effect of exchange rate changes.", "label": "Effect of exchange rate changes" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_FirstStockDepositsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Stock Deposits [Member]", "label": "First Stock Deposits [Member]" } } }, "localname": "FirstStockDepositsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "AGRI_FirstTwelveMonthsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Twelve Months [Member]", "label": "First 12 Months [Member]" } } }, "localname": "FirstTwelveMonthsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_GainLossOnExtensionOfDebtTerm": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gain loss on extension of debt term.", "label": "GainLossOnExtensionOfDebtTerm", "verboseLabel": "Loss on extension of debt term" } } }, "localname": "GainLossOnExtensionOfDebtTerm", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_IPOAndRepresentativeWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IPO And Representative Warrants [Member]", "label": "IPO And Representative Warrants [Member]" } } }, "localname": "IPOAndRepresentativeWarrantsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "AGRI_IPOWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IPO Warrant [Member]", "label": "IPO Warrant [Member]" } } }, "localname": "IPOWarrantMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_IncomeTaxExpenseBenefitGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income Tax Expense Benefit Gross.", "label": "Income Tax Expense Benefit Gross.", "totalLabel": "Total" } } }, "localname": "IncomeTaxExpenseBenefitGross", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation income tax expense benefit at change in fair value of derivative liabilities.", "label": "Change in fair value of derivative liabilities" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_IncreaseDecreaseInDeferredRent": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Deferred Rent", "label": "IncreaseDecreaseInDeferredRent", "verboseLabel": "Deferred rent" } } }, "localname": "IncreaseDecreaseInDeferredRent", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_IncreaseDecreaseInLeaseDeposit": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Lease Deposit", "label": "IncreaseDecreaseInLeaseDeposit", "negatedLabel": "Lease deposit, non-current" } } }, "localname": "IncreaseDecreaseInLeaseDeposit", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_IncreaseDecreaseInRightofuseAsset": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in right of use asset.", "label": "Right-of-use asset" } } }, "localname": "IncreaseDecreaseInRightofuseAsset", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_IncreaseNumberOfAuthorizedSharesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase the number of authorized shares percentage.", "label": "Increase the number of authorized shares percentage" } } }, "localname": "IncreaseNumberOfAuthorizedSharesPercentage", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "percentItemType" }, "AGRI_InitialFairValueOfConversionFeatureOfDebentures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial fair value of conversion feature of debentures.", "label": "Initial fair value of conversion feature of debentures" } } }, "localname": "InitialFairValueOfConversionFeatureOfDebentures", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_InitialFairValueOfWarrantsIssuedInConnectionWithIssuanceOfDebentures": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial fair value of warrants issued in connection with issuance of debentures.", "label": "Initial fair value of warrants issued in connection with issuance of debentures" } } }, "localname": "InitialFairValueOfWarrantsIssuedInConnectionWithIssuanceOfDebentures", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_InitialFairValueOfWarrantsLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial fair value of warrants liability.", "label": "Initial fair value of warrants liability" } } }, "localname": "InitialFairValueOfWarrantsLiability", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_InitialLeaseRightofuseAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial lease right of use asset.", "label": "Initial lease right-of-use asset recognized under Topic 842" } } }, "localname": "InitialLeaseRightofuseAsset", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_InitialOperatingLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial operating lease liability.", "label": "Initial operating lease liability recognized under Topic 842" } } }, "localname": "InitialOperatingLeaseLiability", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_InvestorAndPublicRelations": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investor and public relations.", "label": "Investor and public relations" } } }, "localname": "InvestorAndPublicRelations", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_InvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investors [Member]", "label": "Investors [Member]" } } }, "localname": "InvestorsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_IssuanceCostRelatedToWarrants": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance cost related to warrants.", "label": "Issuance cost related to warrants" } } }, "localname": "IssuanceCostRelatedToWarrants", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_LandDepositAssets": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Land deposit assets", "label": "Land deposit", "verboseLabel": "Land deposits" } } }, "localname": "LandDepositAssets", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AGRI_LandPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Land Purchase Agreement [Member]", "label": "Land Purchase Agreement [Member]" } } }, "localname": "LandPurchaseAgreementMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "AGRI_LandPurchaseAndSaleAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Land Purchase And Sale Agreement [Member]", "label": "Land Purchase And Sale Agreement [Member]" } } }, "localname": "LandPurchaseAndSaleAgreementMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "AGRI_LeaseDepositNonCurrent": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lease Deposit NonCurrent.", "label": "Lease deposit, non-current" } } }, "localname": "LeaseDepositNonCurrent", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "AGRI_LegalRetainer": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Legal retainer.", "label": "Legal retainer" } } }, "localname": "LegalRetainer", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_LicenseAgreement": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails": { "order": 1.0, "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "License agreement.", "label": "License agreement" } } }, "localname": "LicenseAgreement", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_LoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Agreement [Member]", "label": "Loan Agreement [Member]" } } }, "localname": "LoanAgreementMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_LossOnExtensionOfDebtTerm": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on extension of debt term.", "label": "Loss on extension of debt term" } } }, "localname": "LossOnExtensionOfDebtTerm", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_MannaNutritionalGroupLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manna Nutritional Group LLC [Member]", "label": "Manna Nutritional Group LLC [Member]" } } }, "localname": "MannaNutritionalGroupLLCMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_NonCapitalLossesCarryforwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Capital Losses Carryforward [Member]", "label": "Non Capital Losses Carryforward [Member]" } } }, "localname": "NonCapitalLossesCarryforwardMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_NumberOfSharesIssuedUponExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued upon exercise of warrants.", "label": "Number of shares issued upon exercise of warrants" } } }, "localname": "NumberOfSharesIssuedUponExerciseOfWarrants", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AGRI_ObligationToIssueShares": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligation to issue shares.", "label": "Obligation to issue shares" } } }, "localname": "ObligationToIssueShares", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "AGRI_ObligationToIssueSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Obligation To Issue Shares [Member]", "label": "Obligation To Issue Shares [Member]" } } }, "localname": "ObligationToIssueSharesMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "AGRI_OptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Plan [Member]", "label": "Option Plan [Member]" } } }, "localname": "OptionPlanMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_PaymentForAcquisitionOfIntangibleAsset": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment for acquisition of intangible asset.", "label": "PaymentForAcquisitionOfIntangibleAsset", "negatedLabel": "Payment for acquisition of intangible asset" } } }, "localname": "PaymentForAcquisitionOfIntangibleAsset", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_PreferredStockDividendPaidInCommonShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Preferred stock dividend paid in common shares.", "label": "Preferred stock dividend paid in common shares" } } }, "localname": "PreferredStockDividendPaidInCommonShares", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_PrefundedWarrantsIssuedRelatedToIntangibleAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Prefunded warrants issued related to intangible assets.", "label": "Prefunded warrants issued related to intangible assets" } } }, "localname": "PrefundedWarrantsIssuedRelatedToIntangibleAssets", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_PrefundedWarrantsIssuedRelatedToLandDeposit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Prefunded warrants issued related to land deposit.", "label": "Prefunded warrants related to land deposit" } } }, "localname": "PrefundedWarrantsIssuedRelatedToLandDeposit", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_PrefundedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prefunded Warrants [Member]", "label": "Prefunded Warrants [Member]" } } }, "localname": "PrefundedWarrantsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_PrepaidExpensesAndOtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepaid Expenses And Other Current Assets [Text Block]", "label": "PREPAID EXPENSES AND OTHER CURRENT ASSETS AND LAND DEPOSIT" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDeposit" ], "xbrltype": "textBlockItemType" }, "AGRI_ProceedsFromRepaymentsOfDebenturesNetOfIssuanceCosts": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from repayments of debentures net of issuance costs.", "label": "Proceeds from debentures \u2013 net of discount" } } }, "localname": "ProceedsFromRepaymentsOfDebenturesNetOfIssuanceCosts", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_ProductDevelopment": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails": { "order": 2.0, "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Product development.", "label": "Product development" } } }, "localname": "ProductDevelopment", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_PurchaseOfAdditionalTranches": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of additional tranches.", "label": "Purchase of additional tranches" } } }, "localname": "PurchaseOfAdditionalTranches", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AGRI_Purpose": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purpose.", "label": "Purpose" } } }, "localname": "Purpose", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "AGRI_RepaymentsAndConversions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayments and conversions.", "label": "Repayments and conversions" } } }, "localname": "RepaymentsAndConversions", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_ReverseSplitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Split [Member].", "label": "Reverse Split [Member]" } } }, "localname": "ReverseSplitMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Estimated Residual Value Of Computer Equipment And Furniture And Fixtures [Table Text Block]", "label": "SCHEDULE OF ESTIMATED RESIDUAL VALUE OF COMPUTER EQUIPMENT AND FURNITURE AND FIXTURES" } } }, "localname": "ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesTableTextBlock", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "AGRI_ScheduleOfOutstandingAndExercisableStockOptionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Outstanding And Exercisable Stock Options [Table Text Block]", "label": "SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK OPTIONS" } } }, "localname": "ScheduleOfOutstandingAndExercisableStockOptionsTableTextBlock", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "AGRI_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block]", "label": "SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS" } } }, "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositTables" ], "xbrltype": "textBlockItemType" }, "AGRI_ScheduleOfResearchAndDevelopmentCostsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Research And Development Costs [Table Text Block]", "label": "SCHEDULE OF RESEARCH AND DEVELOPMENT COSTS" } } }, "localname": "ScheduleOfResearchAndDevelopmentCostsTableTextBlock", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ResearchAndDevelopmentTables" ], "xbrltype": "textBlockItemType" }, "AGRI_SecondStockDepositsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Stock Deposits [Member]", "label": "Second Stock Deposits [Member]" } } }, "localname": "SecondStockDepositsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "AGRI_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_SeriesAWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Warrants [Member]", "label": "Series A Warrants [Member]" } } }, "localname": "SeriesAWarrantsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_SeriesWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series Warrants [Member]", "label": "Series A Warrants" } } }, "localname": "SeriesWarrantsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "domainItemType" }, "AGRI_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased compensation arrangement by Sharebased payment award fair value assumptions fair value.", "label": "Fair value of options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "AGRI_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice", "verboseLabel": "Weighted average exercise price, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "AGRI_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price", "label": "Weighted average exercise price, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "AGRI_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted average exercise price, beginning balance", "periodStartLabel": "Weighted average exercise price, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "AGRI_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options, cancelled.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled", "negatedLabel": "Number of options, cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "AGRI_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted averave exercise price options, cancelled", "label": "Weighted average exercise price, cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "AGRI_ShareIssueCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share issue costs.", "label": "Share issue costs.", "verboseLabel": "Share issue costs" } } }, "localname": "ShareIssueCosts", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_ShareIssuedForSettlementOfAccruedDirectorsFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share issued for settlement of accrued directors fee.", "label": "Share issued for settlement of accrued director\u2019s fee", "verboseLabel": "Common shares issued for settlement of accrued director's fee, value" } } }, "localname": "ShareIssuedForSettlementOfAccruedDirectorsFee", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "AGRI_ShareIssuedForSettlementOfAccruedDirectorsFeeShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share issued for settlement of accrued directors fee shares.", "label": "Share issued for settlement of accrued director's fee, shares", "verboseLabel": "Common shares issued for settlement of accrued director's fee, shares" } } }, "localname": "ShareIssuedForSettlementOfAccruedDirectorsFeeShares", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AGRI_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased compensation arrangement by sharebased paymentaward options grants in period weighted average remaining contractual term.", "label": "Weighted average remaining life, granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "AGRI_ShareholderAndRegulatory": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 11.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shareholder and regulatory.", "label": "Shareholder and regulatory" } } }, "localname": "ShareholderAndRegulatory", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_SharesIssuedForCompensationAndBonus": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shares issued for compensation and bonus.", "label": "Shares issued for compensation and bonuses" } } }, "localname": "SharesIssuedForCompensationAndBonus", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_SharesIssuedForConversionOfConvertibleDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "shares issued for conversion of convertible debt.", "label": "SharesIssuedForConversionOfConvertibleDebt", "verboseLabel": "Shares issued for conversion of convertible debt" } } }, "localname": "SharesIssuedForConversionOfConvertibleDebt", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_SharesIssuedOnCashlessExerciseOfOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued on cashless exercise of options.", "label": "Shares issued on cashless exercise of options", "verboseLabel": "Common shares issued on cashless exercise of options, value" } } }, "localname": "SharesIssuedOnCashlessExerciseOfOptions", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "AGRI_SharesIssuedOnCashlessExerciseOfOptionsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued on cashless exercise of options shares.", "label": "Shares issued on cashless exercise of options, shares", "verboseLabel": "Common shares issued on cashless exercise of options, shares" } } }, "localname": "SharesIssuedOnCashlessExerciseOfOptionsShares", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AGRI_SharesIssuedOnCashlessExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued on cashless exercise of warrants", "label": "Shares issued on cashless exercise of warrants", "terseLabel": "Common shares issued on cashless exercise of warrants, value", "verboseLabel": "Exercise of warrants" } } }, "localname": "SharesIssuedOnCashlessExerciseOfWarrants", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "AGRI_SharesIssuedOnCashlessExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Issued On Cashless Exercise Of Warrants Shares", "label": "Shares issued on cashless exercise of warrants, shares", "verboseLabel": "Common shares issued on cashless exercise of warrants, shares" } } }, "localname": "SharesIssuedOnCashlessExerciseOfWarrantsShares", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AGRI_SharesIssuedOnExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued on exercise of warrants.", "label": "Shares issued on exercise of warrants", "verboseLabel": "Common shares issued on exercise of warrants, value" } } }, "localname": "SharesIssuedOnExerciseOfWarrants", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "AGRI_SharesIssuedOnExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued on exercise of warrants shares.", "label": "Shares issued on exercise of warrants, shares", "verboseLabel": "Common shares issued on exercise of warrants, shares" } } }, "localname": "SharesIssuedOnExerciseOfWarrantsShares", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AGRI_StockIssuedDuringPeriodSharesTotal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during peirod, shares total.", "label": "Total common shares issued, shares" } } }, "localname": "StockIssuedDuringPeriodSharesTotal", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "AGRI_StockIssuedDuringPeriodValueTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during peirod, value total.", "label": "Total common shares issued, value" } } }, "localname": "StockIssuedDuringPeriodValueTotal", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "AGRI_StockOptionFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option Five [Member].", "label": "Stock Option Five [Member]" } } }, "localname": "StockOptionFiveMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AGRI_StockOptionFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option Four [Member].", "label": "Stock Option Four [Member]" } } }, "localname": "StockOptionFourMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AGRI_StockOptionOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option One [Member].", "label": "Stock Option One [Member]" } } }, "localname": "StockOptionOneMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AGRI_StockOptionThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option Three [Member].", "label": "Stock Option Three [Member]" } } }, "localname": "StockOptionThreeMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AGRI_StockOptionTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option Two [Member].", "label": "Stock Option Two [Member]" } } }, "localname": "StockOptionTwoMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AGRI_StrongholdPowerSystemMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stronghold Power System [Member]", "label": "Stronghold Power System [Member]" } } }, "localname": "StrongholdPowerSystemMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "AGRI_SubsequentTwelveMonthsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsequent Twelve Months [Member]", "label": "Subsequent 12 Months [Member]" } } }, "localname": "SubsequentTwelveMonthsMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_ThereafterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thereafter [Member]", "label": "Thereafter [Member]" } } }, "localname": "ThereafterMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_TrancheMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche [Member]", "label": "Tranche [Member]" } } }, "localname": "TrancheMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AGRI_TravelAndEntertainment": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 10.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Travel and entertainment.", "label": "Travel and entertainment" } } }, "localname": "TravelAndEntertainment", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AGRI_UnFoodCompanyCanadaLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Un Food Company Canada Ltd [Member]", "label": "Un Food Company Canada Ltd [Member]" } } }, "localname": "UnFoodCompanyCanadaLtdMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "AGRI_UnFoodCompanyCanadaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Un Food Company Canada [Member]", "label": "Un Food Company Canada [Member]" } } }, "localname": "UnFoodCompanyCanadaMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "AGRI_UnpaidAmountRelatedToIntangibleAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unpaid amount related to intangible assets", "label": "Unpaid amount related to intangible assets included in accrued expenses" } } }, "localname": "UnpaidAmountRelatedToIntangibleAssets", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AGRI_WarrantsExercisedOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Exercised One [Member]", "label": "Warrants Exercised One [Member]" } } }, "localname": "WarrantsExercisedOneMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AGRI_WarrantsGrantedOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Granted One [Member]", "label": "Warrants Granted One [Member]" } } }, "localname": "WarrantsGrantedOneMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AGRI_WarrantsGrantedTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Granted Two [Member]", "label": "Warrants Granted Two [Member]" } } }, "localname": "WarrantsGrantedTwoMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AGRI_WestPenderHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "West Pender Holdings, Inc. [Member]", "label": "West Pender Holdings, Inc. [Member]" } } }, "localname": "WestPenderHoldingsIncMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "AGRI_WestPenderManagementCoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "West Pender Management Co. [Member]", "label": "West Pender Management Co. [Member]" } } }, "localname": "WestPenderManagementCoMember", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "AGRI_WriteOffOfDeposit": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write off of deposit.", "label": "Write-off of deposit" } } }, "localname": "WriteOffOfDeposit", "nsuri": "http://agriforcegs.com/20221231", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r600", "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r600", "r602", "r603" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r600", "r602", "r603" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r602" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r600", "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r602" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r602" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Date of Incorporation" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r602" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://agriforcegs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MaximumMember": { "auth_ref": [ "r264", "r265", "r266", "r267", "r341", "r484", "r511", "r549", "r550", "r576", "r583", "r588", "r646", "r695", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r264", "r265", "r266", "r267", "r341", "r484", "r511", "r549", "r550", "r576", "r583", "r588", "r646", "r695", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails", "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r264", "r265", "r266", "r267", "r333", "r341", "r370", "r371", "r372", "r460", "r484", "r511", "r549", "r550", "r576", "r583", "r588", "r642", "r646", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails", "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r264", "r265", "r266", "r267", "r333", "r341", "r370", "r371", "r372", "r460", "r484", "r511", "r549", "r550", "r576", "r583", "r588", "r642", "r646", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails", "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r342", "r634", "r709" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r219", "r342", "r610", "r634" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": { "auth_ref": [ "r630", "r710" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/BasisOfPreparationTables" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r241", "r242", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r552", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r577", "r587", "r649" ], "lang": { "en-us": { "role": { "documentation": "Geographical area." } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r241", "r242", "r535", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r552", "r553", "r577", "r587", "r649" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r219", "r342", "r610", "r611", "r634" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r636", "r691" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities", "totalLabel": "Accounts Payable and Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Accounts Payable and Other Accrued Liabilities", "verboseLabel": "Others" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r11", "r586" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r140", "r156" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities", "verboseLabel": "Accounts payable" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r68", "r171" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r27", "r28", "r29", "r177", "r507", "r516", "r517" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r188", "r189", "r422", "r423", "r424", "r425", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r26", "r29", "r117", "r444", "r512", "r513", "r618", "r619", "r620", "r631", "r632", "r633" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r6", "r586" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r375", "r376", "r377", "r631", "r632", "r633", "r680" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition", "verboseLabel": "Share based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r75", "r81", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Prefunded warrants issued" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r33", "r299", "r431", "r626" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Total anti-dilutive weighted average shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r136", "r149", "r173", "r201", "r235", "r237", "r239", "r245", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r404", "r406", "r417", "r586", "r644", "r645", "r693" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r167", "r179", "r201", "r245", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r404", "r406", "r417", "r586", "r644", "r645", "r693" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position)." } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccounting": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "BASIS OF PREPARATION" } } }, "localname": "BasisOfAccounting", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BasisOfPreparation" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r403", "r581", "r582" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r113", "r114", "r403", "r581", "r582" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionNameOfAcquiredEntity": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Name of the acquired entity.", "label": "Business acquisition, description" } } }, "localname": "BusinessAcquisitionNameOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r115", "r116" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Contingent consideration payable" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLossCarryforwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.", "label": "Capital Loss Carryforward [Member]" } } }, "localname": "CapitalLossCarryforwardMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r518", "r519", "r586", "r612" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash [Default Label]", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r48", "r169", "r562" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r42", "r48", "r53" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, end of year", "periodStartLabel": "Cash, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r42", "r129" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r612" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r174", "r175", "r176", "r201", "r222", "r223", "r226", "r228", "r232", "r233", "r245", "r268", "r270", "r271", "r272", "r275", "r276", "r307", "r308", "r310", "r314", "r321", "r417", "r551", "r609", "r627", "r635" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Cover", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format.", "label": "Warrants expire date" } } }, "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r87", "r90" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrant strike price", "verboseLabel": "Class of warrant or right exercise price of warrants or rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Investors received warrants", "verboseLabel": "Class of warrant or right number of securities called by warrants or rights" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrants issued" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r21", "r141", "r155" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r72", "r262", "r263", "r536", "r643" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r631", "r632", "r680" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common stock, no par value" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorizedUnlimited": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is \"Unlimited\".", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorizedUnlimited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheetsParenthetical" ], "xbrltype": "authorizedUnlimitedItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r5", "r81" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r5", "r586" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common shares, no par value per share - unlimited shares authorized; 15,795,798 and 15,176,698 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r30", "r184", "r186", "r191", "r503", "r508" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss attributable to common shareholders" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r50", "r51", "r52" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of stock, shares issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r2", "r138", "r151" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible debt" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Fair value of debentures convertible" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r74", "r277", "r278", "r289", "r290", "r291", "r295", "r296", "r297", "r298", "r299", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r50", "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt instrument converted value" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r50", "r52" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt instrument converted shares" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r79", "r199", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r293", "r300", "r301", "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "DEBENTURES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Debentures" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r0", "r1", "r2", "r137", "r138", "r146", "r205", "r277", "r278", "r279", "r280", "r281", "r283", "r289", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r432", "r571", "r572", "r573", "r574", "r575", "r628" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r2", "r138", "r146", "r304" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debentures (gross)" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r76", "r279" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Convertible into common shares per share" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "auth_ref": [ "r628" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.", "label": "Debt instrument, forgiveness" } } }, "localname": "DebtInstrumentDecreaseForgiveness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r131", "r132", "r277", "r432", "r572", "r573" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r18", "r131", "r296" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Cash Interest Rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r18", "r131", "r306", "r432" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Original issue discount percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r18", "r278" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instrument interest rate percentage", "verboseLabel": "Debt instrument, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r180", "r571", "r682" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity Date", "verboseLabel": "Debt, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt, maturity date description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r20", "r205", "r277", "r278", "r279", "r280", "r281", "r283", "r289", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r432", "r571", "r572", "r573", "r574", "r575", "r628" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r20", "r82", "r83", "r84", "r85", "r130", "r131", "r132", "r145", "r205", "r277", "r278", "r279", "r280", "r281", "r283", "r289", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r302", "r432", "r571", "r572", "r573", "r574", "r575", "r628" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r130", "r132", "r647" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Debt issuance costs and debt discounts" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Convertible Instruments" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r641" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRentCreditNoncurrent": { "auth_ref": [ "r164", "r614", "r689" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of rental payment required by lease over rental income recognized, classified as noncurrent.", "label": "Deferred rent" } } }, "localname": "DeferredRentCreditNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r387" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r109", "r678" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Unused net operating losses carry forward - Canada and United States" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r109", "r678" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Unused capital losses carry forward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r109", "r678" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositAssets": { "auth_ref": [ "r613" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.", "label": "Deposits" } } }, "localname": "DepositAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r46", "r66" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 12.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r46", "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation expense" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r119" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative assets liabilities at fair value net" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r122", "r408" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "DERIVATIVE LIABILITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r181", "r182", "r416", "r564" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Warrant liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r181" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityMeasurementInput": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure derivative liability.", "label": "Debenture convertible measurement input" } } }, "localname": "DerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "decimalItemType" }, "us-gaap_DividendsPreferredStockStock": { "auth_ref": [ "r86", "r144" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.", "label": "Dividend paid to preferred shareholders" } } }, "localname": "DividendsPreferredStockStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToOfficersOrStockholdersNoncurrent": { "auth_ref": [ "r3", "r133", "r147", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are due after one year (or one business cycle).", "label": "Due to officers and directors" } } }, "localname": "DueToOfficersOrStockholdersNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r192", "r211", "r212", "r213", "r214", "r215", "r220", "r222", "r226", "r227", "r228", "r230", "r411", "r412", "r504", "r509", "r567" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic and diluted net loss attributed to common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r56", "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": { "auth_ref": [ "r684" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r203", "r383", "r397" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory tax rate", "verboseLabel": "Effective income tax rate reconciliation at federal statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Recognized over a period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r81", "r165", "r188", "r189", "r190", "r206", "r207", "r208", "r210", "r216", "r218", "r231", "r246", "r323", "r375", "r376", "r377", "r393", "r394", "r410", "r422", "r423", "r424", "r425", "r426", "r427", "r444", "r512", "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r46", "r80" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair value of warrant" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r291", "r334", "r335", "r336", "r337", "r338", "r339", "r413", "r457", "r458", "r459", "r572", "r573", "r578", "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r291", "r334", "r339", "r413", "r457", "r578", "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r291", "r334", "r335", "r336", "r337", "r338", "r339", "r413", "r459", "r572", "r573", "r578", "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r123", "r126" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r123", "r126" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r124" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Additions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Conversions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance at December 31, 2022", "periodStartLabel": "Balance at December 31, 2021" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r291", "r334", "r335", "r336", "r337", "r338", "r339", "r457", "r458", "r459", "r572", "r573", "r578", "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r202", "r382" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Domestic operations - Canada" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SummaryOfIncomeTaxProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r434", "r438" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance leases" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r243", "r244", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r302", "r319", "r408", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r570", "r637", "r638", "r639", "r702", "r703", "r704", "r705", "r706", "r707", "r708" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Estimated useful lives" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r257", "r258", "r259", "r260", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r61", "r63" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r428", "r429" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign currency exchange rate" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r418", "r419", "r420", "r421" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign exchange gain" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r202" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "Foreign operations - United States" } } }, "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SummaryOfIncomeTaxProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r46", "r77", "r78" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on conversion of convertible debentures", "negatedLabel": "Gain on conversion of convertible debt", "negatedTerseLabel": "Gain on debt conversion" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/StatementsOfCashFlows", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r35" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Office and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r64", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r31", "r134", "r142", "r158", "r235", "r236", "r238", "r240", "r505", "r569" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before taxes", "totalLabel": "Total loss before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails", "http://agriforcegs.com/role/SummaryOfIncomeTaxProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r203", "r384", "r385", "r391", "r395", "r398", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income Tax Examination, Description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r204", "r217", "r218", "r234", "r382", "r396", "r399", "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Total income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r187", "r380", "r381", "r385", "r386", "r390", "r392" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r383" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income taxes at the statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "auth_ref": [ "r677" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Non-deductible accretion interest" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r677" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r677" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Others permanent differences" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r677" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount", "verboseLabel": "Foreign currency translation" } } }, "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r45" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r625", "r686" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r45" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other receivables" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r45" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSET" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAsset" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r63", "r485", "r486", "r487", "r489", "r565" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Definite Lived Intangible Asset" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r60", "r62" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible asset", "verboseLabel": "Intangible Assets, Net (Excluding Goodwill)" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r194", "r196", "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid during the period for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value." } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r46" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "verboseLabel": "Shares issued for consulting services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r621" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Wages and salaries" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 9.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Lease expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r437", "r585" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease expenses" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "SCHEDULE OF LEASE EXPENSES" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal expense" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Operating lease discount rate" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r688" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE PAYMENTS UNDER LEASE" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r438" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r438" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Subsequent years" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r438" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r438" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r438" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r438" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r438" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r438" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r685" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating lease for office remaining lease term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r440", "r441", "r442", "r443" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Lessor, Leases [Policy Text Block]", "verboseLabel": "Leases" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r690" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor operating lease term of contract" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r15", "r201", "r245", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r405", "r406", "r407", "r417", "r568", "r644", "r693", "r694" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r10", "r139", "r153", "r586", "r629", "r640", "r683" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r17", "r168", "r201", "r245", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r405", "r406", "r407", "r417", "r586", "r644", "r693", "r694" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Current" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Non-current" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r2", "r138", "r151", "r290", "r305", "r572", "r573" ], "calculation": { "http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Long Term Debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r73", "r205", "r295" ], "calculation": { "http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "verboseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r73", "r205", "r295" ], "calculation": { "http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "verboseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SummaryOfFuturePrincipalPaymentsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "LONG TERM LOAN" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LongTermLoan" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r20" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Long term loan", "verboseLabel": "Long term loans payable" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r195" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r195" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r42", "r44", "r47" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BasisOfPreparationDetailsNarrative", "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r32", "r47", "r143", "r157", "r166", "r183", "r185", "r190", "r201", "r209", "r211", "r212", "r213", "r214", "r217", "r218", "r224", "r235", "r236", "r238", "r240", "r245", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r412", "r417", "r569", "r644" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "negatedLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss for the year" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BasisOfPreparationDetailsNarrative", "http://agriforcegs.com/role/StatementsOfCashFlows", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r211", "r212", "r213", "r214", "r220", "r221", "r225", "r228", "r235", "r236", "r238", "r240", "r569" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss attributable to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash investing and financing transactions" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r235", "r236", "r238", "r240", "r569" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r435", "r585" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r434" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Total lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r434" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Lease liability \u2013 current", "negatedLabel": "Current portion of lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r434" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liability \u2013 non-current", "terseLabel": "Non-current portion of lease liability", "verboseLabel": "Lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/ScheduleOfFuturePaymentsUnderLeaseDetails", "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r433" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use asset", "verboseLabel": "Right of use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Capital losses" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r54", "r55", "r58", "r118" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "BUSINESS OVERVIEW" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BusinessOverview" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r135", "r148", "r172" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Others" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r25" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation", "verboseLabel": "Adjusted for foreign exchange adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r193" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 9.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "negatedLabel": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER EXPENSES / (INCOME)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other receivable" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForConstructionInProcess": { "auth_ref": [ "r36" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from construction costs to date on capital projects that have not been completed and assets being constructed that are not ready to be placed into service.", "label": "Payments for Construction in Process", "negatedLabel": "Construction in progress" } } }, "localname": "PaymentsForConstructionInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfInitialPublicOffering": { "auth_ref": [ "r39" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.", "label": "Payments for Repurchase of Initial Public Offering", "negatedLabel": "Payment of IPO costs" } } }, "localname": "PaymentsForRepurchaseOfInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r41" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedLabel": "Financing costs of debentures" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r36" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Payment against acquisition of intangibles" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireLand": { "auth_ref": [ "r36" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner.", "label": "Payments to acquire land", "negatedLabel": "Deposit for purchase of land" } } }, "localname": "PaymentsToAcquireLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMachineryAndEquipment": { "auth_ref": [ "r36" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of machinery and equipment.", "label": "Payments to Acquire Machinery and Equipment", "negatedLabel": "Acquisition of equipment and leasehold improvements" } } }, "localname": "PaymentsToAcquireMachineryAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r617" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets", "totalLabel": "Prepaid expenses, other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r178", "r255", "r256", "r563" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDepositsOnRealEstateSales": { "auth_ref": [ "r622" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash inflow related to amounts received in advance from a potential buyer showing or confirming an intention to complete an acquisition of land, buildings, other structures, or any item classified as real estate.", "label": "Return of deposit on purchase of land" } } }, "localname": "ProceedsFromDepositsOnRealEstateSales", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r37" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r624" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Gross proceeds of debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r38" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from senior secured debentures - net", "verboseLabel": "Subscription amount" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": { "auth_ref": [ "r38" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).", "label": "Proceeds from long term loan" } } }, "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLoans": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from principal payments made on loans related to operating activities.", "label": "Proceeds from loan" } } }, "localname": "ProceedsFromLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/LongTermLoanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r37", "r101" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r623" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r160", "r161" ], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r71", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property plant and equipment estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r67", "r170" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r69", "r154", "r506", "r586" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r69", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property plant and equipment useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r340", "r447", "r448" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r340", "r447", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r692" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r445", "r446", "r448", "r449", "r450" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r40" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments of Convertible Debt", "negatedLabel": "Repayment of convertible debentures" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r40" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Repayment of senior secured debentures" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development [Abstract]" } } }, "localname": "ResearchAndDevelopmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r103", "r162", "r701" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development", "totalLabel": "Research and development costs", "verboseLabel": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ResearchAndDevelopmentDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfResearchAndDevelopmentCostsDetails", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.", "label": "RESEARCH AND DEVELOPMENT" } } }, "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ResearchAndDevelopment" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r7", "r86", "r152", "r515", "r517", "r586" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/BasisOfPreparationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r165", "r206", "r207", "r208", "r210", "r216", "r218", "r246", "r375", "r376", "r377", "r393", "r394", "r410", "r512", "r514" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r566" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Transaction costs" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF COMPONENTS OF INCOME TAX" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "SCHEDULE OF OUTSTANDING DEBENTURES" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r61", "r63", "r489" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "SUMMARY OF FUTURE PRINCIPAL PAYMENTS OUTSTANDING" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfEstimatedResidualValueOfComputerEquipmentAndFurnitureAndFixturesDetails", "http://agriforcegs.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r343", "r344", "r345", "r346", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r369", "r370", "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r91", "r96", "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK OPTION ACTIVITY" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r87", "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF OUTSTANDING WARRANTS" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "SCHEDULE OF SHARE CAPITAL" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtCurrent": { "auth_ref": [ "r0", "r137", "r150" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Debentures", "terseLabel": "Debentures transaction costs incurred", "verboseLabel": "Total debentures (current)" } } }, "localname": "SecuredDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r615", "r616", "r648" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r45" ], "calculation": { "http://agriforcegs.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agriforcegs.com/role/StatementsOfComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share based compensation", "verboseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative", "http://agriforcegs.com/role/StatementsOfCashFlows", "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Outstanding Options, Expiry Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of warrants, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r92", "r93" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of warrants, beginning balance", "periodStartLabel": "Number of warrants, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Exercisable Options, Number", "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Exercisable Options, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share issue costs, shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Outstanding Options, Number", "periodEndLabel": "Number of Options, ending balance", "periodStartLabel": "Number of Options, beginning balance", "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails", "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Outstanding Options, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, ending balance", "periodStartLabel": "Weighted average exercise price, beginning balance", "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails", "http://agriforcegs.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price, exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted average exercise price, forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r348", "r367", "r368", "r369", "r370", "r373", "r378", "r379" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Exercise price", "verboseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected Term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining life, ending balance", "verboseLabel": "Outstanding Options, Weighted Average Remaining Life (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Stock price" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r436", "r585" ], "calculation": { "http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r54", "r198" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r174", "r175", "r176", "r201", "r222", "r223", "r226", "r228", "r232", "r233", "r245", "r268", "r270", "r271", "r272", "r275", "r276", "r307", "r308", "r310", "r314", "r321", "r417", "r551", "r609", "r627", "r635" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Cover", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r24", "r81", "r165", "r188", "r189", "r190", "r206", "r207", "r208", "r210", "r216", "r218", "r231", "r246", "r323", "r375", "r376", "r377", "r393", "r394", "r410", "r422", "r423", "r424", "r425", "r426", "r427", "r444", "r512", "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingAndExercisableStockOptionsDetails", "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Cover", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r206", "r207", "r208", "r231", "r488" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Cover", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfConsolidatedFinancialStatementsDetails", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockDividendsShares": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits.", "label": "Shares issued for dividend on Preferred Shares, shares", "verboseLabel": "Common shares issued for dividend on preferred shares, shares" } } }, "localname": "StockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "auth_ref": [ "r89", "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share issue costs", "verboseLabel": "Share issue costs, value" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r50", "r51", "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Conversion of Series A preferred stock to common shares" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r23", "r81", "r82", "r86", "r294" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Shares issued for conversion of convertible debt, shares", "verboseLabel": "Common shares issued for conversion of convertible debt, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r4", "r5", "r81", "r82", "r86" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Shares issued for conversion of series A Preferred Stock, shares", "verboseLabel": "Common shares issued for conversion of convertible debt, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Shares issued for consulting services, shares", "terseLabel": "Number of shares issued for services", "verboseLabel": "Common shares issued for consulting services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r4", "r5", "r81", "r86" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares issued for cash, shares", "terseLabel": "Stock issued during period, shares", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/RelatedPartyTransactionsDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r4", "r5", "r81", "r86" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares issued for bonus and compensation, shares", "verboseLabel": "Common shares issued for bonus and compensation, shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r4", "r5", "r81", "r86", "r354" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Shares issued on exercise of options, shares", "negatedLabel": "Number of options, exercised", "verboseLabel": "Common shares issued on exercise of options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/ScheduleOfStockOptionActivityDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r24", "r81", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Shares issued for conversion of convertible debt", "verboseLabel": "Common shares issued for conversion of convertible debt, value" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r24", "r81", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Shares issued for conversion of series A Preferred Stock", "verboseLabel": "Common shares issued for conversion of convertible debt, value" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Shares issued for consulting services", "verboseLabel": "Common shares issued for consulting services, value" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r4", "r5", "r81", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Shares issued for cash", "terseLabel": "Stock issued during period, value", "verboseLabel": "Stock issued during period value new issues" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r4", "r5", "r86", "r97" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares issued for bonus and compensation", "verboseLabel": "Common shares issued for bonus and compensation , value" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockDividend": { "auth_ref": [ "r24", "r81", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued to shareholders as a dividend during the period.", "label": "Shares issued for dividend on Preferred shares", "verboseLabel": "Common shares issued for dividend on preferred shares, shares" } } }, "localname": "StockIssuedDuringPeriodValueStockDividend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r24", "r81", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Shares issued on exercise of options", "verboseLabel": "Common shares issued on exercise of options, value" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfShareCapitalDetails", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r5", "r8", "r9", "r59", "r586", "r629", "r640", "r683" ], "calculation": { "http://agriforcegs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance, value", "periodStartLabel": "Balance, value", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets", "http://agriforcegs.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r88", "r200", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r323", "r409" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "SHARE CAPITAL" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ShareCapital" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r428", "r452" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r428", "r452" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r428", "r452" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r428", "r452" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://agriforcegs.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r451", "r453" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfIncomeTaxExaminationsTextBlock": { "auth_ref": [ "r105", "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.", "label": "SUMMARY OF INCOME TAX PROVISION" } } }, "localname": "SummaryOfIncomeTaxExaminationsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Tax Credit Carryforward [Line Items]" } } }, "localname": "TaxCreditCarryforwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward." } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCreditCarryforwardTable": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Tax Credit Carryforward [Table]" } } }, "localname": "TaxCreditCarryforwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r243", "r244", "r302", "r319", "r408", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r637", "r638", "r639", "r702", "r703", "r704", "r705", "r706", "r707", "r708" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative", "http://agriforcegs.com/role/IntangibleAssetDetailsNarrative", "http://agriforcegs.com/role/LongTermLoanDetailsNarrative", "http://agriforcegs.com/role/PrepaidExpensesAndOtherCurrentAssetsAndLandDepositDetailsNarrative", "http://agriforcegs.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r389" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Change in valuation Allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/ScheduleOfComponentsOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/Anti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and rights outstanding measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/DerivativeLiabilitiesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r220", "r228" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding \u2013 basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://agriforcegs.com/role/StatementsOfComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(17))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "730", "Topic": "985", "URI": "https://asc.fasb.org/subtopic&trid=2197926", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r589": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r591": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r592": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r593": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r594": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r595": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r596": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r597": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r598": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r599": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r601": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r602": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r603": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r604": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r605": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r606": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r607": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r608": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 97 0001493152-23-007486-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-007486-xbrl.zip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�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end

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